Flygut: an atlas of the Drosophila adult midgut

 Mouche Logo lab lemaitre Bbcf logo
Home Overview of gut regions Anatomy Histology Transgene expression mapping Gene expression

Mean expression enrichment by gut region

Filter out everything which GO terms when the expression scale ratio is comprised between -1.5 and 1.5 for all regions
GO term Number of genes Crop
/ Full gut		 R2
/ Full gut		 R3
/ Full gut		 R4
/ Full gut		 R5
/ Full gut		 Hindgut
/ Full gut		 Cardia/R1
/ Full gut
protein deneddylation 3 1.57 -1.01 1.18 1.14 1.14 1.07 -1.1
stress fiber 1 1.76 1.07 1.13 1.08 1.49 1.28 1.15
glycoprotein binding 1 3.21 -1.21 1.67 1.12 1.32 6.4 2.23
lymphocyte mediated immunity 2 -2.37 1.1 1.16 -1.04 1.34 -1.89 1.24
renal sodium ion transport 1 -52.82 -1.7 -31.49 1.13 -9.63 16.55 -13.85
ferrochelatase activity 1 1.62 1.26 1.09 -1.07 1.01 1.21 1.32
nicotinamidase activity 1 -2.04 1.72 -1.29 1.07 1.25 4.26 2.23
lipoate biosynthetic process 2 1.65 1.07 1.42 1.08 1.12 2.67 -1.13
response to UV-B 1 1.85 -1.14 1.04 1.61 1.1 1.04 1.04
ectodermal cell differentiation 2 4.98 -1.19 1.75 -1.46 1.16 1.31 1.35
nuclear matrix 3 -1.0 1.28 1.38 1.16 1.24 1.52 1.32
ceramidase activity 2 -7.56 -2.15 -1.17 1.28 -1.14 -15.17 -6.93
acyl-CoA delta11-desaturase activity 1 -3.53 -3.34 -2.71 -4.29 -3.06 -2.31 4.71
cytokine binding 3 1.17 1.12 1.1 1.02 1.54 1.2 1.72
T-tubule 1 1.33 1.32 2.26 1.11 1.52 1.39 1.48
A band 9 1.95 -1.09 -1.15 -1.11 1.13 1.79 1.07
cleavage furrow 9 -1.04 1.09 1.57 1.01 1.45 1.33 1.15
ESCRT-0 complex 2 -1.75 1.13 2.24 1.06 1.39 1.34 1.26
ribosome localization 1 2.15 -1.01 1.44 1.25 1.44 1.28 1.21
protein localization in Golgi apparatus 10 -1.16 1.12 1.17 1.04 1.21 1.41 1.65
pupation 4 2.01 -1.05 1.24 -1.24 1.14 2.15 1.25
DNA dealkylation 1 1.12 -1.01 1.19 1.74 1.2 1.06 -1.09
AP-2 adaptor complex binding 1 1.51 1.33 2.01 1.25 1.81 2.91 1.9
DNA protection 1 1.02 -1.01 1.31 1.02 1.58 1.3 1.2
presynaptic membrane 8 -1.25 1.03 1.27 -1.02 1.34 1.8 1.18
main axon 2 -1.07 -1.38 -1.02 -1.09 1.18 3.54 1.59
actin nucleation 4 -2.38 1.35 1.23 1.09 1.22 -1.94 1.21
negative regulation of S phase of mitotic cell cycle 11 1.34 1.21 1.41 1.15 1.44 1.65 1.53
habituation 4 1.3 -1.01 1.62 1.18 1.4 1.83 1.26
actin crosslink formation 1 2.2 1.13 -1.01 1.18 1.16 -1.08 1.17
glycolipid binding 1 -2.99 1.35 -1.24 1.41 -1.1 -2.55 -1.06
catecholamine transport 2 3.07 -1.44 -1.47 -1.28 -1.45 -1.2 -1.42
carboxylic ester hydrolase activity 99 -1.69 -1.12 -1.47 -1.07 -1.31 -2.03 -1.33
foraging behavior 1 -12.04 -1.69 9.34 -2.59 -11.09 -12.8 -6.11
regulation of canonical Wnt receptor signaling pathway 6 1.19 1.08 1.68 1.07 1.07 1.06 1.46
establishment of blood-brain barrier 19 2.5 -1.26 1.24 -1.17 1.21 2.3 1.4
Wnt protein secretion 1 1.86 -1.05 2.03 1.04 1.26 2.03 1.19
RISC-loading complex 1 1.44 1.23 1.89 1.19 2.25 1.64 1.56
cellular response to ecdysone 11 1.32 1.19 1.43 1.13 1.47 1.53 1.33
regulation of ion homeostasis 3 1.14 1.14 1.39 1.16 1.04 1.71 1.47
protein thiol-disulfide exchange 1 -1.26 1.49 1.56 1.08 1.23 -1.31 1.33
alpha-1,6-mannosyltransferase activity 1 1.2 1.3 1.28 1.05 1.27 1.14 1.6
trans-hexaprenyltranstransferase activity 2 2.38 1.18 1.12 1.03 1.43 1.86 1.15
phosphopyruvate hydratase complex 1 1.97 1.06 -1.39 -1.17 -1.32 2.59 1.17
alpha-glucoside transport 2 1.24 -2.16 -1.19 -2.0 -1.13 3.38 1.3
regulation of DNA recombination 2 -1.59 1.15 1.13 1.19 1.42 -1.74 -1.31
regulation of mitotic recombination 1 -2.02 1.1 1.06 1.2 1.9 -2.66 -1.77
negative regulation of mitotic recombination 1 -2.02 1.1 1.06 1.2 1.9 -2.66 -1.77
alpha-1,2-mannosyltransferase activity 1 -1.58 1.15 -1.08 1.11 -1.2 -1.77 1.49
acyl carrier activity 6 1.59 1.03 1.12 1.01 1.14 1.4 1.17
very long-chain fatty acid metabolic process 5 3.63 -2.39 -2.2 -3.1 -1.91 -1.08 3.71
long-chain fatty acid transporter activity 7 -2.15 1.3 -1.32 -1.52 -2.35 -1.39 -1.5
protein targeting to Golgi 10 -1.16 1.12 1.17 1.04 1.21 1.41 1.65
autophagic vacuole fusion 2 1.14 1.16 1.85 1.13 1.26 1.5 1.09
urea cycle 1 -31.89 1.77 -20.72 1.41 1.0 -12.66 -3.5
argininosuccinate metabolic process 1 -31.89 1.77 -20.72 1.41 1.0 -12.66 -3.5
ribosomal subunit export from nucleus 1 2.15 -1.01 1.44 1.25 1.44 1.28 1.21
ribosomal large subunit export from nucleus 1 2.15 -1.01 1.44 1.25 1.44 1.28 1.21
protein import into nucleus, docking 2 -1.85 1.21 1.23 1.37 1.53 -1.37 -1.23
protein import into nucleus, translocation 2 1.98 -1.11 1.05 1.22 1.33 2.03 -1.05
fatty-acyl-CoA binding 8 -2.25 -1.27 -1.85 1.18 1.35 -2.52 -1.44
L-ornithine transmembrane transporter activity 1 1.32 1.45 -1.5 1.71 1.05 1.03 -1.1
mitochondrial ornithine transport 1 1.32 1.45 -1.5 1.71 1.05 1.03 -1.1
M phase specific microtubule process 1 1.59 1.65 -1.13 1.13 1.0 -1.46 -1.04
G1 phase of mitotic cell cycle 1 -1.2 1.72 1.55 1.31 1.53 1.21 1.72
G1/S transition of mitotic cell cycle 14 1.35 1.24 1.43 1.21 1.54 1.24 1.25
regulation of transcription involved in G1/S phase of mitotic cell cycle 1 1.31 1.43 1.45 1.16 1.14 1.54 1.46
G2 phase of mitotic cell cycle 1 1.67 1.26 1.32 1.4 1.23 1.13 1.21
mitotic anaphase B 2 1.04 1.25 1.4 1.16 1.52 -1.16 1.12
mitotic telophase 1 1.4 1.02 1.15 1.14 1.72 -1.18 -1.16
sulfur amino acid biosynthetic process 3 1.32 1.11 1.04 -1.09 -1.92 1.19 1.3
sulfur amino acid transmembrane transporter activity 1 -7.18 -1.45 -9.47 1.62 3.49 -2.41 -5.84
sulfur amino acid transport 1 -7.18 -1.45 -9.47 1.62 3.49 -2.41 -5.84
sulfate assimilation 1 -2.63 1.06 1.41 1.07 1.11 -1.64 -1.02
nucleotide-excision repair complex 3 1.73 1.2 1.21 1.15 1.32 1.1 -1.16
regulation of transcription involved in G2/M-phase of mitotic cell cycle 1 1.12 1.4 1.69 -1.0 1.67 1.7 1.71
transcription factor TFIIIB complex 2 1.19 1.29 1.5 1.13 1.51 1.31 1.18
establishment of mitotic spindle orientation 2 1.02 1.4 1.82 1.21 1.49 1.4 1.34
Golgi cis cisterna 1 -1.12 1.19 1.36 1.12 1.23 -1.28 1.74
Golgi trans cisterna 2 -1.03 1.16 1.1 1.38 1.81 1.12 1.1
microfilament motor activity 3 6.28 -1.75 1.12 -1.66 1.09 3.74 -1.21
cytoplasmic ubiquitin ligase complex 1 2.69 1.18 1.72 1.15 -1.01 -1.18 -1.08
rRNA modification 5 1.57 1.18 1.26 1.33 1.41 1.18 -1.02
two-component sensor activity 3 1.12 -1.13 1.03 -1.08 1.69 1.52 -1.14
two-component response regulator activity 1 -1.1 1.39 1.36 1.05 1.38 3.53 1.68
protein phosphatase type 2A complex 8 1.09 1.04 1.37 1.07 1.23 2.15 1.1
two-component signal transduction system (phosphorelay) 3 -1.1 1.14 1.08 -1.02 -1.02 1.53 1.01
protein phosphatase type 1 complex 5 1.43 1.05 1.28 1.01 1.16 1.5 1.4
ribonuclease MRP complex 1 1.84 1.03 1.1 1.42 1.17 1.05 -1.14
rRNA (adenine-N6,N6-)-dimethyltransferase activity 2 1.61 1.27 1.44 1.22 1.57 1.46 1.13
rDNA binding 2 -1.04 1.15 1.82 1.29 2.02 1.26 1.15
activation of MAPK activity 7 1.11 1.21 1.54 1.12 1.37 2.0 1.14
inactivation of MAPK activity 1 2.84 1.44 1.69 1.19 1.68 4.37 1.83
MAPK import into nucleus 1 1.14 1.19 1.6 1.04 1.48 1.45 1.57
protein ubiquitination involved in ubiquitin-dependent protein catabolic process 5 1.02 1.13 2.15 1.07 1.56 1.16 1.11
vacuolar proton-transporting V-type ATPase, V0 domain 13 -2.32 -1.03 1.35 -1.29 -1.38 1.02 -1.29
vacuolar proton-transporting V-type ATPase, V1 domain 12 -1.17 1.02 1.44 -1.12 -1.04 1.8 -1.01
peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity 1 -1.09 1.27 1.39 1.28 1.54 -1.1 1.18
cytoplasmic chromosome 1 1.18 1.16 1.75 1.38 1.68 1.06 -1.24
mitotic prometaphase 1 -1.39 -1.16 -1.07 1.34 1.62 -1.16 -1.17
C-4 methylsterol oxidase activity 2 -1.31 -6.89 -7.44 -1.07 -3.2 -1.65 -1.68
allantoin metabolic process 2 3.32 -1.45 -1.35 -1.39 -1.17 1.29 -1.34
allantoin catabolic process 1 2.85 -1.01 1.16 1.03 -1.08 1.74 -1.1
sodium:amino acid symporter activity 5 1.26 1.14 -2.06 -1.96 -1.76 -1.26 1.36
nucleoside transmembrane transporter activity 6 -1.51 1.3 -1.37 1.14 -1.09 -1.36 -1.05
proton-transporting ATPase activity, rotational mechanism 21 1.15 -1.01 1.22 -1.1 -1.03 1.64 -1.08
mitochondrial chromosome 1 1.18 1.16 1.75 1.38 1.68 1.06 -1.24
mitochondrial fission 2 1.47 -1.03 1.65 1.15 1.07 1.58 -1.11
peptidoglycan metabolic process 12 -1.13 -1.64 -1.19 -1.04 -1.82 -1.69 -1.29
polysaccharide biosynthetic process 22 1.55 1.02 -1.01 1.03 1.12 1.58 1.25
polysaccharide catabolic process 30 -1.17 -1.91 -2.09 -1.67 -1.68 -1.04 1.4
mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) 8 1.58 -1.08 1.12 -1.1 1.01 1.92 -1.31
mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) 9 1.19 1.04 1.31 1.01 1.22 1.62 -1.14
1-phosphatidylinositol-3-phosphate 5-kinase activity 1 -1.33 1.29 1.91 1.33 2.36 1.28 1.16
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay 10 1.48 1.17 1.74 1.19 1.61 1.9 1.56
nuclear-transcribed mRNA poly(A) tail shortening 7 1.62 1.13 1.74 1.15 1.59 2.05 1.42
deadenylation-dependent decapping of nuclear-transcribed mRNA 2 1.27 1.29 1.78 1.53 1.51 1.59 1.46
nuclear-transcribed mRNA catabolic process, exonucleolytic 1 -1.45 1.76 1.14 1.42 1.29 -1.3 1.32
integral to membrane of membrane fraction 2 1.74 1.04 1.6 1.07 1.43 2.77 1.46
retrograde transport, vesicle recycling within Golgi 10 -1.16 1.12 1.17 1.04 1.21 1.41 1.65
response to superoxide 2 1.69 1.17 1.01 1.09 1.11 1.41 -1.08
response to oxygen radical 2 1.69 1.17 1.01 1.09 1.11 1.41 -1.08
nicotinamide-nucleotide adenylyltransferase activity 1 -2.52 1.99 1.32 1.32 1.09 -1.34 1.43
organellar ribosome 72 1.04 1.07 1.23 1.29 1.25 1.45 -1.55
organellar large ribosomal subunit 44 1.03 1.05 1.24 1.3 1.28 1.46 -1.6
protein-methionine-R-oxide reductase activity 1 2.04 1.02 -1.15 -1.19 -1.3 1.08 -1.25
lytic vacuole 28 -2.58 -1.1 -2.35 1.15 -1.08 -2.06 -3.03
alternative nuclear mRNA splicing, via spliceosome 1 1.52 1.27 1.61 1.3 1.51 2.77 1.58
spliceosomal complex disassembly 1 1.69 1.29 1.56 1.32 1.6 1.63 1.44
RNA splicing, via endonucleolytic cleavage and ligation 3 1.93 1.15 1.42 1.2 1.36 1.44 1.34
four-way junction DNA binding 1 -1.12 1.35 2.36 1.33 2.9 1.28 1.43
mitochondrion degradation 1 2.65 1.08 1.15 1.38 1.25 2.74 1.17
maturation of 2S rRNA 1 1.7 -1.05 -1.07 -1.09 -1.18 1.33 1.14
oxidized base lesion DNA N-glycosylase activity 3 2.16 -1.01 1.16 1.13 1.13 1.51 -1.03
oxidized pyrimidine base lesion DNA N-glycosylase activity 1 3.75 1.0 1.19 1.14 1.11 1.95 1.06
meiotic mismatch repair 1 1.34 1.15 1.36 1.37 1.61 1.16 1.18
nucleotide-excision repair, DNA damage recognition 1 1.35 1.22 1.6 1.15 1.67 2.6 1.56
DNA catabolic process, endonucleolytic 4 1.64 1.12 1.39 1.15 1.35 1.4 1.54
DNA catabolic process, exonucleolytic 2 -1.31 1.21 1.11 1.22 1.62 -1.59 -1.29
nuclear chromosome, telomeric region 2 1.89 1.01 1.39 1.11 1.79 1.05 1.11
X chromosome 6 1.37 1.23 1.41 1.11 1.23 1.51 1.37
GINS complex 2 1.77 1.11 1.3 1.14 1.18 1.14 -1.06
inositol-1,4,5-trisphosphate 6-kinase activity 1 -1.15 1.56 -1.07 1.07 -1.15 -1.25 1.09
inositol hexakisphosphate kinase activity 1 -1.38 1.16 2.02 -1.07 2.12 1.33 1.59
translation repressor activity, nucleic acid binding 6 1.94 1.04 2.03 1.04 1.61 1.46 1.82
gamma-tubulin complex 8 1.55 1.01 1.26 1.07 1.31 1.48 1.15
gamma-tubulin large complex 5 1.67 -1.04 1.23 1.09 1.31 1.41 1.1
cytoplasmic mRNA processing body 13 1.31 1.27 1.6 1.18 1.51 1.59 1.3
mitochondrial RNA metabolic process 3 1.29 1.23 1.41 1.12 1.47 1.73 -1.1
RNA polymerase II core promoter proximal region sequence-specific DNA binding 4 1.25 1.09 1.19 1.0 1.33 1.57 1.45
RNA polymerase II basal transcription factor binding transcription factor activity 6 1.58 1.1 1.46 1.16 1.41 1.29 1.2
TFIIA-class transcription factor binding 3 1.34 1.29 1.39 1.2 1.61 1.37 1.28
TFIIF-class transcription factor binding 2 1.1 1.32 1.52 1.2 1.24 1.14 1.45
RNA polymerase II activating transcription factor binding 4 2.11 -1.73 -1.85 -1.26 -1.03 1.44 1.34
RNA polymerase II transcription coactivator activity 8 1.57 -1.19 -1.01 1.03 1.27 1.49 1.13
RNA polymerase II transcription corepressor activity 2 1.12 1.2 1.26 1.29 1.7 1.19 1.25
RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly 2 1.66 -1.04 1.36 1.21 1.19 1.16 -1.0
TBP-class protein binding RNA polymerase II transcription factor activity involved in preinitiation complex assembly 6 1.58 1.1 1.46 1.16 1.41 1.29 1.2
TBP-class protein binding RNA polymerase II transcription factor activity 6 1.58 1.1 1.46 1.16 1.41 1.29 1.2
DNA-dependent transcriptional start site selection 1 2.19 1.23 -1.08 1.33 1.17 -1.1 1.1
transcriptional start site selection at RNA polymerase II promoter 1 2.19 1.23 -1.08 1.33 1.17 -1.1 1.1
RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription 8 1.57 -1.19 -1.01 1.03 1.27 1.49 1.13
entry into host 2 1.04 1.05 1.19 -1.29 -1.39 2.64 1.17
neurotransmitter uptake 1 -1.06 -1.11 -1.0 -1.08 -1.15 3.37 -1.04
acetylcholine catabolic process in synaptic cleft 1 2.27 1.23 -5.17 -1.59 -2.2 -9.9 9.42
regulation of action potential 8 1.57 -1.04 1.3 -1.12 1.17 2.65 1.29
RNA methylation 10 1.62 1.18 1.23 1.26 1.35 1.29 1.02
selenocysteine incorporation 1 1.74 1.02 1.02 1.41 1.48 -1.49 -1.06
peptide amidation 1 2.74 1.3 1.75 1.08 1.98 1.97 2.28
lipopolysaccharide binding 1 8.83 -1.7 -1.73 -1.63 -1.34 3.89 1.3
ovarian follicle development 1 -1.49 2.58 -1.26 -1.23 -1.23 -1.38 1.24
oocyte growth 2 1.25 1.36 1.54 1.22 1.6 1.07 1.72
regulation of cell growth 38 1.09 1.19 1.46 1.1 1.43 1.53 1.25
galactoside binding 2 1.45 -1.07 1.88 1.03 1.06 1.31 1.14
detection of chemical stimulus involved in sensory perception of bitter taste 1 -1.77 -1.51 -1.46 -1.66 9.03 1.38 -1.43
detection of chemical stimulus involved in sensory perception of sweet taste 1 15.43 1.05 -1.1 -1.34 2.06 11.73 3.15
dense fibrillar component 1 -1.19 1.16 -1.05 1.68 1.27 -1.6 -1.28
conditioned taste aversion 3 1.58 1.48 1.62 -1.13 1.26 1.28 1.57
ameboidal cell migration 35 1.62 -1.01 1.31 -1.06 1.21 1.46 1.11
acrosomal vesicle 1 -1.22 1.14 1.06 1.01 -1.52 -1.37 1.04
ATPase activator activity 3 1.77 1.07 1.2 1.24 1.37 1.32 1.35
long-chain fatty acid metabolic process 8 2.31 -2.32 -1.73 -1.98 -1.14 -1.49 1.69
histamine metabolic process 2 1.02 -1.27 1.33 1.09 1.3 1.8 1.14
histamine biosynthetic process 1 -1.31 -1.76 1.72 1.22 1.97 3.11 1.28
formation of primary germ layer 28 1.53 -1.01 1.18 -1.09 1.11 1.67 1.15
ectoderm formation 2 4.98 -1.19 1.75 -1.46 1.16 1.31 1.35
endoderm formation 4 2.13 -1.15 1.08 -1.19 1.07 2.11 1.76
mesoderm formation 26 1.41 1.01 1.15 -1.07 1.1 1.6 1.11
endodermal cell fate commitment 1 8.12 -1.58 1.44 -1.54 1.01 1.69 1.21
ectodermal cell fate commitment 2 4.98 -1.19 1.75 -1.46 1.16 1.31 1.35
ectodermal cell fate specification 2 4.98 -1.19 1.75 -1.46 1.16 1.31 1.35
ruffle 2 1.28 1.39 2.24 -1.02 2.03 1.81 1.72
lipid kinase activity 2 1.57 1.08 1.68 -1.01 1.59 1.77 1.96
ceramide kinase activity 1 2.79 -1.02 1.66 -1.11 1.24 2.25 2.21
establishment of imaginal disc-derived wing hair orientation 22 1.56 1.08 1.28 1.02 1.4 1.32 1.3
neuron migration 1 -1.42 1.01 1.2 1.29 2.44 -1.59 1.35
kidney development 3 -1.1 -1.05 -1.04 -1.15 -1.04 1.01 1.54
pattern binding 116 -1.88 -1.54 -1.66 -1.39 -1.53 -1.88 1.19
response to yeast 1 5.18 -1.34 1.33 -1.5 1.33 6.7 1.77
nucleoside binding 5 -2.97 1.34 -1.45 1.07 -1.17 -2.3 -1.24
endothelial cell development 3 1.7 1.01 1.41 -1.21 1.32 4.52 2.14
selenium compound metabolic process 2 1.76 1.25 1.23 1.04 1.04 1.62 -1.07
tissue homeostasis 20 1.33 -1.02 1.13 -1.12 1.22 1.46 1.54
negative regulation of protein phosphorylation 2 -1.04 1.11 1.79 -1.0 1.29 1.24 1.01
positive regulation of protein phosphorylation 5 1.08 1.17 1.78 1.11 1.35 1.9 1.34
regulation of cell-matrix adhesion 2 1.91 1.0 2.08 1.07 1.96 1.63 1.31
negative regulation of cell-matrix adhesion 1 2.96 1.13 1.75 -1.2 1.98 1.94 1.75
startle response 13 1.09 1.15 1.46 1.07 1.52 1.19 1.26
G-protein alpha-subunit binding 2 -1.16 1.18 -1.02 1.16 1.01 -1.6 -1.07
morphogenesis of an epithelial sheet 1 1.57 1.36 1.53 1.09 1.59 1.28 1.35
regulation of heart rate 3 -2.33 1.98 1.4 -1.73 -1.39 2.29 -1.17
p53 binding 1 1.78 1.16 2.67 1.12 2.53 3.19 2.15
epithelial cell development 14 1.16 1.1 1.33 1.01 1.23 1.71 1.39
protein depalmitoylation 2 2.75 1.12 1.29 1.19 1.61 1.16 1.22
regulation of receptor internalization 2 2.64 -1.34 1.04 -1.28 -1.11 2.63 1.36
positive regulation of receptor internalization 2 2.64 -1.34 1.04 -1.28 -1.11 2.63 1.36
polyprenyltransferase activity 1 1.04 1.26 1.1 1.28 -1.02 -1.97 -1.12
tRNA wobble base modification 2 1.94 1.19 1.23 1.17 1.27 1.92 1.12
tRNA wobble uridine modification 2 1.94 1.19 1.23 1.17 1.27 1.92 1.12
podosome 1 -1.23 -1.76 -1.82 -1.76 -2.16 17.9 -1.88
store-operated calcium entry 1 2.66 -1.14 1.6 1.07 1.44 4.2 2.14
aggressive behavior 44 1.19 1.05 1.23 -1.02 1.15 1.61 1.24
inter-male aggressive behavior 42 1.18 1.06 1.2 1.0 1.15 1.58 1.25
G-quadruplex RNA binding 1 1.1 1.52 1.31 1.18 1.34 1.42 1.38
palmitoyltransferase complex 1 -1.92 1.11 2.34 1.27 1.64 -1.44 -1.26
defense response to insect 1 23.01 -3.14 -2.9 -3.17 -2.48 1.73 2.58
positive regulation of antimicrobial peptide production 1 -1.72 1.19 -1.18 1.31 1.64 3.16 1.11
innate immune response in mucosa 1 -1.37 -1.13 -1.19 -1.54 1.82 7.35 2.8
response to molecule of bacterial origin 3 2.15 1.03 1.06 -1.04 1.33 1.63 1.06
adaptive immune response 2 -2.37 1.1 1.16 -1.04 1.34 -1.89 1.24
organ or tissue specific immune response 7 1.24 1.06 1.29 -1.06 1.56 1.62 1.43
immune effector process 20 1.79 -1.15 1.28 -1.11 1.26 1.41 1.26
activation of immune response 1 1.17 1.46 1.63 1.36 1.42 1.78 1.19
myeloid leukocyte activation 1 2.18 -2.11 2.19 1.49 1.48 1.37 1.38
mucosal immune response 7 1.24 1.06 1.29 -1.06 1.56 1.62 1.43
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis 3 1.28 -1.17 2.05 1.18 1.64 1.24 1.18
inflammatory response to antigenic stimulus 2 -2.37 1.1 1.16 -1.04 1.34 -1.89 1.24
acute inflammatory response to antigenic stimulus 2 -2.37 1.1 1.16 -1.04 1.34 -1.89 1.24
production of molecular mediator of immune response 2 -1.54 1.11 1.81 1.12 1.7 3.17 1.43
leukocyte mediated immunity 2 -2.37 1.1 1.16 -1.04 1.34 -1.89 1.24
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains 2 -2.37 1.1 1.16 -1.04 1.34 -1.89 1.24
hypersensitivity 2 -2.37 1.1 1.16 -1.04 1.34 -1.89 1.24
positive regulation of immune system process 8 1.43 1.03 1.15 1.01 1.19 1.8 1.48
positive regulation of immune effector process 1 -1.72 1.19 -1.18 1.31 1.64 3.16 1.11
positive regulation of production of molecular mediator of immune response 1 -1.72 1.19 -1.18 1.31 1.64 3.16 1.11
antimicrobial peptide production 2 -1.54 1.11 1.81 1.12 1.7 3.17 1.43
antifungal peptide production 1 -1.72 1.19 -1.18 1.31 1.64 3.16 1.11
regulation of antifungal peptide production 7 2.0 -1.32 -1.17 1.03 1.03 1.92 1.18
peptide secretion 1 1.36 -1.09 1.47 1.03 1.67 -1.23 2.47
positive regulation of antifungal peptide production 1 -1.72 1.19 -1.18 1.31 1.64 3.16 1.11
negative regulation of antimicrobial peptide biosynthetic process 2 1.03 1.14 1.57 1.07 1.57 -1.03 -1.32
positive regulation of antimicrobial peptide biosynthetic process 23 1.75 -1.22 -1.09 -1.11 -1.01 1.39 1.29
negative regulation of antibacterial peptide biosynthetic process 2 1.03 1.14 1.57 1.07 1.57 -1.03 -1.32
regulation of antifungal peptide biosynthetic process 6 2.45 -1.42 -1.16 -1.01 -1.05 1.77 1.2
regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria 7 1.96 -1.11 1.11 -1.19 1.09 1.65 1.22
negative regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria 2 1.03 1.14 1.57 1.07 1.57 -1.03 -1.32
regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria 4 1.05 -1.9 -2.24 -1.85 -1.9 -1.18 1.68
negative regulation of response to biotic stimulus 7 1.37 1.0 1.62 1.21 1.38 -1.12 -1.13
positive regulation of response to biotic stimulus 1 8.35 -1.25 -1.3 -1.07 -1.15 1.62 -1.07
negative regulation of humoral immune response 4 1.35 1.1 1.46 1.15 1.8 1.12 1.2
skeletal muscle contraction 2 -1.89 -1.52 -1.42 -1.43 -1.62 -1.61 2.67
renal system process 6 -4.46 1.18 -1.92 -1.14 -3.52 -1.44 -1.93
negative regulation of heart induction by canonical Wnt receptor signaling pathway 3 1.09 1.1 1.13 1.08 1.18 1.14 2.09
outflow tract morphogenesis 3 -1.03 1.08 1.55 1.17 2.15 1.03 1.48
regulation of organ formation 8 1.56 -1.2 -1.1 1.04 1.14 1.2 -1.02
endothelium development 3 1.7 1.01 1.41 -1.21 1.32 4.52 2.14
Wnt receptor signaling pathway involved in heart development 3 1.09 1.1 1.13 1.08 1.18 1.14 2.09
amino acid transmembrane transport 30 -1.61 -1.12 -1.51 -1.16 -1.02 -1.08 -1.1
apical constriction 4 -1.26 1.28 1.59 1.06 1.39 1.15 1.23
cytoneme morphogenesis 2 -1.85 -1.12 1.68 1.29 1.66 1.71 -2.53
neural retina development 1 -1.1 -1.15 -1.07 -1.18 1.52 1.28 1.24
bent DNA binding 2 1.7 1.14 1.37 1.1 1.36 1.18 1.22
lamin binding 1 1.4 1.14 1.18 1.58 1.38 1.2 1.19
satellite DNA binding 5 1.25 1.13 1.51 1.21 1.5 1.17 1.18
termination of RNA polymerase II transcription 1 -1.51 -1.02 1.38 1.04 1.42 1.11 -1.1
cytoplasmic sequestering of transcription factor 4 2.74 1.08 1.33 1.02 1.2 2.19 1.75
double-stranded RNA binding 16 1.33 -1.04 1.19 -1.13 1.16 1.42 1.51
double-stranded RNA adenosine deaminase activity 1 1.13 1.14 1.55 1.01 1.4 2.0 1.26
mRNA 3'-UTR binding 17 1.34 1.14 1.46 1.02 1.31 1.89 1.29
response to unfolded protein 2 1.04 1.38 1.16 -1.1 1.05 1.03 1.56
contractile fiber 33 2.45 -1.47 -1.08 -1.25 1.2 1.97 -1.14
actin filament bundle assembly 17 1.57 -1.02 1.24 -1.1 1.24 1.29 1.51
barbed-end actin filament capping 2 -1.38 -1.03 2.18 1.01 1.59 -1.39 -1.04
actin monomer binding 1 -3.23 -1.14 1.86 -1.09 2.26 -4.44 -1.1
acute-phase response 1 1.84 1.22 1.59 1.61 1.65 1.41 1.04
lysozyme activity 14 1.98 -1.64 -2.07 -1.66 -1.61 -1.16 1.06
defense response to fungus 28 1.68 -1.27 -1.31 -1.29 -1.25 1.08 1.24
response to virus 12 2.35 -1.64 -1.09 -1.61 1.07 1.84 1.26
serine-type endopeptidase activity 263 -2.24 -1.42 -1.67 -1.14 -1.46 -2.32 -1.65
protein-glutamine gamma-glutamyltransferase activity 2 5.84 -1.94 -1.03 -1.59 -1.03 2.32 1.28
antigen binding 1 -1.71 -1.18 -1.3 -1.15 -1.23 -1.3 1.07
alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity 1 1.32 -4.96 -6.02 -4.98 -1.62 7.64 -3.94
alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity 1 3.18 1.02 1.47 1.11 1.44 4.09 2.36
beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity 1 3.39 -1.12 1.06 -1.11 1.06 1.27 -1.12
beta-alanyl-dopamine hydrolase activity 1 -1.31 -1.76 1.72 1.22 1.97 3.11 1.28
beta-ureidopropionase activity 1 17.28 -3.07 -1.83 -2.92 -2.4 3.32 1.6
gamma-glutamyltransferase activity 4 1.24 -1.34 -1.15 1.08 1.94 1.31 -1.06
1-acylglycerol-3-phosphate O-acyltransferase activity 6 -1.56 -1.19 -1.0 1.18 2.24 -2.62 -1.99
1-pyrroline-5-carboxylate dehydrogenase activity 3 1.56 -1.48 -1.15 -1.62 -1.43 2.14 1.15
1,3-beta-D-glucan synthase activity 1 12.72 -1.88 -1.16 -3.3 -1.54 3.13 2.87
1,4-alpha-glucan branching enzyme activity 1 3.55 -1.35 -1.97 1.08 1.09 1.58 1.19
1-alkyl-2-acetylglycerophosphocholine esterase activity 1 3.85 1.07 1.8 1.09 1.57 2.16 1.8
2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity 5 -4.34 1.01 1.27 1.24 1.5 -3.41 -1.26
3-beta-hydroxy-delta5-steroid dehydrogenase activity 1 7.52 -1.63 -1.52 -1.44 -1.48 2.76 1.78
3-hydroxyisobutyryl-CoA hydrolase activity 1 1.35 1.24 1.18 -1.16 -1.11 6.95 -1.22
3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity 2 1.67 1.29 1.69 -1.02 1.34 1.99 1.11
3-oxo-5-alpha-steroid 4-dehydrogenase activity 1 -1.31 1.28 -1.32 1.3 1.08 -2.32 -1.18
4-aminobutyrate transaminase activity 1 -1.88 3.07 -1.92 -1.52 -1.3 -2.05 1.06
4-hydroxyphenylpyruvate dioxygenase activity 1 1.86 -1.07 1.21 1.03 1.14 1.09 -1.06
5-aminolevulinate synthase activity 1 1.58 1.36 -1.31 -1.09 -1.26 1.25 1.23
6-phosphofructokinase activity 1 2.63 -1.22 -1.22 1.02 -1.12 5.11 1.3
6-phosphofructo-2-kinase activity 1 1.09 -1.34 2.59 -1.04 1.14 3.38 -1.06
6-pyruvoyltetrahydropterin synthase activity 1 2.12 1.31 1.32 1.23 1.73 1.01 2.0
AMP deaminase activity 1 1.21 1.11 1.3 -1.14 1.24 3.4 1.06
protein C-terminal carboxyl O-methyltransferase activity 1 -2.13 1.18 1.09 1.41 1.8 -1.71 -1.76
CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity 1 2.1 -1.04 1.71 -1.1 1.9 -1.29 1.13
CDP-diacylglycerol-serine O-phosphatidyltransferase activity 1 1.61 1.37 2.22 1.0 1.13 1.67 1.83
D-amino-acid oxidase activity 2 -2.82 -1.69 -2.22 1.7 1.95 -1.63 -1.83
DNA-(apurinic or apyrimidinic site) lyase activity 5 1.72 -1.0 1.07 1.11 1.19 1.32 1.0
methylated-DNA-[protein]-cysteine S-methyltransferase activity 1 1.12 -1.01 1.19 1.74 1.2 1.06 -1.09
DNA ligase (ATP) activity 2 1.29 1.46 1.49 1.24 1.5 1.27 1.28
DNA topoisomerase (ATP-hydrolyzing) activity 3 -1.26 1.43 1.56 1.29 1.52 1.12 1.27
GMP synthase activity 1 1.14 1.09 1.34 -1.05 1.24 1.35 2.12
GMP synthase (glutamine-hydrolyzing) activity 1 1.14 1.09 1.34 -1.05 1.24 1.35 2.12
GPI-anchor transamidase activity 1 1.21 1.1 1.8 1.25 1.66 -1.16 1.35
synaptic vesicle uncoating 2 -1.44 1.22 1.71 1.06 1.91 1.53 1.42
GTP cyclohydrolase activity 1 33.5 -5.63 -5.79 -6.03 -4.58 -1.32 6.94
GTP cyclohydrolase I activity 1 33.5 -5.63 -5.79 -6.03 -4.58 -1.32 6.94
hydrogen ion transporting ATP synthase activity, rotational mechanism 16 1.35 -1.04 1.11 -1.09 -1.01 1.54 -1.13
IMP cyclohydrolase activity 1 -1.39 1.0 -1.49 -1.01 -1.06 1.63 -1.09
IMP dehydrogenase activity 1 1.16 1.34 1.12 1.03 1.08 -1.1 1.99
L-iditol 2-dehydrogenase activity 3 1.17 -1.39 -1.37 1.12 1.23 1.74 -1.02
L-iduronidase activity 1 -1.71 1.0 1.11 -1.04 1.62 -1.12 -1.27
N-acetylgalactosamine-4-sulfatase activity 4 1.55 -1.16 -1.4 1.09 1.42 2.61 -1.17
NAD+ ADP-ribosyltransferase activity 1 -2.18 1.38 1.41 1.1 1.13 -1.47 1.05
NAD+ synthase (glutamine-hydrolyzing) activity 1 2.07 1.6 1.04 1.19 1.4 2.13 1.77
NADH dehydrogenase activity 36 1.13 1.03 1.27 1.06 1.1 1.72 -1.29
NADPH-hemoprotein reductase activity 1 1.63 1.35 1.12 -1.0 1.2 -1.04 1.34
NADPH dehydrogenase activity 1 -1.51 1.45 1.08 1.06 -1.12 -1.58 -1.42
RNA-directed DNA polymerase activity 1 1.54 1.82 1.92 -1.04 1.87 1.15 2.39
UDP-N-acetylglucosamine diphosphorylase activity 1 -1.57 -1.13 1.65 -1.09 1.26 -1.83 1.72
UDP-glucose:glycoprotein glucosyltransferase activity 1 1.21 1.16 1.35 -1.04 1.59 1.69 2.54
acetate-CoA ligase activity 2 1.63 1.11 -1.36 -1.04 -1.71 1.16 1.18
acetyl-CoA C-acyltransferase activity 4 1.58 1.11 -1.25 1.12 1.08 1.06 -1.32
acetyl-CoA carboxylase activity 1 7.73 1.2 -1.41 -2.71 1.2 3.14 4.69
acetylcholinesterase activity 1 2.27 1.23 -5.17 -1.59 -2.2 -9.9 9.42
acid phosphatase activity 12 1.44 1.13 -1.05 -1.03 -1.02 1.81 1.28
aconitate hydratase activity 4 1.11 1.25 1.22 -1.14 -1.03 1.75 1.32
acyl-CoA dehydrogenase activity 15 -1.17 1.11 -1.37 1.1 1.1 -1.79 -1.3
acyl-CoA oxidase activity 6 -2.19 1.03 -1.7 1.08 1.14 -3.66 -1.47
acylphosphatase activity 6 1.57 1.0 -1.02 1.01 -1.1 1.04 -1.12
adenosine deaminase activity 8 -1.69 1.1 1.06 -1.03 -1.09 1.15 -1.16
cation-transporting ATPase activity 26 1.1 1.0 1.24 -1.08 1.02 1.51 -1.05
copper-exporting ATPase activity 1 -2.22 1.33 3.02 1.07 -1.16 -1.12 1.08
phospholipid-translocating ATPase activity 6 -2.65 1.11 -1.12 1.22 1.24 -1.33 -1.09
adenosylhomocysteinase activity 3 -2.93 -1.82 -1.21 -1.07 1.22 1.86 -1.16
adenosylmethionine decarboxylase activity 1 1.82 1.07 1.08 1.22 1.03 1.75 -1.05
adenylate kinase activity 6 1.61 -1.18 1.01 1.04 1.05 1.04 -1.33
adenylosuccinate synthase activity 1 2.08 1.19 1.56 -1.1 -1.15 1.56 -1.05
adenylylsulfate kinase activity 1 -2.63 1.06 1.41 1.07 1.11 -1.64 -1.02
L-alanine:2-oxoglutarate aminotransferase activity 1 -2.33 1.13 1.14 1.09 1.76 1.77 -1.09
alcohol dehydrogenase (NAD) activity 5 1.66 -1.09 -1.8 -1.39 -1.21 1.37 1.27
aldehyde dehydrogenase (NAD) activity 3 -1.65 1.15 -1.65 1.05 -1.41 -1.9 -1.31
aldehyde dehydrogenase [NAD(P)+] activity 1 1.67 -1.24 -1.26 1.36 2.03 -1.43 1.25
aldose 1-epimerase activity 3 -1.46 1.17 -1.47 -1.07 1.13 -1.58 -1.03
alkaline phosphatase activity 13 -5.32 -1.81 -4.2 -1.19 -1.19 -4.42 -4.05
allantoinase activity 1 2.85 -1.01 1.16 1.03 -1.08 1.74 -1.1
amidase activity 1 1.54 -1.32 2.9 1.39 -1.83 -6.19 -2.79
amidophosphoribosyltransferase activity 2 1.11 1.02 -1.15 -1.13 -1.43 1.89 -1.09
aminoacyl-tRNA hydrolase activity 3 1.72 -1.02 1.14 1.1 1.0 1.49 -1.08
aminoacylase activity 6 -1.72 -1.86 -1.07 -1.63 1.29 -1.6 -1.71
aminomethyltransferase activity 4 1.27 1.14 1.17 1.01 -1.01 1.6 1.08
nucleoside-diphosphatase activity 3 -2.29 1.44 -2.09 1.33 -1.38 -3.32 1.1
arginase activity 2 1.73 -1.09 1.02 -1.05 -1.18 2.27 1.17
argininosuccinate synthase activity 1 -31.89 1.77 -20.72 1.41 1.0 -12.66 -3.5
argininosuccinate lyase activity 1 -15.39 1.51 -7.96 1.39 1.15 -4.77 -1.11
arginyltransferase activity 1 1.03 1.39 1.46 1.24 1.37 1.69 1.36
aromatic-L-amino-acid decarboxylase activity 4 2.04 -1.66 -1.74 -1.59 -1.59 1.51 1.84
aralkylamine N-acetyltransferase activity 1 -8.98 1.77 -2.05 -1.02 -2.08 -14.22 1.22
arylamine N-acetyltransferase activity 1 -8.98 1.77 -2.05 -1.02 -2.08 -14.22 1.22
aryldialkylphosphatase activity 1 1.9 -1.44 -1.39 -2.02 1.17 21.38 -1.25
asparaginase activity 4 1.31 -1.05 -1.24 -1.15 1.04 1.97 1.03
L-aspartate:2-oxoglutarate aminotransferase activity 2 1.83 1.18 -1.32 -1.0 1.19 1.57 1.14
aspartate carbamoyltransferase activity 1 -1.12 1.14 1.63 1.21 1.33 1.0 1.05
biliverdin reductase activity 1 -1.51 1.45 1.08 1.06 -1.12 -1.58 -1.42
biotin carboxylase activity 3 2.88 1.25 -1.21 -1.16 -1.0 2.26 1.91
bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity 1 -1.85 1.12 1.37 1.12 1.23 -1.02 1.02
branched-chain-amino-acid transaminase activity 1 5.21 1.63 1.44 -1.45 -2.46 1.42 2.6
carbamoyl-phosphate synthase (ammonia) activity 1 -1.12 1.14 1.63 1.21 1.33 1.0 1.05
carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity 1 -1.12 1.14 1.63 1.21 1.33 1.0 1.05
carbonyl reductase (NADPH) activity 3 1.57 1.0 -1.52 -1.25 -1.09 1.43 1.09
carnitine O-palmitoyltransferase activity 1 1.55 1.41 -1.09 1.13 1.34 -1.06 1.05
catalase activity 3 1.88 -1.66 -2.02 -1.59 -1.55 2.15 -1.21
catechol oxidase activity 1 1.73 1.33 1.02 1.13 -1.06 -1.05 1.06
chitin deacetylase activity 2 2.14 -1.13 1.05 -1.06 -1.29 -1.18 -1.25
chitin synthase activity 2 -4.74 1.25 1.37 -1.3 1.38 1.09 1.15
choline kinase activity 2 1.11 1.13 1.36 1.19 1.43 2.57 1.13
cholinesterase activity 2 -1.12 1.28 -2.63 -1.13 -1.28 -3.75 2.43
choline-phosphate cytidylyltransferase activity 2 1.06 -1.23 1.07 1.02 1.15 -1.4 1.55
coproporphyrinogen oxidase activity 1 -1.38 1.31 1.39 1.26 1.22 -1.88 -1.39
cyclic-nucleotide phosphodiesterase activity 8 1.68 1.07 1.28 1.01 1.26 2.25 1.48
3',5'-cyclic-nucleotide phosphodiesterase activity 8 1.68 1.07 1.28 1.01 1.26 2.25 1.48
3',5'-cyclic-AMP phosphodiesterase activity 4 1.06 1.26 1.31 1.05 1.3 1.79 1.4
cystathionine beta-synthase activity 1 1.25 1.1 1.48 -1.98 -7.11 -1.17 2.59
cytidine deaminase activity 3 -2.8 1.04 -1.39 1.2 1.32 -1.87 -1.06
cytosine deaminase activity 1 1.58 1.21 -1.04 1.33 -1.0 -1.93 1.34
dCMP deaminase activity 1 2.54 -1.17 -1.05 1.35 1.96 1.77 -1.1
glycogen debranching enzyme activity 1 1.91 -1.57 -1.98 1.36 -1.16 2.47 1.07
4-alpha-glucanotransferase activity 1 1.91 -1.57 -1.98 1.36 -1.16 2.47 1.07
amylo-alpha-1,6-glucosidase activity 1 1.91 -1.57 -1.98 1.36 -1.16 2.47 1.07
deoxyribose-phosphate aldolase activity 1 -1.52 1.52 -1.38 1.37 -1.06 -2.8 1.21
dephospho-CoA kinase activity 2 1.04 1.25 -1.2 1.45 1.19 -1.52 -1.32
diacylglycerol cholinephosphotransferase activity 1 -3.65 1.65 3.17 1.08 1.15 -2.09 2.51
diacylglycerol kinase activity 8 1.65 1.05 -1.03 -1.02 -1.04 1.17 1.24
diacylglycerol O-acyltransferase activity 1 -1.05 1.33 3.49 1.16 1.98 2.09 1.25
dihydrofolate reductase activity 1 2.25 -1.1 -1.03 1.28 1.09 2.14 -1.24
dihydrolipoamide branched chain acyltransferase activity 1 1.74 1.44 1.67 1.01 1.35 1.38 1.19
dihydrolipoyl dehydrogenase activity 1 -1.4 -1.14 2.27 -1.25 -1.48 1.94 -1.5
dihydrolipoyllysine-residue succinyltransferase activity 1 1.27 -1.02 1.79 -1.24 1.05 3.95 -1.37
dihydroorotase activity 1 -1.12 1.14 1.63 1.21 1.33 1.0 1.05
6,7-dihydropteridine reductase activity 1 2.26 1.17 1.35 1.12 1.23 1.64 1.14
dihydrouracil dehydrogenase (NAD+) activity 1 -2.4 1.52 -1.09 1.53 -1.18 -2.54 -1.54
dimethylallyltranstransferase activity 2 2.38 1.13 2.21 -1.02 1.58 1.4 1.7
diphosphomevalonate decarboxylase activity 1 2.36 -1.19 -1.1 1.02 -1.17 1.09 1.24
diphthine synthase activity 1 1.75 1.22 1.1 1.3 1.08 -1.18 -1.03
dodecenoyl-CoA delta-isomerase activity 5 1.65 1.02 -1.16 1.25 1.08 1.17 -1.36
dopachrome isomerase activity 2 2.9 -1.22 -1.25 -1.08 -1.28 3.34 -1.14
dolichol kinase activity 1 -2.66 1.27 -1.76 1.39 1.67 -4.72 -1.84
dolichyl-phosphate-mannose-protein mannosyltransferase activity 2 1.57 1.01 1.07 -1.18 -1.11 1.61 1.23
dUTP diphosphatase activity 1 -1.36 -1.27 1.07 1.7 1.82 -3.47 -2.13
ecdysteroid UDP-glucosyltransferase activity 2 -2.06 1.41 -1.15 1.08 1.07 -2.31 -1.09
electron-transferring-flavoprotein dehydrogenase activity 1 2.09 1.59 -1.41 1.19 1.36 1.02 -1.19
endopeptidase activity 433 -1.75 -1.28 -1.35 -1.08 -1.23 -1.79 -1.45
aminopeptidase activity 36 -2.28 -1.12 -1.52 1.05 1.14 -1.43 -1.98
metalloexopeptidase activity 41 -2.37 -1.56 -1.46 1.02 -1.31 -2.4 -1.85
carboxypeptidase activity 35 -2.91 -1.85 -1.55 -1.01 -1.63 -3.14 -1.86
metallocarboxypeptidase activity 24 -4.15 -2.21 -1.86 -1.01 -1.57 -4.07 -2.61
serine-type carboxypeptidase activity 11 -1.26 -1.29 -1.05 -1.03 -1.8 -1.77 1.1
aspartic-type endopeptidase activity 19 -1.6 -1.03 1.15 -1.16 -1.46 -1.86 -1.32
calcium-dependent cysteine-type endopeptidase activity 4 2.12 1.16 1.44 1.14 1.21 1.24 1.16
lysosome 28 -2.58 -1.1 -2.35 1.15 -1.08 -2.06 -3.03
pyroglutamyl-peptidase activity 2 2.37 -1.16 1.04 -1.04 1.14 1.57 1.04
ubiquitin thiolesterase activity 27 1.19 1.22 1.57 1.17 1.42 1.39 1.24
metallopeptidase activity 153 -1.78 -1.24 -1.3 1.02 -1.0 -1.44 -1.51
peptidyl-dipeptidase activity 6 -1.43 -1.17 -1.51 -1.07 1.03 1.0 -1.19
vacuole 54 -2.1 -1.04 -1.32 -1.01 -1.13 -1.28 -1.9
serine-type peptidase activity 288 -2.24 -1.4 -1.61 -1.12 -1.45 -2.28 -1.59
tripeptidyl-peptidase activity 2 -2.48 1.24 -1.3 1.26 1.28 -1.53 -1.15
peptidase activity 576 -1.77 -1.28 -1.36 -1.05 -1.15 -1.74 -1.45
epoxide hydrolase activity 3 -2.11 1.3 -1.14 -1.06 -1.44 -4.35 1.38
ethanolamine kinase activity 2 1.11 1.13 1.36 1.19 1.43 2.57 1.13
ethanolamine-phosphate cytidylyltransferase activity 1 1.81 -1.85 1.07 -1.42 1.03 1.7 2.82
ethanolaminephosphotransferase activity 1 -1.35 1.28 1.66 1.08 1.2 1.32 1.18
farnesyltranstransferase activity 2 1.07 1.18 1.54 1.21 1.32 1.31 -1.04
fatty acid synthase activity 8 1.58 -1.38 -1.32 -1.5 -1.29 1.18 1.72
[acyl-carrier-protein] S-acetyltransferase activity 2 3.49 -1.07 -1.08 -1.15 1.4 1.97 2.1
[acyl-carrier-protein] S-malonyltransferase activity 3 2.14 -1.05 -1.1 -1.07 1.17 1.47 1.42
3-oxoacyl-[acyl-carrier-protein] synthase activity 3 2.25 -1.02 -1.08 -1.11 1.15 1.9 1.44
3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity 2 3.49 -1.07 -1.08 -1.15 1.4 1.97 2.1
3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity 2 3.49 -1.07 -1.08 -1.15 1.4 1.97 2.1
enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity 2 3.49 -1.07 -1.08 -1.15 1.4 1.97 2.1
oleoyl-[acyl-carrier-protein] hydrolase activity 2 3.49 -1.07 -1.08 -1.15 1.4 1.97 2.1
fatty-acyl-CoA synthase activity 1 2.47 -1.2 -1.84 1.79 2.31 -2.71 -1.43
ferroxidase activity 3 -1.88 -2.6 -2.43 -2.04 1.07 -1.41 2.03
iron ion transmembrane transporter activity 7 1.31 -1.87 -2.05 -1.74 -1.19 1.52 1.79
ferredoxin-NADP+ reductase activity 1 -1.19 1.24 1.2 1.43 1.53 -1.12 -1.13
tetrahydrofolylpolyglutamate synthase activity 2 -1.63 1.22 -1.26 1.27 -1.21 -1.7 -1.32
S-(hydroxymethyl)glutathione dehydrogenase activity 1 1.29 1.1 1.03 1.22 1.29 1.66 -1.14
formate-tetrahydrofolate ligase activity 1 -2.72 1.36 -1.4 1.55 -1.7 -1.17 -2.58
fructose-2,6-bisphosphate 2-phosphatase activity 1 1.09 -1.34 2.59 -1.04 1.14 3.38 -1.06
fructose-bisphosphate aldolase activity 1 1.83 1.08 -1.27 -1.04 1.23 2.05 1.42
fumarylacetoacetase activity 1 2.81 -1.06 -1.21 -1.09 1.58 2.01 -1.24
geranyltranstransferase activity 2 2.38 1.13 2.21 -1.02 1.58 1.4 1.7
glucosamine-6-phosphate deaminase activity 1 -1.22 1.14 1.64 1.24 2.02 -2.96 -2.72
glucosamine 6-phosphate N-acetyltransferase activity 1 1.02 1.09 -1.02 1.16 1.08 -1.06 2.5
glucose dehydrogenase activity 4 2.07 -1.33 -1.32 -1.38 -1.39 2.15 -1.49
glucose-6-phosphate dehydrogenase activity 2 1.97 -1.14 -2.0 -1.18 -1.53 1.18 1.65
glucose-6-phosphate isomerase activity 1 4.0 1.26 -2.38 -1.3 -1.5 3.87 2.36
glucosylceramidase activity 3 -3.7 -1.06 -2.39 1.57 -1.6 -3.65 -2.05
glutamate 5-kinase activity 1 -29.94 1.93 -2.31 -1.05 -1.13 -7.63 1.24
glutamate-5-semialdehyde dehydrogenase activity 1 -29.94 1.93 -2.31 -1.05 -1.13 -7.63 1.24
glutamate dehydrogenase (NAD+) activity 1 -1.32 -1.9 1.3 -2.14 3.35 4.87 -4.48
glutamate dehydrogenase [NAD(P)+] activity 2 -1.13 -1.34 1.15 -1.41 1.89 2.28 -2.14
glutamate synthase (NADPH) activity 1 2.14 1.19 1.24 1.03 -1.73 3.68 2.51
glutamate-ammonia ligase activity 2 1.91 -1.99 2.01 -1.44 1.52 -1.73 -1.25
glutamate-cysteine ligase activity 2 -1.84 1.49 -1.21 1.04 -1.06 1.03 1.54
glutamine-fructose-6-phosphate transaminase (isomerizing) activity 2 -1.0 -1.44 1.48 -1.44 1.38 1.11 2.78
glutaryl-CoA dehydrogenase activity 1 -1.51 -1.6 -1.42 1.8 -1.74 2.0 -2.55
glutathione-disulfide reductase activity 1 -1.86 1.42 -1.95 1.12 1.15 -1.81 1.13
glutathione synthase activity 1 -4.56 1.3 -1.17 1.44 -1.72 -2.63 -1.17
glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity 3 1.41 -1.11 -1.14 -1.08 -1.06 1.76 1.01
glycerol-3-phosphate O-acyltransferase activity 2 3.16 -1.05 -1.54 1.04 2.3 -1.34 1.05
glycerol-3-phosphate dehydrogenase [NAD+] activity 2 1.2 1.12 -1.49 1.16 1.79 -1.21 -1.08
glycine hydroxymethyltransferase activity 1 4.17 -1.15 1.23 1.12 1.08 1.16 -1.19
glycogen (starch) synthase activity 1 3.34 -1.14 1.48 -1.05 1.39 2.94 1.3
glycine decarboxylation via glycine cleavage system 1 1.73 -1.01 1.7 -1.04 1.38 3.31 -1.03
glycine dehydrogenase (decarboxylating) activity 1 -1.37 -1.08 -1.16 -1.21 -1.14 1.68 -1.06
glycolipid mannosyltransferase activity 1 -1.85 1.22 -1.04 1.31 1.1 -2.17 1.06
glycylpeptide N-tetradecanoyltransferase activity 1 -1.49 1.29 1.71 1.24 1.7 1.05 1.0
guanosine-diphosphatase activity 1 -1.51 1.28 -1.3 1.09 -1.1 -3.57 1.37
guanylate kinase activity 5 3.22 1.04 1.21 -1.15 1.05 2.62 1.29
heme oxygenase (decyclizing) activity 1 2.0 1.05 2.09 1.06 1.46 2.34 1.12
heparan sulfate 2-O-sulfotransferase activity 2 2.25 1.13 1.26 1.01 1.22 1.54 1.62
hexokinase activity 4 -1.31 1.0 -1.96 1.11 1.37 1.21 -1.77
holocytochrome-c synthase activity 1 1.66 1.03 1.71 1.06 1.0 2.28 -1.41
hyalurononglucosaminidase activity 1 1.16 1.5 1.47 1.26 1.67 1.16 1.31
hydroxyacylglutathione hydrolase activity 1 -2.43 1.25 -1.81 1.44 1.13 -2.07 -1.36
hydroxymethylglutaryl-CoA lyase activity 1 -1.23 1.82 1.48 1.33 1.52 1.63 1.08
hydroxymethylglutaryl-CoA synthase activity 1 1.84 -1.29 1.3 -1.14 1.76 1.59 1.19
iduronate-2-sulfatase activity 1 1.62 1.05 1.28 1.01 1.11 1.28 1.12
phosphatidylinositol phosphate kinase activity 6 -1.3 1.22 1.48 1.12 1.58 1.08 1.01
phosphatidylinositol kinase activity 5 -1.09 1.17 1.62 1.11 1.75 1.32 1.12
phosphatidylinositol bisphosphate kinase activity 3 -1.46 1.15 1.53 1.18 1.77 -1.09 -1.14
1-phosphatidylinositol 4-kinase activity 2 1.44 1.21 1.76 1.02 1.71 2.28 1.63
phosphatidylinositol phospholipase C activity 2 2.58 1.12 1.89 -1.08 1.02 1.84 1.76
phosphatidylinositol trisphosphate phosphatase activity 1 2.96 1.13 1.75 -1.2 1.98 1.94 1.75
inositol phosphate phosphatase activity 13 1.85 -1.04 -1.08 -1.1 1.15 1.89 1.3
phosphatidylinositol-3-phosphatase activity 1 -1.51 1.05 1.08 1.24 -1.11 -1.13 -1.35
inositol-1,4-bisphosphate 1-phosphatase activity 1 3.45 -1.15 1.32 1.0 -1.07 1.6 -1.16
inositol trisphosphate phosphatase activity 6 1.66 1.07 1.37 -1.03 1.33 2.5 1.26
inositol-polyphosphate 5-phosphatase activity 3 1.23 1.22 1.55 1.08 1.34 1.47 1.38
isocitrate dehydrogenase activity 7 1.09 1.14 1.28 -1.23 1.01 1.93 1.09
isocitrate dehydrogenase (NAD+) activity 6 1.03 1.08 1.46 -1.19 1.02 2.18 1.06
isocitrate dehydrogenase (NADP+) activity 1 1.5 1.55 -1.65 -1.56 -1.01 -1.09 1.26
isopentenyl-diphosphate delta-isomerase activity 1 3.32 -1.02 1.27 1.26 1.27 1.92 1.53
lactate dehydrogenase activity 2 1.05 1.2 1.7 -1.34 -1.08 -2.44 1.33
L-lactate dehydrogenase activity 2 1.05 1.2 1.7 -1.34 -1.08 -2.44 1.33
lactoylglutathione lyase activity 1 -1.59 1.09 -1.01 1.22 -1.05 -1.39 -1.43
leukotriene-A4 hydrolase activity 1 -1.74 1.11 -2.01 1.51 1.27 -1.87 -1.55
lipoprotein lipase activity 5 -2.69 -1.1 -1.42 1.06 1.23 -1.76 -1.32
long-chain fatty acid-CoA ligase activity 7 1.81 -1.3 -1.35 1.09 1.2 -1.91 -1.26
malic enzyme activity 4 -1.07 1.26 1.14 -1.52 -1.06 1.05 1.65
malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity 4 -1.07 1.26 1.14 -1.52 -1.06 1.05 1.65
mannose-1-phosphate guanylyltransferase activity 2 -2.09 1.14 1.2 1.25 1.24 -1.89 1.17
mannose-6-phosphate isomerase activity 2 3.41 1.03 1.33 -1.05 -1.02 3.9 1.9
methenyltetrahydrofolate cyclohydrolase activity 2 1.63 -1.3 -1.28 -1.04 -1.47 2.82 -1.53
methionine adenosyltransferase activity 1 1.6 1.05 1.23 -1.23 1.41 1.78 1.98
methionyl-tRNA formyltransferase activity 1 1.38 1.09 1.78 1.2 1.53 2.7 -1.25
mRNA guanylyltransferase activity 1 1.69 1.28 1.3 1.3 1.17 1.5 1.34
methylcrotonoyl-CoA carboxylase activity 2 1.38 1.49 1.32 1.28 1.37 1.61 1.17
methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity 1 2.55 -3.49 -3.06 -4.0 -1.9 6.63 -1.86
methylenetetrahydrofolate dehydrogenase (NAD+) activity 1 7.21 -2.31 -1.17 -1.68 -1.27 9.3 1.1
methylenetetrahydrofolate dehydrogenase (NADP+) activity 2 1.63 -1.3 -1.28 -1.04 -1.47 2.82 -1.53
methylenetetrahydrofolate reductase (NADPH) activity 1 1.73 -1.17 -1.14 -1.13 -1.11 2.12 -1.29
methylmalonate-semialdehyde dehydrogenase (acylating) activity 1 -1.74 1.44 -1.08 -1.1 -1.07 1.5 1.28
monooxygenase activity 35 1.52 -1.2 -1.23 -1.13 -1.16 -1.04 1.06
N,N-dimethylaniline monooxygenase activity 2 1.33 1.51 -1.79 -1.37 -1.35 1.43 1.59
peptidylglycine monooxygenase activity 1 2.74 1.3 1.75 1.08 1.98 1.97 2.28
phenylalanine 4-monooxygenase activity 2 1.24 -1.3 -1.46 -1.42 -1.18 2.11 -1.36
tryptophan 5-monooxygenase activity 2 1.24 -1.3 -1.46 -1.42 -1.18 2.11 -1.36
tyrosine 3-monooxygenase activity 1 -1.05 -1.1 1.05 1.12 -1.1 -1.1 1.78
inositol-3-phosphate synthase activity 1 1.86 -1.46 -1.12 -1.51 1.13 1.83 1.71
nicotinate-nucleotide diphosphorylase (carboxylating) activity 1 8.31 1.05 -1.79 -1.54 -1.19 1.17 2.54
nicotinate phosphoribosyltransferase activity 1 8.31 1.05 -1.79 -1.54 -1.19 1.17 2.54
ribonuclease III activity 4 1.01 1.12 1.7 -1.0 1.33 1.5 1.2
deoxyribonuclease II activity 1 3.57 -3.74 -3.12 -4.14 -2.27 -1.33 4.32
5'-3' exoribonuclease activity 2 -1.11 1.53 1.16 1.33 1.34 -1.11 1.19
poly(A)-specific ribonuclease activity 2 1.33 1.15 1.69 1.2 1.62 2.01 1.48
octanol dehydrogenase activity 1 1.29 1.1 1.03 1.22 1.29 1.66 -1.14
hydrolase activity, hydrolyzing O-glycosyl compounds 93 -1.83 -1.29 -2.4 -1.22 -1.47 -1.78 -1.26
alpha,alpha-trehalase activity 3 -2.73 1.23 -2.68 1.17 -1.22 -2.41 1.01
alpha-amylase activity 2 -34.84 -2.22 -3.89 2.13 -10.58 -52.06 -2.46
alpha-galactosidase activity 1 -4.17 1.11 -1.19 -1.11 -1.3 -2.49 3.87
alpha-glucosidase activity 13 -7.82 -1.11 -3.92 1.01 -2.19 -4.92 -2.34
alpha-mannosidase activity 9 -14.64 -1.14 -7.39 1.54 -1.15 -14.33 -25.61
alpha-L-fucosidase activity 1 -1.1 -1.19 -1.53 -1.9 -1.86 -1.28 7.99
alpha-N-acetylglucosaminidase activity 1 -1.03 -1.29 -2.28 -2.21 -1.93 20.24 3.19
beta-N-acetylhexosaminidase activity 4 2.6 -1.04 -1.38 1.02 1.14 -1.03 1.23
beta-galactosidase activity 2 -4.22 1.94 -2.65 -1.31 -2.65 -1.75 -2.68
beta-glucuronidase activity 2 -2.98 1.22 1.8 1.28 1.95 -1.65 1.15
beta-mannosidase activity 1 -5.95 1.18 1.25 1.37 1.4 -3.3 -1.02
chitinase activity 17 -1.5 -2.2 -3.34 -2.35 -1.62 1.11 2.06
mannosyl-oligosaccharide 1,2-alpha-mannosidase activity 5 1.56 1.24 -1.27 -1.11 -1.07 2.0 1.29
mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity 2 2.21 -1.18 -1.12 1.09 -1.0 4.22 1.53
mannosyl-oligosaccharide glucosidase activity 1 1.11 1.54 -1.06 1.25 1.09 -1.47 1.06
oligo-1,6-glucosidase activity 1 -7.77 -4.97 -3.61 4.46 -5.62 -8.7 -6.61
dolichyl-diphosphooligosaccharide-protein glycotransferase activity 2 -2.3 1.16 -1.02 1.14 1.1 -1.42 1.33
dolichyl-phosphate beta-glucosyltransferase activity 1 -1.18 1.16 1.9 1.06 1.5 -1.14 1.68
dolichyl-phosphate beta-D-mannosyltransferase activity 1 1.01 1.25 1.35 1.09 1.77 -1.32 1.33
ornithine decarboxylase activity 2 -1.3 -1.56 -1.58 -1.19 -1.51 1.68 -1.8
ornithine-oxo-acid transaminase activity 2 -3.39 1.33 -4.62 1.16 1.17 -3.49 1.2
orotate phosphoribosyltransferase activity 1 1.61 1.06 1.09 1.15 1.38 -1.09 1.01
orotidine-5'-phosphate decarboxylase activity 1 1.61 1.06 1.09 1.15 1.38 -1.09 1.01
oxoglutarate dehydrogenase (succinyl-transferring) activity 2 -2.58 1.25 1.08 -1.04 1.34 -1.08 -1.45
pantothenate kinase activity 1 2.17 1.37 -1.41 1.23 1.4 -1.72 1.12
pantetheine-phosphate adenylyltransferase activity 1 -1.07 1.17 -1.47 1.46 1.3 -2.5 -1.32
peptide alpha-N-acetyltransferase activity 2 -1.32 1.41 1.74 1.19 1.16 -1.05 -1.05
cyclosporin A binding 1 -1.56 1.12 -1.6 -1.09 -1.49 -1.56 -1.26
glutathione peroxidase activity 8 -1.36 1.09 -1.0 -1.35 -1.25 -2.14 1.1
phosphatidate cytidylyltransferase activity 1 3.07 1.1 2.07 -1.42 3.13 -1.11 1.4
phosphatidylserine decarboxylase activity 1 2.68 -1.15 1.36 1.05 1.26 2.6 1.26
phosphoacetylglucosamine mutase activity 1 -2.86 1.51 1.12 1.09 1.09 -5.18 1.1
phosphoenolpyruvate carboxykinase activity 2 -2.6 -1.77 1.37 -1.78 2.07 1.05 -1.67
phosphoenolpyruvate carboxykinase (GTP) activity 2 -2.6 -1.77 1.37 -1.78 2.07 1.05 -1.67
phosphoglucomutase activity 1 3.54 -1.2 -2.31 -1.28 -1.28 4.52 1.34
phosphogluconate dehydrogenase (decarboxylating) activity 4 1.7 1.24 -1.62 -1.03 -1.05 1.36 1.59
phosphoglycerate dehydrogenase activity 2 2.82 -1.08 -1.11 1.42 -1.05 1.77 -1.02
phosphoglycerate kinase activity 2 1.52 -1.04 -1.22 1.01 -1.05 1.8 -1.0
phosphoglycerate mutase activity 4 1.53 -1.02 -1.23 -1.07 -1.15 1.51 1.11
phospholipase activity 42 -2.02 -1.32 -1.4 -1.24 -1.44 -1.94 -1.19
lysophospholipase activity 5 -1.5 -1.08 -1.31 -1.5 -1.48 1.02 1.77
phospholipase A2 activity 10 1.72 -1.05 -1.16 -1.1 -1.05 -1.02 1.07
calcium-independent phospholipase A2 activity 2 1.71 1.33 1.36 1.12 1.41 1.4 1.33
phosphomevalonate kinase activity 1 2.16 -1.1 1.03 -1.13 1.06 2.2 1.18
phosphopantothenate--cysteine ligase activity 1 -1.95 1.39 1.68 1.01 1.49 -1.24 1.08
phosphopantothenoylcysteine decarboxylase activity 1 3.72 -1.03 1.39 1.15 1.52 2.47 1.16
phosphopyruvate hydratase activity 1 1.97 1.06 -1.39 -1.17 -1.32 2.59 1.17
phosphoribosylaminoimidazole carboxylase activity 2 -1.17 -1.46 -1.46 -1.15 -1.17 1.65 -1.07
phosphoribosylaminoimidazolesuccinocarboxamide synthase activity 2 -1.17 -1.46 -1.46 -1.15 -1.17 1.65 -1.07
phosphoribosylformylglycinamidine synthase activity 1 -1.91 1.54 -1.81 1.0 -1.5 -1.22 1.08
phosphoribosylaminoimidazolecarboxamide formyltransferase activity 1 -1.39 1.0 -1.49 -1.01 -1.06 1.63 -1.09
phosphorylase activity 1 2.98 -1.08 1.5 -1.31 1.12 4.86 1.33
phosphoserine phosphatase activity 1 2.48 1.99 -2.53 -1.16 1.91 2.86 1.87
O-phospho-L-serine:2-oxoglutarate aminotransferase activity 1 2.63 -1.02 -1.9 1.11 -1.04 2.51 1.93
poly(ADP-ribose) glycohydrolase activity 1 1.16 1.03 1.19 1.34 1.67 -1.1 1.01
polynucleotide 5'-phosphatase activity 1 1.69 1.28 1.3 1.3 1.17 1.5 1.34
polypeptide N-acetylgalactosaminyltransferase activity 14 -1.29 -1.23 -1.25 -1.28 -1.26 -1.61 1.75
porphobilinogen synthase activity 1 -2.33 1.65 -1.72 1.07 -2.09 -1.28 -1.14
iron ion transport 7 1.59 -1.3 -1.22 -1.23 -1.14 1.5 1.12
proline dehydrogenase activity 1 2.07 -7.1 -4.47 -7.74 -3.15 31.25 -1.33
protein farnesyltransferase activity 1 -1.83 -1.28 -1.22 1.05 -1.01 -1.04 2.75
protein geranylgeranyltransferase activity 6 -1.57 1.19 1.22 1.14 1.21 -1.62 1.21
CAAX-protein geranylgeranyltransferase activity 2 -2.28 1.15 1.11 1.06 1.05 -2.22 1.78
protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity 1 -2.13 1.18 1.09 1.41 1.8 -1.71 -1.76
protein histidine kinase activity 3 1.12 -1.13 1.03 -1.08 1.69 1.52 -1.14
transmembrane receptor protein serine/threonine kinase activity 5 -1.03 1.52 1.48 1.18 1.61 1.07 1.49
DNA-dependent protein kinase activity 1 1.33 1.54 1.93 1.1 1.72 1.13 1.74
calmodulin-dependent protein kinase activity 8 2.03 1.07 1.21 1.02 1.3 2.02 1.5
elongation factor-2 kinase activity 2 1.62 1.17 1.62 -1.04 1.48 1.47 1.77
myosin light chain kinase activity 4 1.66 -1.14 1.36 -1.04 1.61 1.38 1.02
phosphorylase kinase activity 1 1.92 1.23 1.07 1.1 1.35 3.19 1.58
cyclic nucleotide-dependent protein kinase activity 6 -1.04 -1.05 1.23 -1.15 1.2 2.46 1.34
cAMP-dependent protein kinase activity 3 1.72 -1.04 1.4 -1.32 1.33 4.14 1.26
cGMP-dependent protein kinase activity 3 -1.85 -1.05 1.07 1.01 1.09 1.46 1.42
protein kinase C activity 7 1.66 -1.04 1.77 -1.14 1.06 2.51 1.12
calcium-dependent protein kinase C activity 3 1.12 1.04 2.13 -1.07 1.01 3.21 -1.04
G-protein coupled receptor kinase activity 3 1.16 1.4 1.53 1.09 1.29 1.52 1.29
JUN kinase activity 2 -1.09 1.03 1.52 1.15 1.41 -1.08 1.01
JUN kinase kinase kinase activity 2 1.23 1.27 1.56 1.2 1.54 1.23 1.3
MAP kinase kinase kinase activity 5 -1.39 1.21 1.48 1.15 1.82 1.09 1.04
MAPK/ERK kinase kinase activity 1 1.83 1.46 1.17 -1.02 1.24 1.79 1.33
ribosomal protein S6 kinase activity 1 -2.62 1.78 1.7 1.33 1.66 1.52 1.3
transmembrane receptor protein tyrosine kinase activity 21 1.55 -1.07 1.14 -1.01 1.13 1.58 1.42
non-membrane spanning protein tyrosine kinase activity 7 1.37 1.16 1.77 1.12 1.46 1.64 1.42
protein-L-isoaspartate (D-aspartate) O-methyltransferase activity 1 2.93 1.03 1.2 1.19 1.05 1.97 1.02
calcium-dependent protein serine/threonine phosphatase activity 6 1.52 -1.02 1.2 1.05 1.13 1.24 1.06
prenylated protein tyrosine phosphatase activity 1 1.54 1.27 2.19 -1.23 1.74 3.0 1.51
receptor signaling protein tyrosine phosphatase activity 3 2.8 -1.06 1.33 -1.06 1.35 3.49 1.47
pseudouridylate synthase activity 3 1.57 1.31 1.17 1.55 1.45 1.03 1.08
pyridoxamine-phosphate oxidase activity 3 1.93 1.06 -1.17 1.32 1.07 1.07 -1.07
pyrroline-5-carboxylate reductase activity 2 -1.77 1.27 -1.94 1.07 -1.03 -1.14 -1.01
pyruvate carboxylase activity 1 2.41 -1.07 -1.67 1.11 -2.11 1.65 1.08
pyruvate dehydrogenase activity 3 -1.02 1.01 1.31 1.1 -1.0 1.57 -1.25
pyruvate dehydrogenase (acetyl-transferring) activity 3 -1.02 1.01 1.31 1.1 -1.0 1.57 -1.25
pyruvate dehydrogenase (acetyl-transferring) kinase activity 1 1.67 -1.54 1.2 -1.13 7.02 3.44 1.09
[pyruvate dehydrogenase (lipoamide)] phosphatase activity 1 1.78 1.13 1.46 1.23 1.08 1.92 1.02
dihydrolipoyllysine-residue acetyltransferase activity 1 1.23 1.19 1.96 -1.07 1.35 3.33 1.11
ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor 2 -2.27 -1.06 1.44 1.36 1.87 -1.61 -1.54
ribose phosphate diphosphokinase activity 2 2.41 1.04 1.7 -1.06 1.1 2.9 1.34
ribulose-phosphate 3-epimerase activity 1 3.69 1.12 -1.44 1.15 1.15 1.38 1.6
ribose-5-phosphate isomerase activity 1 2.8 1.42 -1.73 1.16 1.1 1.26 1.25
saccharopine dehydrogenase activity 1 1.21 1.36 -1.07 1.24 -1.06 1.55 1.4
saccharopine dehydrogenase (NAD+, L-lysine-forming) activity 1 1.21 1.36 -1.07 1.24 -1.06 1.55 1.4
selenide, water dikinase activity 2 1.76 1.25 1.23 1.04 1.04 1.62 -1.07
sepiapterin reductase activity 3 2.14 -1.76 -1.79 -1.65 -1.36 2.93 -1.29
serine C-palmitoyltransferase activity 2 -2.24 1.07 2.48 1.17 1.31 -1.71 -1.18
serine-pyruvate transaminase activity 1 1.1 -1.81 -2.08 -1.81 -1.6 3.21 -1.83
sphingomyelin phosphodiesterase activity 5 -5.07 -3.51 -4.56 1.49 -1.12 -3.62 -4.08
stearoyl-CoA 9-desaturase activity 7 -1.4 1.15 -1.2 1.26 1.01 -1.67 -1.18
sterol esterase activity 1 -139.1 -18.6 -1.99 2.08 -24.32 -152.96 -197.4
sterol O-acyltransferase activity 3 -2.3 -1.64 -1.24 1.46 1.26 -1.59 -2.16
succinate-semialdehyde dehydrogenase activity 1 -2.19 1.37 2.06 1.34 1.0 1.58 -1.11
sulfate adenylyltransferase activity 1 -2.63 1.06 1.41 1.07 1.11 -1.64 -1.02
sulfate adenylyltransferase (ATP) activity 1 -2.63 1.06 1.41 1.07 1.11 -1.64 -1.02
sulfinoalanine decarboxylase activity 1 -1.56 1.66 -7.28 1.14 -1.03 -3.47 1.18
thiosulfate sulfurtransferase activity 1 1.15 -1.38 2.62 1.38 1.04 -1.42 -1.83
threonine aldolase activity 1 1.44 -1.1 -1.93 1.6 -1.06 1.8 -2.26
L-threonine ammonia-lyase activity 1 -3.81 -2.74 -2.14 -1.15 11.07 -1.69 -3.46
thymidylate kinase activity 1 1.27 1.13 1.91 1.21 1.41 -1.17 -1.08
thymidylate synthase activity 1 -1.63 -1.08 1.19 1.46 1.72 -2.2 -2.17
sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity 1 3.18 1.11 -3.27 1.02 -1.44 -1.1 1.46
transketolase activity 2 2.03 1.17 -1.56 1.02 1.12 1.44 1.62
trehalose-phosphatase activity 2 5.88 -2.14 -1.49 -1.62 1.02 4.6 1.12
triglyceride lipase activity 38 -3.83 -1.33 -1.88 -1.09 -1.77 -4.41 -2.22
aspartate-tRNA ligase activity 1 -1.97 1.61 1.28 -1.18 1.45 -1.88 1.38
cysteine-tRNA ligase activity 2 -1.01 1.37 1.43 1.08 1.22 1.24 1.76
histidine-tRNA ligase activity 1 -1.32 1.37 -1.07 1.31 -1.14 -1.74 -1.19
isoleucine-tRNA ligase activity 2 1.35 1.22 1.54 1.02 1.38 1.61 1.38
methionine-tRNA ligase activity 2 -1.59 1.18 1.28 1.38 1.17 -1.27 -1.03
threonine-tRNA ligase activity 2 -1.65 1.24 1.06 1.13 -1.08 -1.17 1.02
valine-tRNA ligase activity 2 -1.62 1.31 1.29 1.15 1.04 -1.25 1.17
tryptophan 2,3-dioxygenase activity 1 1.33 -1.46 -1.36 -1.56 -1.39 2.84 -1.33
tyrosine decarboxylase activity 2 2.12 -1.17 -1.18 -1.17 1.11 1.9 -1.07
ubiquitin activating enzyme activity 3 1.07 1.19 1.42 1.25 1.55 1.31 1.05
ubiquitin-specific protease activity 8 1.17 1.21 1.8 1.18 1.58 1.96 1.41
uracil DNA N-glycosylase activity 2 2.91 -1.23 -1.13 -1.34 1.04 2.88 1.17
uracil phosphoribosyltransferase activity 1 1.85 1.12 1.41 1.03 1.01 1.67 1.33
urate oxidase activity 1 3.87 -2.08 -2.11 -2.0 -1.26 -1.05 -1.64
uridine kinase activity 2 4.18 -1.72 1.72 -1.65 -1.27 3.76 1.43
uridine phosphorylase activity 3 -2.2 -1.73 1.35 -1.47 -1.37 -2.19 1.39
uroporphyrinogen decarboxylase activity 1 2.27 -1.08 -1.25 1.43 1.04 1.18 1.26
xanthine dehydrogenase activity 2 1.25 1.78 -1.17 -1.32 -1.19 -1.3 1.66
xanthine oxidase activity 1 1.38 1.39 -1.09 1.59 1.39 -1.89 1.34
cyclin-dependent protein kinase inhibitor activity 2 1.97 -1.0 1.05 1.02 1.15 1.58 1.04
protein phosphatase inhibitor activity 7 1.59 -1.08 -1.01 -1.03 1.27 1.27 -1.01
protein serine/threonine phosphatase inhibitor activity 1 1.57 1.1 -1.11 1.22 1.13 -1.01 -1.25
endopeptidase inhibitor activity 73 1.41 -1.48 -1.45 -1.49 -1.3 1.51 1.04
serine-type endopeptidase inhibitor activity 58 1.2 -1.48 -1.57 -1.54 -1.37 1.38 -1.05
cysteine-type endopeptidase inhibitor activity 6 3.11 -1.78 -1.05 -1.54 -1.18 1.44 1.41
carbohydrate binding 166 -1.92 -1.36 -1.53 -1.23 -1.33 -1.85 -1.01
boss receptor activity 1 2.09 -1.24 -1.34 -1.08 -1.33 -1.62 1.07
Wnt-activated receptor activity 5 1.17 1.03 1.52 -1.14 1.66 -1.04 1.31
Wnt receptor signaling pathway, calcium modulating pathway 2 1.15 1.15 1.16 1.02 1.3 1.14 2.54
calcitonin receptor activity 5 1.36 -1.25 1.11 -1.21 1.02 -1.07 1.56
N-methyl-D-aspartate selective glutamate receptor activity 5 -2.2 1.03 -1.01 -1.04 -1.02 -1.52 1.05
neuropeptide Y receptor activity 6 -1.12 -1.28 1.15 -1.08 1.23 2.07 -1.01
tachykinin receptor activity 6 -1.02 -1.12 1.07 -1.2 -1.05 1.79 1.44
transmembrane receptor protein tyrosine phosphatase activity 6 1.57 1.05 1.23 1.03 1.35 2.22 1.25
ephrin receptor activity 1 2.31 1.1 1.68 1.08 2.32 2.06 2.34
epidermal growth factor-activated receptor activity 1 2.54 -1.11 -1.09 1.14 1.59 3.23 1.89
fibroblast growth factor-activated receptor activity 3 1.8 -1.38 2.01 1.04 -1.27 -1.03 -1.21
insulin-activated receptor activity 1 1.01 1.43 1.57 1.5 2.27 1.72 1.64
insulin-like growth factor-activated receptor activity 2 -1.08 -1.38 -1.23 -1.3 -1.24 5.4 3.24
growth factor binding 5 -1.0 1.2 1.22 1.22 1.63 1.18 1.29
transforming growth factor beta-activated receptor activity 5 -1.03 1.52 1.48 1.18 1.61 1.07 1.49
transforming growth factor beta receptor activity, type I 3 -1.44 1.44 1.63 1.24 1.98 1.37 1.58
transforming growth factor beta receptor activity, type II 2 1.6 1.65 1.28 1.09 1.17 -1.35 1.36
tumor necrosis factor-activated receptor activity 1 10.08 -2.23 1.27 -2.86 -1.97 3.13 1.07
osmosensor activity 1 -6.38 -3.77 -11.1 -5.2 -1.19 28.07 -1.66
death receptor activity 1 10.08 -2.23 1.27 -2.86 -1.97 3.13 1.07
death receptor binding 1 1.78 1.11 1.56 1.24 1.76 -1.03 1.11
netrin receptor activity 2 -1.2 1.24 1.26 1.34 2.11 -1.46 1.04
KDEL sequence binding 1 -1.48 1.27 1.01 1.14 -1.01 -1.37 1.53
nuclear export signal receptor activity 3 1.18 1.05 2.95 1.07 1.92 2.19 1.34
peroxisome 39 1.3 -1.06 -1.53 1.05 1.16 -1.5 -1.16
peroxisomal membrane 14 1.87 1.14 -1.32 1.28 1.36 -1.33 -1.09
laminin receptor activity 1 -9.63 1.35 1.66 1.05 1.52 -7.44 1.13
transforming growth factor beta receptor, cytoplasmic mediator activity 4 1.26 1.21 1.59 1.07 1.32 1.36 1.28
transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity 1 2.8 1.17 2.77 -1.14 1.51 2.43 1.42
transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity 1 -2.15 1.12 -1.08 1.29 -1.07 -2.29 1.33
protein kinase A binding 3 -1.23 1.19 1.19 1.03 1.27 1.0 1.5
protein kinase C binding 5 1.76 1.33 1.56 1.07 1.48 1.92 1.83
guanyl-nucleotide exchange factor activity 52 1.11 1.15 1.38 1.01 1.29 1.52 1.26
ARF guanyl-nucleotide exchange factor activity 6 -1.22 1.21 1.27 -1.01 1.25 1.49 1.58
GDP-dissociation inhibitor activity 2 -1.01 -1.04 1.34 1.09 1.21 -1.08 -1.54
Rho GDP-dissociation inhibitor activity 1 -1.46 -1.08 1.63 1.09 1.3 -1.27 -1.71
Ran GTPase activator activity 1 1.34 1.36 1.62 1.42 1.91 1.35 1.2
fibroblast growth factor receptor binding 3 1.57 1.01 2.07 -1.12 1.29 2.72 1.05
ephrin receptor binding 1 1.81 1.29 1.78 1.1 1.94 2.77 1.53
anchored to plasma membrane 3 3.1 -2.01 -3.22 -2.43 -1.37 2.44 1.37
frizzled binding 3 -1.65 -1.07 1.18 -1.29 1.31 1.28 1.51
frizzled-2 binding 2 -1.8 1.01 1.43 -1.3 -1.11 1.61 2.1
patched binding 2 -1.41 -1.16 1.11 1.42 1.34 -1.32 -2.31
sevenless binding 2 2.05 1.08 1.52 1.1 1.59 1.98 1.31
smoothened binding 1 1.33 1.48 1.27 1.38 1.17 1.23 1.56
Toll binding 6 2.0 -1.13 -1.18 -1.1 -1.05 3.64 1.27
torso binding 2 4.82 -2.22 -1.24 -1.06 1.12 2.59 1.13
cytokine activity 3 2.09 -1.14 -1.06 -1.07 1.06 1.89 1.58
epidermal growth factor receptor binding 8 2.02 -1.02 1.33 1.03 1.43 2.13 1.51
positive regulation of epidermal growth factor-activated receptor activity 1 -1.21 1.16 2.16 -1.11 1.4 1.68 1.37
insulin-like growth factor receptor binding 1 2.22 1.3 2.31 -1.1 1.87 2.8 1.91
transforming growth factor beta receptor binding 7 1.67 1.01 -1.0 -1.48 -1.16 1.33 1.27
tumor necrosis factor receptor binding 1 1.09 -1.11 -1.93 -1.35 4.12 -1.38 6.18
hormone activity 52 -1.48 -1.33 -1.19 -1.09 -1.16 -1.59 -1.16
neuropeptide hormone activity 35 -1.76 -1.5 -1.27 -1.18 -1.19 -1.89 -1.23
structural constituent of cell wall 2 4.29 -1.81 -1.38 -1.64 -1.67 1.06 1.01
collagen 3 1.14 -1.43 1.08 -1.25 -1.21 1.82 -1.14
structural constituent of eye lens 1 -23.09 -8.59 -4.86 2.62 -1.02 -36.83 -31.54
intracellular ligand-gated ion channel activity 7 1.42 1.03 1.28 1.0 1.1 1.59 1.16
intracellular ligand-gated calcium channel activity 3 1.97 -1.03 1.18 1.08 1.09 1.76 1.17
ryanodine-sensitive calcium-release channel activity 1 3.82 -1.03 1.3 -1.12 1.16 2.73 1.18
inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity 1 2.52 1.29 3.07 -1.16 1.37 5.13 2.97
volume-sensitive anion channel activity 2 1.92 1.08 -1.06 -1.08 2.11 2.25 1.09
calcium activated cation channel activity 3 -1.25 -1.55 1.25 1.49 -1.39 -1.46 -1.49
inhibitory extracellular ligand-gated ion channel activity 4 -1.54 1.26 1.47 -1.43 -1.72 -1.63 -1.04
inward rectifier potassium channel activity 4 -1.18 -1.13 -1.58 -3.21 -3.46 1.87 -1.7
gap junction channel activity 6 -1.73 -1.09 -1.05 -1.09 -1.25 -1.21 1.35
voltage-gated chloride channel activity 3 -1.31 1.23 -1.16 1.19 1.05 1.88 1.52
A-type (transient outward) potassium channel activity 2 3.38 -1.08 1.04 -1.08 1.22 1.8 -1.38
open rectifier potassium channel activity 3 2.34 -1.1 -1.13 -1.16 1.03 1.04 -1.38
amine transmembrane transporter activity 58 -1.3 -1.08 -1.61 -1.23 -1.04 -1.08 -1.11
hydrogen:amino acid symporter activity 2 1.74 1.43 -1.72 -1.09 1.17 -1.0 1.38
amino acid transmembrane transporter activity 53 -1.39 -1.07 -1.67 -1.24 -1.03 -1.11 -1.1
L-tyrosine transmembrane transporter activity 2 3.0 -1.1 1.15 -1.28 -1.42 2.49 1.13
organic acid:sodium symporter activity 8 -1.17 1.19 -1.85 -1.42 -1.96 -1.64 1.15
L-glutamate transmembrane transporter activity 4 -2.07 1.33 -5.17 -2.48 -1.62 -1.72 -2.15
high-affinity glutamate transmembrane transporter activity 1 -51.3 1.56 -15.93 -1.24 2.78 -3.27 -134.18
inorganic phosphate transmembrane transporter activity 3 2.26 -1.45 1.37 -1.34 1.47 3.74 -1.03
high affinity inorganic phosphate:sodium symporter activity 18 -3.67 1.02 -3.81 -1.03 -1.98 -1.81 -2.84
neurotransmitter transporter activity 24 1.11 -1.3 -1.53 -1.28 1.11 1.77 1.29
neurotransmitter:sodium symporter activity 18 1.0 -1.4 -1.72 -1.34 1.19 1.93 1.23
sugar:hydrogen symporter activity 8 1.06 -1.15 -1.17 -1.12 -1.18 -1.05 1.82
glucose transmembrane transporter activity 15 -1.29 -1.15 -1.91 -1.13 -1.42 -1.88 1.23
tricarboxylate secondary active transmembrane transporter activity 3 -1.58 1.64 -1.92 -1.18 -1.42 1.07 1.16
water transmembrane transporter activity 7 -2.13 1.26 -1.34 -1.07 -2.07 -2.5 -1.23
secondary active transmembrane transporter activity 155 -1.44 -1.11 -1.62 -1.18 -1.13 1.21 -1.17
manganese ion transmembrane transporter activity 2 -1.53 1.28 -1.11 1.02 -1.23 -1.54 1.12
sodium:potassium-exchanging ATPase activity 8 1.13 -1.11 1.22 -1.35 -1.0 1.53 1.06
cation:sugar symporter activity 8 1.06 -1.15 -1.17 -1.12 -1.18 -1.05 1.82
nucleoside:sodium symporter activity 2 -7.59 1.47 -2.97 -1.0 -2.3 -5.85 -2.0
cation:amino acid symporter activity 13 1.13 -1.27 -2.32 -1.57 1.11 1.18 1.23
proton-dependent oligopeptide secondary active transmembrane transporter activity 3 1.69 -1.17 -1.51 -1.15 -1.07 1.17 1.2
synaptic vesicle amine transmembrane transporter activity 1 9.63 -2.21 -1.97 -1.79 -1.94 -1.46 -1.99
calcium:sodium antiporter activity 2 -1.37 1.7 1.3 -1.23 1.65 2.01 1.96
sodium:phosphate symporter activity 21 -3.19 1.03 -3.12 -1.03 -1.89 -1.53 -2.45
monovalent cation:hydrogen antiporter activity 4 -2.37 -1.01 -1.35 1.01 -1.74 3.33 -1.27
inorganic anion exchanger activity 2 -3.68 -3.74 3.73 -4.0 -1.27 -1.18 -1.53
CMP-N-acetylneuraminate transmembrane transporter activity 3 -1.73 1.25 -1.03 1.28 -1.06 -1.84 1.23
UDP-galactose transmembrane transporter activity 6 -1.21 1.24 1.0 1.15 1.18 -1.35 1.53
UDP-glucuronic acid transmembrane transporter activity 4 -1.46 1.25 1.0 1.26 1.04 -1.57 1.43
UDP-N-acetylgalactosamine transmembrane transporter activity 2 -2.31 1.25 -1.08 1.21 1.09 -2.5 1.48
UDP-xylose transmembrane transporter activity 3 -1.4 1.3 1.05 1.18 -1.06 -1.45 1.9
carnitine:acyl carnitine antiporter activity 2 1.34 1.32 -1.91 1.22 1.14 -1.7 -1.23
synaptic vesicle to endosome fusion 1 1.73 -1.06 2.32 1.09 1.39 3.26 1.36
synaptic vesicle targeting 9 1.07 1.25 1.5 1.16 1.39 1.39 1.23
soluble NSF attachment protein activity 6 1.55 1.06 1.18 1.07 1.23 1.28 1.16
steroid binding 19 -2.28 -1.49 -1.79 1.11 -1.16 -2.3 -2.31
retinoid binding 8 2.32 -6.6 -7.06 -2.49 -1.68 1.78 1.1
fatty acid binding 11 -1.61 -1.59 -2.07 -1.15 1.3 -1.68 -1.56
copper ion binding 20 -1.87 -1.23 -1.09 -1.21 -1.25 -1.59 1.03
detection of calcium ion 3 -1.58 -1.06 -1.06 1.03 1.08 -1.26 -1.33
cytoskeletal regulatory protein binding 1 -1.55 1.24 2.16 1.01 1.73 1.49 1.71
tropomyosin binding 3 5.21 -1.74 1.31 -1.52 1.36 3.43 -1.33
galactose binding 11 -1.6 -1.21 1.22 -1.04 -1.07 -1.49 -1.08
folic acid binding 4 -1.96 -1.02 -2.85 1.48 -1.35 -1.15 -2.07
phosphatidylinositol-4,5-bisphosphate binding 2 -1.07 1.2 1.71 1.09 1.37 1.09 1.1
protein tag 2 2.12 -1.08 -1.18 1.19 1.03 -1.14 1.1
collagen type IV 2 1.15 -1.7 -1.07 -1.48 -1.42 2.42 -1.33
basement membrane 10 1.55 -1.19 1.13 -1.32 1.1 2.13 1.42
basal lamina 3 2.42 -1.01 1.11 -1.14 1.47 4.1 1.43
laminin-1 complex 1 3.52 1.3 1.81 1.23 2.46 6.46 1.6
integrin complex 8 -1.75 1.03 1.23 -1.07 1.36 -1.33 1.18
interstitial matrix 1 -3.11 1.08 3.33 -1.03 2.28 -1.55 -1.14
nuclear inner membrane 7 1.5 -1.14 1.37 1.22 1.72 1.02 -1.06
integral to nuclear inner membrane 2 -1.02 -2.05 1.59 1.21 2.03 -1.95 -2.17
nuclear outer membrane 1 2.5 -1.28 -1.45 -1.24 1.61 3.68 4.91
nuclear envelope lumen 2 1.16 1.03 1.1 1.15 1.11 1.57 -1.14
Ran GTPase binding 7 -1.02 1.21 1.82 1.21 1.53 1.48 1.33
nucleolar ribonuclease P complex 1 1.84 1.03 1.1 1.42 1.17 1.05 -1.14
pre-replicative complex 9 -1.14 1.11 1.17 1.27 1.56 -1.1 -1.11
DNA replication factor C complex 5 1.37 1.06 1.26 1.45 1.6 1.11 -1.08
PCNA complex 2 -1.29 1.09 1.33 1.22 1.3 -1.6 -1.28
DNA replication factor A complex 3 1.13 1.13 1.31 1.42 1.65 1.03 -1.21
transcription factor TFIIE complex 2 1.86 1.06 1.16 1.23 1.25 1.2 1.16
chromatin assembly complex 8 1.08 -1.4 -1.04 -1.4 1.24 1.6 1.04
U12 snRNP 1 1.7 -1.05 -1.07 -1.09 -1.18 1.33 1.14
nuclear euchromatin 4 1.52 1.39 1.51 1.2 1.41 1.55 1.43
beta-heterochromatin 1 1.4 1.27 1.49 -1.01 1.2 1.7 1.58
nuclear telomeric heterochromatin 1 -1.17 1.26 1.25 1.08 2.11 -1.1 1.25
mitochondrial respiratory chain 68 1.11 1.0 1.19 1.01 1.07 1.57 -1.31
mitochondrial respiratory chain complex I 37 1.15 1.04 1.27 1.07 1.11 1.72 -1.29
mitochondrial proton-transporting ATP synthase complex 18 1.31 -1.01 1.22 -1.03 1.11 1.68 -1.22
proton-transporting ATP synthase complex, coupling factor F(o) 9 1.19 1.04 1.31 1.01 1.22 1.62 -1.14
mitochondrial proton-transporting ATP synthase, central stalk 1 1.03 1.03 1.17 1.01 1.11 1.58 -1.38
mitochondrial ribosome 72 1.04 1.07 1.23 1.29 1.25 1.45 -1.55
mitochondrial large ribosomal subunit 44 1.03 1.05 1.24 1.3 1.28 1.46 -1.6
lysosomal membrane 4 1.09 -1.11 -1.38 1.13 1.63 2.55 1.04
secondary lysosome 1 1.17 -2.03 2.67 -1.12 -2.24 1.02 -1.06
multivesicular body 6 -1.01 1.0 1.49 1.07 1.26 1.31 1.59
vacuolar membrane 30 -1.55 -1.0 1.28 -1.14 -1.08 1.41 -1.12
integral to peroxisomal membrane 5 1.37 1.29 -1.51 1.15 1.08 -1.33 -1.13
protein targeting to peroxisome 3 1.5 1.17 -1.6 1.44 1.46 -2.19 -1.64
peroxisomal part 14 1.87 1.14 -1.32 1.28 1.36 -1.33 -1.09
Sec61 translocon complex 8 -1.51 1.3 -1.14 -1.0 -1.28 -1.7 1.22
signal recognition particle receptor complex 4 -1.91 1.42 -1.08 1.06 -1.35 -1.79 1.42
signal recognition particle, endoplasmic reticulum targeting 9 -1.25 1.37 1.01 1.14 -1.09 -1.57 1.26
signal peptidase complex 3 1.12 -1.0 1.0 -1.02 -1.02 -1.01 1.75
smooth endoplasmic reticulum 5 2.12 -1.15 1.68 -1.13 1.04 1.12 1.23
rough endoplasmic reticulum 15 -1.44 1.23 -1.0 1.01 -1.26 -1.5 1.29
endoplasmic reticulum-Golgi intermediate compartment 1 -1.08 1.49 -1.64 1.02 -1.4 -2.11 -1.11
ER to Golgi transport vesicle 4 1.31 1.22 1.29 1.04 1.28 1.43 2.03
trans-Golgi network 6 -1.72 1.13 1.32 1.15 1.37 1.03 1.11
transport vesicle 15 1.23 1.06 1.2 -1.01 1.17 1.53 1.45
transport vesicle membrane 4 -1.16 1.25 1.59 1.05 1.44 1.76 1.54
actomyosin contractile ring 4 -1.06 1.15 1.51 1.14 1.77 1.47 1.16
polysome 1 2.2 1.38 1.27 1.25 1.7 1.45 1.27
mRNA cap binding complex 2 1.35 1.18 1.45 1.11 1.5 1.76 1.35
mRNA cleavage and polyadenylation specificity factor complex 7 1.3 1.31 1.42 1.47 1.64 1.34 1.15
eukaryotic translation initiation factor 3 complex 16 1.44 1.14 1.33 1.03 1.2 1.61 1.17
eukaryotic translation elongation factor 1 complex 5 2.72 -1.02 1.29 -1.13 1.23 1.37 1.32
nascent polypeptide-associated complex 3 1.55 -1.11 1.12 1.0 1.05 1.16 1.07
muscle myosin complex 5 4.08 -1.62 1.08 -1.52 1.03 2.86 -1.26
troponin complex 2 6.95 -2.33 -1.12 -1.86 1.08 3.33 -1.76
muscle thin filament tropomyosin 2 3.23 -1.38 1.31 -1.15 1.21 2.24 -1.26
striated muscle myosin thick filament 3 2.91 -1.49 1.05 -1.32 1.04 2.39 -1.29
striated muscle thin filament 5 3.24 -1.5 1.09 -1.38 1.25 2.3 -1.28
nuclear microtubule 1 1.51 1.15 1.47 1.1 1.35 1.02 -1.14
Arp2/3 protein complex 5 -3.04 -1.69 -1.35 1.45 1.29 -2.9 -1.36
sodium:potassium-exchanging ATPase complex 8 1.13 -1.11 1.22 -1.35 -1.0 1.53 1.06
insulin receptor complex 1 1.01 1.43 1.57 1.5 2.27 1.72 1.64
caveola 1 3.68 -1.06 -1.03 1.16 1.0 1.99 -1.04
microvillus 5 1.36 1.2 1.61 -1.02 1.17 1.09 1.29
brush border 3 -22.7 -1.04 -2.81 1.01 -1.94 1.91 -2.7
cell-cell junction 66 1.52 -1.07 1.19 -1.11 1.18 1.85 1.41
cell-cell adherens junction 13 1.51 1.27 1.67 1.06 1.61 1.75 1.74
spot adherens junction 4 1.12 1.24 1.44 1.07 1.52 1.53 1.48
zonula adherens 9 1.2 1.26 1.62 1.08 1.63 1.49 1.6
nephrocyte diaphragm 3 -3.44 1.01 1.01 1.15 1.01 -2.84 -1.29
septate junction 22 2.96 -1.28 1.21 -1.34 1.26 3.68 1.76
pleated septate junction 3 3.11 -1.4 1.27 -1.39 1.24 4.46 1.69
gap junction 8 -1.22 -1.27 -1.23 -1.25 -1.39 1.09 1.54
tight junction 4 1.14 1.05 1.46 1.03 1.1 1.55 1.04
connecting hemi-adherens junction 1 1.1 1.42 2.42 1.36 2.63 2.12 3.14
muscle tendon junction 5 2.04 -1.05 1.1 -1.07 -1.09 1.36 1.08
septin ring 5 -1.56 1.08 1.09 1.16 1.34 -1.29 1.06
phosphatidylinositol 3-kinase complex 4 -1.6 1.29 1.4 1.19 1.74 -1.12 -1.04
1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex 2 -1.54 1.47 1.35 1.15 1.83 1.07 1.48
6-phosphofructokinase complex 1 2.63 -1.22 -1.22 1.02 -1.12 5.11 1.3
mitochondrial alpha-ketoglutarate dehydrogenase complex 1 -1.4 -1.14 2.27 -1.25 -1.48 1.94 -1.5
cAMP-dependent protein kinase complex 6 1.3 1.06 1.3 -1.12 1.18 1.98 1.03
calcium- and calmodulin-dependent protein kinase complex 2 1.81 1.24 1.48 1.18 1.44 2.31 1.51
calcineurin complex 5 1.63 -1.01 1.24 1.04 1.14 1.3 1.06
DNA-dependent protein kinase-DNA ligase 4 complex 2 -1.03 1.29 1.58 1.29 1.51 -1.21 1.27
glycine cleavage complex 4 1.1 -1.07 1.31 -1.13 -1.08 2.33 -1.17
mitochondrial isocitrate dehydrogenase complex (NAD+) 1 -1.07 1.16 -1.05 -1.13 1.15 1.71 1.06
phosphorylase kinase complex 3 1.8 1.28 1.21 1.07 1.13 2.26 1.63
protein farnesyltransferase complex 1 -1.83 -1.28 -1.22 1.05 -1.01 -1.04 2.75
mitochondrial pyruvate dehydrogenase complex 1 1.23 1.19 1.96 -1.07 1.35 3.33 1.11
ribonucleoside-diphosphate reductase complex 2 -2.27 -1.06 1.44 1.36 1.87 -1.61 -1.54
polysaccharide metabolic process 131 -1.49 -1.56 -1.71 -1.43 -1.46 -1.36 1.27
glycogen metabolic process 9 2.15 1.01 -1.12 1.0 1.05 2.73 1.34
glycogen biosynthetic process 5 2.74 -1.19 -1.42 1.04 1.07 2.78 1.29
glycogen catabolic process 1 2.98 -1.08 1.5 -1.31 1.12 4.86 1.33
disaccharide metabolic process 5 2.21 -1.79 -2.13 -1.71 -1.22 2.7 -1.01
trehalose metabolic process 5 2.21 -1.79 -2.13 -1.71 -1.22 2.7 -1.01
trehalose biosynthetic process 3 3.57 -2.83 -2.37 -2.36 -1.16 5.45 -1.46
monosaccharide metabolic process 74 -1.39 -1.01 -1.54 1.02 -1.04 -1.38 -1.41
fructose metabolic process 1 1.09 -1.34 2.59 -1.04 1.14 3.38 -1.06
fructose 2,6-bisphosphate metabolic process 1 1.09 -1.34 2.59 -1.04 1.14 3.38 -1.06
fucose metabolic process 4 -1.24 1.16 -1.09 -1.11 1.15 -1.73 2.16
L-fucose biosynthetic process 2 -1.67 1.21 1.13 1.24 1.36 -1.89 -1.14
glucose catabolic process 33 1.52 1.06 -1.18 -1.03 -1.06 1.37 1.2
galactose metabolic process 1 -2.18 1.44 -1.11 -1.39 1.11 -2.6 2.04
mannose metabolic process 11 -9.63 -1.07 -4.72 1.44 -1.08 -9.35 -13.32
inositol metabolic process 2 2.7 -2.43 -2.03 -2.2 -1.38 3.25 -1.23
inositol biosynthetic process 1 1.86 -1.46 -1.12 -1.51 1.13 1.83 1.71
aminoglycan metabolic process 120 -1.64 -1.63 -1.78 -1.48 -1.53 -1.5 1.27
aminoglycan catabolic process 29 -1.22 -1.95 -2.17 -1.68 -1.71 -1.1 1.4
glycosaminoglycan catabolic process 12 -1.13 -1.64 -1.19 -1.04 -1.82 -1.69 -1.29
chitin metabolic process 96 -1.91 -1.76 -2.05 -1.64 -1.62 -1.64 1.34
chitin biosynthetic process 4 1.85 -1.21 -1.08 -1.24 -1.23 2.11 1.33
chitin catabolic process 17 -1.28 -2.2 -3.31 -2.38 -1.64 1.24 2.14
cuticle chitin metabolic process 7 -1.6 -1.5 -2.17 -1.7 -1.06 1.36 1.67
cuticle chitin biosynthetic process 3 1.16 -1.14 1.05 -1.21 -1.11 2.09 1.42
cuticle chitin catabolic process 4 -2.55 -1.85 -4.04 -2.19 -1.03 -1.02 1.9
ethanol metabolic process 2 1.95 -1.28 -2.91 -1.89 1.06 1.72 1.15
ethanol oxidation 2 1.95 -1.28 -2.91 -1.89 1.06 1.72 1.15
cellular glucan metabolic process 9 2.15 1.01 -1.12 1.0 1.05 2.73 1.34
cellular aldehyde metabolic process 8 1.58 -1.07 -1.41 -1.33 -1.03 1.21 1.04
acetyl-CoA biosynthetic process from pyruvate 1 1.23 1.19 1.96 -1.07 1.35 3.33 1.11
pyruvate metabolic process 10 1.06 1.22 1.23 -1.11 1.04 1.51 1.12
generation of precursor metabolites and energy 140 1.11 1.05 1.13 1.0 1.09 1.53 -1.12
gluconeogenesis 4 1.09 -1.28 -1.21 -1.39 1.08 1.63 -1.02
glyoxylate cycle 1 1.5 1.55 -1.65 -1.56 -1.01 -1.09 1.26
pentose-phosphate shunt 7 2.13 1.17 -1.85 1.03 -1.09 1.03 1.53
tricarboxylic acid cycle 36 -1.0 1.09 1.26 -1.05 1.07 1.52 -1.04
2-oxoglutarate metabolic process 2 -1.13 -1.34 1.15 -1.41 1.89 2.28 -2.14
fumarate metabolic process 6 -1.06 -1.08 1.01 -1.19 1.09 1.49 -1.51
isocitrate metabolic process 1 1.5 1.55 -1.65 -1.56 -1.01 -1.09 1.26
regulation of carbohydrate metabolic process 3 -1.56 -1.05 -1.43 -1.32 1.05 1.6 2.11
energy reserve metabolic process 9 2.15 1.01 -1.12 1.0 1.05 2.73 1.34
NADH oxidation 1 -1.32 -1.9 1.3 -2.14 3.35 4.87 -4.48
acetaldehyde metabolic process 2 2.78 -1.16 -2.38 -2.31 -1.44 1.4 1.22
respiratory electron transport chain 63 1.04 1.03 1.18 1.06 1.12 1.53 -1.32
oxidative phosphorylation 65 1.08 1.05 1.19 1.05 1.1 1.53 -1.32
mitochondrial electron transport, NADH to ubiquinone 31 1.15 1.03 1.29 1.07 1.13 1.74 -1.29
mitochondrial electron transport, succinate to ubiquinone 3 -1.1 1.07 1.36 -1.03 -1.0 1.57 -1.31
glycerophosphate shuttle 2 1.11 -1.19 -1.41 1.22 2.52 1.34 -1.21
glutathione metabolic process 4 -2.31 1.0 -1.94 1.16 1.13 -1.72 1.13
ADP biosynthetic process 2 -1.29 -1.01 -1.04 1.37 1.42 -2.05 -1.57
GMP biosynthetic process 2 1.15 1.21 1.23 -1.01 1.16 1.11 2.05
IMP biosynthetic process 7 1.14 1.03 -1.12 -1.04 -1.13 1.95 -1.01
'de novo' IMP biosynthetic process 6 1.13 1.02 -1.2 -1.03 -1.2 1.78 -1.03
'de novo' pyrimidine base biosynthetic process 6 1.66 -1.0 1.02 -1.03 -1.03 1.11 1.08
pyrimidine base catabolic process 3 2.92 -1.42 -1.24 -1.35 -1.35 1.45 1.16
cytidine catabolic process 3 -2.8 1.04 -1.39 1.2 1.32 -1.87 -1.06
dTDP biosynthetic process 1 1.27 1.13 1.91 1.21 1.41 -1.17 -1.08
DNA ligation 2 1.6 1.14 1.36 1.04 1.35 1.44 1.13
pre-replicative complex assembly 7 -1.21 1.08 1.17 1.27 1.62 -1.3 -1.19
DNA strand elongation involved in DNA replication 3 -1.21 -1.08 1.4 1.14 1.61 -1.08 -1.25
leading strand elongation 1 -1.9 -1.01 1.54 1.17 1.67 -2.38 -1.41
RNA-dependent DNA replication 1 1.54 1.82 1.92 -1.04 1.87 1.15 2.39
base-excision repair 6 1.51 -1.01 1.25 1.11 1.19 1.33 -1.13
nucleotide-excision repair, DNA incision, 5'-to lesion 1 1.98 1.16 1.33 1.18 1.39 1.07 1.02
DNA dealkylation involved in DNA repair 1 1.12 -1.01 1.19 1.74 1.2 1.06 -1.09
DNA catabolic process 9 1.71 -1.1 1.05 -1.12 1.18 1.29 1.41
DNA fragmentation involved in apoptotic nuclear change 3 1.86 1.09 1.48 1.14 1.43 1.6 1.67
DNA replication-independent nucleosome assembly 1 -1.49 1.47 -1.04 1.39 1.42 -1.65 -1.06
chromatin-mediated maintenance of transcription 8 1.92 1.19 1.53 1.04 1.43 1.72 1.45
chromatin silencing at telomere 2 1.51 1.1 1.54 1.1 1.65 2.14 1.15
regulation of transcription from RNA polymerase III promoter 5 1.56 1.19 1.46 1.24 1.48 1.38 1.12
mRNA polyadenylation 16 1.4 1.12 1.26 1.13 1.32 1.72 1.2
adenosine to inosine editing 1 1.13 1.14 1.55 1.01 1.4 2.0 1.26
tRNA splicing, via endonucleolytic cleavage and ligation 3 1.93 1.15 1.42 1.2 1.36 1.44 1.34
transcription from mitochondrial promoter 3 1.29 1.23 1.41 1.12 1.47 1.73 -1.1
snRNA export from nucleus 2 1.9 1.18 1.33 1.29 1.62 1.23 1.13
tRNA export from nucleus 1 1.48 1.1 1.33 1.32 1.54 -1.18 -1.04
translational termination 6 1.2 1.18 1.21 1.16 1.16 1.51 1.06
aspartyl-tRNA aminoacylation 1 -1.97 1.61 1.28 -1.18 1.45 -1.88 1.38
cysteinyl-tRNA aminoacylation 2 -1.01 1.37 1.43 1.08 1.22 1.24 1.76
glutamyl-tRNA aminoacylation 2 1.05 1.23 1.54 -1.01 1.6 1.42 1.27
histidyl-tRNA aminoacylation 1 -1.32 1.37 -1.07 1.31 -1.14 -1.74 -1.19
isoleucyl-tRNA aminoacylation 2 1.35 1.22 1.54 1.02 1.38 1.61 1.38
methionyl-tRNA aminoacylation 2 -1.59 1.18 1.28 1.38 1.17 -1.27 -1.03
threonyl-tRNA aminoacylation 2 -1.65 1.24 1.06 1.13 -1.08 -1.17 1.02
valyl-tRNA aminoacylation 2 -1.62 1.31 1.29 1.15 1.04 -1.25 1.17
regulation of translational initiation 10 1.76 -1.0 1.08 -1.04 1.23 1.53 1.27
regulation of translational initiation by iron 2 1.36 1.24 1.32 -1.06 1.1 1.69 1.16
regulation of translational elongation 3 1.5 1.19 1.07 1.08 1.04 1.01 1.17
regulation of translational termination 1 1.71 1.01 1.01 -1.13 1.21 1.32 1.15
translational readthrough 2 1.54 1.17 1.08 1.41 1.45 -1.1 -1.08
translational frameshifting 1 1.71 1.01 1.01 -1.13 1.21 1.32 1.15
signal peptide processing 3 1.12 -1.0 1.0 -1.02 -1.02 -1.01 1.75
negative regulation of protein kinase activity 12 1.53 1.14 1.46 1.09 1.41 1.69 1.32
N-terminal protein amino acid acetylation 1 -1.5 1.47 2.65 1.15 1.31 -1.14 -1.06
C-terminal protein methylation 1 -2.13 1.18 1.09 1.41 1.8 -1.71 -1.76
protein demethylation 7 1.18 1.25 1.72 1.13 1.59 1.68 1.3
protein N-linked glycosylation 14 1.33 1.02 1.11 1.03 1.13 1.55 1.26
N-glycan processing 1 3.13 1.28 1.73 1.05 1.33 2.12 2.37
N-terminal protein lipidation 2 -1.18 1.31 1.73 1.36 1.77 -1.01 -1.01
N-terminal protein myristoylation 1 -1.49 1.29 1.71 1.24 1.7 1.05 1.0
N-terminal protein palmitoylation 1 1.07 1.32 1.75 1.48 1.85 -1.07 -1.03
protein geranylgeranylation 1 1.07 1.22 1.65 1.13 1.53 -1.02 -1.05
proteolysis 624 -1.68 -1.23 -1.28 -1.03 -1.1 -1.65 -1.4
membrane protein ectodomain proteolysis 2 -1.1 1.22 1.43 1.31 1.8 -1.31 1.17
protein monoubiquitination 1 -1.01 -1.28 2.49 -1.24 1.59 -1.44 -1.52
misfolded or incompletely synthesized protein catabolic process 1 2.66 -1.19 -1.04 1.2 -1.17 1.37 1.41
glycoprotein catabolic process 1 -1.09 1.27 1.39 1.28 1.54 -1.1 1.18
protein deglycosylation 1 3.0 -1.25 -1.04 1.43 1.17 2.32 1.34
alanine metabolic process 1 1.7 1.2 1.13 1.08 -1.16 -1.08 1.29
alanine biosynthetic process 1 1.7 1.2 1.13 1.08 -1.16 -1.08 1.29
arginine metabolic process 5 -5.16 1.27 -5.44 1.2 1.07 -3.1 -1.21
arginine biosynthetic process 2 -22.15 1.64 -12.84 1.4 1.07 -7.77 -1.97
arginine catabolic process 2 -3.2 -1.06 -5.13 -1.12 -1.07 -1.58 1.05
aspartate metabolic process 2 1.83 1.18 -1.32 -1.0 1.19 1.57 1.14
cysteine metabolic process 3 1.38 1.11 1.22 -1.23 -2.05 -1.02 1.55
cysteine biosynthetic process from serine 1 1.25 1.1 1.48 -1.98 -7.11 -1.17 2.59
glutamate metabolic process 10 -1.06 -1.22 -1.57 -1.37 1.12 1.73 -1.05
glutamate biosynthetic process 5 1.59 -1.31 -1.43 -1.5 -1.34 2.96 1.23
glutamate catabolic process 4 -1.09 -1.24 1.09 -1.34 1.82 1.75 -1.68
glutamine metabolic process 5 -1.72 -1.12 -1.2 -1.13 1.54 -1.57 -3.03
glutamine biosynthetic process 2 1.91 -1.99 2.01 -1.44 1.52 -1.73 -1.25
glutamine catabolic process 1 -1.12 1.14 1.63 1.21 1.33 1.0 1.05
glycine metabolic process 9 1.41 1.01 1.25 -1.01 -1.01 1.77 -1.06
glycine biosynthetic process 1 2.25 -1.1 -1.03 1.28 1.09 2.14 -1.24
glycine catabolic process 6 1.21 1.07 1.39 -1.04 -1.02 1.86 -1.02
leucine metabolic process 4 1.15 1.54 1.31 1.24 1.31 1.45 1.1
lysine metabolic process 1 -1.51 -1.6 -1.42 1.8 -1.74 2.0 -2.55
lysine catabolic process 1 -1.51 -1.6 -1.42 1.8 -1.74 2.0 -2.55
methionine metabolic process 6 1.26 -1.05 -1.1 -1.03 -1.11 1.66 -1.23
S-adenosylmethionine biosynthetic process 1 1.6 1.05 1.23 -1.23 1.41 1.78 1.98
L-phenylalanine metabolic process 4 1.52 -1.14 -1.01 -1.01 -1.02 2.14 -1.13
L-phenylalanine catabolic process 4 1.52 -1.14 -1.01 -1.01 -1.02 2.14 -1.13
proline metabolic process 7 -1.43 -1.33 -1.79 -1.62 -1.41 1.63 1.05
proline biosynthetic process 4 -1.95 -1.03 -1.89 -1.37 -1.23 1.12 1.21
proline catabolic process 2 1.19 -2.55 -2.04 -2.77 -1.87 5.01 -1.07
L-serine metabolic process 5 2.33 1.11 -1.22 1.0 -1.34 1.61 1.43
L-serine biosynthetic process 4 2.73 1.12 -1.41 1.19 1.13 1.89 1.23
tryptophan catabolic process 2 1.18 -1.21 -1.17 -1.24 -1.21 1.62 -1.18
tyrosine metabolic process 8 1.53 -1.29 -1.23 -1.14 -1.34 1.56 1.15
betaine biosynthetic process 1 1.3 -1.08 -1.07 -1.13 -1.19 1.96 -1.06
ethanolamine metabolic process 1 1.07 -1.05 2.34 1.23 1.45 3.99 1.1
acetylcholine catabolic process 1 2.27 1.23 -5.17 -1.59 -2.2 -9.9 9.42
melanin metabolic process 16 2.27 -1.2 -1.16 -1.18 1.1 1.65 1.32
melanin biosynthetic process from tyrosine 4 1.82 -1.08 -1.09 -1.03 -1.18 1.82 -1.13
catecholamine metabolic process 9 -1.02 -1.18 -1.26 -1.16 -1.28 -1.1 1.52
dopamine biosynthetic process from tyrosine 1 1.23 -4.96 -5.74 -3.75 -6.41 -1.0 6.11
indolalkylamine metabolic process 8 -1.18 -1.2 -1.54 -1.13 -1.45 -1.17 1.22
serotonin biosynthetic process from tryptophan 2 1.67 -2.04 -2.31 -1.94 -2.17 1.48 3.91
activation of tryptophan 5-monooxygenase activity 1 2.28 1.19 1.07 -1.0 1.37 2.2 2.5
ornithine metabolic process 3 -2.2 1.14 -2.13 1.11 -1.02 -1.24 -1.28
polyamine biosynthetic process 5 1.03 -1.1 -1.08 1.04 -1.04 1.59 -1.28
spermine biosynthetic process 2 1.12 1.21 1.31 1.22 1.2 1.92 1.01
NLS-bearing substrate import into nucleus 7 -1.09 1.31 1.37 1.28 1.56 1.0 1.17
protein export from nucleus 5 1.19 1.11 2.28 1.15 1.72 1.71 1.32
cotranslational protein targeting to membrane 16 -1.27 1.37 -1.06 1.05 -1.21 -1.6 1.25
SRP-dependent cotranslational protein targeting to membrane 15 -1.21 1.37 -1.05 1.04 -1.19 -1.54 1.26
SRP-dependent cotranslational protein targeting to membrane, translocation 5 -1.62 1.28 -1.17 -1.01 -1.28 -1.9 1.13
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition 1 -1.09 1.62 1.41 1.12 1.35 1.19 1.81
protein retention in ER lumen 3 -1.9 1.28 -1.09 1.08 -1.19 -2.08 1.34
protein targeting to lysosome 3 1.19 1.18 1.82 1.21 1.4 1.29 1.24
protein targeting to vacuole 4 1.47 1.26 2.02 1.17 1.52 1.6 1.47
fatty acid biosynthetic process 25 1.1 -1.38 -1.52 -1.26 -1.29 1.04 1.14
fatty acid beta-oxidation 12 -1.2 1.1 -1.58 1.06 1.17 -2.29 -1.36
unsaturated fatty acid biosynthetic process 1 -1.74 1.11 -2.01 1.51 1.27 -1.87 -1.55
acyl-CoA metabolic process 6 2.01 1.03 1.27 1.12 1.42 1.33 1.06
neutral lipid metabolic process 10 1.74 -1.01 1.02 -1.04 1.58 -1.11 -1.1
acylglycerol metabolic process 10 1.74 -1.01 1.02 -1.04 1.58 -1.11 -1.1
triglyceride metabolic process 7 1.7 1.03 -1.06 -1.02 1.5 1.09 -1.06
triglyceride mobilization 1 -2.11 1.69 -1.72 -1.16 2.47 -2.75 -1.82
membrane lipid metabolic process 28 -2.18 -1.19 -1.19 1.18 1.02 -2.06 -1.41
phosphatidylethanolamine biosynthetic process 1 1.07 -1.05 2.34 1.23 1.45 3.99 1.1
diacylglycerol biosynthetic process 2 4.42 -1.06 2.12 -1.4 1.56 1.46 1.74
phosphatidylglycerol biosynthetic process 1 -3.36 1.4 1.32 1.25 1.35 -2.25 1.21
phosphatidylcholine biosynthetic process 1 -1.0 -1.38 1.09 1.05 1.26 -1.4 2.06
phosphatidylserine metabolic process 1 1.61 1.37 2.22 1.0 1.13 1.67 1.83
phosphatidylserine biosynthetic process 1 1.61 1.37 2.22 1.0 1.13 1.67 1.83
glycolipid metabolic process 8 1.02 1.23 1.09 1.02 1.05 -1.13 1.74
sphingolipid metabolic process 24 -2.32 -1.33 -1.28 1.19 1.03 -2.16 -1.6
ceramide metabolic process 7 -1.82 -1.06 1.22 1.15 1.12 -2.11 -1.7
sphingomyelin metabolic process 5 -5.26 -3.33 -4.18 1.39 -1.08 -3.6 -4.11
sphingomyelin catabolic process 3 -14.19 -8.88 -14.23 1.69 -1.38 -9.59 -10.93
sphingomyelin biosynthetic process 1 -1.01 1.47 1.74 -1.23 1.22 1.11 1.04
glycosphingolipid metabolic process 5 1.35 1.03 1.0 1.01 1.04 1.17 1.95
glycosphingolipid biosynthetic process 4 1.47 1.01 -1.03 -1.08 1.02 1.2 2.34
icosanoid metabolic process 1 -1.74 1.11 -2.01 1.51 1.27 -1.87 -1.55
leukotriene metabolic process 1 -1.74 1.11 -2.01 1.51 1.27 -1.87 -1.55
cholesterol biosynthetic process 1 2.16 -1.1 1.03 -1.13 1.06 2.2 1.18
cholesterol catabolic process 1 -1.19 1.24 1.2 1.43 1.53 -1.12 -1.13
sesquiterpenoid metabolic process 6 -1.16 -1.26 -1.56 -1.5 -1.43 -2.35 1.61
juvenile hormone metabolic process 6 -1.16 -1.26 -1.56 -1.5 -1.43 -2.35 1.61
juvenile hormone biosynthetic process 2 1.77 -2.92 -3.1 -3.09 -1.69 -1.43 2.62
juvenile hormone catabolic process 4 -1.67 1.21 -1.1 -1.05 -1.31 -3.02 1.26
terpenoid metabolic process 11 -1.32 -1.26 -1.61 -1.13 -1.21 -1.86 1.01
pteridine biosynthetic process 5 2.4 -1.22 -1.26 -1.24 -1.16 -1.04 1.7
tetrahydrobiopterin biosynthetic process 4 7.84 -1.48 -1.41 -1.58 -1.23 1.76 2.48
one-carbon metabolic process 15 -1.73 -1.28 1.21 -1.29 1.06 1.32 -1.1
oxidoreduction coenzyme metabolic process 16 1.6 1.17 -1.26 1.03 1.09 1.19 1.2
NADH metabolic process 1 -1.32 -1.9 1.3 -2.14 3.35 4.87 -4.48
NADP metabolic process 7 2.13 1.17 -1.85 1.03 -1.09 1.03 1.53
NADPH regeneration 7 2.13 1.17 -1.85 1.03 -1.09 1.03 1.53
lipoamide metabolic process 1 -1.4 -1.14 2.27 -1.25 -1.48 1.94 -1.5
glutathione biosynthetic process 3 -2.99 1.44 -1.36 1.22 -1.32 -2.2 1.15
ATP biosynthetic process 25 1.34 1.04 1.24 -1.05 1.09 1.66 -1.1
folic acid-containing compound metabolic process 8 1.68 -1.27 -1.29 -1.11 -1.33 1.27 1.0
vitamin metabolic process 11 1.53 1.22 -1.23 -1.04 -1.18 1.35 1.13
water-soluble vitamin metabolic process 7 1.81 1.34 -1.5 -1.06 -1.3 1.43 1.2
riboflavin metabolic process 2 1.78 2.05 -2.11 -2.16 -2.52 2.14 1.44
thiamine metabolic process 1 1.06 1.62 -1.26 1.22 -1.14 -1.11 1.12
protoporphyrinogen IX biosynthetic process 1 1.62 1.26 1.09 -1.07 1.01 1.21 1.32
heme a biosynthetic process 1 -1.08 1.29 1.99 1.12 1.3 1.57 -1.3
porphyrin-containing compound catabolic process 1 2.0 1.05 2.09 1.06 1.46 2.34 1.12
heme oxidation 1 2.0 1.05 2.09 1.06 1.46 2.34 1.12
xenobiotic metabolic process 10 1.1 -1.02 -1.79 -1.06 -1.28 -1.46 1.06
response to insecticide 16 1.05 1.09 -1.54 -1.14 -1.27 -1.41 1.29
calcium ion transport 24 1.54 -1.04 1.07 -1.11 1.19 1.63 1.19
phosphate ion transport 10 -1.16 -1.04 -1.52 -1.15 1.01 2.17 -1.68
chloride transport 6 1.12 1.13 -1.09 1.06 1.34 1.82 1.32
water transport 3 -1.65 1.03 -1.57 1.34 -1.36 -2.48 1.11
dicarboxylic acid transport 8 1.09 -1.04 -1.41 -1.66 -1.35 1.44 1.09
serotonin transport 1 -1.06 -1.11 -1.0 -1.08 -1.15 3.37 -1.04
alpha-ketoglutarate transport 3 -1.11 -1.06 1.14 -1.03 -1.15 1.61 -1.21
malate transport 5 -1.06 -1.22 1.26 -1.12 1.12 2.23 -1.26
mitochondrial citrate transport 1 -1.29 1.86 -1.38 -1.29 -2.25 1.02 -1.13
acyl carnitine transport 2 1.34 1.32 -1.91 1.22 1.14 -1.7 -1.23
aspartate transport 1 2.24 1.81 -38.59 -31.15 -18.58 -3.21 4.55
L-glutamate transport 4 -2.92 -1.1 -4.98 -1.98 -1.32 -2.35 -3.75
mitochondrial calcium ion transport 1 1.01 1.3 1.51 1.08 2.35 4.41 1.77
drug transmembrane transport 1 -10.37 1.6 -11.08 1.04 2.2 -3.48 1.28
oligopeptide transport 3 1.69 -1.17 -1.51 -1.15 -1.07 1.17 1.2
amino acid transport 39 -1.51 -1.14 -1.83 -1.24 1.0 -1.08 -1.16
glutamine transport 1 -3.47 -4.26 1.06 2.44 2.17 -3.37 -7.09
lipid transport 28 -2.26 -1.6 -1.93 -1.01 -1.22 -1.56 -1.89
cellular calcium ion homeostasis 10 1.86 -1.02 1.36 -1.1 -1.04 1.64 1.18
cellular copper ion homeostasis 2 -1.26 1.35 2.1 1.13 1.14 1.39 1.07
cellular zinc ion homeostasis 1 -1.15 1.5 3.36 1.09 -1.02 -1.02 -1.03
cell volume homeostasis 2 1.92 1.08 -1.06 -1.08 2.11 2.25 1.09
regulation of pH 9 -1.27 1.25 1.91 -1.01 1.19 1.86 1.45
retrograde vesicle-mediated transport, Golgi to ER 8 -1.71 1.25 -1.07 1.15 -1.15 -1.33 1.34
intra-Golgi vesicle-mediated transport 18 -1.13 1.2 1.21 1.08 1.18 1.32 1.58
Golgi to vacuole transport 1 1.54 1.27 1.89 1.07 1.6 1.7 1.58
receptor-mediated endocytosis 11 1.09 1.13 1.29 1.01 1.19 1.55 1.26
anti-apoptosis 18 1.77 1.02 1.32 -1.0 1.46 1.51 1.52
cellular component disassembly involved in apoptotic process 4 -1.16 1.19 1.65 1.21 1.51 -1.05 -1.11
cleavage of lamin 1 -11.86 1.52 2.29 1.45 1.79 -4.95 -7.15
cleavage of cytoskeletal proteins involved in apoptosis 1 -11.86 1.52 2.29 1.45 1.79 -4.95 -7.15
regulation of muscle contraction 5 2.39 -1.02 -2.05 -2.54 -2.17 1.16 1.24
striated muscle contraction 4 -1.17 -1.12 -1.49 -1.32 -1.09 1.16 1.78
regulation of striated muscle contraction 2 1.48 1.35 -6.16 -5.66 -4.42 -1.74 2.14
response to mechanical stimulus 14 1.05 -1.27 1.01 -1.36 -1.07 1.88 1.17
pattern orientation 1 1.15 1.52 1.62 1.11 1.74 1.53 2.02
positive regulation of antibacterial peptide biosynthetic process 17 1.54 -1.16 -1.04 -1.14 1.02 1.29 1.37
positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria 5 2.54 -1.22 -1.03 -1.31 -1.06 2.04 1.48
positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria 4 1.05 -1.9 -2.24 -1.85 -1.9 -1.18 1.68
positive regulation of antifungal peptide biosynthetic process 6 2.45 -1.42 -1.16 -1.01 -1.05 1.77 1.2
cellular defense response 1 1.57 1.3 1.87 1.1 1.6 2.04 2.1
hyperosmotic response 1 1.22 1.33 2.18 1.07 1.72 2.05 1.61
response to lipid hydroperoxide 1 2.0 -1.09 -1.07 1.14 1.47 1.02 -1.28
ER overload response 2 -1.22 1.43 1.56 1.09 1.42 -1.17 1.79
nuclear pore organization 1 1.8 1.61 2.39 1.2 2.33 2.16 2.46
nucleolus organization 3 1.16 1.19 1.66 1.24 2.3 1.1 1.42
plasma membrane organization 12 1.23 1.13 1.5 1.02 1.84 1.37 1.27
cytoskeletal anchoring at plasma membrane 17 1.37 1.1 1.43 1.03 1.41 1.51 1.32
microtubule nucleation 7 1.67 1.03 1.42 1.09 1.45 1.62 1.17
negative regulation of microtubule depolymerization 15 1.06 1.15 1.48 1.04 1.41 1.59 1.26
endoplasmic reticulum organization 7 1.12 1.24 1.29 1.1 1.28 1.04 1.52
peroxisome organization 15 1.58 1.07 -1.39 1.25 1.36 -1.44 -1.19
vacuolar transport 17 1.14 1.17 1.78 1.13 1.5 1.47 1.29
vacuolar acidification 4 -2.16 1.36 2.14 -1.07 1.21 2.24 1.25
lysosomal transport 13 -1.01 1.15 1.71 1.13 1.47 1.31 1.22
cell-cell junction assembly 36 1.91 -1.1 1.31 -1.15 1.22 2.16 1.42
cell-substrate junction assembly 1 -1.1 -1.15 -1.07 -1.18 1.52 1.28 1.24
cell cycle arrest 8 1.45 1.2 1.34 1.1 1.36 1.5 1.38
spindle assembly involved in male meiosis 3 -1.71 1.36 1.08 1.16 1.08 -1.71 1.01
spindle assembly involved in male meiosis I 1 1.11 1.51 1.01 1.21 1.06 -1.41 1.26
mitotic sister chromatid cohesion 5 1.6 1.06 1.64 1.1 1.59 1.67 1.28
regulation of S phase of mitotic cell cycle 16 1.38 1.18 1.34 1.13 1.4 1.63 1.43
optokinetic behavior 2 1.16 1.09 1.72 1.19 1.37 1.2 2.11
cytokinesis after meiosis I 8 1.52 -1.23 1.02 -1.47 1.08 1.67 1.38
cytokinesis after meiosis II 7 1.71 -1.31 -1.08 -1.6 1.08 2.04 1.46
male meiosis cytokinesis 14 1.82 -1.04 1.11 -1.11 1.39 1.32 1.33
meiotic prophase I 1 1.5 1.02 1.68 -1.05 1.78 1.86 1.49
meiotic metaphase I 1 1.38 1.21 1.33 1.18 1.64 1.12 1.06
homophilic cell adhesion 27 1.7 -1.16 -1.1 -1.17 1.12 1.92 1.39
negative regulation of cell adhesion 9 1.95 1.17 1.32 1.03 1.28 1.88 1.51
signal complex assembly 1 1.01 1.19 1.87 1.24 1.92 1.43 1.32
transforming growth factor beta binding 1 -2.53 1.23 -1.01 1.28 2.46 1.22 1.76
transforming growth factor beta receptor complex assembly 1 -2.53 1.23 -1.01 1.28 2.46 1.22 1.76
transmembrane receptor protein tyrosine phosphatase signaling pathway 1 1.65 1.02 2.09 -1.05 1.83 4.08 1.95
elevation of cytosolic calcium ion concentration 3 1.46 1.16 1.52 -1.0 1.18 1.77 1.54
activation of protein kinase C activity by G-protein coupled receptor protein signaling pathway 8 1.65 1.05 -1.03 -1.02 -1.04 1.17 1.24
tachykinin receptor signaling pathway 5 -1.04 -1.19 1.08 -1.24 -1.02 1.95 1.43
neuropeptide signaling pathway 38 -1.86 -1.39 -1.2 -1.15 -1.16 -1.83 -1.26
Notch receptor processing 4 -1.0 1.17 1.21 1.25 1.56 1.22 1.41
patched ligand maturation 1 1.07 1.32 1.75 1.48 1.85 -1.07 -1.03
signal transduction downstream of smoothened 5 1.03 1.18 1.56 1.12 1.42 1.4 1.07
positive regulation of hh target transcription factor activity 5 1.03 1.18 1.56 1.12 1.42 1.4 1.07
integrin-mediated signaling pathway 4 -1.54 1.07 1.65 1.1 1.77 -1.22 1.11
I-kappaB kinase/NF-kappaB cascade 2 1.26 1.28 1.33 1.08 1.48 1.61 1.39
JNK cascade 25 1.0 1.14 1.47 1.1 1.5 1.24 1.42
activation of JNKK activity 2 1.23 1.27 1.56 1.2 1.54 1.23 1.3
activation of JUN kinase activity 2 -1.08 1.31 1.72 1.2 1.5 1.32 1.54
tyrosine phosphorylation of STAT protein 1 1.57 1.3 1.87 1.1 1.6 2.04 2.1
STAT protein import into nucleus 1 1.57 1.3 1.87 1.1 1.6 2.04 2.1
Ras protein signal transduction 25 1.08 1.28 1.57 1.08 1.47 1.22 1.49
Rho protein signal transduction 4 -1.15 1.27 1.54 1.2 1.45 1.01 1.39
neuron-neuron synaptic transmission 5 1.1 -1.05 -1.09 -1.15 1.01 2.0 1.04
synaptic transmission, cholinergic 1 2.27 1.23 -5.17 -1.59 -2.2 -9.9 9.42
ensheathment of neurons 6 1.77 -1.07 1.38 -1.13 1.24 3.0 1.46
pole cell fate determination 3 2.8 1.18 2.04 1.19 1.51 2.12 1.41
primary spermatocyte growth 5 2.0 1.25 1.67 1.27 1.92 1.51 1.27
growth of a germarium-derived egg chamber 5 1.5 1.13 1.67 1.04 1.5 1.59 1.41
vitellogenesis 7 1.4 -3.65 -4.11 -4.07 -1.34 2.21 1.12
ovarian follicle cell-cell adhesion 3 -1.5 1.41 1.37 1.22 1.72 -1.12 -1.09
nurse cell nucleus anchoring 1 -1.33 1.57 2.09 1.17 1.77 1.11 1.58
eggshell chorion gene amplification 17 1.11 1.21 1.43 1.19 1.52 1.14 1.14
oocyte dorsal/ventral axis specification 34 1.43 1.04 1.13 1.01 1.1 1.5 1.28
maternal specification of dorsal/ventral axis, oocyte, germ-line encoded 7 1.96 -1.07 -1.01 -1.08 1.03 2.21 1.39
pole plasm protein localization 10 1.29 1.15 1.44 1.11 1.37 1.64 1.23
negative regulation of oskar mRNA translation 8 1.19 -1.01 1.28 -1.09 1.13 1.88 1.01
regulation of preblastoderm mitotic cell cycle 1 2.87 1.19 1.15 1.16 1.39 3.16 1.43
zygotic specification of dorsal/ventral axis 5 1.69 1.14 1.51 1.04 1.21 1.21 1.19
zygotic determination of anterior/posterior axis, embryo 31 1.57 -1.1 1.04 -1.14 1.04 1.27 1.27
anterior region determination 3 1.62 -1.05 1.0 -1.14 -1.1 1.06 -1.02
posterior abdomen determination 1 2.58 1.01 1.0 1.14 -1.0 -1.14 1.0
determination of left/right symmetry 4 -3.48 1.34 1.25 1.01 1.41 -1.67 1.12
ventral furrow formation 13 1.35 1.11 1.28 1.08 1.5 1.38 1.28
posterior midgut invagination 4 1.75 1.13 1.9 1.13 1.88 1.93 1.72
anterior midgut invagination 3 1.4 1.11 1.46 1.17 1.72 1.88 1.31
germ-band extension 8 -1.08 -1.25 1.17 1.08 1.55 1.32 -1.22
amnioserosa formation 5 1.56 -1.06 1.14 -1.19 -1.08 -1.04 1.05
specification of segmental identity, antennal segment 3 1.59 -1.13 1.32 1.09 -1.18 -1.05 -1.16
specification of segmental identity, thorax 2 1.34 1.12 1.12 1.65 -1.14 1.05 -1.1
germ-band shortening 18 1.2 1.11 1.38 1.07 1.46 1.23 1.55
initiation of dorsal closure 17 1.16 1.17 1.59 1.07 1.56 1.2 1.36
dorsal closure, leading edge cell fate determination 3 1.0 1.08 1.89 1.0 1.21 -1.44 -1.04
dorsal closure, elongation of leading edge cells 12 1.22 1.22 1.4 1.12 1.59 1.38 1.41
dorsal closure, spreading of leading edge cells 4 1.03 1.07 2.59 -1.02 1.79 1.38 1.66
suture of dorsal opening 3 -1.66 1.12 1.92 -1.03 1.4 -1.35 1.31
glial cell fate determination 3 1.44 1.3 1.68 1.12 1.63 1.5 1.59
negative regulation of neuroblast proliferation 7 -1.32 1.13 1.47 1.06 1.79 1.22 1.08
stomatogastric nervous system development 3 1.52 1.02 1.2 1.12 1.56 1.54 1.47
open tracheal system development 179 1.41 1.03 1.26 -1.02 1.26 1.52 1.28
epithelial cell fate determination, open tracheal system 5 1.83 1.1 1.52 -1.02 1.42 1.21 1.34
epithelial cell migration, open tracheal system 28 1.66 -1.03 1.29 -1.07 1.21 1.38 1.11
primary branching, open tracheal system 14 1.41 1.06 1.72 1.04 1.34 1.6 1.2
secondary branching, open tracheal system 4 -1.26 1.18 1.54 -1.02 1.25 1.45 1.01
terminal branching, open tracheal system 10 1.25 1.17 1.56 1.07 1.46 1.37 1.13
salivary gland boundary specification 12 1.24 1.02 1.3 1.14 1.55 1.11 1.19
larval salivary gland morphogenesis 6 -1.03 1.12 1.25 1.04 1.36 1.52 1.57
ectodermal digestive tract development 5 1.46 1.11 -1.0 1.02 1.62 1.8 1.33
dorsal/ventral lineage restriction, imaginal disc 7 1.04 1.11 1.08 1.07 1.41 1.38 1.52
progression of morphogenetic furrow involved in compound eye morphogenesis 8 1.62 -1.01 1.33 1.05 1.35 1.15 1.12
regulation of rhodopsin gene expression 2 1.63 1.26 1.37 1.04 1.38 1.48 1.42
wing disc proximal/distal pattern formation 6 1.82 -1.07 1.3 1.34 1.32 1.02 -1.06
apposition of dorsal and ventral imaginal disc-derived wing surfaces 17 1.92 1.04 1.15 -1.07 1.24 1.93 1.28
haltere disc morphogenesis 2 2.21 -1.24 1.11 1.19 -1.26 -1.2 -1.1
imaginal disc-derived genitalia development 22 1.56 1.05 1.18 1.02 1.13 1.11 1.24
imaginal disc-derived male genitalia development 20 1.63 1.05 1.2 1.02 1.16 1.13 1.28
analia development 6 -1.15 -1.64 -1.26 1.2 1.4 -1.24 -1.79
histoblast morphogenesis 8 -1.19 1.09 1.37 1.16 1.65 -1.2 1.21
maintenance of imaginal histoblast diploidy 1 -10.7 -1.04 2.18 1.33 2.43 -8.45 -1.16
endodermal cell fate determination 1 8.12 -1.58 1.44 -1.54 1.01 1.69 1.21
anterior midgut development 3 -1.08 1.25 1.25 -1.4 1.12 1.13 1.58
mesodermal cell fate determination 5 1.66 1.11 1.13 -1.01 1.25 1.53 1.29
larval heart development 2 1.04 -1.11 1.46 -1.3 -1.07 -1.65 1.78
mesoderm migration involved in gastrulation 10 1.62 -1.05 1.42 -1.16 1.22 2.32 1.08
hemocyte development 5 1.5 1.11 1.52 1.05 1.28 1.12 1.43
larval visceral muscle development 5 1.28 -1.03 1.19 -1.12 1.18 1.12 1.5
larval somatic muscle development 8 1.66 1.08 1.35 1.03 1.17 1.3 1.22
adult somatic muscle development 10 1.25 1.07 1.59 1.07 1.35 1.16 1.08
primary sex determination, germ-line 4 1.82 1.02 1.1 1.07 1.07 1.73 1.13
regulation of ecdysteroid metabolic process 1 -1.55 1.2 1.21 -1.19 -1.12 1.05 1.03
regulation of ecdysteroid secretion 1 -1.14 1.41 1.3 1.24 1.17 1.85 1.43
regulation of juvenile hormone metabolic process 2 -8.29 -1.83 1.21 1.4 1.08 -7.35 -3.84
regulation of juvenile hormone biosynthetic process 2 -8.29 -1.83 1.21 1.4 1.08 -7.35 -3.84
response to nutrient 14 -1.16 1.15 1.37 1.05 1.35 1.65 1.19
digestion 3 -4.6 1.02 -2.88 -1.01 -3.41 -5.92 -1.12
excretion 1 1.59 -1.18 -1.24 -1.07 -1.14 4.1 -1.27
body fluid secretion 5 -1.82 -1.14 1.09 1.02 1.2 -2.0 -1.34
storage protein import into fat body 1 -1.43 -1.07 1.81 1.21 1.62 -1.56 -1.76
hemostasis 5 1.95 -1.51 -1.67 -1.6 -1.41 1.79 -1.02
phototransduction, UV 5 -1.46 -1.43 -1.51 1.22 -1.06 -1.54 -1.62
detection of chemical stimulus involved in sensory perception of taste 5 1.32 -1.06 -1.09 -1.07 1.79 1.58 1.13
short-term memory 12 1.22 1.21 1.62 -1.01 1.53 1.26 1.48
long-term memory 38 1.27 1.07 1.27 1.02 1.25 1.51 1.25
grooming behavior 2 2.8 1.39 1.39 -1.27 -1.08 1.53 1.56
adult walking behavior 9 -1.95 1.22 1.15 1.1 1.23 -1.39 1.15
jump response 7 1.63 -1.18 1.1 -1.09 1.06 1.45 -1.03
mechanosensory behavior 6 -1.75 1.04 1.58 1.06 1.09 1.12 -1.04
calcium-dependent cell-cell adhesion 18 1.55 -1.07 -1.04 -1.12 1.13 1.76 1.45
pattern recognition receptor activity 6 6.25 -1.32 -1.34 -1.44 -1.26 3.38 1.39
positive transcription elongation factor complex b 3 1.59 1.11 1.57 1.18 1.65 1.7 1.24
diazepam binding 5 -4.23 -1.51 -3.23 1.14 1.44 -4.78 -1.66
monocarboxylic acid transmembrane transporter activity 16 -2.06 1.03 -1.25 1.14 1.09 -1.24 -1.32
diuretic hormone receptor activity 3 1.32 -1.32 1.22 -1.4 -1.1 -1.32 2.54
intracellular ferritin complex 3 -1.78 1.04 1.19 1.02 -1.06 -2.25 -1.21
calcium sensitive guanylate cyclase activator activity 1 4.81 -1.03 -1.02 1.21 1.81 1.05 1.23
mitochondrial fusion 4 -1.03 1.3 1.41 1.13 1.32 1.68 1.08
chitin binding 82 -2.26 -1.76 -2.0 -1.6 -1.65 -2.02 1.28
Toll signaling pathway 33 2.4 -1.26 -1.12 -1.26 -1.03 2.14 1.22
establishment of blood-nerve barrier 3 1.7 1.01 1.41 -1.21 1.32 4.52 2.14
maternal determination of dorsal/ventral axis, ovarian follicular epithelium, germ-line encoded 1 8.32 -1.09 1.22 1.02 1.27 3.95 1.61
maternal determination of dorsal/ventral axis, ovarian follicular epithelium, soma encoded 1 2.54 -1.11 -1.09 1.14 1.59 3.23 1.89
mesodermal cell migration 6 1.63 -1.09 1.53 -1.13 1.3 1.85 -1.09
imaginal disc growth factor receptor binding 5 4.12 -4.42 -5.25 -6.0 -2.16 10.45 2.09
spectrin 3 -2.12 1.38 2.51 1.03 1.66 1.56 1.52
juvenile hormone epoxide hydrolase activity 3 -2.11 1.3 -1.14 -1.06 -1.44 -4.35 1.38
decapentaplegic signaling pathway 11 1.19 1.18 1.63 1.11 1.61 1.49 1.44
N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity 1 -2.23 -1.22 -3.38 -1.38 1.35 1.93 6.67
alpha-methylacyl-CoA racemase activity 1 4.0 -1.32 -1.02 1.57 2.33 1.69 -1.27
peptide-methionine-(S)-S-oxide reductase activity 2 -1.8 -2.02 -4.93 1.56 -1.77 -2.69 -2.87
sphinganine-1-phosphate aldolase activity 1 -4.18 -1.48 1.63 1.57 1.8 -2.56 -3.36
ceramide glucosyltransferase activity 1 -2.39 1.12 1.45 -1.07 -1.2 -1.93 -1.3
4-alpha-hydroxytetrahydrobiopterin dehydratase activity 1 7.73 -1.1 1.09 -1.29 -1.0 2.46 1.16
primary amine oxidase activity 1 -1.01 1.1 1.17 1.35 1.05 -1.29 -1.96
NADH dehydrogenase (ubiquinone) activity 30 1.12 1.03 1.27 1.07 1.1 1.73 -1.3
nuclear localization sequence binding 1 -1.11 1.3 1.01 1.22 1.27 1.55 1.52
cAMP response element binding protein binding 1 2.75 1.33 1.9 1.11 2.22 3.34 2.0
oxysterol binding 3 -2.13 1.47 1.84 1.14 1.36 1.14 1.32
drug binding 19 -1.19 -1.07 -1.35 1.08 1.12 -1.56 -1.08
hedgehog receptor activity 5 1.99 1.03 1.37 -1.02 1.31 2.39 1.55
positive regulation of transcription elongation, DNA-dependent 11 1.03 1.26 1.29 -1.01 1.22 1.24 1.55
response to carbamate 1 2.27 1.23 -5.17 -1.59 -2.2 -9.9 9.42
response to DDT 1 -5.76 1.9 -16.55 1.25 -6.77 -4.39 3.09
response to organophosphorus 2 -1.59 1.53 -9.25 -1.13 -3.86 -6.59 5.39
O-methyltransferase activity 8 2.13 -1.36 -1.3 -1.24 1.01 1.32 1.14
S-methyltransferase activity 3 -1.85 1.29 -1.98 1.47 1.67 -1.31 -1.12
tRNA (guanine-N7-)-methyltransferase activity 1 1.71 1.4 1.24 1.52 1.28 1.04 1.1
succinate dehydrogenase (ubiquinone) activity 4 -1.04 1.01 1.45 -1.06 -1.01 1.58 -1.36
glycogen phosphorylase activity 1 2.98 -1.08 1.5 -1.31 1.12 4.86 1.33
poly-pyrimidine tract binding 11 1.49 1.11 1.46 1.08 1.34 1.6 1.2
eukaryotic initiation factor 4E binding 1 1.26 1.58 1.86 1.05 1.71 1.8 2.46
metalloendopeptidase inhibitor activity 1 8.96 -2.17 1.12 -1.71 -1.16 3.1 2.84
phosphatidate phosphatase activity 9 2.18 -1.22 -1.33 -1.14 1.06 -1.03 1.06
ferrous iron binding 3 -1.78 1.04 1.19 1.02 -1.06 -2.25 -1.21
ferric iron binding 6 1.86 -1.38 -1.24 -1.34 -1.27 1.74 1.1
steroid metabolic process 25 1.6 -1.17 1.06 -1.05 -1.04 1.23 1.07
cholesterol metabolic process 4 1.71 1.17 -1.04 1.01 1.09 1.45 1.5
androgen metabolic process 1 1.03 -1.04 1.2 -1.01 1.0 2.11 -1.07
estrogen metabolic process 1 1.03 -1.04 1.2 -1.01 1.0 2.11 -1.07
protein dealkylation 7 1.18 1.25 1.72 1.13 1.59 1.68 1.3
spermine metabolic process 2 1.12 1.21 1.31 1.22 1.2 1.92 1.01
cytolysis 1 2.51 -2.79 -2.4 2.63 1.21 1.32 -1.1
defense response to Gram-negative bacterium 32 1.66 -1.16 -1.17 -1.19 -1.05 1.16 1.24
exopeptidase activity 98 -1.97 -1.3 -1.45 1.04 -1.09 -1.69 -1.59
omega peptidase activity 7 1.51 -1.0 -1.02 1.11 1.16 1.09 1.0
oligosaccharyltransferase complex 2 -1.97 1.27 1.32 1.05 1.26 -1.0 1.71
nucleotidase activity 10 -1.98 1.08 -1.56 1.17 -1.11 -1.91 -1.09
5'-nucleotidase activity 7 -2.99 1.07 -1.74 1.18 -1.15 -2.4 -1.14
3-oxoacid CoA-transferase activity 1 -1.42 1.61 -1.39 -1.13 -1.97 3.73 -1.22
importin-alpha export receptor activity 1 1.02 1.3 1.9 1.26 1.85 1.34 1.32
Mo-molybdopterin cofactor sulfurase activity 3 -1.23 1.5 -1.02 1.17 -1.21 -2.29 1.26
JAK pathway signal transduction adaptor activity 1 -2.42 1.28 1.48 1.16 1.17 -1.51 1.15
secondary active sulfate transmembrane transporter activity 9 -1.49 -1.12 -1.96 -1.28 -1.37 2.2 -1.04
sulfate transport 4 -1.28 -1.14 1.13 -1.09 1.33 2.21 -1.19
calcium, potassium:sodium antiporter activity 5 -1.42 1.17 -1.18 1.1 -1.14 -1.59 -1.02
gamma-tubulin ring complex 5 1.67 -1.04 1.23 1.09 1.31 1.41 1.1
gamma-tubulin small complex 4 1.69 1.04 1.32 1.06 1.39 1.77 1.19
cohesin core heterodimer 1 2.72 1.09 2.08 1.56 2.05 2.2 1.21
sulfonylurea receptor activity 1 2.13 1.07 1.24 -1.07 1.02 1.64 1.13
ATP-sensitive potassium channel complex 1 2.13 1.07 1.24 -1.07 1.02 1.64 1.13
protein serine/threonine phosphatase complex 28 1.25 1.08 1.34 1.05 1.22 1.54 1.16
F-actin capping protein complex 2 -1.38 -1.03 2.18 1.01 1.59 -1.39 -1.04
acetylcholine metabolic process 3 1.5 1.03 -1.96 -1.22 -1.24 -2.29 2.08
calcium- and calmodulin-responsive adenylate cyclase activity 1 4.63 2.09 1.35 -1.43 -1.28 1.63 2.43
spermidine biosynthetic process 3 1.26 1.15 1.19 1.19 1.22 1.53 -1.02
single-stranded DNA specific exodeoxyribonuclease activity 1 1.7 -1.05 -1.07 -1.09 -1.18 1.33 1.14
isoprenoid biosynthetic process 12 1.73 -1.18 1.02 -1.16 1.13 1.29 1.36
isoprenoid catabolic process 4 -1.67 1.21 -1.1 -1.05 -1.31 -3.02 1.26
female germline ring canal formation, actin assembly 2 1.08 1.2 1.17 -1.17 1.32 2.65 1.46
caspase complex 2 -3.83 1.28 1.42 1.35 1.72 -4.2 -3.4
structural constituent of muscle 14 2.28 -1.15 1.21 -1.08 1.27 1.81 -1.09
single-stranded DNA specific 3'-5' exodeoxyribonuclease activity 1 1.7 -1.05 -1.07 -1.09 -1.18 1.33 1.14
gurken-activated receptor activity 1 2.54 -1.11 -1.09 1.14 1.59 3.23 1.89
gurken receptor signaling pathway 4 2.03 1.05 1.12 1.25 1.3 1.58 1.1
meiotic G2/MI transition 5 -1.32 1.33 1.45 1.2 1.64 1.0 1.18
gurken receptor binding 2 3.37 -1.03 1.31 1.11 1.37 1.92 1.47
protein prenyltransferase activity 7 -1.61 1.12 1.15 1.12 1.17 -1.52 1.36
Ral guanyl-nucleotide exchange factor activity 1 8.19 -2.13 1.05 -1.9 1.69 3.12 2.66
larval feeding behavior 14 -1.24 1.04 1.52 -1.07 -1.05 -1.09 1.18
methyl-CpG binding 1 2.49 1.08 1.5 1.28 1.63 1.64 1.5
endosome to lysosome transport 7 1.05 1.14 1.56 1.12 1.35 1.31 1.19
gamma-butyrobetaine dioxygenase activity 4 -2.34 -1.03 -1.77 -1.06 -1.07 -1.32 1.02
behavioral response to cocaine 9 1.31 1.15 1.55 1.04 1.35 1.53 1.26
adult feeding behavior 7 1.32 -1.86 -1.97 -2.12 -2.07 -1.51 2.24
negative regulation of antimicrobial humoral response 4 1.35 1.1 1.46 1.15 1.8 1.12 1.2
RNA polymerase II carboxy-terminal domain kinase activity 5 1.49 1.22 1.54 1.24 1.64 1.52 1.29
regulation of bicoid mRNA localization 2 -1.31 1.2 1.89 -1.13 1.39 2.71 1.31
chitin-based embryonic cuticle biosynthetic process 18 1.73 -1.03 1.1 -1.15 1.04 1.97 1.4
pupal chitin-based cuticle development 1 14.19 -4.21 -4.1 -3.94 -3.79 21.36 -4.46
axon ensheathment 6 1.77 -1.07 1.38 -1.13 1.24 3.0 1.46
O-acyltransferase activity 20 -1.13 -1.08 -1.14 1.21 1.65 -1.68 -1.37
acetylgalactosaminyltransferase activity 18 -1.14 -1.09 -1.18 -1.18 -1.19 -1.47 1.62
mechanically-gated ion channel activity 1 -1.05 1.0 -1.06 -1.03 -1.14 1.01 1.95
5'-3' exonuclease activity 2 -1.11 1.53 1.16 1.33 1.34 -1.11 1.19
CoA-transferase activity 2 -1.15 1.38 -1.15 1.04 -1.3 1.87 -1.04
4-hydroxybenzoate octaprenyltransferase activity 1 1.04 1.26 1.1 1.28 -1.02 -1.97 -1.12
CDP-alcohol phosphotransferase activity 1 -10.11 1.17 -1.48 1.2 1.57 -5.09 -1.84
delta5-delta2,4-dienoyl-CoA isomerase activity 2 1.86 -1.05 1.02 1.19 1.39 1.16 -1.03
protein-N-terminal asparagine amidohydrolase activity 1 6.19 -1.42 -1.44 -1.3 -1.36 1.94 1.84
glycoprotein 6-alpha-L-fucosyltransferase activity 1 1.63 1.17 -1.53 -1.05 -1.49 4.17 1.53
protein kinase C inhibitor activity 2 1.45 1.07 1.48 1.05 1.45 1.77 1.84
betaine transport 2 1.34 1.32 -1.91 1.22 1.14 -1.7 -1.23
ribonuclease inhibitor activity 2 1.78 1.2 1.19 -1.04 1.08 2.12 1.24
selenium binding 4 1.26 1.16 1.54 1.18 1.1 1.17 -1.12
vitamin E binding 10 -2.36 -2.69 -2.86 -1.36 -1.28 -1.63 -1.06
heterogeneous nuclear ribonucleoprotein complex 7 1.06 1.34 1.44 1.06 1.21 1.65 1.29
3'(2'),5'-bisphosphate nucleotidase activity 2 1.61 1.02 -1.31 1.13 -1.08 1.03 1.2
phosphofructokinase activity 2 1.69 -1.28 1.45 -1.01 1.01 4.15 1.1
CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity 1 1.09 1.12 -1.13 1.16 1.11 -1.64 -1.3
D-aspartate oxidase activity 2 -2.82 -1.69 -2.22 1.7 1.95 -1.63 -1.83
GDP-mannose 4,6-dehydratase activity 1 -3.57 1.21 1.13 1.39 1.5 -2.8 -1.34
N-acetylglucosamine-6-phosphate deacetylase activity 1 1.05 -1.01 -1.53 1.51 1.2 -1.51 -1.4
N-acetylglucosamine-6-sulfatase activity 2 4.3 -1.11 1.07 -1.47 1.62 8.46 1.92
alanine-glyoxylate transaminase activity 3 -2.83 1.14 -4.47 -1.13 -1.51 -1.62 1.13
alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity 2 1.98 -1.1 1.19 -1.09 1.23 2.85 1.26
alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity 1 3.56 -1.43 -1.34 -1.25 -1.02 7.35 1.28
carnitine O-octanoyltransferase activity 1 2.33 -1.31 -2.71 1.32 2.24 -2.61 1.02
dTDP-glucose 4,6-dehydratase activity 1 2.45 1.09 2.09 -1.01 1.2 1.56 1.31
glycogenin glucosyltransferase activity 2 7.0 -1.59 1.16 -1.42 1.29 4.38 -1.04
[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity 2 1.57 1.14 -1.02 1.0 1.08 -1.33 -1.08
histone-arginine N-methyltransferase activity 2 1.08 1.15 1.55 1.17 1.64 1.08 1.14
hydroquinone:oxygen oxidoreductase activity 2 -3.8 -3.2 -3.92 -3.61 -4.08 -3.9 3.04
palmitoyl-(protein) hydrolase activity 2 2.75 1.12 1.29 1.19 1.61 1.16 1.22
procollagen-lysine 5-dioxygenase activity 2 1.13 1.08 1.05 -1.04 1.19 1.95 1.17
protein-tyrosine sulfotransferase activity 1 -1.29 1.27 1.45 -1.08 1.08 1.07 2.33
queuine tRNA-ribosyltransferase activity 2 -1.08 1.07 1.01 1.12 1.08 -1.67 -1.22
sulfite oxidase activity 1 -1.72 1.15 -1.04 1.56 -1.05 1.22 -1.45
sulfuric ester hydrolase activity 8 1.82 -1.14 -1.15 -1.09 1.33 2.75 1.13
diphosphoinositol-polyphosphate diphosphatase activity 1 1.43 1.14 1.21 1.02 1.13 1.54 1.16
translation activator activity 1 1.37 1.21 2.02 -1.05 1.64 2.25 1.61
protoheme IX farnesyltransferase activity 1 -1.18 1.24 1.2 1.18 -1.04 1.79 -1.68
phospholipid scrambling 2 2.57 -1.14 1.03 -1.07 2.13 1.16 1.16
UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity 7 1.21 1.06 1.08 1.06 -1.01 1.55 1.16
glycine binding 1 2.28 1.03 1.38 -1.44 -1.34 1.53 1.42
thienylcyclohexylpiperidine binding 1 2.28 1.03 1.38 -1.44 -1.34 1.53 1.42
melatonin receptor activity 1 1.09 1.23 3.2 1.05 2.53 1.91 1.95
benzodiazepine receptor activity 1 -1.12 -1.26 1.76 1.06 1.23 -1.31 -1.61
monoamine transmembrane transporter activity 3 2.07 -1.32 -1.3 -1.21 -1.34 1.32 -1.28
sucrose:hydrogen symporter activity 1 2.52 -1.26 -1.18 -1.09 -1.25 2.25 1.03
sodium:iodide symporter activity 7 1.13 -1.12 -1.82 -1.93 -1.54 -1.43 1.18
bile acid:sodium symporter activity 2 -3.13 1.41 -2.05 1.29 -3.5 -4.18 -1.28
sodium:potassium:chloride symporter activity 3 -1.68 -1.44 1.14 -1.49 -1.04 2.8 -1.1
secondary active organic cation transmembrane transporter activity 24 -1.27 -1.38 -1.63 -1.24 -1.0 2.31 -1.46
organic anion transmembrane transporter activity 8 -2.06 1.07 -1.1 -1.04 1.14 -1.35 1.33
sucrose transmembrane transporter activity 1 2.52 -1.26 -1.18 -1.09 -1.25 2.25 1.03
folic acid transporter activity 1 -1.3 -1.21 1.08 -1.14 1.42 1.82 -1.08
reduced folate carrier activity 3 -2.47 1.26 -3.59 2.04 -1.22 -1.96 -2.06
L-ascorbate:sodium symporter activity 1 1.92 -5.29 -3.19 -3.44 7.65 2.58 1.23
acetyl-CoA transporter activity 1 -1.28 1.24 -1.24 1.18 -1.13 -1.69 1.59
sodium-dependent multivitamin transmembrane transporter activity 5 1.01 1.09 -2.28 -1.32 1.1 -1.3 1.01
glucose 6-phosphate:phosphate antiporter activity 1 1.19 1.35 1.39 1.1 1.22 1.13 2.76
phosphatidylcholine transporter activity 3 3.03 -1.11 1.31 -1.04 1.16 1.62 1.22
phosphatidylinositol transporter activity 3 2.87 -1.14 1.55 -1.02 1.46 1.97 1.15
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity 3 -3.66 1.03 -1.66 1.15 1.31 -2.05 -1.18
oxidized purine base lesion DNA N-glycosylase activity 2 1.64 -1.01 1.15 1.12 1.14 1.33 -1.07
regulation of proteasomal protein catabolic process 5 1.57 1.06 1.14 1.24 1.16 1.17 1.01
fibroblast growth factor receptor signaling pathway 10 1.63 -1.12 2.13 -1.03 1.14 1.56 1.09
cadmium ion transmembrane transporter activity 1 -1.37 1.35 1.68 1.28 1.12 -1.35 -1.15
potassium-transporting ATPase activity 8 1.13 -1.11 1.22 -1.35 -1.0 1.53 1.06
actin filament-based movement 2 -1.84 1.42 2.86 1.0 1.74 1.92 1.21
mystery cell differentiation 1 -1.03 1.35 2.46 1.15 2.45 2.67 1.87
release of cytoplasmic sequestered NF-kappaB 1 1.41 1.35 1.47 1.02 1.54 2.41 1.84
regulation of smoothened signaling pathway 27 1.49 1.16 1.31 1.06 1.3 1.61 1.15
regulation of Toll signaling pathway 15 2.33 -1.32 -1.29 -1.35 -1.14 1.81 1.29
protein phosphatase type 1 regulator activity 6 1.88 -1.31 1.12 1.03 1.16 1.14 1.17
protein phosphatase type 2A regulator activity 7 1.44 -1.06 1.23 -1.02 1.16 2.34 1.17
alkylglycerone-phosphate synthase activity 1 5.42 -21.99 -24.45 -20.82 -3.99 -1.47 6.54
ether lipid biosynthetic process 1 5.42 -21.99 -24.45 -20.82 -3.99 -1.47 6.54
diuretic hormone activity 4 -1.94 -1.06 1.2 1.12 1.34 -2.14 -1.37
pyridoxine metabolic process 4 2.09 1.04 -1.32 1.26 1.04 1.32 1.12
pyridoxine biosynthetic process 4 2.09 1.04 -1.32 1.26 1.04 1.32 1.12
queuosine biosynthetic process 2 -1.08 1.07 1.01 1.12 1.08 -1.67 -1.22
guanosine metabolic process 2 -1.08 1.07 1.01 1.12 1.08 -1.67 -1.22
7-methylguanosine metabolic process 2 -1.08 1.07 1.01 1.12 1.08 -1.67 -1.22
epsilon DNA polymerase complex 3 1.73 1.2 1.21 1.15 1.32 1.1 -1.16
chromatin accessibility complex 4 1.2 1.15 1.7 1.23 1.78 1.39 1.32
induction of apoptosis by ionic changes 2 1.02 1.0 -1.02 -1.06 -1.0 -1.03 1.59
DNA damage response, signal transduction resulting in induction of apoptosis 9 1.53 1.18 1.1 1.13 1.27 1.31 1.44
activation of pro-apoptotic gene products 1 1.78 1.11 1.56 1.24 1.76 -1.03 1.11
carbohydrate transport 13 1.22 -1.13 -1.12 -1.07 1.01 1.59 1.23
hexose transport 2 -1.9 1.16 -1.07 1.04 -1.18 -1.96 1.78
rRNA (uridine-2'-O-)-methyltransferase activity 3 1.55 1.21 1.1 1.32 1.19 1.02 -1.14
actin filament polymerization 6 -1.34 1.04 1.42 1.14 1.28 -1.56 -1.16
2'-phosphotransferase activity 1 3.82 1.09 1.67 1.1 1.4 2.3 1.73
N-acetylmuramoyl-L-alanine amidase activity 11 -1.39 -1.63 -1.15 1.01 -1.87 -2.01 -1.36
oxidoreductase activity, acting on NADH or NADPH 44 1.12 1.05 1.23 1.06 1.09 1.58 -1.22
UDP-N-acetylmuramate dehydrogenase activity 3 1.89 -2.35 -2.83 -2.17 -1.54 -1.15 1.9
acetaldehyde dehydrogenase (acetylating) activity 2 2.78 -1.16 -2.38 -2.31 -1.44 1.4 1.22
bis(5'-nucleosyl)-tetraphosphatase activity 1 -1.85 1.12 1.37 1.12 1.23 -1.02 1.02
carbon-monoxide oxygenase activity 1 2.72 -3.32 -2.57 -3.03 -1.93 22.15 -2.83
diaminohydroxyphosphoribosylaminopyrimidine deaminase activity 1 2.99 3.14 -4.72 -4.54 -4.51 3.75 1.74
DNA N-glycosylase activity 6 2.07 -1.07 1.03 -1.04 1.05 1.76 1.02
exodeoxyribonuclease III activity 1 -1.62 1.33 -1.09 1.09 -1.15 -1.69 -1.15
exoribonuclease II activity 1 1.38 1.19 2.04 1.07 1.63 2.14 1.72
glycerate kinase activity 1 1.02 1.55 -1.07 1.39 -1.43 -1.25 -1.1
glycerophosphodiester phosphodiesterase activity 6 -2.04 1.29 -1.08 1.03 -1.68 -2.4 1.09
guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity 1 1.81 -1.03 1.57 1.17 1.71 1.48 -1.14
holo-[acyl-carrier-protein] synthase activity 1 1.84 1.09 2.09 1.3 2.04 2.34 1.11
homocysteine S-methyltransferase activity 2 -2.66 1.46 -3.05 1.35 1.97 -1.55 -1.14
mannose-phosphate guanylyltransferase activity 2 -2.09 1.14 1.2 1.25 1.24 -1.89 1.17
inositol monophosphate 1-phosphatase activity 6 1.86 -1.14 -1.69 -1.19 1.02 1.47 1.43
oxalyl-CoA decarboxylase activity 1 -4.09 -1.02 -5.68 1.78 1.15 -8.6 -2.19
phosphoglycolate phosphatase activity 4 1.72 1.3 -1.05 1.15 1.06 1.1 -1.14
phosphatidylcholine 1-acylhydrolase activity 9 -31.12 -1.57 -1.58 -2.13 -3.67 -22.6 -1.69
site-specific DNA-methyltransferase (adenine-specific) activity 1 1.54 1.35 -1.17 1.42 -1.06 -1.14 -1.22
tRNA thio-modification 3 1.78 1.18 1.12 1.35 1.22 1.11 -1.02
sulfurtransferase activity 4 1.34 1.04 1.57 1.22 1.05 1.11 -1.14
dosage compensation by hyperactivation of X chromosome 6 1.52 1.11 1.3 1.04 1.23 1.53 1.43
pentose-phosphate shunt, non-oxidative branch 2 2.98 1.26 -2.38 1.09 -1.14 1.07 1.35
aerobic respiration 37 -1.01 1.07 1.26 -1.07 1.11 1.57 -1.08
fatty acid catabolic process 14 -1.01 1.07 -1.43 1.07 1.18 -1.97 -1.26
cellular amino acid catabolic process 26 1.02 -1.11 -1.05 -1.1 1.01 1.7 -1.18
glutamine family amino acid metabolic process 23 -1.67 -1.06 -1.81 -1.18 1.04 -1.04 -1.34
glutamine family amino acid catabolic process 9 -1.31 -1.36 -1.54 -1.44 1.15 1.66 -1.26
aspartate family amino acid metabolic process 11 1.2 -1.0 -1.12 1.08 -1.05 1.59 -1.22
aspartate family amino acid catabolic process 2 -1.01 -1.12 -1.04 1.37 -1.27 1.52 -1.61
serine family amino acid metabolic process 17 1.58 1.09 1.09 1.0 -1.11 1.65 1.1
serine family amino acid biosynthetic process 8 2.16 1.12 -1.08 1.04 -1.18 1.67 1.19
serine family amino acid catabolic process 6 1.21 1.07 1.39 -1.04 -1.02 1.86 -1.02
aromatic amino acid family catabolic process 6 1.4 -1.16 -1.06 -1.08 -1.08 1.95 -1.14
pyruvate family amino acid metabolic process 1 1.7 1.2 1.13 1.08 -1.16 -1.08 1.29
pyruvate family amino acid biosynthetic process 1 1.7 1.2 1.13 1.08 -1.16 -1.08 1.29
branched chain family amino acid metabolic process 7 1.25 1.54 1.17 1.06 -1.04 1.35 1.33
branched chain family amino acid biosynthetic process 1 5.21 1.63 1.44 -1.45 -2.46 1.42 2.6
glutamine family amino acid biosynthetic process 13 -1.5 -1.15 -1.86 -1.29 -1.1 1.05 -1.0
lipoate metabolic process 3 1.25 1.0 1.66 -1.03 -1.05 2.4 -1.24
coenzyme biosynthetic process 38 1.65 1.09 1.07 1.05 1.11 1.24 1.16
vitamin biosynthetic process 9 1.68 1.27 -1.29 -1.05 -1.17 1.44 1.19
purine base biosynthetic process 4 1.18 1.13 1.03 1.06 -1.06 1.6 -1.13
nucleoside diphosphate biosynthetic process 3 -1.09 1.03 1.21 1.32 1.42 -1.7 -1.39
purine nucleoside diphosphate metabolic process 2 -1.29 -1.01 -1.04 1.37 1.42 -2.05 -1.57
purine nucleoside diphosphate biosynthetic process 2 -1.29 -1.01 -1.04 1.37 1.42 -2.05 -1.57
pyrimidine nucleoside diphosphate metabolic process 1 1.27 1.13 1.91 1.21 1.41 -1.17 -1.08
pyrimidine nucleoside diphosphate biosynthetic process 1 1.27 1.13 1.91 1.21 1.41 -1.17 -1.08
nucleoside triphosphate biosynthetic process 29 1.28 1.05 1.25 -1.01 1.13 1.56 -1.1
purine nucleoside triphosphate biosynthetic process 29 1.28 1.05 1.25 -1.01 1.13 1.56 -1.1
nucleoside catabolic process 3 -2.8 1.04 -1.39 1.2 1.32 -1.87 -1.06
purine ribonucleoside diphosphate metabolic process 2 -1.29 -1.01 -1.04 1.37 1.42 -2.05 -1.57
purine ribonucleoside diphosphate biosynthetic process 2 -1.29 -1.01 -1.04 1.37 1.42 -2.05 -1.57
ribonucleoside diphosphate metabolic process 2 -1.29 -1.01 -1.04 1.37 1.42 -2.05 -1.57
deoxyribonucleoside diphosphate metabolic process 2 -1.56 -1.01 1.45 1.31 1.53 -1.54 -1.56
muscle attachment 28 1.6 1.08 1.3 -1.01 1.35 1.36 1.25
ribonucleoside diphosphate biosynthetic process 2 -1.29 -1.01 -1.04 1.37 1.42 -2.05 -1.57
deoxyribonucleoside diphosphate biosynthetic process 1 1.27 1.13 1.91 1.21 1.41 -1.17 -1.08
pyrimidine deoxyribonucleoside diphosphate metabolic process 1 1.27 1.13 1.91 1.21 1.41 -1.17 -1.08
pyrimidine deoxyribonucleoside diphosphate biosynthetic process 1 1.27 1.13 1.91 1.21 1.41 -1.17 -1.08
deoxyribonucleoside triphosphate metabolic process 1 -1.36 -1.27 1.07 1.7 1.82 -3.47 -2.13
ribonucleoside triphosphate biosynthetic process 29 1.28 1.05 1.25 -1.01 1.13 1.56 -1.1
purine ribonucleoside triphosphate biosynthetic process 29 1.28 1.05 1.25 -1.01 1.13 1.56 -1.1
pyrimidine deoxyribonucleoside triphosphate metabolic process 1 -1.36 -1.27 1.07 1.7 1.82 -3.47 -2.13
nucleotide-sugar metabolic process 4 -1.38 1.14 1.12 1.14 1.22 -1.6 -1.01
nucleotide-sugar biosynthetic process 4 -1.38 1.14 1.12 1.14 1.22 -1.6 -1.01
thiamine diphosphate biosynthetic process 1 1.06 1.62 -1.26 1.22 -1.14 -1.11 1.12
riboflavin biosynthetic process 2 1.78 2.05 -2.11 -2.16 -2.52 2.14 1.44
menaquinone metabolic process 1 1.46 1.06 1.55 -1.07 1.35 1.82 1.43
menaquinone biosynthetic process 1 1.46 1.06 1.55 -1.07 1.35 1.82 1.43
glycolipid biosynthetic process 7 1.02 1.24 1.08 -1.02 1.04 -1.16 1.9
glucan biosynthetic process 5 2.74 -1.19 -1.42 1.04 1.07 2.78 1.29
glucan catabolic process 1 2.98 -1.08 1.5 -1.31 1.12 4.86 1.33
peptidoglycan catabolic process 12 -1.13 -1.64 -1.19 -1.04 -1.82 -1.69 -1.29
10-formyltetrahydrofolate metabolic process 2 2.31 -1.37 1.2 -1.19 -1.05 2.92 1.06
10-formyltetrahydrofolate catabolic process 1 -1.35 1.22 1.7 1.18 1.15 -1.09 1.03
deoxyribonucleotide catabolic process 1 -1.52 1.52 -1.38 1.37 -1.06 -2.8 1.21
cellular response to starvation 14 1.29 1.12 1.14 1.05 1.06 1.68 1.18
response to humidity 2 2.35 -1.29 -1.39 -1.42 -1.06 2.35 1.81
cell outer membrane 2 2.45 -1.01 1.06 1.01 1.14 1.16 1.19
nucleoid 1 1.18 1.16 1.75 1.38 1.68 1.06 -1.24
GDP-mannose biosynthetic process 1 -1.31 1.22 1.33 1.17 1.22 -1.88 1.41
rRNA transcription 1 -1.18 1.5 1.2 1.21 1.41 -1.06 1.52
tRNA transcription 1 1.67 1.25 1.56 1.07 1.53 1.47 1.26
response to drug 6 -1.83 -1.23 -1.66 1.04 1.16 -1.94 -1.32
dihydrolipoyl dehydrogenase complex 1 -1.4 -1.14 2.27 -1.25 -1.48 1.94 -1.5
pyruvate dehydrogenase complex 4 1.04 1.05 1.45 1.06 1.07 1.89 -1.15
mitochondrial oxoglutarate dehydrogenase complex 3 1.31 1.13 2.04 -1.28 1.13 2.68 -1.02
oxoglutarate dehydrogenase complex 3 1.31 1.13 2.04 -1.28 1.13 2.68 -1.02
succinate-CoA ligase complex (ADP-forming) 1 1.64 -1.15 2.7 -1.43 1.36 4.94 -1.1
endopeptidase Clp complex 1 -1.01 1.55 1.36 1.04 1.26 2.38 1.15
peptidase activity, acting on L-amino acid peptides 556 -1.79 -1.27 -1.34 -1.05 -1.19 -1.74 -1.45
phospholipid catabolic process 4 -7.22 -4.62 -6.48 1.55 -1.18 -4.98 -5.49
folic acid-containing compound biosynthetic process 6 1.83 -1.4 -1.53 -1.23 -1.52 1.23 1.04
folic acid-containing compound catabolic process 1 -1.35 1.22 1.7 1.18 1.15 -1.09 1.03
response to toxin 23 -1.02 1.14 -1.39 -1.1 -1.24 -1.6 1.25
toxin metabolic process 10 1.1 -1.02 -1.79 -1.06 -1.28 -1.46 1.06
pathogenesis 1 -117.62 -1.03 2.87 -1.15 -1.31 -23.49 -2.28
toxin catabolic process 4 -1.27 -1.2 -4.97 -1.06 -1.84 -3.14 1.18
response to xenobiotic stimulus 10 1.1 -1.02 -1.79 -1.06 -1.28 -1.46 1.06
response to metal ion 16 -1.69 1.12 1.25 1.08 1.07 -1.25 -1.13
response to water deprivation 3 -1.08 -2.2 -2.66 -2.3 -1.91 1.61 -1.02
response to water 7 1.12 -1.5 -1.68 -1.54 -1.43 1.5 1.17
NAD biosynthetic process 3 1.9 1.5 -1.09 1.01 1.09 1.23 1.86
glyoxylate catabolic process 1 1.1 -1.81 -2.08 -1.81 -1.6 3.21 -1.83
gamma-aminobutyric acid metabolic process 3 -1.67 1.65 -1.0 -1.05 -1.15 -1.16 -1.07
gamma-aminobutyric acid catabolic process 1 -2.19 1.37 2.06 1.34 1.0 1.58 -1.11
RNA capping 3 1.59 1.23 1.42 1.29 1.28 1.33 1.13
electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity 2 1.19 1.13 1.42 -1.04 1.3 1.64 -1.09
detection of UV 5 -1.46 -1.43 -1.51 1.22 -1.06 -1.54 -1.62
detection of nutrient 1 1.24 1.34 2.02 1.2 1.78 5.29 1.65
detection of biotic stimulus 6 -1.12 -1.97 1.21 1.05 -1.56 -1.46 -2.39
detection of virus 1 -1.09 1.04 3.03 -1.09 1.76 1.29 1.77
detection of symbiont 1 -1.09 1.04 3.03 -1.09 1.76 1.29 1.77
response to symbiont 7 -1.49 1.04 -1.1 1.15 1.18 -1.6 -1.03
response to symbiotic bacterium 2 -5.67 -1.13 -2.52 1.36 1.12 -4.93 -1.8
response to fungus 31 1.98 -1.28 -1.31 -1.33 -1.26 1.23 1.29
response to insect 1 23.01 -3.14 -2.9 -3.17 -2.48 1.73 2.58
response to blue light 1 1.37 -1.11 -1.04 1.15 1.03 2.71 1.13
response to red or far red light 2 1.78 1.07 -1.24 1.28 -1.04 1.5 -1.03
response to light intensity 3 2.14 -1.51 1.43 -1.06 -1.34 1.03 -1.36
response to high light intensity 1 3.41 -1.85 -1.6 -1.39 -1.6 6.88 -1.28
UV protection 1 1.47 1.08 -1.62 1.31 -1.48 3.54 -1.09
catechol-containing compound metabolic process 9 -1.02 -1.18 -1.26 -1.16 -1.28 -1.1 1.52
catechol-containing compound biosynthetic process 3 -1.04 -2.12 -1.47 -1.4 -1.53 1.41 2.4
response to carbohydrate stimulus 6 1.99 -1.0 1.23 1.06 1.32 1.59 1.29
response to sucrose stimulus 3 2.79 -1.08 1.21 1.01 1.44 1.96 1.48
regulation of asymmetric cell division 2 -1.7 1.32 1.22 1.23 1.24 -1.9 -1.09
specification of symmetry 5 -2.92 1.25 1.15 -1.01 1.23 -1.58 1.16
unidimensional cell growth 17 1.27 1.19 1.53 1.1 1.7 1.49 1.46
determination of bilateral symmetry 5 -2.92 1.25 1.15 -1.01 1.23 -1.58 1.16
blue light photoreceptor activity 1 1.37 -1.11 -1.04 1.15 1.03 2.71 1.13
negative regulation of catabolic process 8 -1.33 1.25 1.01 1.18 1.01 -1.53 -1.03
fatty acid elongase activity 3 1.46 -2.22 -1.95 -2.84 -2.14 -1.24 3.42
basal plasma membrane 1 1.33 1.32 2.26 1.11 1.52 1.39 1.48
calcium-dependent protein serine/threonine kinase activity 3 1.12 1.04 2.13 -1.07 1.01 3.21 -1.04
proximal/distal axis specification 1 -1.27 1.59 1.07 1.18 1.42 1.16 1.47
cytidine deamination 3 -2.8 1.04 -1.39 1.2 1.32 -1.87 -1.06
pseudouridine synthase activity 10 1.65 1.34 1.08 1.11 1.11 1.56 1.14
glial cell differentiation 26 2.31 -1.1 1.3 -1.1 1.28 1.79 1.37
cardioblast differentiation 12 1.8 -1.05 1.29 -1.1 1.12 1.16 1.3
endosome membrane 1 1.78 1.14 -1.44 1.08 1.0 3.89 1.83
meiotic chromosome condensation 1 -1.65 -1.11 -1.2 -1.08 1.07 -1.43 -1.21
response to zinc ion 2 -1.79 1.33 -1.11 -1.01 -1.24 -1.87 -1.3
response to red light 2 1.78 1.07 -1.24 1.28 -1.04 1.5 -1.03
response to X-ray 4 1.1 1.11 1.34 1.23 1.84 -1.18 -1.06
production of miRNAs involved in gene silencing by miRNA 6 1.56 1.12 1.48 1.03 1.19 1.57 1.34
response to lithium ion 1 -1.01 -1.09 -1.11 -1.17 -1.13 13.69 -1.18
response to organic nitrogen 4 1.59 -1.01 1.38 1.29 1.34 1.2 -1.18
endomembrane system organization 2 -1.26 1.07 1.65 1.14 1.45 1.05 1.02
NADH dehydrogenase complex assembly 1 1.08 1.05 1.31 1.03 1.07 1.99 -1.52
acireductone dioxygenase [iron(II)-requiring] activity 1 1.79 1.32 -1.5 1.17 -1.1 1.63 1.03
response to gamma radiation 1 4.35 1.1 2.37 1.09 1.77 2.6 1.18
response to trehalose stimulus 3 3.3 1.01 1.16 -1.06 1.46 2.79 1.63
histone H3-K36 methylation 1 1.08 1.46 1.5 -1.1 1.11 1.44 1.39
centriole-centriole cohesion 1 3.23 -1.13 1.38 1.13 1.64 2.38 1.04
negative regulation of peptidase activity 3 -1.25 -1.08 1.67 1.12 1.52 -1.68 -1.23
cytoplasmic stress granule 1 1.54 1.07 -1.03 1.11 1.17 1.09 1.04
intercellular transport 2 1.93 -1.45 -1.44 -1.31 -1.47 2.84 3.08
negative regulation of autophagy 4 -1.64 1.35 -1.16 1.08 -1.15 -1.93 1.04
regulation of glycoprotein biosynthetic process 1 -1.37 -1.13 -1.19 -1.54 1.82 7.35 2.8
positive regulation of phosphorus metabolic process 8 1.51 1.21 1.82 1.05 1.45 2.01 1.56
metalloenzyme regulator activity 1 8.96 -2.17 1.12 -1.71 -1.16 3.1 2.84
miRNA metabolic process 2 3.15 1.1 1.2 1.08 -1.05 1.81 1.29
regulation of lamellipodium assembly 7 -1.2 1.11 1.6 1.12 1.38 -1.25 -1.04
negative regulation of lamellipodium assembly 1 -1.18 1.31 1.55 1.08 1.49 1.22 1.14
positive regulation of cytoplasmic mRNA processing body assembly 1 3.49 1.22 2.63 -1.09 2.31 4.69 1.68
epithelial cell migration 28 1.66 -1.03 1.29 -1.07 1.21 1.38 1.11
regulation of epithelial cell migration 5 2.13 -1.29 -1.2 -1.27 1.01 -1.13 2.14
regulation of cellular carbohydrate metabolic process 3 -1.56 -1.05 -1.43 -1.32 1.05 1.6 2.11
positive regulation of cell development 6 1.51 1.15 1.49 1.06 1.33 1.5 1.37
regulation of peptidyl-threonine phosphorylation 1 1.11 1.2 3.72 1.08 1.65 2.06 2.0
positive regulation of peptidyl-threonine phosphorylation 1 1.11 1.2 3.72 1.08 1.65 2.06 2.0
regulation of cell-substrate adhesion 2 1.91 1.0 2.08 1.07 1.96 1.63 1.31
negative regulation of cell-substrate adhesion 1 2.96 1.13 1.75 -1.2 1.98 1.94 1.75
positive regulation of mitochondrion organization 2 -1.0 1.14 -1.27 1.12 -1.13 -1.52 -1.35
regulation of centrosome duplication 4 1.33 1.11 1.56 1.02 1.41 1.58 1.14
regulation of chromatin assembly 3 1.21 1.11 1.43 1.11 1.52 1.35 1.11
cyclase regulator activity 1 4.81 -1.03 -1.02 1.21 1.81 1.05 1.23
cyclase activator activity 1 4.81 -1.03 -1.02 1.21 1.81 1.05 1.23
calcium-dependent protein kinase activity 3 1.12 1.04 2.13 -1.07 1.01 3.21 -1.04
regulation of triglyceride biosynthetic process 1 -1.2 1.03 1.07 -1.11 1.52 -1.28 -1.06
lipid localization 42 -1.57 -1.37 -1.54 1.04 -1.02 -1.33 -1.47
positive regulation of lipid storage 1 -2.11 1.69 -1.72 -1.16 2.47 -2.75 -1.82
negative regulation of lipid storage 2 1.04 1.46 1.79 1.31 1.26 1.68 1.1
regulation of sequestering of triglyceride 2 1.65 1.42 1.72 -1.12 -1.11 1.9 1.54
negative regulation of sequestering of triglyceride 1 1.15 1.61 -1.09 1.48 -1.24 1.35 -1.03
regulation of glucose metabolic process 2 -1.67 -1.02 -1.57 -1.22 -1.25 -1.34 1.83
negative regulation of endopeptidase activity 3 -1.25 -1.08 1.67 1.12 1.52 -1.68 -1.23
negative regulation of protein processing 1 -2.9 -1.14 1.64 1.56 2.18 -4.01 -1.31
magnesium ion homeostasis 1 -1.13 1.01 1.23 1.08 1.32 1.53 1.35
regulation of microtubule nucleation 1 2.49 1.3 2.87 -1.0 2.26 3.13 2.77
regulation of translational initiation by eIF2 alpha phosphorylation 3 3.45 -1.5 -1.27 -1.43 1.18 2.31 1.49
ER to Golgi transport vesicle membrane 1 1.02 1.56 2.15 1.06 2.07 2.36 2.5
trans-Golgi network transport vesicle membrane 3 -1.23 1.16 1.44 1.05 1.28 1.6 1.31
regulation of gliogenesis 4 1.83 1.22 1.55 -1.02 1.23 1.76 1.45
negative regulation of gliogenesis 2 1.15 1.57 1.36 1.13 1.31 1.77 1.58
positive regulation of gliogenesis 2 2.9 -1.05 1.75 -1.19 1.16 1.75 1.33
neuroblast fate specification 1 2.48 -1.28 1.14 -1.16 1.81 2.29 3.17
glutamate secretion 1 -3.47 -4.26 1.06 2.44 2.17 -3.37 -7.09
postsynaptic density 3 1.62 -1.01 1.32 -1.1 1.45 2.01 1.64
response to tropane 13 1.28 1.17 1.57 1.07 1.39 1.83 1.27
response to amine stimulus 4 1.59 -1.01 1.38 1.29 1.34 1.2 -1.18
muscle cell migration 1 1.49 1.07 1.15 1.04 -1.03 1.53 -1.09
regulation of skeletal muscle contraction 1 2.24 1.81 -38.59 -31.15 -18.58 -3.21 4.55
phasic smooth muscle contraction 1 1.69 1.43 1.3 1.01 1.12 1.63 -1.01
regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction 1 2.24 1.81 -38.59 -31.15 -18.58 -3.21 4.55
regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction 1 2.24 1.81 -38.59 -31.15 -18.58 -3.21 4.55
skeletal myofibril assembly 7 2.48 -1.3 1.04 -1.21 1.0 1.67 -1.05
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process 4 1.19 1.5 1.46 1.15 1.54 1.21 1.67
[heparan sulfate]-glucosamine N-sulfotransferase activity 1 -1.1 1.79 1.14 1.04 1.02 -1.23 2.55
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity 3 1.19 -1.06 -1.32 -1.33 -1.21 1.07 3.7
glucuronosyltransferase activity 34 -1.54 -1.06 -1.26 1.13 1.11 -1.57 -1.05
anchored to membrane 3 3.1 -2.01 -3.22 -2.43 -1.37 2.44 1.37
NADPH-adrenodoxin reductase activity 1 -1.19 1.24 1.2 1.43 1.53 -1.12 -1.13
retinal binding 6 3.18 -5.84 -5.89 -2.35 -1.77 1.79 1.62
1-phosphatidylinositol-3-kinase activity 3 -1.46 1.15 1.53 1.18 1.77 -1.09 -1.14
1-phosphatidylinositol-4-phosphate 3-kinase activity 3 -1.46 1.15 1.53 1.18 1.77 -1.09 -1.14
phosphatidylinositol-4,5-bisphosphate 3-kinase activity 3 -1.46 1.15 1.53 1.18 1.77 -1.09 -1.14
sodium ion transmembrane transporter activity 81 -1.48 -1.05 -1.89 -1.26 -1.27 1.0 -1.16
copper uptake transmembrane transporter activity 1 1.39 1.37 1.47 1.19 1.52 2.16 1.06
organic cation transmembrane transporter activity 36 -1.2 -1.18 -1.56 -1.22 -1.06 1.61 -1.27
inorganic anion transmembrane transporter activity 44 -1.75 -1.05 -1.79 -1.14 -1.41 1.18 -1.54
arsenite transmembrane transporter activity 2 2.24 1.06 1.22 -1.13 -1.15 2.07 1.19
chloride transmembrane transporter activity 4 -2.12 -1.32 1.67 -1.4 1.05 1.49 -1.53
phosphate ion transmembrane transporter activity 28 -2.04 -1.01 -2.2 -1.07 -1.55 -1.11 -1.87
sulfate transmembrane transporter activity 11 -1.38 -1.18 -1.62 -1.28 -1.18 2.41 -1.09
thiosulfate transmembrane transporter activity 2 1.03 -1.5 1.48 -1.27 1.66 3.63 -1.34
bile acid transmembrane transporter activity 2 -3.13 1.41 -2.05 1.29 -3.5 -4.18 -1.28
oxaloacetate transmembrane transporter activity 1 -1.02 -2.78 1.86 -1.91 2.75 13.01 -1.81
citrate transmembrane transporter activity 6 1.66 1.03 1.2 -1.17 -1.14 1.49 1.13
malate transmembrane transporter activity 6 -1.06 -1.19 1.21 -1.11 1.09 1.9 -1.26
succinate transmembrane transporter activity 2 1.52 -1.49 2.44 -1.88 1.67 5.92 1.16
urate transmembrane transporter activity 2 1.45 -1.07 1.88 1.03 1.06 1.31 1.14
monosaccharide transmembrane transporter activity 21 -1.07 -1.11 -1.82 -1.2 -1.34 -1.42 1.07
hexose transmembrane transporter activity 18 -1.2 -1.08 -1.91 -1.2 -1.46 -1.81 1.09
disaccharide transmembrane transporter activity 1 2.52 -1.26 -1.18 -1.09 -1.25 2.25 1.03
polyol transmembrane transporter activity 1 -2.04 1.18 -1.02 1.21 1.32 -1.45 1.81
glycerol transmembrane transporter activity 1 -2.04 1.18 -1.02 1.21 1.32 -1.45 1.81
glycerol-3-phosphate transmembrane transporter activity 1 -2.04 1.18 -1.02 1.21 1.32 -1.45 1.81
acidic amino acid transmembrane transporter activity 4 -2.07 1.33 -5.17 -2.48 -1.62 -1.72 -2.15
aromatic amino acid transmembrane transporter activity 2 3.0 -1.1 1.15 -1.28 -1.42 2.49 1.13
neutral amino acid transmembrane transporter activity 5 -1.05 -1.63 -1.94 -1.23 1.36 1.17 1.17
L-amino acid transmembrane transporter activity 14 -1.06 -1.11 -2.62 -1.34 1.08 -1.05 -1.21
L-aspartate transmembrane transporter activity 2 1.6 1.38 -6.52 -5.62 -4.41 -1.75 2.45
L-cystine transmembrane transporter activity 1 -7.18 -1.45 -9.47 1.62 3.49 -2.41 -5.84
L-gamma-aminobutyric acid transmembrane transporter activity 3 1.55 1.3 -1.41 -1.0 1.17 -1.0 1.21
peptide transporter activity 3 1.69 -1.17 -1.51 -1.15 -1.07 1.17 1.2
oligopeptide transporter activity 3 1.69 -1.17 -1.51 -1.15 -1.07 1.17 1.2
nucleobase transmembrane transporter activity 1 2.22 1.18 2.27 1.0 1.25 2.33 2.07
purine nucleoside transmembrane transporter activity 2 1.45 1.3 1.01 1.18 1.09 1.6 1.46
serotonin transmembrane transporter activity 1 -1.06 -1.11 -1.0 -1.08 -1.15 3.37 -1.04
vitamin transporter activity 7 -1.0 1.07 -1.8 -1.21 1.11 -1.18 1.04
carnitine transporter activity 6 -1.28 1.49 -1.43 -1.09 -1.24 -2.46 -1.13
thiamine transmembrane transporter activity 1 1.18 1.26 -1.06 1.24 -1.11 -1.61 1.34
fatty acid transporter activity 7 -2.15 1.3 -1.32 -1.52 -2.35 -1.39 -1.5
sterol transporter activity 1 -1.06 1.09 -1.0 1.4 1.63 -1.48 -1.12
water channel activity 5 -2.72 1.35 -1.04 -1.24 -3.15 -2.7 -1.32
sugar transmembrane transporter activity 26 -1.05 -1.08 -1.66 -1.14 -1.28 -1.32 1.13
calcium-activated potassium channel activity 3 -1.25 -1.55 1.25 1.49 -1.39 -1.46 -1.49
outward rectifier potassium channel activity 4 1.21 1.23 1.58 -1.53 -1.48 1.98 -1.52
ATP-activated inward rectifier potassium channel activity 1 -2.21 1.6 1.01 1.47 -3.02 -10.91 -2.13
kainate selective glutamate receptor activity 11 2.2 -1.06 1.07 -1.1 -1.06 1.26 1.02
calcium-release channel activity 4 2.09 1.04 1.5 1.02 1.16 2.3 1.48
store-operated calcium channel activity 4 1.41 -1.11 1.15 1.07 1.1 1.6 1.28
symporter activity 76 -1.49 -1.09 -1.95 -1.27 -1.28 -1.09 -1.13
solute:cation symporter activity 74 -1.49 -1.1 -1.98 -1.28 -1.29 -1.08 -1.14
solute:hydrogen symporter activity 10 1.17 -1.04 -1.27 -1.11 -1.11 -1.04 1.72
anion:cation symporter activity 36 -2.03 -1.02 -2.27 -1.32 -1.7 -1.35 -1.62
solute:cation antiporter activity 13 -1.59 1.16 -1.1 1.0 -1.16 1.34 1.01
solute:hydrogen antiporter activity 6 -1.84 1.01 -1.18 -1.0 -1.46 2.19 -1.2
anion:anion antiporter activity 7 -1.5 -1.45 1.6 -1.5 -1.11 1.16 -1.09
organophosphate:inorganic phosphate antiporter activity 1 1.19 1.35 1.39 1.1 1.22 1.13 2.76
sodium:inorganic phosphate symporter activity 1 -51.3 1.56 -15.93 -1.24 2.78 -3.27 -134.18
sodium-dependent phosphate transmembrane transporter activity 1 -1.14 1.17 1.24 1.15 -1.13 -1.05 2.26
secondary active oligopeptide transmembrane transporter activity 3 1.69 -1.17 -1.51 -1.15 -1.07 1.17 1.2
cationic amino acid transmembrane transporter activity 5 -2.27 1.25 -1.58 -1.02 1.06 1.04 -1.06
sodium-independent organic anion transmembrane transporter activity 3 -1.97 -1.09 1.04 1.04 1.56 -1.02 -1.01
secondary active monocarboxylate transmembrane transporter activity 6 -2.96 -1.49 -1.43 1.36 1.66 1.29 -1.83
solute:sodium symporter activity 58 -1.57 -1.09 -2.44 -1.32 -1.33 -1.17 -1.25
monovalent anion:sodium symporter activity 7 1.13 -1.12 -1.82 -1.93 -1.54 -1.43 1.18
cation:chloride symporter activity 4 -2.12 -1.32 1.67 -1.4 1.05 1.49 -1.53
potassium:chloride symporter activity 1 -4.23 -1.01 5.33 -1.14 1.37 -4.42 -4.03
high affinity sulfate transmembrane transporter activity 8 -1.57 -1.12 -2.1 -1.3 -1.39 2.29 -1.04
sodium:hydrogen antiporter activity 4 -2.37 -1.01 -1.35 1.01 -1.74 3.33 -1.27
potassium channel regulator activity 2 1.41 1.19 1.44 1.03 1.46 1.62 1.3
G-protein activated inward rectifier potassium channel activity 1 4.33 -4.87 -19.75 -19.08 -6.11 18.23 -1.15
cation:cation antiporter activity 11 -1.7 1.18 -1.14 1.01 -1.19 1.42 1.03
gamma-aminobutyric acid:hydrogen symporter activity 2 1.74 1.43 -1.72 -1.09 1.17 -1.0 1.38
glutamate:sodium symporter activity 2 1.6 1.38 -6.52 -5.62 -4.41 -1.75 2.45
C4-dicarboxylate transmembrane transporter activity 7 1.08 -1.13 1.39 -1.2 1.08 1.99 -1.07
thiamine pyrophosphate-transporting ATPase activity 1 1.18 1.26 -1.06 1.24 -1.11 -1.61 1.34
fatty acid ligase activity 7 1.81 -1.3 -1.35 1.09 1.2 -1.91 -1.26
quaternary ammonium group transmembrane transporter activity 6 -1.28 1.49 -1.43 -1.09 -1.24 -2.46 -1.13
gas transport 3 2.18 1.01 1.23 -1.11 -1.43 1.5 -1.22
oxygen transport 3 2.18 1.01 1.23 -1.11 -1.43 1.5 -1.22
copper ion import 2 -1.71 1.19 -1.03 1.03 -1.3 -1.51 1.21
plasma membrane copper ion transport 1 1.39 1.37 1.47 1.19 1.52 2.16 1.06
cadmium ion transport 1 -1.37 1.35 1.68 1.28 1.12 -1.35 -1.15
organic cation transport 6 -1.21 -1.29 -1.94 -1.42 -1.18 1.53 1.11
quaternary ammonium group transport 2 1.34 1.32 -1.91 1.22 1.14 -1.7 -1.23
inorganic anion transport 18 -1.11 1.04 -1.32 -1.05 1.11 1.94 -1.22
thiosulfate transport 2 1.03 -1.5 1.48 -1.27 1.66 3.63 -1.34
monocarboxylic acid transport 2 1.54 1.0 1.06 1.2 -1.29 1.7 1.68
oxaloacetate transport 1 -1.02 -2.78 1.86 -1.91 2.75 13.01 -1.81
taurine transport 2 -1.75 -2.01 -1.02 1.55 1.44 -1.8 -2.32
C4-dicarboxylate transport 5 -1.06 -1.22 1.26 -1.12 1.12 2.23 -1.26
succinate transport 1 -1.02 -2.78 1.86 -1.91 2.75 13.01 -1.81
galactose transport 1 -3.25 1.38 -1.03 -1.03 -1.21 -3.18 3.55
disaccharide transport 3 1.57 -1.8 -1.19 -1.63 -1.17 2.95 1.2
sucrose transport 1 2.52 -1.26 -1.18 -1.09 -1.25 2.25 1.03
trehalose transport 2 1.24 -2.16 -1.19 -2.0 -1.13 3.38 1.3
oligosaccharide transport 3 1.57 -1.8 -1.19 -1.63 -1.17 2.95 1.2
nucleotide-sugar transport 4 -1.46 1.25 1.0 1.26 1.04 -1.57 1.43
pyrimidine nucleotide-sugar transport 4 -1.46 1.25 1.0 1.26 1.04 -1.57 1.43
CMP-N-acetylneuraminate transport 3 -1.73 1.25 -1.03 1.28 -1.06 -1.84 1.23
UDP-galactose transport 3 -1.67 1.25 -1.02 1.2 1.18 -1.82 1.71
UDP-N-acetylgalactosamine transport 2 -2.31 1.25 -1.08 1.21 1.09 -2.5 1.48
polyol transport 1 -1.32 1.18 1.15 1.08 1.65 -1.36 1.01
myo-inositol transport 1 -1.32 1.18 1.15 1.08 1.65 -1.36 1.01
acidic amino acid transport 4 -2.92 -1.1 -4.98 -1.98 -1.32 -2.35 -3.75
branched-chain aliphatic amino acid transport 3 1.2 -1.03 -1.17 1.06 1.15 -1.13 2.49
neutral amino acid transport 6 -1.07 -2.12 -1.83 1.1 1.71 -1.03 1.19
L-amino acid transport 3 -7.27 -2.77 -15.38 -1.15 4.25 -1.2 -8.88
L-cystine transport 1 -7.18 -1.45 -9.47 1.62 3.49 -2.41 -5.84
leucine transport 3 1.2 -1.03 -1.17 1.06 1.15 -1.13 2.49
ornithine transport 1 1.32 1.45 -1.5 1.71 1.05 1.03 -1.1
peptide transport 4 1.61 -1.15 -1.24 -1.1 1.08 1.07 1.44
amine transport 43 -1.38 -1.14 -1.77 -1.23 -1.02 -1.05 -1.16
synaptic vesicle amine transport 1 9.63 -2.21 -1.97 -1.79 -1.94 -1.46 -1.99
monoamine transport 3 2.07 -1.32 -1.3 -1.21 -1.34 1.32 -1.28
organic acid transport 54 -1.28 -1.1 -1.53 -1.18 -1.03 1.07 -1.12
organic alcohol transport 3 1.93 -1.21 -1.24 -1.15 -1.08 -1.25 -1.26
nucleoside transport 3 1.64 1.2 1.17 1.2 1.5 1.69 1.3
purine nucleoside transport 1 1.9 1.27 1.23 1.06 1.26 2.28 1.58
dopamine transport 2 3.07 -1.44 -1.47 -1.28 -1.45 -1.2 -1.42
vitamin transport 5 -1.7 1.08 -1.68 1.05 1.16 -1.37 -1.11
carnitine transport 2 1.34 1.32 -1.91 1.22 1.14 -1.7 -1.23
folic acid transport 1 -1.3 -1.21 1.08 -1.14 1.42 1.82 -1.08
thiamine transport 1 1.18 1.26 -1.06 1.24 -1.11 -1.61 1.34
drug transport 5 -1.71 1.01 -2.04 -1.18 1.46 -1.6 -1.08
fatty acid transport 2 1.54 1.0 1.06 1.2 -1.29 1.7 1.68
long-chain fatty acid transport 2 1.54 1.0 1.06 1.2 -1.29 1.7 1.68
phospholipid transport 7 -2.51 1.11 -1.27 1.27 1.28 -1.64 -1.28
sterol transport 9 -4.78 -2.96 -3.21 1.02 -1.76 -3.24 -5.0
aspartate oxidase activity 2 -2.82 -1.69 -2.22 1.7 1.95 -1.63 -1.83
mannosidase activity 15 -4.86 1.01 -3.54 1.28 -1.09 -4.24 -6.43
mannosyl-oligosaccharide mannosidase activity 7 1.72 1.11 -1.23 -1.05 -1.05 2.48 1.36
galactosidase activity 3 -4.2 1.61 -2.03 -1.24 -2.09 -1.97 -1.23
glucosidase activity 16 -6.01 -1.16 -3.27 1.15 -2.07 -4.27 -2.24
trehalase activity 3 -2.73 1.23 -2.68 1.17 -1.22 -2.41 1.01
fucosidase activity 1 -1.1 -1.19 -1.53 -1.9 -1.86 -1.28 7.99
hexosaminidase activity 7 1.77 -1.0 -1.28 -1.06 1.05 1.54 1.4
glutamate synthase activity 2 2.76 -1.53 2.1 -1.11 -1.64 -1.33 1.55
nucleobase-containing small molecule interconversion 1 2.25 -1.1 -1.03 1.28 1.09 2.14 -1.24
pyrimidine nucleotide interconversion 1 2.25 -1.1 -1.03 1.28 1.09 2.14 -1.24
pyrimidine deoxyribonucleotide interconversion 1 2.25 -1.1 -1.03 1.28 1.09 2.14 -1.24
guanosine tetraphosphate metabolic process 1 1.81 -1.03 1.57 1.17 1.71 1.48 -1.14
guanosine tetraphosphate catabolic process 1 1.81 -1.03 1.57 1.17 1.71 1.48 -1.14
carbon utilization 1 3.68 1.14 -1.19 1.01 1.66 1.38 1.25
energy derivation by oxidation of organic compounds 106 1.09 1.04 1.19 1.01 1.12 1.62 -1.17
energy coupled proton transport, down electrochemical gradient 18 1.37 -1.0 1.2 -1.02 1.12 1.7 -1.2
ATP synthesis coupled proton transport 18 1.37 -1.0 1.2 -1.02 1.12 1.7 -1.2
phospholipase activator activity 2 -1.41 1.32 1.65 1.18 1.23 1.2 -1.03
dystrophin-associated glycoprotein complex 8 1.62 1.02 1.14 1.04 1.13 1.2 1.02
dystroglycan complex 4 2.12 1.06 1.24 1.03 1.2 1.2 1.03
sarcoglycan complex 3 2.49 -1.02 1.02 1.01 1.11 1.14 -1.09
dystrobrevin complex 1 4.45 -1.13 -1.95 -1.08 1.28 3.01 -1.11
morphogen activity 7 2.09 -1.17 1.11 -1.12 1.1 1.31 1.31
peptidoglycan receptor activity 3 2.74 -1.01 1.12 -1.1 1.04 2.17 1.15
CDP-diacylglycerol biosynthetic process 1 3.07 1.1 2.07 -1.42 3.13 -1.11 1.4
subrhabdomeral cisterna 3 2.2 -1.44 1.68 1.01 -1.15 1.14 1.11
maleylacetoacetate isomerase activity 2 1.58 1.0 1.35 1.16 1.16 1.96 -1.03
zeta DNA polymerase complex 1 -1.03 1.1 1.04 -1.05 1.06 2.37 1.1
glutamate synthase (NADH) activity 1 2.14 1.19 1.24 1.03 -1.73 3.68 2.51
lipid catabolic process 41 -1.2 -1.2 -1.43 1.05 1.03 -1.9 -1.34
detection of bacterium 5 -1.12 -2.27 1.01 1.08 -1.9 -1.65 -3.19
carbohydrate catabolic process 70 1.14 -1.3 -1.52 -1.28 -1.28 1.14 1.27
regulation of light-activated channel activity 1 -1.83 1.06 1.22 1.16 1.68 -1.18 -1.24
rhodopsin biosynthetic process 8 -1.84 -1.59 -2.1 1.54 1.04 -1.85 -2.07
immunoglobulin mediated immune response 2 -2.37 1.1 1.16 -1.04 1.34 -1.89 1.24
type I hypersensitivity 2 -2.37 1.1 1.16 -1.04 1.34 -1.89 1.24
snRNA metabolic process 2 -1.23 1.23 1.84 1.26 1.56 -1.27 1.05
rRNA catabolic process 1 1.49 1.15 1.39 1.19 1.14 2.46 1.32
myoinhibitory hormone activity 2 -14.64 -2.67 -1.05 2.16 -1.19 -12.67 -5.89
negative regulation of juvenile hormone biosynthetic process 1 -84.21 -3.59 1.42 2.07 1.14 -58.36 -15.07
ecdysiostatic hormone activity 1 -2.55 -1.98 -1.56 2.24 -1.62 -2.75 -2.3
positive regulation of lipid biosynthetic process 1 -3.9 1.39 1.21 1.36 1.18 -2.17 -1.43
prenol metabolic process 1 4.21 1.14 2.47 -1.3 1.39 2.06 1.87
prenol biosynthetic process 1 4.21 1.14 2.47 -1.3 1.39 2.06 1.87
sesquiterpenoid biosynthetic process 2 1.77 -2.92 -3.1 -3.09 -1.69 -1.43 2.62
sesquiterpenoid catabolic process 4 -1.67 1.21 -1.1 -1.05 -1.31 -3.02 1.26
tetraterpenoid metabolic process 3 -1.97 -1.44 -2.29 1.38 1.12 -1.8 -2.35
terpenoid biosynthetic process 3 1.46 -1.92 -2.16 -2.04 -1.39 -1.28 1.88
terpenoid catabolic process 4 -1.67 1.21 -1.1 -1.05 -1.31 -3.02 1.26
carotenoid metabolic process 3 -1.97 -1.44 -2.29 1.38 1.12 -1.8 -2.35
sterol catabolic process 1 -1.19 1.24 1.2 1.43 1.53 -1.12 -1.13
glycoside metabolic process 7 1.73 -1.53 -1.79 -1.54 -1.23 1.97 1.32
glycoside biosynthetic process 3 3.57 -2.83 -2.37 -2.36 -1.16 5.45 -1.46
glycoside catabolic process 2 -1.06 -1.02 -1.16 -1.17 -1.27 -1.11 2.75
O-glycoside metabolic process 2 -1.06 -1.02 -1.16 -1.17 -1.27 -1.11 2.75
O-glycoside catabolic process 2 -1.06 -1.02 -1.16 -1.17 -1.27 -1.11 2.75
translation release factor activity, codon specific 2 1.29 1.19 1.11 1.18 1.06 1.64 1.05
formyltetrahydrofolate dehydrogenase activity 1 -1.35 1.22 1.7 1.18 1.15 -1.09 1.03
amylase activity 2 -34.84 -2.22 -3.89 2.13 -10.58 -52.06 -2.46
superoxide-generating NADPH oxidase activity 1 2.71 -1.01 1.01 -1.06 -1.03 2.12 1.84
synaptic vesicle maturation 1 1.21 1.12 1.66 1.2 1.79 2.51 1.99
synaptic target attraction 3 1.93 -1.35 1.08 -1.19 1.21 2.92 1.18
synaptic target inhibition 1 -1.51 -1.03 1.25 1.21 2.96 -2.96 1.02
determination of muscle attachment site 4 1.72 1.1 1.18 1.13 1.38 1.37 1.04
selenocysteine methyltransferase activity 2 -2.66 1.46 -3.05 1.35 1.97 -1.55 -1.14
4-coumarate-CoA ligase activity 5 -15.09 -1.26 -3.1 -1.62 -4.07 -3.87 -5.45
AMP binding 1 3.48 1.38 -1.48 1.01 -2.42 1.73 1.65
ammonia ligase activity 2 1.91 -1.99 2.01 -1.44 1.52 -1.73 -1.25
acyl-CoA desaturase activity 8 -1.57 -1.03 -1.33 1.02 -1.14 -1.74 1.05
steroid dehydrogenase activity 8 3.51 -1.74 -1.02 -1.08 -1.5 -2.16 -1.12
sphingomyelin phosphodiesterase activator activity 1 -1.61 1.4 2.58 1.07 1.35 1.37 1.11
beta-N-acetylglucosaminidase activity 3 3.05 -1.03 -1.72 -1.02 1.13 -1.04 1.42
HNK-1 sulfotransferase activity 2 2.01 1.05 1.17 1.04 1.08 1.34 -1.13
telomere capping 7 1.48 1.09 1.57 1.16 1.48 1.55 1.18
negative regulation of macroautophagy 1 -1.06 1.16 1.2 1.34 1.78 -1.33 -1.11
selenocysteine metabolic process 2 1.76 1.25 1.23 1.04 1.04 1.62 -1.07
selenocysteine biosynthetic process 2 1.76 1.25 1.23 1.04 1.04 1.62 -1.07
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity 1 -3.7 1.32 1.71 1.03 1.54 -3.12 1.7
O-glycan processing 3 -2.23 1.15 1.26 1.19 1.31 -2.5 1.12
O-glycan processing, core 1 1 -3.7 1.32 1.71 1.03 1.54 -3.12 1.7
eukaryotic 43S preinitiation complex 1 2.17 1.18 1.52 -1.1 1.33 2.16 1.32
glycerone-phosphate O-acyltransferase activity 1 2.26 1.05 1.14 1.04 1.53 -1.65 1.6
CoA hydrolase activity 4 1.3 1.08 1.01 1.04 -1.02 1.91 -1.09
myristoyl-[acyl-carrier-protein] hydrolase activity 2 3.49 -1.07 -1.08 -1.15 1.4 1.97 2.1
palmitoyl-[acyl-carrier-protein] hydrolase activity 2 3.49 -1.07 -1.08 -1.15 1.4 1.97 2.1
acyl-[acyl-carrier-protein] hydrolase activity 2 3.49 -1.07 -1.08 -1.15 1.4 1.97 2.1
lipase activity 84 -1.92 -1.25 -1.55 -1.09 -1.32 -2.03 -1.49
inositol bisphosphate phosphatase activity 1 3.45 -1.15 1.32 1.0 -1.07 1.6 -1.16
phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity 1 2.96 1.13 1.75 -1.2 1.98 1.94 1.75
basolateral plasma membrane 34 1.42 1.0 1.32 -1.08 1.36 1.58 1.36
apical plasma membrane 27 1.33 1.11 1.29 1.04 1.28 1.55 1.44
oocyte microtubule cytoskeleton organization 31 1.08 1.2 1.51 1.08 1.36 1.59 1.25
apicolateral plasma membrane 50 1.77 -1.05 1.29 -1.11 1.27 2.3 1.5
lateral plasma membrane 9 2.47 -1.11 1.23 -1.25 1.22 2.79 1.7
establishment or maintenance of polarity of embryonic epithelium 8 1.29 1.17 1.66 1.02 1.38 1.51 1.32
morphogenesis of larval imaginal disc epithelium 8 1.12 1.06 1.78 1.05 1.53 1.28 1.0
establishment or maintenance of polarity of larval imaginal disc epithelium 4 1.09 1.11 2.19 -1.04 1.64 1.48 1.2
calcium-dependent cell-matrix adhesion 2 -3.06 1.2 1.48 1.02 1.55 -3.22 1.1
catenin complex 2 1.43 1.06 1.57 1.11 1.6 1.7 1.6
imaginal disc-derived leg joint morphogenesis 8 -2.19 1.03 -1.69 -1.64 2.1 1.1 1.32
activin receptor activity, type I 1 -1.85 1.82 2.01 1.27 1.8 1.64 1.57
palmitoyl-CoA oxidase activity 3 1.38 -1.55 -1.39 1.44 1.71 -2.77 -1.43
pristanoyl-CoA oxidase activity 2 -15.88 1.87 -3.13 -1.51 -1.49 -10.5 -1.82
dimethylargininase activity 1 1.77 1.6 1.45 1.13 1.23 1.13 1.16
CoA-ligase activity 13 -2.56 -1.1 -1.57 -1.26 -1.84 -1.46 -2.12
acylglycerol O-acyltransferase activity 7 -1.48 -1.12 1.19 1.18 2.2 -2.06 -1.75
O-octanoyltransferase activity 1 2.33 -1.31 -2.71 1.32 2.24 -2.61 1.02
octanoyltransferase activity 2 2.01 -1.16 -1.62 1.18 1.39 -1.12 -1.11
O-palmitoyltransferase activity 1 1.55 1.41 -1.09 1.13 1.34 -1.06 1.05
S-acetyltransferase activity 3 2.46 1.01 1.19 -1.13 1.38 2.35 1.7
S-malonyltransferase activity 3 2.14 -1.05 -1.1 -1.07 1.17 1.47 1.42
malonyltransferase activity 3 2.14 -1.05 -1.1 -1.07 1.17 1.47 1.42
CoA carboxylase activity 3 2.45 1.39 1.08 -1.18 1.31 2.01 1.86
tRNA (cytosine) methyltransferase activity 1 -1.06 1.07 1.05 1.57 1.09 -1.37 -1.08
tRNA (cytosine-5-)-methyltransferase activity 1 -1.06 1.07 1.05 1.57 1.09 -1.37 -1.08
rRNA (adenine) methyltransferase activity 2 1.61 1.27 1.44 1.22 1.57 1.46 1.13
rRNA (uridine) methyltransferase activity 3 1.55 1.21 1.1 1.32 1.19 1.02 -1.14
RNA-induced silencing complex 7 -1.01 1.19 1.52 1.03 1.34 1.15 1.36
somatic cell DNA recombination 1 -1.03 1.26 1.39 1.47 1.41 -1.54 -1.18
C-palmitoyltransferase activity 2 -2.24 1.07 2.48 1.17 1.31 -1.71 -1.18
X chromosome located dosage compensation complex, transcription activating 6 1.37 1.23 1.41 1.11 1.23 1.51 1.37
dosage compensation complex assembly involved in dosage compensation by hyperactivation of X chromosome 3 1.47 1.24 1.5 1.08 1.32 1.62 1.47
myosin II complex 7 2.46 -1.39 1.28 -1.33 1.16 2.04 -1.08
unconventional myosin complex 8 -1.34 1.12 1.71 1.02 1.43 -1.05 1.11
vacuolar proton-transporting V-type ATPase complex 25 -1.7 1.0 1.39 -1.2 -1.2 1.32 -1.15
negative regulation of transcription from RNA polymerase III promoter 2 2.38 1.05 1.63 1.37 1.48 1.65 1.1
tryptophan hydroxylase activator activity 1 2.28 1.19 1.07 -1.0 1.37 2.2 2.5
peptide hormone processing 2 -3.69 1.49 2.0 -1.05 1.12 -3.53 1.27
structural constituent of peritrophic membrane 24 -1.99 -1.49 -1.95 -1.18 -1.6 -2.02 1.66
protein-hormone receptor activity 6 1.04 -1.23 -1.1 -1.21 -1.12 1.72 -1.28
apoptotic protease activator activity 3 1.67 1.11 1.24 1.1 1.19 1.2 1.4
mitochondrial fatty acid beta-oxidation multienzyme complex 2 2.42 1.07 -1.08 1.02 1.26 1.66 -1.08
long-chain-enoyl-CoA hydratase activity 1 2.19 1.13 1.21 -1.05 1.43 2.22 1.16
long-chain-3-hydroxyacyl-CoA dehydrogenase activity 2 2.42 1.07 -1.08 1.02 1.26 1.66 -1.08
core-binding factor complex 2 1.8 -1.02 -1.19 1.07 -1.13 1.06 -1.05
latrotoxin receptor activity 1 -1.05 -1.14 -1.15 1.03 1.21 1.62 2.05
sarcoplasm 4 2.04 -1.34 1.12 -1.41 -1.15 -1.13 1.11
sarcoplasmic reticulum 3 2.05 -1.41 1.18 -1.55 -1.18 -1.27 1.12
metallochaperone activity 3 1.48 1.1 1.32 1.12 1.03 1.6 -1.13
microvillus assembly 1 -2.22 -1.56 -1.05 -1.91 -2.01 -2.21 7.0
copper chaperone activity 2 1.54 1.13 1.31 -1.02 -1.15 1.51 -1.05
intein-mediated protein splicing 1 -1.72 -1.51 1.07 1.74 1.86 -2.25 -3.98
protein autoprocessing 4 1.71 -1.09 1.55 1.25 1.59 1.29 -1.21
base conversion or substitution editing 1 1.13 1.14 1.55 1.01 1.4 2.0 1.26
mRNA modification 1 1.13 1.14 1.55 1.01 1.4 2.0 1.26
protein import into peroxisome matrix 1 -1.21 1.08 -2.37 1.65 1.29 -3.85 -2.28
peroxisome fission 3 2.08 -1.17 -1.4 1.43 1.51 -1.91 1.09
protein import into peroxisome matrix, docking 1 -1.21 1.08 -2.37 1.65 1.29 -3.85 -2.28
histone demethylation 7 1.18 1.25 1.72 1.13 1.59 1.68 1.3
Sin3 complex 3 1.26 1.15 1.58 1.16 1.67 1.6 1.21
NuRD complex 4 1.58 1.23 1.59 1.18 1.53 1.55 1.45
nucleosome positioning 3 1.19 1.07 1.82 1.21 1.88 1.74 1.38
NURF complex 5 1.15 1.22 1.63 1.19 1.59 1.56 1.32
ACF complex 5 1.33 -1.77 -1.21 -1.79 1.3 2.26 1.17
protein arginylation 1 1.03 1.39 1.46 1.24 1.37 1.69 1.36
flotillin complex 1 3.68 -1.06 -1.03 1.16 1.0 1.99 -1.04
Rac protein signal transduction 2 -1.38 1.43 1.79 1.19 1.71 -1.05 1.42
CCAAT-binding factor complex 1 4.06 1.06 1.04 1.34 1.6 1.05 1.52
glutaminyl-peptide cyclotransferase activity 2 2.71 -1.35 -1.37 -1.7 -1.26 -1.18 2.94
malate dehydrogenase (oxaloacetate-decarboxylating) activity 4 -1.07 1.26 1.14 -1.52 -1.06 1.05 1.65
oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor 34 1.38 -1.54 -1.84 -1.66 -1.29 1.37 1.27
oxidoreductase activity, acting on the aldehyde or oxo group of donors, cytochrome as acceptor 1 2.72 -3.32 -2.57 -3.03 -1.93 22.15 -2.83
oxidoreductase activity, acting on the aldehyde or oxo group of donors 42 1.3 -1.42 -1.6 -1.54 -1.21 1.48 1.15
oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor 11 -1.64 1.16 -1.22 1.19 1.14 -2.19 -1.33
oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor 3 1.19 -1.14 1.18 -1.25 1.27 2.68 -1.22
oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor 1 -1.37 -1.08 -1.16 -1.21 -1.14 1.68 -1.06
oxidoreductase activity, acting on the CH-NH group of donors 20 1.39 -1.16 -1.24 -1.21 -1.13 1.8 -1.06
oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor 13 1.38 -1.17 -1.24 -1.18 -1.19 1.9 -1.08
transferase activity, transferring amino-acyl groups 10 1.86 -1.26 -1.16 -1.23 1.18 1.3 1.33
oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor 1 2.09 1.59 -1.41 1.19 1.36 1.02 -1.19
oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor 30 1.12 1.03 1.27 1.07 1.1 1.73 -1.3
oxidoreductase activity, acting on NADH or NADPH, nitrogenous group as acceptor 1 1.29 1.1 1.03 1.22 1.29 1.66 -1.14
oxidoreductase activity, acting on other nitrogenous compounds as donors 2 2.03 -1.43 -1.4 -1.33 -1.08 1.05 -1.28
oxidoreductase activity, acting on other nitrogenous compounds as donors, oxygen as acceptor 1 3.87 -2.08 -2.11 -2.0 -1.26 -1.05 -1.64
oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor 3 -1.6 -1.4 -2.5 1.38 -1.37 -2.12 -1.83
oxidoreductase activity, acting on diphenols and related substances as donors, oxygen as acceptor 4 -1.73 -1.69 -2.0 -1.92 -2.12 -2.06 1.73
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NADH or NADPH as one donor, and incorporation of one atom of oxygen 7 1.08 -1.49 -2.16 -1.08 -1.58 -1.06 -1.04
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen 1 1.6 1.35 -1.72 -1.6 -1.17 -1.33 1.5
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen 3 1.14 -1.23 -1.27 -1.21 -1.15 1.59 -1.01
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen 4 1.53 1.13 1.14 1.01 1.23 1.29 1.28
oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water 10 -1.69 -1.14 -1.69 -1.05 -1.38 -1.35 1.04
oxidoreductase activity, oxidizing metal ions 4 -1.43 -2.04 -1.83 -1.64 1.18 -1.2 1.72
oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor 1 1.59 1.02 1.27 1.16 1.58 1.37 1.04
oxidoreductase activity, oxidizing metal ions, oxygen as acceptor 3 -1.88 -2.6 -2.43 -2.04 1.07 -1.41 2.03
oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor 2 1.25 1.78 -1.17 -1.32 -1.19 -1.3 1.66
oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor 1 1.38 1.39 -1.09 1.59 1.39 -1.89 1.34
oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor 2 -2.27 -1.06 1.44 1.36 1.87 -1.61 -1.54
carboxyl- or carbamoyltransferase activity 1 -1.12 1.14 1.63 1.21 1.33 1.0 1.05
transferase activity, transferring aldehyde or ketonic groups 3 2.36 1.15 -2.0 1.02 -1.05 1.23 1.57
succinyltransferase activity 2 1.41 1.15 1.17 -1.16 -1.1 2.22 -1.06
N-succinyltransferase activity 1 1.58 1.36 -1.31 -1.09 -1.26 1.25 1.23
S-succinyltransferase activity 1 1.27 -1.02 1.79 -1.24 1.05 3.95 -1.37
spermine synthase activity 1 -1.46 1.37 1.59 1.23 1.4 2.11 1.08
phosphotransferase activity, carboxyl group as acceptor 3 -2.35 1.21 -1.51 -1.01 -1.08 -1.33 1.07
phosphotransferase activity, phosphate group as acceptor 19 1.61 -1.01 1.22 1.02 1.17 1.37 -1.03
diphosphotransferase activity 4 1.52 1.16 1.32 1.12 1.12 1.57 1.12
phosphotransferase activity, paired acceptors 2 1.76 1.25 1.23 1.04 1.04 1.62 -1.07
transferase activity, transferring selenium-containing groups 1 6.68 -1.68 1.43 -1.05 1.36 2.98 1.28
diphosphoric monoester hydrolase activity 1 1.81 -1.03 1.57 1.17 1.71 1.48 -1.14
hydrolase activity, acting on glycosyl bonds 100 -1.69 -1.27 -2.25 -1.21 -1.43 -1.66 -1.24
hydrolase activity, hydrolyzing N-glycosyl compounds 6 2.07 -1.07 1.03 -1.04 1.05 1.76 1.02
hydrolase activity, acting on ether bonds 7 -2.36 -1.14 -1.27 1.0 -1.04 -1.57 1.01
trialkylsulfonium hydrolase activity 3 -2.93 -1.82 -1.21 -1.07 1.22 1.86 -1.16
ether hydrolase activity 4 -2.01 1.25 -1.31 1.06 -1.24 -3.52 1.14
hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines 3 1.74 1.1 1.15 1.01 -1.04 1.8 1.17
hydrolase activity, acting on acid carbon-carbon bonds 1 2.81 -1.06 -1.21 -1.09 1.58 2.01 -1.24
hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances 1 2.81 -1.06 -1.21 -1.09 1.58 2.01 -1.24
oxo-acid-lyase activity 1 -1.23 1.82 1.48 1.33 1.52 1.63 1.08
carbon-oxygen lyase activity, acting on phosphates 1 2.12 1.31 1.32 1.23 1.73 1.01 2.0
carbon-nitrogen lyase activity 5 -2.25 -1.05 -1.88 1.19 2.05 -1.63 -1.2
ammonia-lyase activity 1 -3.81 -2.74 -2.14 -1.15 11.07 -1.69 -3.46
amidine-lyase activity 2 -3.73 1.28 -2.46 1.25 1.21 -1.91 1.03
amine-lyase activity 2 -1.04 1.14 -1.34 1.32 1.5 -1.36 1.15
strictosidine synthase activity 2 -1.04 1.14 -1.34 1.32 1.5 -1.36 1.15
intramolecular oxidoreductase activity 26 1.67 1.02 1.03 1.12 1.09 1.42 1.03
intramolecular oxidoreductase activity, interconverting aldoses and ketoses 5 2.55 1.17 -1.07 1.0 1.07 1.9 1.31
intramolecular oxidoreductase activity, transposing C=C bonds 10 2.03 -1.04 -1.1 1.17 1.08 1.51 -1.15
intramolecular lyase activity 1 1.86 -1.46 -1.12 -1.51 1.13 1.83 1.71
ligase activity, forming carbon-sulfur bonds 20 -1.5 -1.17 -1.49 -1.12 -1.4 -1.6 -1.77
acid-thiol ligase activity 13 -2.56 -1.1 -1.57 -1.26 -1.84 -1.46 -2.12
acid-ammonia (or amide) ligase activity 2 1.91 -1.99 2.01 -1.44 1.52 -1.73 -1.25
carbon-nitrogen ligase activity, with glutamine as amido-N-donor 13 1.37 1.08 -1.29 -1.04 -1.04 1.51 1.21
ligase activity, forming carbon-carbon bonds 4 2.44 1.26 -1.08 -1.11 1.01 1.91 1.62
endodeoxyribonuclease activity, producing 5'-phosphomonoesters 2 2.29 1.05 1.61 -1.06 1.36 1.86 1.38
endodeoxyribonuclease activity, producing 3'-phosphomonoesters 2 1.96 -1.84 -1.77 -1.88 -1.43 -1.2 2.09
endoribonuclease activity, producing 3'-phosphomonoesters 2 1.91 1.08 1.3 1.12 1.28 1.27 1.22
endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters 4 1.94 -1.3 -1.17 -1.3 -1.06 1.03 1.6
oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor 1 1.11 1.03 -1.05 1.12 4.21 1.26 -1.02
ligand-dependent nuclear receptor binding 5 1.26 1.45 1.61 1.27 1.41 1.59 1.27
thyroid hormone receptor binding 1 -1.32 1.3 -1.05 1.3 1.04 2.32 -1.33
protein sumoylation 3 1.29 1.14 1.26 1.29 1.5 1.22 -1.02
SUMO-specific protease activity 1 1.48 1.3 2.69 1.46 2.61 3.81 1.95
extracellular-glycine-gated ion channel activity 7 -1.5 1.06 -1.1 -1.52 -1.91 -1.85 1.36
extracellular-glycine-gated chloride channel activity 4 -1.54 1.26 1.47 -1.43 -1.72 -1.63 -1.04
glycine-gated chloride channel complex 4 -1.54 1.26 1.47 -1.43 -1.72 -1.63 -1.04
short-branched-chain-acyl-CoA dehydrogenase activity 2 -1.12 1.32 -1.16 1.05 1.12 -1.93 1.2
kinesin II complex 1 1.07 1.09 1.33 1.24 1.41 1.98 -1.06
lipoate-protein ligase activity 2 1.65 1.07 1.42 1.08 1.12 2.67 -1.13
lipoate synthase activity 1 1.58 1.18 1.95 1.1 1.45 3.43 -1.02
cell wall macromolecule catabolic process 9 -1.18 -1.16 -1.42 -1.31 -1.28 -2.35 -1.08
antibiotic metabolic process 1 -1.31 -1.76 1.72 1.22 1.97 3.11 1.28
antibiotic biosynthetic process 1 -1.31 -1.76 1.72 1.22 1.97 3.11 1.28
activin-activated receptor activity 2 -1.14 1.57 1.93 1.23 1.67 1.43 1.4
protein-heme linkage 1 1.66 1.03 1.71 1.06 1.0 2.28 -1.41
cytochrome complex assembly 3 1.45 1.07 1.3 1.03 1.04 1.58 -1.23
3'-tyrosyl-DNA phosphodiesterase activity 1 -1.61 -1.07 -1.0 -1.17 -1.28 -1.58 -1.34
protein-tetrapyrrole linkage 1 1.66 1.03 1.71 1.06 1.0 2.28 -1.41
myosin phosphatase activity 3 1.52 1.01 1.94 -1.04 1.33 1.77 1.57
myosin phosphatase regulator activity 1 -3.34 1.3 1.86 1.22 1.27 -2.0 1.07
myosin phosphatase complex 1 5.19 -1.26 2.54 -1.39 1.19 2.56 1.75
TBP-class protein binding 3 1.62 1.22 1.38 1.2 1.3 1.46 1.18
potassium:amino acid symporter activity 5 -1.79 -1.85 -2.57 -1.19 1.65 1.54 1.09
GTP-Rho binding 1 -1.55 1.88 -1.17 -1.09 -1.11 -1.68 1.84
D-erythro-sphingosine kinase activity 3 2.17 1.08 -1.12 -1.03 -1.02 1.22 1.39
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly 3 1.71 1.26 1.41 1.3 1.44 1.38 1.2
6-phosphogluconolactonase activity 1 2.54 1.2 -1.43 1.17 1.05 -1.15 1.18
serine C-palmitoyltransferase complex 1 -1.92 1.11 2.34 1.27 1.64 -1.44 -1.26
fatty acid amide hydrolase activity 4 1.42 1.22 -1.76 -1.03 -1.09 2.22 1.2
tyrosine-ester sulfotransferase activity 1 -11.7 1.38 -1.27 1.16 1.17 -8.03 1.02
syntaxin-1 binding 1 -1.34 1.17 1.4 1.35 1.51 1.53 1.84
delta1-pyrroline-5-carboxylate synthetase activity 1 -29.94 1.93 -2.31 -1.05 -1.13 -7.63 1.24
3-methyl-2-oxobutanoate dehydrogenase (lipoamide) complex 2 1.67 1.29 1.69 -1.02 1.34 1.99 1.11
mitochondrial processing peptidase complex 1 -1.11 1.21 1.34 -1.03 -1.05 2.16 -1.38
glycolipid transporter activity 1 -2.99 1.35 -1.24 1.41 -1.1 -2.55 -1.06
AU-rich element binding 1 -1.76 1.11 1.26 1.23 1.05 -1.22 -1.69
heparan sulfate 6-O-sulfotransferase activity 1 1.37 -1.51 7.55 1.04 1.53 1.73 1.66
sulfonylurea receptor binding 1 2.98 -1.49 1.51 -1.4 1.16 14.12 1.01
very-long-chain-acyl-CoA dehydrogenase activity 1 1.8 1.71 -1.79 -1.14 1.11 -1.09 1.11
glutamate-cysteine ligase complex 3 -1.79 1.47 -1.22 1.17 -1.04 -1.53 1.26
Rab guanyl-nucleotide exchange factor activity 2 -1.44 1.17 1.82 1.09 1.3 1.78 1.08
dihydropyrimidine dehydrogenase (NADP+) activity 1 -2.4 1.52 -1.09 1.53 -1.18 -2.54 -1.54
peptidase inhibitor activity 76 1.39 -1.53 -1.49 -1.55 -1.32 1.49 1.05
single-stranded DNA-dependent ATP-dependent DNA helicase complex 1 -1.41 1.08 1.3 1.52 1.33 -1.66 -1.08
lipoyltransferase activity 1 1.33 -1.19 1.85 1.0 1.1 2.24 -1.59
Golgi transport complex 2 1.23 1.33 1.33 1.17 1.27 1.38 1.89
SH3 domain binding 8 1.15 1.04 1.33 1.04 1.19 1.55 1.28
deoxycytidyl transferase activity 1 1.75 -1.08 2.07 1.17 1.37 2.15 1.01
nucleologenesis 1 1.32 1.42 1.69 1.17 1.76 1.08 1.69
cholesterol transporter activity 1 -1.06 1.09 -1.0 1.4 1.63 -1.48 -1.12
phospholipid scramblase activity 2 2.57 -1.14 1.03 -1.07 2.13 1.16 1.16
triglyceride binding 1 4.36 -1.08 -1.33 -1.1 1.06 2.49 1.49
fibroblast growth factor binding 1 3.07 1.39 2.07 1.3 2.02 1.75 1.45
NAD-dependent histone deacetylase activity 2 1.85 1.16 1.29 1.09 1.23 1.67 1.46
response to arsenic-containing substance 8 1.07 1.17 1.52 1.13 1.46 1.14 1.14
insecticide metabolic process 10 1.1 -1.02 -1.79 -1.06 -1.28 -1.46 1.06
drug metabolic process 1 -1.31 -1.76 1.72 1.22 1.97 3.11 1.28
N-methyl-D-aspartate selective glutamate receptor complex 3 -3.51 1.06 1.06 -1.04 1.07 -1.9 1.09
Wnt-protein binding 11 1.57 -1.01 1.22 -1.02 1.31 -1.0 1.28
tRNA dihydrouridine synthase activity 4 1.57 1.16 1.09 1.25 1.12 1.12 -1.03
DEAD/H-box RNA helicase binding 2 1.24 1.45 1.49 1.18 1.41 1.54 1.43
sodium:dicarboxylate symporter activity 3 1.33 1.26 -3.33 -3.11 -2.74 -1.43 1.86
semaphorin receptor activity 2 1.69 1.12 2.14 -1.0 1.95 2.34 1.53
regulation of exocytosis 9 -1.22 1.13 1.23 1.07 1.14 1.53 1.05
regulation of calcium ion-dependent exocytosis 1 -1.33 -1.11 -1.13 -1.17 -1.09 12.66 1.12
pantetheine hydrolase activity 3 -3.81 -1.17 -3.75 2.31 -1.17 -3.72 -1.67
aryl hydrocarbon receptor binding 1 1.71 1.13 1.25 1.13 1.02 1.11 -1.02
vinculin binding 1 2.93 1.13 1.23 -1.06 1.04 3.7 1.38
5-oxoprolinase (ATP-hydrolyzing) activity 1 -1.27 -1.09 -1.84 1.84 -1.17 -2.01 -1.59
CDP-alcohol phosphatidyltransferase activity 6 -1.0 1.26 1.69 1.08 1.28 -1.12 1.22
KU70 binding 1 -1.09 -1.0 1.57 1.36 1.26 1.16 -2.0
serine hydrolase activity 290 -2.22 -1.39 -1.61 -1.12 -1.45 -2.28 -1.59
glycine N-methyltransferase activity 1 1.02 -2.19 -1.44 -1.75 -1.84 4.35 -2.08
phosphatidylinositol N-acetylglucosaminyltransferase activity 4 1.26 1.36 1.66 1.37 1.48 -1.0 1.01
glucosidase II complex 4 -1.98 1.19 -1.8 1.24 1.01 1.0 -1.01
peptidyl-diphthamide metabolic process 3 1.96 1.14 1.33 1.22 1.29 1.28 -1.07
peptidyl-diphthamide biosynthetic process from peptidyl-histidine 3 1.96 1.14 1.33 1.22 1.29 1.28 -1.07
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase 2 2.71 -1.35 -1.37 -1.7 -1.26 -1.18 2.94
N-terminal peptidyl-methionine acetylation 1 -1.5 1.47 2.65 1.15 1.31 -1.14 -1.06
N-terminal peptidyl-L-cysteine N-palmitoylation 1 1.07 1.32 1.75 1.48 1.85 -1.07 -1.03
peptidyl-lysine methylation 4 1.32 1.26 1.73 1.16 1.81 1.88 1.52
peptidyl-lysine trimethylation 3 1.35 1.23 1.68 1.16 1.73 1.61 1.45
peptidyl-lysine monomethylation 1 1.22 1.34 1.86 1.14 2.08 2.98 1.75
peptidyl-lysine dimethylation 1 1.41 1.59 1.77 1.23 1.83 1.65 1.69
cytochrome c-heme linkage 1 1.66 1.03 1.71 1.06 1.0 2.28 -1.41
peptidyl-histidine phosphorylation 1 1.67 -1.54 1.2 -1.13 7.02 3.44 1.09
peptidyl-threonine phosphorylation 1 1.19 -1.04 1.15 1.11 1.6 1.03 1.09
peptidyl-tyrosine phosphorylation 5 1.6 1.02 1.5 1.02 1.17 1.5 1.38
peptide cross-linking 3 3.33 -1.61 -1.45 -1.67 -1.2 1.72 1.67
peptidyl-asparagine modification 3 -1.19 1.11 1.12 1.13 1.21 1.27 1.61
peptidyl-glutamine modification 2 2.71 -1.35 -1.37 -1.7 -1.26 -1.18 2.94
peptidyl-histidine modification 4 1.89 -1.01 1.3 1.12 1.97 1.64 -1.03
peptidyl-methionine modification 2 1.17 1.23 1.52 -1.02 1.0 -1.03 -1.15
peptidyl-threonine modification 1 1.19 -1.04 1.15 1.11 1.6 1.03 1.09
peptidyl-tyrosine modification 6 1.5 1.01 1.39 1.05 1.14 1.41 1.3
protein phosphopantetheinylation 1 1.84 1.09 2.09 1.3 2.04 2.34 1.11
protein N-linked glycosylation via asparagine 3 -1.19 1.11 1.12 1.13 1.21 1.27 1.61
protein myristoylation 1 -1.49 1.29 1.71 1.24 1.7 1.05 1.0
glycoprotein 3-alpha-L-fucosyltransferase activity 1 -1.29 1.13 -1.16 1.54 2.78 1.39 1.18
prothoracicotrophic hormone activity 1 -1.06 -1.47 -1.01 -1.23 -1.12 1.54 -1.14
acetoacetyl-CoA reductase activity 1 1.03 -1.04 1.2 -1.01 1.0 2.11 -1.07
alkane 1-monooxygenase activity 1 1.6 1.35 -1.72 -1.6 -1.17 -1.33 1.5
S-formylglutathione hydrolase activity 1 1.41 1.06 -1.13 1.33 1.12 -1.09 -1.51
alkyl sulfatase activity 1 2.4 1.23 1.72 -1.4 3.44 4.52 1.64
phenol-containing compound metabolic process 9 -1.02 -1.18 -1.26 -1.16 -1.28 -1.1 1.52
germ-line sex determination 5 1.56 1.08 1.18 1.1 1.06 1.51 1.13
GDP binding 3 2.03 -1.04 1.6 1.01 1.54 1.95 1.24
molybdopterin synthase complex 1 2.51 1.28 2.88 1.18 3.18 1.65 1.8
farnesoic acid O-methyltransferase activity 2 3.79 -5.16 -3.85 -4.65 -1.93 1.64 2.51
viral envelope 1 2.63 -1.41 1.69 -1.89 -1.48 14.61 -1.02
viral envelope fusion with host membrane 1 2.63 -1.41 1.69 -1.89 -1.48 14.61 -1.02
virus-host interaction 2 1.04 1.05 1.19 -1.29 -1.39 2.64 1.17
viral infectious cycle 3 -1.12 1.07 1.27 -1.16 -1.11 1.69 1.21
initiation of viral infection 2 1.04 1.05 1.19 -1.29 -1.39 2.64 1.17
mitochondrial rRNA export from mitochondrion 1 3.27 1.48 4.47 -1.01 2.24 5.65 2.22
mitochondrial RNA localization 1 3.27 1.48 4.47 -1.01 2.24 5.65 2.22
female germ-line sex determination 4 1.82 1.02 1.1 1.07 1.07 1.73 1.13
female somatic sex determination 5 1.87 1.25 1.34 1.23 1.35 1.16 1.18
male somatic sex determination 2 2.22 1.29 1.1 1.16 1.11 -1.15 1.06
myristoyltransferase activity 1 -1.49 1.29 1.71 1.24 1.7 1.05 1.0
trans-2-enoyl-CoA reductase (NADPH) activity 1 1.29 -1.03 1.55 1.16 1.07 1.93 -1.33
3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity 2 3.49 -1.07 -1.08 -1.15 1.4 1.97 2.1
snRNA-activating protein complex 2 1.7 1.14 1.37 1.1 1.36 1.18 1.22
acyl-CoA N-acyltransferase activity 1 1.2 1.15 1.75 1.03 1.4 1.08 1.36
beta-1,4-mannosyltransferase activity 2 -2.16 1.25 1.27 1.12 1.95 -1.56 -1.08
transmembrane receptor protein phosphatase activity 6 1.57 1.05 1.23 1.03 1.35 2.22 1.25
nucleotide kinase activity 13 1.94 -1.05 1.14 -1.01 1.08 1.44 -1.06
amino acid kinase activity 4 -2.33 1.24 -1.02 1.02 -1.11 -1.42 -1.1
carbohydrate phosphatase activity 5 3.03 -1.36 1.1 -1.47 -1.11 2.72 1.19
nucleobase-containing compound kinase activity 24 1.52 -1.0 1.19 1.05 1.13 1.31 -1.03
nucleoside kinase activity 7 1.64 -1.1 1.15 -1.01 1.03 1.51 1.03
kinase activator activity 5 1.59 1.12 1.23 1.13 1.26 1.27 1.08
phosphatase inhibitor activity 9 1.54 -1.03 1.13 1.03 1.34 1.35 1.05
regulation of lipid metabolic process 9 -2.45 -1.13 1.14 1.12 1.3 -2.52 -1.85
regulation of steroid metabolic process 1 -1.55 1.2 1.21 -1.19 -1.12 1.05 1.03
neuronal action potential propagation 1 -1.57 1.18 1.51 1.08 1.08 -1.02 1.18
regulation of action potential in neuron 6 1.77 -1.07 1.38 -1.13 1.24 3.0 1.46
sensory perception of pain 2 2.05 -1.17 1.22 1.13 1.44 2.13 1.2
cyclohydrolase activity 4 2.83 -1.76 -1.94 -1.6 -1.8 1.77 1.28
mannose biosynthetic process 1 -1.31 1.22 1.33 1.17 1.22 -1.88 1.41
inositol catabolic process 1 3.92 -4.04 -3.69 -3.19 -2.14 5.76 -2.59
hexose metabolic process 62 -1.54 -1.05 -1.7 1.0 -1.08 -1.5 -1.54
hexose catabolic process 33 1.52 1.06 -1.18 -1.03 -1.06 1.37 1.2
phenol-containing compound catabolic process 1 -8.98 1.77 -2.05 -1.02 -2.08 -14.22 1.22
cysteine biosynthetic process via cystathionine 1 1.25 1.1 1.48 -1.98 -7.11 -1.17 2.59
cysteine biosynthetic process 1 1.25 1.1 1.48 -1.98 -7.11 -1.17 2.59
nicotinate nucleotide biosynthetic process 1 8.31 1.05 -1.79 -1.54 -1.19 1.17 2.54
nicotinate nucleotide salvage 1 8.31 1.05 -1.79 -1.54 -1.19 1.17 2.54
nicotinamide nucleotide biosynthetic process 3 1.9 1.5 -1.09 1.01 1.09 1.23 1.86
pyridine nucleotide metabolic process 11 1.88 1.17 -1.48 -1.05 1.08 1.25 1.36
pyridine nucleotide biosynthetic process 3 1.9 1.5 -1.09 1.01 1.09 1.23 1.86
pyridine nucleotide salvage 1 8.31 1.05 -1.79 -1.54 -1.19 1.17 2.54
fatty acid elongation, unsaturated fatty acid 1 -5.51 -5.31 -5.23 -5.58 -5.15 -5.86 15.65
leukotriene biosynthetic process 1 -1.74 1.11 -2.01 1.51 1.27 -1.87 -1.55
fatty acid oxidation 13 -1.06 1.08 -1.52 1.06 1.2 -2.01 -1.29
alditol catabolic process 2 1.2 1.12 -1.49 1.16 1.79 -1.21 -1.08
allantoin biosynthetic process 1 3.87 -2.08 -2.11 -2.0 -1.26 -1.05 -1.64
removal of superoxide radicals 2 1.69 1.17 1.01 1.09 1.11 1.41 -1.08
triglyceride biosynthetic process 1 -1.05 1.33 3.49 1.16 1.98 2.09 1.25
triglyceride catabolic process 2 1.6 1.03 -1.14 -1.01 1.9 -1.45 -1.11
aromatic compound biosynthetic process 24 1.66 -1.07 -1.13 -1.07 -1.14 1.23 1.24
tryptophan catabolic process to kynurenine 1 1.33 -1.46 -1.36 -1.56 -1.39 2.84 -1.33
L-methionine salvage from methylthioadenosine 1 1.92 1.16 1.15 1.28 1.06 2.87 -1.21
arginine catabolic process to glutamate 1 -13.01 1.26 -21.51 1.04 1.21 -8.69 1.74
arginine catabolic process to ornithine 1 1.27 -1.42 -1.22 -1.31 -1.39 3.47 -1.56
glutamate catabolic process to 2-oxoglutarate 2 -1.13 -1.34 1.15 -1.41 1.89 2.28 -2.14
glycerol catabolic process 2 1.2 1.12 -1.49 1.16 1.79 -1.21 -1.08
catechol-containing compound catabolic process 1 -8.98 1.77 -2.05 -1.02 -2.08 -14.22 1.22
urea metabolic process 1 -31.89 1.77 -20.72 1.41 1.0 -12.66 -3.5
GDP-mannose metabolic process 2 -2.16 1.21 1.23 1.27 1.35 -2.29 1.03
NAD metabolic process 4 1.51 1.15 -1.0 -1.2 1.44 1.73 1.09
choline metabolic process 1 2.27 1.23 -5.17 -1.59 -2.2 -9.9 9.42
B cell mediated immunity 2 -2.37 1.1 1.16 -1.04 1.34 -1.89 1.24
antibacterial humoral response 22 1.72 -1.69 -1.59 -1.57 -1.23 1.37 1.27
antifungal humoral response 8 4.25 -1.39 -1.37 -1.5 -1.09 3.13 1.41
regulation of isoprenoid metabolic process 2 -8.29 -1.83 1.21 1.4 1.08 -7.35 -3.84
secondary metabolic process 53 1.57 -1.09 -1.23 -1.11 -1.05 1.14 1.21
cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte 1 -3.92 1.08 1.44 1.19 1.39 -1.01 -1.05
small conjugating protein-specific protease activity 9 1.26 1.18 1.74 1.17 1.51 1.89 1.35
NEDD8-specific protease activity 1 2.27 1.0 1.29 1.04 1.1 1.44 -1.06
NEDD8 ligase activity 2 -1.0 -1.06 1.71 -1.01 1.42 -1.21 -1.32
response to cadmium ion 7 -1.02 1.14 1.52 1.17 1.43 -1.04 1.03
isoprenoid binding 10 1.91 -4.39 -4.6 -2.0 -1.48 1.68 1.12
retinol binding 1 1.33 -27.02 -29.08 -25.07 -1.99 8.32 -2.83
vitamin binding 93 -1.14 -1.23 -1.54 -1.07 -1.09 -1.09 -1.12
pyrimidine base biosynthetic process 6 1.66 -1.0 1.02 -1.03 -1.03 1.11 1.08
pteridine metabolic process 5 2.4 -1.22 -1.26 -1.24 -1.16 -1.04 1.7
protein kinase binding 24 1.38 1.18 1.53 1.14 1.4 1.3 1.3
[pyruvate dehydrogenase (lipoamide)] phosphatase regulator activity 1 1.97 1.3 1.52 -1.19 1.01 1.99 1.65
mitochondrial pyruvate dehydrogenase (lipoamide) phosphatase complex 1 1.97 1.3 1.52 -1.19 1.01 1.99 1.65
phosphatidylinositol-mediated signaling 4 -1.13 1.15 1.6 1.12 1.84 1.36 1.05
inositol lipid-mediated signaling 4 -1.13 1.15 1.6 1.12 1.84 1.36 1.05
protein neddylation 3 1.49 1.06 1.55 1.26 1.54 1.44 -1.06
SUMO activating enzyme activity 2 1.33 1.09 1.29 1.43 1.67 1.2 -1.13
SMT3-dependent protein catabolic process 2 1.33 1.09 1.29 1.43 1.67 1.2 -1.13
negative regulation of anti-apoptosis 1 -1.96 -1.03 2.81 1.35 1.53 -2.84 -1.09
charged-tRNA amino acid modification 1 1.38 1.09 1.78 1.2 1.53 2.7 -1.25
septate junction assembly 24 2.8 -1.27 1.3 -1.27 1.2 2.89 1.48
diacylglycerol binding 24 1.82 -1.05 1.33 -1.08 1.26 1.8 1.26
spinal cord development 1 6.63 -1.06 1.58 -1.04 1.02 3.09 1.27
spinal cord patterning 1 6.63 -1.06 1.58 -1.04 1.02 3.09 1.27
spinal cord dorsal/ventral patterning 1 6.63 -1.06 1.58 -1.04 1.02 3.09 1.27
telencephalon development 2 -1.33 -1.42 -1.06 1.28 1.22 -1.65 -2.16
central nervous system morphogenesis 3 -1.29 1.06 1.02 -1.08 -1.1 -1.62 1.35
central nervous system formation 1 2.75 -1.14 -1.16 -1.07 -1.18 1.11 1.67
nerve development 4 1.97 -1.1 1.31 -1.24 1.47 2.5 1.71
nerve maturation 3 3.11 -1.4 1.27 -1.39 1.24 4.46 1.69
glial cell fate commitment 3 1.44 1.3 1.68 1.12 1.63 1.5 1.59
glial cell development 20 2.6 -1.18 1.22 -1.13 1.22 1.95 1.32
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning 1 6.63 -1.06 1.58 -1.04 1.02 3.09 1.27
BMP signaling pathway involved in spinal cord dorsal/ventral patterning 1 6.63 -1.06 1.58 -1.04 1.02 3.09 1.27
central nervous system projection neuron axonogenesis 2 -1.33 -1.42 -1.06 1.28 1.22 -1.65 -2.16
central nervous system neuron axonogenesis 3 -1.36 -1.18 1.1 1.26 1.32 -1.27 -1.53
anterior commissure morphogenesis 2 -1.33 -1.42 -1.06 1.28 1.22 -1.65 -2.16
regulation of cell-cell adhesion 11 1.5 1.16 1.29 1.11 1.45 1.61 1.51
negative regulation of cell-cell adhesion 8 1.85 1.18 1.27 1.06 1.22 1.87 1.48
positive regulation of cell-cell adhesion 2 1.24 1.07 1.55 1.24 2.26 1.04 1.52
viral reproductive process 3 -1.12 1.07 1.27 -1.16 -1.11 1.69 1.21
digestive system process 1 1.59 -1.18 -1.24 -1.07 -1.14 4.1 -1.27
ovulation cycle process 1 -1.49 2.58 -1.26 -1.23 -1.23 -1.38 1.24
establishment of proximal/distal cell polarity 3 1.72 -1.01 1.03 -1.08 1.97 1.34 1.24
dormancy process 1 -1.14 1.2 1.7 1.09 2.04 1.39 1.74
DNA strand elongation 3 -1.21 -1.08 1.4 1.14 1.61 -1.08 -1.25
extracellular matrix disassembly 3 -2.47 1.3 1.22 1.11 1.41 -1.09 1.18
potassium ion symporter activity 5 -1.79 -1.85 -2.57 -1.19 1.65 1.54 1.09
potassium ion antiporter activity 5 -1.42 1.17 -1.18 1.1 -1.14 -1.59 -1.02
copper-transporting ATPase activity 1 -2.22 1.33 3.02 1.07 -1.16 -1.12 1.08
wide pore channel activity 7 -1.65 -1.07 -1.04 -1.07 -1.24 -1.19 1.29
mechanically gated channel activity 1 -1.05 1.0 -1.06 -1.03 -1.14 1.01 1.95
ion gated channel activity 3 -1.25 -1.55 1.25 1.49 -1.39 -1.46 -1.49
regulation of transmembrane transporter activity 7 1.44 -1.04 1.16 -1.02 1.15 1.52 1.13
cellular response to amino acid stimulus 4 1.59 -1.01 1.38 1.29 1.34 1.2 -1.18
termination of signal transduction 9 1.61 1.14 1.6 1.12 1.38 1.47 1.34
cellular response to mechanical stimulus 1 -1.7 -15.86 -19.15 -19.05 -4.94 3.57 1.25
cellular monovalent inorganic cation homeostasis 6 -1.56 1.28 1.81 1.0 1.29 1.81 1.32
cellular divalent inorganic cation homeostasis 11 1.74 1.02 1.47 -1.09 -1.04 1.57 1.16
TRAPP complex 3 1.9 1.04 1.48 1.37 1.5 1.53 1.03
maintenance of cell polarity 12 -1.07 1.19 1.56 1.06 1.35 1.28 1.22
CCR4-NOT complex 7 1.25 1.15 1.58 1.15 1.35 1.67 1.21
myofibril 29 2.16 -1.42 -1.09 -1.18 1.24 1.83 -1.17
sarcomere 28 2.2 -1.44 -1.09 -1.19 1.26 1.88 -1.18
Z disc 19 1.85 -1.41 -1.18 -1.11 1.31 1.7 -1.14
extracellular matrix binding 1 -1.18 -1.04 -1.07 -1.26 1.04 1.06 5.07
lamellipodium 1 -1.44 1.23 1.5 1.23 1.55 1.34 1.29
lamellipodium assembly 7 1.05 1.14 1.49 1.08 1.51 1.25 1.41
microvillar actin bundle assembly 1 -2.22 -1.56 -1.05 -1.91 -2.01 -2.21 7.0
contractile actin filament bundle assembly 1 2.13 1.0 -1.14 -1.14 1.0 1.74 1.58
cell junction 105 1.39 -1.0 1.25 -1.05 1.25 1.62 1.33
desmosome 1 1.71 1.23 1.34 1.26 1.67 -1.28 -1.04
mitochondrial crista 1 1.79 1.07 1.12 1.18 1.43 1.54 -1.19
protein repair 1 2.93 1.03 1.2 1.19 1.05 1.97 1.02
regulation of endocytosis 16 1.17 1.02 1.49 1.1 1.26 1.72 1.22
water homeostasis 2 -1.06 -1.23 1.57 -1.02 -2.03 1.99 1.2
AP-3 adaptor complex 1 1.85 1.2 1.21 1.06 1.07 1.4 1.37
clathrin vesicle coat 4 -1.28 1.18 1.41 1.09 1.26 1.54 1.36
COPII vesicle coat 1 1.02 1.56 2.15 1.06 2.07 2.36 2.5
clathrin coat of synaptic vesicle 1 -1.18 1.22 1.63 -1.04 1.48 2.58 1.85
clathrin coat of trans-Golgi network vesicle 3 -1.23 1.16 1.44 1.05 1.28 1.6 1.31
clathrin coat of coated pit 2 -1.13 1.16 1.51 1.02 1.41 1.68 1.45
sphingolipid biosynthetic process 7 -1.12 1.12 1.25 -1.02 1.07 -1.09 1.53
sphingolipid catabolic process 7 -6.83 -3.3 -2.99 1.5 -1.08 -6.52 -5.81
molybdenum ion binding 3 -1.62 1.26 -1.41 1.36 -1.14 -1.63 -1.18
regulation of cell adhesion 16 1.49 1.13 1.37 1.1 1.52 1.6 1.42
proteoglycan biosynthetic process 17 1.25 1.14 1.21 1.06 1.15 1.25 1.53
integral to Golgi membrane 5 1.35 1.04 -1.19 1.04 1.29 1.43 1.52
filopodium 4 1.02 1.09 1.65 -1.04 1.56 1.24 1.53
integral to endoplasmic reticulum membrane 10 -1.46 1.11 1.14 1.2 1.05 -1.72 -1.17
negative regulation of Wnt receptor signaling pathway 21 1.2 1.09 1.17 1.1 1.24 1.55 1.3
heparin metabolic process 2 1.46 1.48 1.74 1.25 2.09 1.65 1.44
heparin biosynthetic process 2 1.46 1.48 1.74 1.25 2.09 1.65 1.44
semaphorin receptor binding 2 -1.18 -1.21 1.16 -1.17 1.87 1.3 1.34
female sex determination 10 1.73 1.13 1.2 1.13 1.18 1.32 1.12
male sex determination 2 2.22 1.29 1.1 1.16 1.11 -1.15 1.06
myofibril assembly 27 2.23 -1.17 1.24 -1.18 1.21 1.85 1.04
skeletal muscle thin filament assembly 2 3.07 -1.51 -1.03 -1.18 1.0 1.63 -1.62
skeletal muscle myosin thick filament assembly 4 2.6 -1.28 1.1 -1.18 1.07 1.9 -1.04
polysaccharide binding 116 -1.88 -1.54 -1.66 -1.39 -1.53 -1.88 1.19
guanylate cyclase regulator activity 1 4.81 -1.03 -1.02 1.21 1.81 1.05 1.23
guanylate cyclase activator activity 1 4.81 -1.03 -1.02 1.21 1.81 1.05 1.23
entry into host cell 2 1.04 1.05 1.19 -1.29 -1.39 2.64 1.17
apoptotic nuclear change 3 1.86 1.09 1.48 1.14 1.43 1.6 1.67
glyoxylate reductase (NADP) activity 2 -4.26 1.85 -1.64 1.04 -1.41 -1.97 -1.08
outer membrane-bounded periplasmic space 9 1.87 -1.07 1.01 -1.1 -1.04 1.24 -1.01
protein phosphatase 4 complex 1 -1.33 1.33 1.64 1.24 1.24 1.44 1.37
protein serine/threonine kinase inhibitor activity 4 1.69 1.03 1.25 1.04 1.29 1.67 1.38
protein tyrosine kinase inhibitor activity 1 1.36 1.39 1.33 -1.1 1.25 1.42 1.59
protein kinase activator activity 5 1.59 1.12 1.23 1.13 1.26 1.27 1.08
protein tyrosine kinase activator activity 3 1.95 1.11 1.44 1.07 1.38 1.82 1.28
cholesterol transport 1 2.58 -1.39 1.67 -1.07 1.62 11.34 1.83
positive regulation of cell growth 16 1.03 1.18 1.5 1.1 1.49 1.39 1.32
negative regulation of cell growth 9 1.27 1.11 1.45 1.06 1.45 1.67 1.24
cell envelope 11 1.96 -1.06 1.02 -1.08 -1.01 1.22 1.03
junctional membrane complex 1 2.03 -1.16 -1.04 -1.08 -1.05 1.25 1.07
stabilization of membrane potential 2 1.77 1.24 2.44 -1.13 1.42 2.96 1.8
DNA damage response, signal transduction by p53 class mediator 2 1.7 1.37 1.03 1.24 1.62 1.04 1.2
regulation of cell migration 10 2.17 -1.1 1.06 -1.11 1.21 1.34 1.71
negative regulation of cell migration 2 2.1 1.1 1.42 -1.08 1.39 1.72 1.26
DNA polymerase processivity factor activity 2 -1.29 1.09 1.33 1.22 1.3 -1.6 -1.28
iron-responsive element binding 2 1.36 1.24 1.32 -1.06 1.1 1.69 1.16
translation repressor activity 10 1.56 1.06 1.57 1.02 1.3 1.21 1.77
ligand-dependent nuclear receptor transcription coactivator activity 3 1.32 1.16 1.48 1.23 1.62 1.33 1.22
chorion-containing eggshell pattern formation 8 1.93 1.01 1.22 1.01 1.3 1.72 1.37
sperm mitochondrion organization 5 1.07 1.08 1.53 1.1 1.13 1.48 -1.14
symbiosis, encompassing mutualism through parasitism 2 1.04 1.05 1.19 -1.29 -1.39 2.64 1.17
defecation 1 1.59 -1.18 -1.24 -1.07 -1.14 4.1 -1.27
targeting of mRNA for destruction involved in RNA interference 4 1.09 1.13 1.5 1.03 1.41 1.21 1.37
axon 64 1.18 1.07 1.23 -1.05 1.23 1.51 1.31
peristalsis 1 1.69 1.43 1.3 1.01 1.12 1.63 -1.01
nuclear migration along microtubule 1 2.24 -1.02 -1.01 1.05 1.3 1.83 1.39
actin cap 1 1.67 1.22 2.78 1.16 2.89 2.99 1.93
fatty acid elongation 3 1.23 -2.04 -1.81 -2.67 -2.07 -1.23 3.6
ankyrin binding 2 -1.35 1.17 1.37 -1.02 1.05 1.36 1.56
spectrin binding 2 2.03 1.57 2.46 1.05 2.04 3.15 3.44
positive regulation of transforming growth factor beta receptor signaling pathway 1 2.13 -1.08 1.11 -1.24 -1.05 1.06 1.61
negative regulation of transforming growth factor beta receptor signaling pathway 6 1.52 1.09 1.44 -1.04 1.19 1.36 1.28
negative regulation of BMP signaling pathway 6 -1.26 1.23 1.3 1.36 1.55 -1.44 1.09
negative regulation of axon extension 3 -1.29 1.15 1.64 1.15 1.3 -1.22 -1.1
intracellular steroid hormone receptor signaling pathway 8 1.35 1.22 1.56 1.09 1.48 1.56 1.37
intracellular receptor mediated signaling pathway 12 1.17 1.24 1.48 1.1 1.54 1.37 1.29
dihydrolipoamide S-acyltransferase activity 2 1.46 1.31 1.81 -1.03 1.35 2.15 1.15
receptor regulator activity 3 1.55 1.1 1.06 1.1 1.12 1.11 1.09
receptor inhibitor activity 2 1.75 1.03 1.01 1.06 1.08 1.1 1.1
cyclic nucleotide binding 2 -1.42 -1.32 -1.55 -1.36 -1.51 4.6 1.1
nuclear body organization 2 -1.19 1.31 1.94 1.17 1.95 1.12 1.41
Cajal body organization 1 -1.52 1.47 1.59 1.32 1.75 -1.53 1.07
[methionine synthase] reductase activity 1 1.59 1.02 1.27 1.16 1.58 1.37 1.04
pseudocleavage 8 1.05 1.14 1.52 1.06 1.52 1.39 1.23
pseudocleavage involved in syncytial blastoderm formation 8 1.05 1.14 1.52 1.06 1.52 1.39 1.23
U2 snRNA binding 1 1.41 -1.11 1.3 1.34 1.31 1.54 -1.14
U4 snRNA binding 1 1.3 1.4 1.21 1.52 1.46 1.03 1.12
regulation of cellular pH 6 -1.56 1.28 1.81 1.0 1.29 1.81 1.32
beta-lactam antibiotic metabolic process 1 -1.31 -1.76 1.72 1.22 1.97 3.11 1.28
beta-lactam antibiotic biosynthetic process 1 -1.31 -1.76 1.72 1.22 1.97 3.11 1.28
endocytic vesicle membrane 1 -1.65 1.56 1.35 1.0 1.12 1.4 1.32
clathrin-coated endocytic vesicle membrane 1 -1.65 1.56 1.35 1.0 1.12 1.4 1.32
axolemma 1 -1.08 -1.3 -1.04 1.04 1.56 8.15 2.89
Rac guanyl-nucleotide exchange factor activity 1 1.08 -1.14 -1.07 -1.55 -1.02 9.19 -1.47
ribonuclease P complex 2 1.64 1.07 1.01 1.46 1.23 -1.08 -1.15
multimeric ribonuclease P complex 1 1.84 1.03 1.1 1.42 1.17 1.05 -1.14
germarium-derived female germ-line cyst encapsulation 9 1.21 1.23 1.43 1.1 1.5 1.55 1.38
border follicle cell delamination 3 1.2 1.5 1.32 1.16 1.13 2.96 1.24
regulation of border follicle cell delamination 1 3.22 -1.06 2.29 -1.13 1.79 4.58 1.49
anterior/posterior axis specification, follicular epithelium 1 8.32 -1.09 1.22 1.02 1.27 3.95 1.61
P granule organization 3 2.26 1.16 2.01 1.13 1.7 2.29 1.38
oocyte localization involved in germarium-derived egg chamber formation 13 -1.17 1.14 1.37 1.1 1.6 1.17 1.26
spectrosome organization 3 -1.62 1.17 1.61 1.01 1.24 1.17 1.31
establishment of oocyte nucleus localization involved in oocyte dorsal/ventral axis specification 7 1.43 1.14 1.16 1.14 1.19 1.51 1.04
male germline ring canal formation 1 1.93 1.13 1.83 -1.03 2.06 4.41 1.79
ovulation 4 1.89 -1.58 -1.76 -1.74 -1.47 1.25 -1.0
regulation of actin filament polymerization 15 -1.69 1.07 1.43 1.05 1.39 -1.34 1.16
regulation of actin filament depolymerization 2 -1.38 -1.03 2.18 1.01 1.59 -1.39 -1.04
negative regulation of actin filament depolymerization 2 -1.38 -1.03 2.18 1.01 1.59 -1.39 -1.04
negative regulation of actin filament polymerization 2 -1.38 -1.03 2.18 1.01 1.59 -1.39 -1.04
regulation of epithelial cell differentiation 1 2.56 -1.26 -1.08 -1.5 1.05 6.9 -1.01
positive regulation of epithelial cell differentiation 1 2.56 -1.26 -1.08 -1.5 1.05 6.9 -1.01
polarized epithelial cell differentiation 7 1.7 1.04 1.19 -1.07 1.56 1.4 1.47
cortical cytoskeleton 9 -1.53 1.16 1.66 1.07 1.5 1.1 1.12
cortical actin cytoskeleton 5 -1.47 1.27 2.09 1.06 1.65 1.57 1.46
cortical cytoskeleton organization 14 -1.11 1.14 1.62 1.14 1.46 -1.07 1.15
cortical actin cytoskeleton organization 11 -1.18 1.16 1.79 1.14 1.58 -1.08 1.2
rough endoplasmic reticulum membrane 12 -1.63 1.34 -1.12 1.02 -1.3 -1.73 1.28
Mre11 complex 1 1.57 1.18 2.73 1.11 1.99 2.12 1.59
VCB complex 1 2.69 1.18 1.72 1.15 -1.01 -1.18 -1.08
actin-dependent ATPase activity 2 -1.22 1.77 3.71 -1.0 2.23 2.34 2.03
forebrain development 2 -1.33 -1.42 -1.06 1.28 1.22 -1.65 -2.16
retromer complex 2 1.62 1.07 1.77 1.2 1.41 1.97 1.23
protein splicing 1 -1.72 -1.51 1.07 1.74 1.86 -2.25 -3.98
sheet-forming collagen 2 1.15 -1.7 -1.07 -1.48 -1.42 2.42 -1.33
establishment or maintenance of microtubule cytoskeleton polarity 37 1.09 1.2 1.47 1.08 1.38 1.52 1.25
establishment or maintenance of cytoskeleton polarity 37 1.09 1.2 1.47 1.08 1.38 1.52 1.25
NADH dehydrogenase complex 37 1.15 1.04 1.27 1.07 1.11 1.72 -1.29
thiamine pyrophosphate transport 1 1.18 1.26 -1.06 1.24 -1.11 -1.61 1.34
thiamine pyrophosphate binding 3 -3.01 1.15 -1.69 1.18 1.27 -2.15 -1.66
mismatched DNA binding 4 1.52 1.1 1.22 1.23 1.58 1.11 -1.01
regulation of centriole-centriole cohesion 1 2.67 1.08 1.26 1.12 2.08 1.82 1.58
filamin binding 1 2.75 1.01 2.14 1.09 1.93 1.21 1.34
ISWI complex 5 1.15 1.22 1.63 1.19 1.59 1.56 1.32
actomyosin structure organization 47 1.76 -1.18 1.14 -1.18 1.17 1.52 1.04
myosin filament organization 6 1.72 -1.12 1.39 -1.09 1.33 1.39 1.1
myosin filament assembly 6 1.72 -1.12 1.39 -1.09 1.33 1.39 1.1
myosin II filament assembly 1 -1.92 1.09 4.17 -1.09 2.38 -1.63 1.77
myosin II filament organization 1 -1.92 1.09 4.17 -1.09 2.38 -1.63 1.77
chromatin silencing by small RNA 2 1.38 1.18 -1.01 1.15 1.25 2.63 1.7
primary miRNA processing 2 1.34 1.2 1.3 1.21 1.21 1.82 1.22
pre-miRNA processing 4 1.68 1.08 1.58 -1.04 1.19 1.45 1.4
regulation of histone modification 9 1.21 1.16 1.45 1.22 1.51 1.41 1.3
negative regulation of histone modification 1 1.22 1.34 1.86 1.14 2.08 2.98 1.75
positive regulation of histone modification 4 1.11 1.17 1.59 1.27 1.57 1.16 1.28
positive regulation of histone methylation 1 -1.35 1.14 1.74 1.14 1.47 1.35 1.12
regulation of histone deacetylation 1 1.03 1.14 1.11 1.37 1.92 -1.3 1.15
positive regulation of histone deacetylation 1 1.03 1.14 1.11 1.37 1.92 -1.3 1.15
cysteine desulfurase activity 1 1.7 1.2 1.13 1.08 -1.16 -1.08 1.29
nuclear pore distribution 1 1.83 -1.06 1.02 1.15 1.17 1.57 -1.03
BLOC complex 6 1.36 1.17 1.47 1.26 1.26 1.6 -1.09
BLOC-1 complex 6 1.36 1.17 1.47 1.26 1.26 1.6 -1.09
neuron projection regeneration 3 -1.12 1.14 1.65 1.16 1.31 -1.01 1.22
axon regeneration 3 -1.12 1.14 1.65 1.16 1.31 -1.01 1.22
septin ring organization 1 -1.85 1.14 1.04 1.39 1.46 -1.41 -1.29
negative regulation of microtubule polymerization or depolymerization 15 1.06 1.15 1.48 1.04 1.41 1.59 1.26
positive regulation of microtubule depolymerization 1 -1.6 1.37 1.36 1.04 1.54 1.63 1.47
snRNA pseudouridine synthesis 2 -1.23 1.23 1.84 1.26 1.56 -1.27 1.05
RNA 3'-end processing 29 1.37 1.09 1.31 1.15 1.34 1.62 1.18
mRNA 3'-end processing 27 1.4 1.1 1.31 1.15 1.35 1.67 1.18
proteasome localization 1 2.41 1.38 1.34 1.27 1.62 1.86 1.17
rRNA methylation 1 1.49 1.34 1.76 1.04 1.9 2.28 1.25
phosphopantetheine binding 4 -2.32 -1.22 -1.89 1.2 1.1 -1.46 -1.99
peptide modification 1 2.74 1.3 1.75 1.08 1.98 1.97 2.28
POZ domain binding 1 1.78 1.16 2.67 1.12 2.53 3.19 2.15
endoplasmic reticulum palmitoyltransferase complex 1 -1.92 1.11 2.34 1.27 1.64 -1.44 -1.26
intrinsic to Golgi membrane 5 1.35 1.04 -1.19 1.04 1.29 1.43 1.52
intrinsic to nuclear inner membrane 2 -1.02 -2.05 1.59 1.21 2.03 -1.95 -2.17
intrinsic to peroxisomal membrane 5 1.37 1.29 -1.51 1.15 1.08 -1.33 -1.13
external side of cell outer membrane 1 5.43 -1.29 -1.04 -1.06 1.21 1.62 1.41
protein acetyltransferase complex 1 2.72 1.09 2.08 1.56 2.05 2.2 1.21
cell leading edge 10 1.31 1.13 1.5 1.03 1.41 1.43 1.48
cell projection membrane 4 -1.03 1.05 1.14 1.11 1.34 1.84 1.38
leading edge membrane 2 -1.25 -1.03 1.2 1.13 1.56 3.31 1.93
lamellipodium membrane 1 -1.44 1.23 1.5 1.23 1.55 1.34 1.29
intrinsic to mitochondrial inner membrane 1 -1.27 1.34 1.46 1.01 -1.06 2.1 -1.33
integral to mitochondrial inner membrane 1 -1.27 1.34 1.46 1.01 -1.06 2.1 -1.33
intrinsic to mitochondrial outer membrane 1 1.09 1.16 1.56 1.4 1.39 1.34 -1.11
integral to mitochondrial outer membrane 1 1.09 1.16 1.56 1.4 1.39 1.34 -1.11
RNAi effector complex 7 -1.01 1.19 1.52 1.03 1.34 1.15 1.36
negative regulation of protein complex assembly 2 -1.38 -1.03 2.18 1.01 1.59 -1.39 -1.04
positive regulation of cell projection organization 6 1.15 1.11 1.56 1.11 1.48 -1.16 1.25
regulation of defense response 35 1.89 -1.19 -1.0 -1.08 -1.03 1.26 1.14
negative regulation of defense response 5 2.13 -1.29 1.2 -1.05 -1.19 -1.21 -1.11
positive regulation of defense response 6 2.51 -1.09 1.1 -1.06 1.06 1.76 1.22
N-terminal protein amino acid modification 3 -1.27 1.36 1.99 1.28 1.6 -1.05 -1.03
bursicon neuropeptide hormone complex 2 -1.74 -1.0 -1.2 1.19 1.42 -1.55 -1.19
regulation of protein ubiquitination 10 1.62 1.07 1.68 1.03 1.28 1.35 1.26
positive regulation of protein modification process 11 1.08 1.11 1.65 1.11 1.39 1.35 1.2
response to methotrexate 11 -1.41 1.08 -1.36 -1.03 1.36 -1.33 1.53
M band 6 1.68 1.03 -1.27 -1.02 1.18 1.68 1.16
mitogen-activated protein kinase kinase binding 1 1.22 1.33 2.18 1.07 1.72 2.05 1.61
negative regulation of mRNA 3'-end processing 1 1.92 1.01 1.57 -1.13 1.41 2.91 1.31
regulation of heterochromatin assembly 3 1.21 1.11 1.43 1.11 1.52 1.35 1.11
negative regulation of heterochromatin assembly 1 1.22 1.33 2.18 1.07 1.72 2.05 1.61
myosin VI complex 3 -1.98 1.02 1.13 1.07 1.24 -1.12 -1.15
nucleosome binding 2 -1.08 1.25 1.65 1.07 1.57 1.08 1.51
nucleosomal DNA binding 1 -1.26 1.34 1.15 1.09 1.13 -1.62 1.24
protein complex localization 2 2.1 1.14 1.17 1.2 1.38 1.71 1.06
SUMO activating enzyme complex 2 1.33 1.09 1.29 1.43 1.67 1.2 -1.13
Myb complex 11 1.43 1.19 1.32 1.2 1.4 1.5 1.18
actin cytoskeleton reorganization 9 1.38 1.0 1.56 1.0 1.39 1.59 1.34
plus-end directed microtubule sliding 1 1.34 1.07 1.06 1.01 1.45 -1.14 -1.53
positive regulation of exit from mitosis 1 2.76 -2.65 -2.69 -2.98 -1.9 34.44 -1.85
contractile ring maintenance involved in cell cycle cytokinesis 1 -1.85 1.14 1.04 1.39 1.46 -1.41 -1.29
mitotic cell cycle G1/S transition DNA damage checkpoint 2 1.09 1.49 1.71 1.02 1.44 1.9 1.73
mitotic cell cycle G1/S transition checkpoint 2 1.09 1.49 1.71 1.02 1.44 1.9 1.73
neuromuscular junction 29 1.64 -1.02 1.13 -1.17 1.09 1.63 1.22
spindle pole centrosome 3 1.78 1.17 1.45 -1.07 1.38 1.95 1.49
NMS complex 3 1.88 1.01 1.19 1.2 1.44 1.48 -1.09
nuclear centromeric heterochromatin 1 -1.2 1.03 1.07 -1.11 1.52 -1.28 -1.06
receptor internalization 3 1.27 -1.02 1.22 -1.05 1.11 1.66 1.17
ubiquitin conjugating enzyme binding 1 1.42 -1.23 1.7 1.22 1.08 1.57 -1.21
ubiquitin protein ligase binding 9 1.11 1.17 1.66 1.19 1.63 1.3 1.36
synaptic vesicle fusion to presynaptic membrane 2 -3.55 -1.94 -2.8 1.67 -1.37 -8.1 -3.92
regulation of neuronal synaptic plasticity in response to neurotrophin 1 2.75 -1.14 -1.16 -1.07 -1.18 1.11 1.67
zymogen activation 4 3.67 -1.44 -1.39 -1.42 -1.27 2.44 1.48
positive regulation of neurological system process 2 -1.81 1.29 2.08 -1.04 1.39 1.52 1.29
cellular response to nutrient 1 -36.3 1.49 1.05 1.2 1.58 -8.6 -1.57
I band 19 1.85 -1.41 -1.18 -1.11 1.31 1.7 -1.14
late endosome membrane 1 1.78 1.14 -1.44 1.08 1.0 3.89 1.83
microbody membrane 14 1.87 1.14 -1.32 1.28 1.36 -1.33 -1.09
positive regulation of chromatin silencing 3 1.21 1.14 -1.1 -1.08 1.08 1.29 1.99
beta-alanyl-histamine hydrolase activity 1 -1.31 -1.76 1.72 1.22 1.97 3.11 1.28
nuclear membrane 16 1.66 -1.06 1.3 1.05 1.4 1.42 1.19
locomotion involved in locomotory behavior 14 -1.12 1.15 1.42 1.11 1.53 1.07 1.2
mRNA export from nucleus in response to heat stress 2 -1.27 1.03 1.6 -1.01 1.13 1.81 1.1
regulation of TOR signaling cascade 3 -2.06 1.16 1.27 1.19 1.19 -1.72 1.0
negative regulation of TOR signaling cascade 1 1.13 1.46 1.84 1.15 1.31 1.41 1.45
positive regulation of TOR signaling cascade 2 -3.14 1.04 1.05 1.2 1.13 -2.68 -1.2
regulation of ARF protein signal transduction 14 -1.12 1.16 1.23 1.01 1.21 1.19 1.55
cardiolipin metabolic process 1 -3.36 1.4 1.32 1.25 1.35 -2.25 1.21
cardiolipin biosynthetic process 1 -3.36 1.4 1.32 1.25 1.35 -2.25 1.21
clathrin heavy chain binding 2 -1.49 1.38 1.52 1.18 1.43 -1.03 1.15
cortical protein anchoring 1 -1.33 1.57 2.09 1.17 1.77 1.11 1.58
regulation of nuclease activity 1 1.58 1.16 -1.09 1.12 1.04 1.36 -1.13
negative regulation of nuclease activity 1 1.58 1.16 -1.09 1.12 1.04 1.36 -1.13
SAM domain binding 1 1.45 1.28 1.83 1.25 2.05 1.81 1.62
regulation of response to food 2 -2.4 -1.4 3.96 -1.44 -2.81 -4.01 -2.19
regulation of response to external stimulus 9 -1.23 1.03 1.62 -1.03 -1.11 -1.21 -1.18
regulation of response to extracellular stimulus 4 -1.71 -1.02 2.0 -1.11 -1.48 -1.65 -1.49
negative regulation of response to extracellular stimulus 1 -1.06 1.16 1.2 1.34 1.78 -1.33 -1.11
regulation of response to nutrient levels 4 -1.71 -1.02 2.0 -1.11 -1.48 -1.65 -1.49
negative regulation of response to nutrient levels 1 -1.06 1.16 1.2 1.34 1.78 -1.33 -1.11
cell division site 12 -1.06 1.09 1.54 1.06 1.53 1.28 1.13
cell division site part 12 -1.06 1.09 1.54 1.06 1.53 1.28 1.13
small conjugating protein binding 3 1.59 1.33 1.88 1.29 1.84 1.63 1.43
SUMO binding 1 1.3 1.31 1.72 1.5 1.61 1.9 1.2
septin cytoskeleton organization 1 -1.85 1.14 1.04 1.39 1.46 -1.41 -1.29
contractile ring localization involved in cell cycle cytokinesis 2 -1.56 1.16 1.2 1.2 1.28 -1.0 1.03
maintenance of contractile ring localization involved in cell cycle cytokinesis 1 -1.85 1.14 1.04 1.39 1.46 -1.41 -1.29
regulation of actin filament bundle assembly 3 1.54 1.04 1.3 -1.03 2.35 1.13 1.3
regulation of calcium ion transport via store-operated calcium channel activity 3 1.93 -1.03 1.33 1.03 1.24 2.17 1.55
positive regulation of calcium ion transport via store-operated calcium channel activity 2 2.64 -1.06 1.57 1.01 1.45 3.25 1.94
activation of store-operated calcium channel activity 1 2.63 1.01 1.53 -1.05 1.46 2.52 1.76
regulation of nucleobase-containing compound transport 1 1.52 1.17 1.71 1.25 2.2 8.74 2.48
negative regulation of nucleobase-containing compound transport 1 1.52 1.17 1.71 1.25 2.2 8.74 2.48
regulation of protein polymerization 17 -1.53 1.06 1.38 1.05 1.34 -1.31 1.14
negative regulation of protein polymerization 2 -1.38 -1.03 2.18 1.01 1.59 -1.39 -1.04
double-stranded RNA-specific ribonuclease activity 1 6.73 -1.62 -1.13 -2.09 1.01 8.39 1.39
mismatch repair complex 1 2.58 -1.1 1.19 1.19 2.02 -1.05 -1.35
MutSalpha complex 1 2.58 -1.1 1.19 1.19 2.02 -1.05 -1.35
MutSbeta complex 1 2.58 -1.1 1.19 1.19 2.02 -1.05 -1.35
regulation of ARF GTPase activity 8 -1.06 1.12 1.2 1.04 1.17 1.01 1.53
regulation of Rac GTPase activity 1 1.08 -1.14 -1.07 -1.55 -1.02 9.19 -1.47
regulation of Rap GTPase activity 1 -1.22 2.43 -1.06 -1.67 1.03 1.44 -1.08
regulation of Rho GTPase activity 4 1.14 1.13 1.64 1.03 1.74 2.44 1.19
positive regulation of Ras GTPase activity 3 1.01 1.31 1.81 1.2 1.9 1.82 1.38
positive regulation of Rho GTPase activity 2 -1.11 1.35 2.32 1.27 2.42 1.41 1.46
regulation of hormone metabolic process 4 -4.19 -1.34 1.3 1.27 1.23 -3.79 -2.08
negative regulation of hormone metabolic process 2 -15.63 -2.03 1.53 1.8 1.58 -15.3 -4.44
negative regulation of hormone biosynthetic process 1 -84.21 -3.59 1.42 2.07 1.14 -58.36 -15.07
intracellular lipid transport 1 -2.39 1.47 1.51 1.07 -1.25 -2.16 1.24
regulation of lipid transport 1 2.58 -1.39 1.67 -1.07 1.62 11.34 1.83
regulation of sterol transport 1 2.58 -1.39 1.67 -1.07 1.62 11.34 1.83
regulation of cholesterol transport 1 2.58 -1.39 1.67 -1.07 1.62 11.34 1.83
negative regulation of intracellular transport 6 2.03 1.13 1.29 1.08 1.28 1.86 1.59
regulation of transporter activity 7 1.44 -1.04 1.16 -1.02 1.15 1.52 1.13
positive regulation of transporter activity 2 2.64 -1.06 1.57 1.01 1.45 3.25 1.94
regulation of ion transmembrane transporter activity 7 1.44 -1.04 1.16 -1.02 1.15 1.52 1.13
positive regulation of ion transmembrane transporter activity 2 2.64 -1.06 1.57 1.01 1.45 3.25 1.94
beta-N-acetylgalactosaminidase activity 1 3.13 1.28 1.73 1.05 1.33 2.12 2.37
actin filament bundle 1 1.76 1.07 1.13 1.08 1.49 1.28 1.15
filopodium tip 2 1.13 -1.0 1.96 -1.15 1.62 1.33 1.8
regulation of proteasomal ubiquitin-dependent protein catabolic process 4 1.63 1.06 1.19 1.23 1.22 1.17 1.04
positive regulation of proteasomal ubiquitin-dependent protein catabolic process 1 2.44 1.03 1.21 1.16 1.33 1.95 1.23
demethylase activity 6 1.22 1.23 1.76 1.12 1.66 1.8 1.31
histone demethylase activity 6 1.22 1.23 1.76 1.12 1.66 1.8 1.31
histone demethylase activity (H3-K4 specific) 2 1.08 1.42 1.76 1.01 1.58 2.53 1.88
histone demethylase activity (H3-K9 specific) 2 1.08 1.24 1.45 1.25 1.55 1.06 1.05
endocytic recycling 5 1.33 1.24 1.42 1.12 1.35 1.65 1.25
endoplasmic reticulum calcium ion homeostasis 1 4.45 1.05 -1.49 1.14 1.22 1.67 1.4
regulation of Rap protein signal transduction 1 -1.22 2.43 -1.06 -1.67 1.03 1.44 -1.08
response to peptidoglycan 1 9.16 -1.23 -1.57 -1.54 -1.3 2.66 -1.01
response to lipopolysaccharide 2 1.04 1.17 1.37 1.17 1.75 1.28 1.1
muramyl dipeptide binding 1 9.16 -1.23 -1.57 -1.54 -1.3 2.66 -1.01
protein exit from endoplasmic reticulum 1 -1.49 1.52 1.25 1.12 1.19 1.46 1.78
microvillus organization 4 -2.72 -1.1 -1.32 -1.18 -1.23 -2.04 1.51
follicle cell microvillus organization 2 1.82 -1.12 -1.27 -1.14 -1.29 -1.07 1.07
regulation of microvillus organization 1 3.92 -1.13 -1.16 -1.25 -1.38 1.21 1.43
regulation of follicle cell microvillus organization 1 3.92 -1.13 -1.16 -1.25 -1.38 1.21 1.43
regulation of microvillus length 1 3.92 -1.13 -1.16 -1.25 -1.38 1.21 1.43
regulation of follicle cell microvillus length 1 3.92 -1.13 -1.16 -1.25 -1.38 1.21 1.43
regulation of cell projection size 1 3.92 -1.13 -1.16 -1.25 -1.38 1.21 1.43
mitochondrial translation 1 1.16 1.26 1.14 1.19 1.28 1.6 -1.22
O-linoleoyltransferase activity 1 -3.36 1.4 1.32 1.25 1.35 -2.25 1.21
phosphatidylcholine:cardiolipin O-linoleoyltransferase activity 1 -3.36 1.4 1.32 1.25 1.35 -2.25 1.21
Golgi cisterna membrane 3 1.17 1.23 -1.14 1.08 -1.09 1.82 1.37
neuron projection membrane 1 -1.08 -1.3 -1.04 1.04 1.56 8.15 2.89
integral to mitochondrial membrane 3 -1.04 1.18 1.43 1.19 1.11 1.64 -1.32
regulation of monooxygenase activity 2 1.57 1.18 -1.18 1.24 1.17 1.04 1.44
negative regulation of monooxygenase activity 1 1.08 1.16 -1.5 1.55 1.01 -2.04 -1.2
positive regulation of monooxygenase activity 1 2.28 1.19 1.07 -1.0 1.37 2.2 2.5
ELL-EAF complex 8 1.25 1.11 1.53 1.07 1.44 1.46 1.18
positive regulation of CREB transcription factor activity 1 2.75 1.33 1.9 1.11 2.22 3.34 2.0
low-density lipoprotein receptor particle metabolic process 1 2.53 -1.21 1.11 1.26 1.02 1.58 1.04
tumor necrosis factor receptor superfamily binding 2 1.39 1.0 -1.11 -1.04 2.69 -1.2 2.61
regulation of homeostatic process 3 1.14 1.14 1.39 1.16 1.04 1.71 1.47
positive regulation of Rab GTPase activity 1 1.3 1.23 1.1 1.08 1.16 2.99 1.24
positive regulation of Rac GTPase activity 2 -1.11 1.35 2.32 1.27 2.42 1.41 1.46
activation of Ras GTPase activity 2 -1.11 1.35 2.32 1.27 2.42 1.41 1.46
activation of Rho GTPase activity 2 -1.11 1.35 2.32 1.27 2.42 1.41 1.46
activation of Rac GTPase activity 2 -1.11 1.35 2.32 1.27 2.42 1.41 1.46
positive regulation of stress-activated MAPK cascade 12 1.07 1.28 1.47 1.07 1.29 1.52 1.25
regulation of DNA endoreduplication 5 -1.5 1.1 1.17 1.11 1.42 -1.56 1.43
negative regulation of DNA endoreduplication 2 -3.55 -1.04 1.42 1.03 1.59 -2.82 2.09
regulation of polysaccharide metabolic process 1 -2.86 1.25 -1.2 1.45 1.26 1.29 -1.32
regulation of microtubule-based process 29 1.19 1.14 1.41 1.06 1.41 1.52 1.27
circadian regulation of gene expression 3 1.48 1.24 1.41 1.04 1.37 1.9 1.48
activin receptor signaling pathway 3 -2.1 2.02 -1.27 -1.55 -1.26 -1.31 1.66
regulation of activin receptor signaling pathway 1 1.88 -1.02 -1.08 -1.19 -1.0 2.96 -1.02
negative regulation of activin receptor signaling pathway 1 1.88 -1.02 -1.08 -1.19 -1.0 2.96 -1.02
positive regulation of activin receptor signaling pathway 1 1.88 -1.02 -1.08 -1.19 -1.0 2.96 -1.02
sterol binding 17 -2.71 -1.57 -1.93 1.12 -1.21 -2.6 -2.64
positive regulation of transcription elongation from RNA polymerase II promoter 10 -1.01 1.29 1.32 -1.05 1.22 1.32 1.65
mitochondrial respiratory chain complex I assembly 1 1.08 1.05 1.31 1.03 1.07 1.99 -1.52
myosin filament 3 2.91 -1.49 1.05 -1.32 1.04 2.39 -1.29
ribonucleoprotein complex disassembly 1 1.69 1.29 1.56 1.32 1.6 1.63 1.44
protein-carbohydrate complex 1 2.19 1.14 2.0 1.19 2.09 1.71 1.7
tetrapyrrole catabolic process 1 2.0 1.05 2.09 1.06 1.46 2.34 1.12
bitter taste receptor activity 2 -1.31 -1.2 -1.22 -1.24 3.17 1.22 -1.17
conversion of ds siRNA to ss siRNA involved in RNA interference 1 1.02 1.47 1.88 1.06 1.63 2.09 1.83
histone H3-K9 demethylation 2 1.08 1.24 1.45 1.25 1.55 1.06 1.05
proton-transporting V-type ATPase complex 28 -1.62 -1.0 1.32 -1.18 -1.18 1.26 -1.13
proton-transporting two-sector ATPase complex, proton-transporting domain 24 -1.5 1.0 1.3 -1.13 -1.09 1.2 -1.21
proton-transporting two-sector ATPase complex, catalytic domain 24 1.11 -1.0 1.24 -1.09 -1.02 1.63 -1.09
proton-transporting V-type ATPase, V0 domain 15 -2.14 -1.02 1.29 -1.23 -1.29 1.0 -1.25
proton-transporting V-type ATPase, V1 domain 14 -1.13 1.02 1.36 -1.11 -1.05 1.59 1.0
response to hydroperoxide 1 2.0 -1.09 -1.07 1.14 1.47 1.02 -1.28
cytokinesis after meiosis 19 1.55 1.01 1.2 -1.08 1.35 1.45 1.26
iron assimilation 1 -2.45 1.57 -1.18 1.13 -1.31 -2.1 1.39
regulation of S phase 16 1.38 1.18 1.34 1.13 1.4 1.63 1.43
axon part 31 1.25 1.05 1.11 -1.11 1.16 1.72 1.28
monocarboxylic acid binding 11 -1.61 -1.59 -2.07 -1.15 1.3 -1.68 -1.56
cell cycle comprising mitosis without cytokinesis 14 1.58 -1.04 1.19 -1.07 1.25 1.21 1.5
meiotic cell cycle checkpoint 1 1.5 1.02 1.68 -1.05 1.78 1.86 1.49
carbohydrate homeostasis 5 1.14 1.16 -1.21 -1.59 -1.34 1.07 1.69
fatty acid beta-oxidation using acyl-CoA oxidase 1 -1.23 1.06 -2.67 1.58 1.11 -5.4 -1.98
multicellular organismal response to stress 2 1.88 -1.18 1.22 1.16 1.43 1.98 1.19
unsaturated fatty acid metabolic process 1 -1.74 1.11 -2.01 1.51 1.27 -1.87 -1.55
dorsal/ventral axon guidance 2 1.25 1.19 1.54 1.04 1.22 1.73 1.43
protein glycosylation in endoplasmic reticulum 1 2.78 -1.05 1.02 -1.07 1.12 2.02 1.06
protein glycosylation in Golgi 1 1.63 1.17 -1.53 -1.05 -1.49 4.17 1.53
Elongator holoenzyme complex 1 -1.53 1.18 -1.12 1.34 -1.02 -1.63 -1.29
mitochondrial proton-transporting ATP synthase complex assembly 1 1.02 1.07 1.3 1.18 1.05 1.56 -1.57
regulation of growth of symbiont in host 7 2.04 -1.02 1.37 1.07 1.52 1.47 1.08
negative regulation of growth of symbiont in host 7 2.04 -1.02 1.37 1.07 1.52 1.47 1.08
negative regulation of kinase activity 12 1.53 1.14 1.46 1.09 1.41 1.69 1.32
nucleotide-excision repair, DNA incision 1 1.98 1.16 1.33 1.18 1.39 1.07 1.02
cellular polysaccharide biosynthetic process 11 1.69 1.06 -1.03 1.08 1.23 1.68 1.33
establishment of ribosome localization 1 2.15 -1.01 1.44 1.25 1.44 1.28 1.21
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor 3 2.12 -1.18 -1.46 -1.03 -1.03 1.26 -1.06
steroid dehydrogenase activity, acting on the CH-CH group of donors 1 -1.31 1.28 -1.32 1.3 1.08 -2.32 -1.18
SUMO-targeted ubiquitin ligase complex 1 1.3 1.31 1.72 1.5 1.61 1.9 1.2
O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity 1 1.31 1.46 -1.17 -1.24 1.74 -1.95 3.54
N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity 2 -1.04 1.82 1.08 1.06 -1.12 -1.39 1.31
ribonuclease T2 activity 1 2.66 -1.03 1.81 1.01 1.48 1.86 1.52
mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity 1 -1.77 -1.11 1.92 1.18 1.33 -1.27 -1.19
cis-stilbene-oxide hydrolase activity 3 -2.11 1.3 -1.14 -1.06 -1.44 -4.35 1.38
cytoplasmic mRNA processing body assembly 5 1.3 1.16 1.47 1.28 1.54 1.31 1.13
5-(carboxyamino)imidazole ribonucleotide mutase activity 1 1.05 -1.55 -1.44 -1.5 -1.3 3.7 1.09
endosomal vesicle fusion 4 1.19 1.07 2.26 1.26 1.71 1.76 1.23
response to disaccharide stimulus 5 2.19 -1.05 1.25 1.03 1.35 1.69 1.35
primary alcohol metabolic process 2 1.95 -1.28 -2.91 -1.89 1.06 1.72 1.15
diol metabolic process 9 -1.02 -1.18 -1.26 -1.16 -1.28 -1.1 1.52
diol biosynthetic process 3 -1.04 -2.12 -1.47 -1.4 -1.53 1.41 2.4
diol catabolic process 1 -8.98 1.77 -2.05 -1.02 -2.08 -14.22 1.22
Arp2/3 complex-mediated actin nucleation 2 -1.4 1.24 1.37 1.14 1.19 -1.91 1.02
cell junction assembly 37 1.87 -1.1 1.3 -1.15 1.23 2.13 1.42
cell junction organization 46 1.6 -1.06 1.34 -1.1 1.25 1.87 1.32
cell junction maintenance 9 -1.01 1.16 1.73 1.07 1.49 1.28 1.13
adherens junction maintenance 7 -1.01 1.13 1.67 1.07 1.42 1.13 -1.02
lipid particle organization 6 1.5 -1.3 -1.62 1.09 1.28 -1.38 1.28
nuclear-transcribed mRNA catabolic process, exonucleolytic, 5'-3' 1 -1.45 1.76 1.14 1.42 1.29 -1.3 1.32
lipid oxidation 14 -1.0 1.05 -1.49 1.08 1.25 -1.91 -1.22
microtubule anchoring at centrosome 1 -1.51 -1.02 1.38 1.04 1.42 1.11 -1.1
heparan sulfate sulfotransferase activity 6 1.58 1.12 1.54 1.02 1.18 1.11 1.46
protein localization to kinetochore 1 2.47 1.54 1.18 1.04 1.48 1.78 1.43
protein localization to chromosome 1 2.47 1.54 1.18 1.04 1.48 1.78 1.43
piRNA binding 2 1.58 1.07 1.4 1.11 1.03 1.55 1.05
cellular protein complex localization 2 2.1 1.14 1.17 1.2 1.38 1.71 1.06
cellular carbohydrate biosynthetic process 22 1.52 -1.16 -1.16 -1.14 1.15 1.68 1.12
establishment of mitochondrion localization, microtubule-mediated 5 -1.72 1.29 1.54 1.18 1.39 1.16 1.27
cellular response to UV 11 -1.5 -1.74 -2.0 -1.64 -1.56 -1.07 -1.13
histone demethylase activity (H3-trimethyl-K4 specific) 2 1.08 1.42 1.76 1.01 1.58 2.53 1.88
ncRNA catabolic process 1 1.49 1.15 1.39 1.19 1.14 2.46 1.32
tripeptidase activity 1 -2.16 -1.91 -1.31 1.97 1.89 -1.93 -2.32
chloride channel complex 6 -1.41 1.18 1.24 -1.25 -1.53 -1.47 -1.09
methyltransferase complex 16 1.51 1.16 1.4 1.13 1.36 1.38 1.21
histone H3-K4 demethylation 3 1.04 1.4 1.66 1.06 1.46 1.94 1.65
histone H3-K4 demethylation, trimethyl-H3-K4-specific 1 1.33 1.27 1.61 -1.08 1.55 2.66 1.67
DNA replication-independent nucleosome organization 1 -1.49 1.47 -1.04 1.39 1.42 -1.65 -1.06
negative regulation of transmembrane transport 6 1.84 1.13 1.25 1.03 1.14 1.94 1.57
regulation of ion transmembrane transport 8 1.33 -1.01 1.17 -1.03 1.1 1.52 1.12
basement membrane disassembly 3 -2.47 1.3 1.22 1.11 1.41 -1.09 1.18
histone H4-K20 methylation 3 1.22 1.28 1.67 1.2 1.75 1.82 1.4
histone H4-K20 monomethylation 1 1.22 1.34 1.86 1.14 2.08 2.98 1.75
histone H4-K20 dimethylation 1 1.41 1.59 1.77 1.23 1.83 1.65 1.69
histone H4-K20 trimethylation 2 1.21 1.25 1.58 1.24 1.6 1.43 1.25
response to endoplasmic reticulum stress 3 -1.16 1.37 1.28 -1.02 1.1 -1.11 1.57
NAD-dependent protein deacetylase activity 2 1.85 1.16 1.29 1.09 1.23 1.67 1.46
iron chaperone activity 1 1.38 1.05 1.33 1.44 1.46 1.81 -1.29
dorsal trunk growth, open tracheal system 4 1.59 -1.02 1.16 -1.15 1.19 1.9 1.23
liquid clearance, open tracheal system 6 1.48 1.17 1.29 1.11 1.28 1.82 1.45
subapical complex 13 1.4 1.1 1.14 1.01 1.29 2.02 1.24
phosphatidylinositol 3-kinase activity 3 -1.46 1.15 1.53 1.18 1.77 -1.09 -1.14
melanization defense response 12 2.45 -1.25 -1.18 -1.23 1.2 1.6 1.51
regulation of melanization defense response 3 10.08 -1.98 -1.97 -2.05 -1.49 4.83 1.41
positive regulation of melanization defense response 1 13.93 -2.44 -2.81 -2.18 -1.62 11.32 -1.11
negative regulation of melanization defense response 1 23.01 -3.14 -2.9 -3.17 -2.48 1.73 2.58
encapsulation of foreign target 6 2.07 -1.07 1.2 -1.17 1.1 1.42 1.52
melanotic encapsulation of foreign target 2 5.77 -1.55 -1.53 -1.72 -1.45 1.51 1.76
myosuppressin receptor activity 1 13.14 -1.35 -1.29 -1.22 -1.17 -1.49 -1.27
phosphatidylinositol 3-kinase regulator activity 1 -2.08 1.8 1.08 1.22 1.65 -1.22 1.26
cuticle pattern formation 23 1.0 1.04 1.21 -1.06 1.14 1.06 1.51
regulation of Rac protein signal transduction 2 1.51 1.07 1.28 -1.16 1.49 6.25 1.07
negative regulation of Rac protein signal transduction 1 2.11 1.3 1.76 1.16 2.29 4.26 1.69
regulation of Rho protein signal transduction 26 1.09 1.14 1.48 1.09 1.46 1.56 1.26
positive regulation of Rho protein signal transduction 1 2.11 1.3 1.76 1.16 2.29 4.26 1.69
leading edge cell differentiation 5 1.03 1.07 2.19 -1.04 1.49 -1.17 1.24
leading edge cell fate commitment 3 1.0 1.08 1.89 1.0 1.21 -1.44 -1.04
leading edge cell fate determination 3 1.0 1.08 1.89 1.0 1.21 -1.44 -1.04
dorsal closure, leading edge cell fate commitment 3 1.0 1.08 1.89 1.0 1.21 -1.44 -1.04
sperm plasma membrane disassembly 1 -1.22 1.14 1.06 1.01 -1.52 -1.37 1.04
juvenile hormone acid methyltransferase activity 1 2.57 -9.13 -9.92 -9.08 -2.93 -2.21 6.69
cardiac cell differentiation 20 1.36 -1.01 1.21 -1.08 1.08 1.53 1.21
dorsal vessel heart proper cell fate commitment 2 1.33 1.12 1.13 1.09 1.14 1.5 1.21
RCAF complex 1 -1.52 1.22 1.31 1.37 1.19 -1.61 -1.48
nuclear speck organization 1 1.08 1.17 2.37 1.04 2.17 1.91 1.84
regulation of histone acetylation 5 1.41 1.17 1.61 1.2 1.61 1.62 1.46
positive regulation of histone acetylation 2 1.41 1.2 1.81 1.29 1.46 1.33 1.45
negative regulation of histone acetylation 1 1.22 1.34 1.86 1.14 2.08 2.98 1.75
micro-ribonucleoprotein complex 1 -1.57 1.18 1.13 1.01 1.08 -1.1 1.28
pupariation 7 1.31 1.04 1.24 -1.05 1.2 2.66 1.16
response to ecdysone 27 1.12 1.07 1.54 1.02 1.35 1.59 1.26
ecdysone receptor-mediated signaling pathway 8 1.35 1.22 1.56 1.09 1.48 1.56 1.37
polytene chromosome puffing 3 1.97 -1.0 -1.28 -1.11 1.05 -1.03 2.22
heat shock-mediated polytene chromosome puffing 3 1.97 -1.0 -1.28 -1.11 1.05 -1.03 2.22
cilium axoneme assembly 2 -1.34 1.15 1.69 1.06 -1.04 -1.19 -1.09
siRNA loading onto RISC involved in RNA interference 4 1.18 1.15 1.71 1.01 1.53 1.21 1.39
establishment of apical/basal cell polarity 8 1.65 1.12 1.18 -1.06 1.49 1.45 1.45
maintenance of apical/basal cell polarity 7 1.32 1.27 1.59 1.12 1.39 1.26 1.25
response to nicotine 5 -1.06 -1.07 -1.59 -1.13 1.17 1.09 1.28
behavioral response to nicotine 1 1.09 1.23 3.2 1.05 2.53 1.91 1.95
larval midgut cell programmed cell death 3 2.11 1.08 -1.08 1.13 -1.02 1.36 1.42
histone methyltransferase complex 16 1.51 1.16 1.4 1.13 1.36 1.38 1.21
ecdysone binding 1 2.23 1.01 -1.05 1.07 1.28 -1.09 1.2
PRC1 complex 10 1.56 1.15 1.36 1.07 1.32 1.49 1.36
sterol regulatory element binding protein cleavage 4 1.66 1.17 1.17 1.07 1.36 1.15 1.2
regulation of tube size 46 2.31 -1.17 1.1 -1.22 1.13 2.15 1.48
regulation of tube size, open tracheal system 43 2.4 -1.2 1.11 -1.24 1.13 2.23 1.49
regulation of tube architecture, open tracheal system 66 1.86 -1.09 1.16 -1.16 1.17 1.89 1.38
negative regulation of terminal cell fate specification, open tracheal system 4 -1.37 1.26 1.57 1.19 1.57 1.09 1.17
fusion cell fate specification 2 -1.28 -1.08 2.4 -1.03 1.63 -2.97 1.01
negative regulation of fusion cell fate specification 3 1.21 1.19 1.16 1.18 1.53 1.57 1.32
regulation of tube diameter, open tracheal system 9 2.29 -1.02 1.09 -1.22 -1.05 2.19 1.55
regulation of tube length, open tracheal system 24 1.81 -1.04 1.23 -1.13 1.27 1.82 1.36
post-embryonic hemopoiesis 11 1.28 1.08 1.31 1.05 1.27 1.44 1.7
larval lymph gland hemopoiesis 11 1.28 1.08 1.31 1.05 1.27 1.44 1.7
larval lymph gland hemocyte differentiation 9 1.36 1.08 1.37 1.04 1.33 1.5 1.66
lymph gland crystal cell differentiation 4 1.1 1.01 1.11 1.06 1.31 1.74 2.25
lamellocyte differentiation 4 1.23 1.27 1.61 1.19 1.65 1.45 1.54
hemocyte proliferation 10 1.23 1.17 1.5 1.16 1.47 1.44 1.37
histone kinase activity 3 1.34 1.23 1.39 1.12 1.46 1.54 1.4
histone serine kinase activity 2 1.43 1.39 1.53 1.13 1.4 1.89 1.58
histone kinase activity (H3-S10 specific) 1 1.82 1.38 1.39 1.27 1.17 2.09 1.46
social behavior 1 -12.04 -1.69 9.34 -2.59 -11.09 -12.8 -6.11
larval foraging behavior 1 -12.04 -1.69 9.34 -2.59 -11.09 -12.8 -6.11
larval wandering behavior 2 -1.11 1.48 1.63 -1.09 1.06 -1.13 1.6
female germline ring canal outer rim 1 2.22 1.2 -1.59 -1.27 1.13 5.56 1.6
female germline ring canal inner rim 2 2.33 1.09 -1.29 -1.15 -1.06 2.19 1.56
histone threonine kinase activity 1 1.19 -1.04 1.15 1.11 1.6 1.03 1.09
preblastoderm mitotic cell cycle 2 6.0 -2.29 -2.45 -2.24 -2.05 -1.18 2.53
hatching behavior 2 -5.42 -1.46 -1.97 1.51 -1.45 -12.25 -3.05
hatching 3 -2.59 -1.22 -1.47 1.31 -1.21 -4.45 -1.84
syncytial nuclear migration 6 1.4 1.18 1.66 1.17 1.63 1.47 1.43
nuclear axial expansion 3 1.16 1.2 2.08 1.13 1.79 1.3 1.53
siRNA binding 4 -1.07 -1.68 -1.17 -1.84 -1.07 1.05 2.69
tracheal pit formation in open tracheal system 4 1.93 -1.11 -1.01 -1.1 1.21 1.33 1.64
regulation of lamellocyte differentiation 4 1.31 1.15 -1.09 -1.04 1.03 1.64 1.15
negative regulation of lamellocyte differentiation 3 1.53 1.17 -1.05 -1.05 1.11 2.06 1.23
regulation of hemocyte proliferation 3 1.68 1.14 1.31 -1.06 1.35 1.48 1.49
pupal development 6 2.46 -1.28 -1.05 -1.42 -1.1 2.95 -1.08
prepupal development 9 1.36 1.03 1.2 -1.03 1.16 2.15 1.14
cell competition in a multicellular organism 8 -1.44 1.26 1.72 1.12 1.65 1.02 1.13
clypeo-labral disc development 6 1.03 1.0 1.19 1.01 1.08 1.14 1.54
labial disc development 4 1.69 -1.22 1.25 -1.11 1.22 1.33 1.1
genital disc pattern formation 8 -1.0 -1.63 -1.11 1.02 1.25 1.06 -1.49
genital disc anterior/posterior pattern formation 8 -1.0 -1.63 -1.11 1.02 1.25 1.06 -1.49
glutamate-cysteine ligase catalytic subunit binding 1 -1.69 1.43 -1.23 1.48 -1.02 -3.82 -1.18
regulation of glutamate-cysteine ligase activity 1 -1.69 1.43 -1.23 1.48 -1.02 -3.82 -1.18
positive regulation of glutamate-cysteine ligase activity 1 -1.69 1.43 -1.23 1.48 -1.02 -3.82 -1.18
cytoneme assembly 2 -1.85 -1.12 1.68 1.29 1.66 1.71 -2.53
germ cell attraction 1 -1.72 -1.51 1.07 1.74 1.86 -2.25 -3.98
germ cell repulsion 2 1.22 1.02 1.17 1.16 2.02 -1.19 -1.06
germ cell programmed cell death 6 1.26 1.15 1.12 1.12 1.68 1.26 1.1
protein-arginine omega-N monomethyltransferase activity 2 1.08 1.15 1.55 1.17 1.64 1.08 1.14
protein-arginine omega-N asymmetric methyltransferase activity 2 1.08 1.15 1.55 1.17 1.64 1.08 1.14
alpha-1,4-N-acetylgalactosaminyltransferase activity 1 3.56 1.12 1.2 1.23 1.49 1.56 1.46
UDP-galactosyltransferase activity 13 -1.53 1.04 1.17 1.15 1.2 -1.26 -1.01
UDP-glucosyltransferase activity 10 1.76 -1.24 -1.02 -1.41 1.08 1.69 1.09
steroid hormone receptor binding 2 1.48 1.23 1.51 1.28 1.77 1.32 1.19
genital disc sexually dimorphic development 5 1.78 1.05 1.16 -1.11 -1.05 -1.07 1.31
multicellular organism growth 3 1.09 1.05 1.05 -1.19 -1.03 1.35 1.92
NuA4 histone acetyltransferase complex 5 1.44 1.1 1.23 1.2 1.27 1.53 -1.03
protein mannosylation 2 1.57 1.01 1.07 -1.18 -1.11 1.61 1.23
protein O-linked mannosylation 2 1.57 1.01 1.07 -1.18 -1.11 1.61 1.23
miRNA loading onto RISC involved in gene silencing by miRNA 1 1.78 1.14 -1.44 1.08 1.0 3.89 1.83
central nervous system segmentation 4 -1.45 -1.33 2.24 -1.39 -1.52 -1.44 -1.38
brain segmentation 4 -1.45 -1.33 2.24 -1.39 -1.52 -1.44 -1.38
appendage segmentation 20 -1.29 1.07 -1.1 -1.14 1.65 1.34 1.29
imaginal disc-derived leg segmentation 20 -1.29 1.07 -1.1 -1.14 1.65 1.34 1.29
regulation of tube diameter 12 2.01 1.03 1.06 -1.16 1.02 1.94 1.48
regulation of Malpighian tubule size 4 1.53 1.16 1.13 -1.02 1.37 1.52 1.41
Hedgehog signaling complex 4 2.07 1.18 1.21 1.01 1.19 2.13 1.37
negative regulation of dephosphorylation 4 1.52 1.1 1.03 1.13 1.22 1.28 1.01
negative regulation of protein dephosphorylation 4 1.52 1.1 1.03 1.13 1.22 1.28 1.01
wing and notum subfield formation 12 1.93 -1.1 1.05 -1.1 1.08 1.14 1.87
notum cell fate specification 4 1.88 -1.36 -1.26 -1.21 1.01 1.16 3.54
wing cell fate specification 3 -1.07 1.05 1.06 -1.14 1.2 -1.05 2.07
imaginal disc-derived wing hair outgrowth 1 -2.13 1.07 2.17 -1.03 1.35 -1.42 -1.02
imaginal disc-derived wing hair site selection 3 1.72 -1.01 1.03 -1.08 1.97 1.34 1.24
maintenance of imaginal disc-derived wing hair orientation 3 1.52 1.13 1.79 1.02 1.81 2.37 1.98
male germline ring canal 3 -1.27 1.18 1.18 1.26 1.55 -1.01 1.01
female germline ring canal 3 1.66 1.08 -1.16 1.04 1.18 1.57 1.3
transcriptionally silent chromatin 1 1.82 1.17 1.65 -1.11 1.49 1.95 1.38
regulation of hippo signaling cascade 2 3.69 1.25 1.96 -1.14 1.8 2.24 2.45
negative regulation of hippo signaling cascade 1 3.54 1.08 1.48 -1.26 1.42 1.25 1.69
fatty-acyl-CoA metabolic process 4 1.86 1.19 1.27 1.15 1.54 1.19 1.01
microtubule plus end 2 1.59 1.18 1.94 -1.04 1.66 1.95 1.8
thioester metabolic process 6 2.01 1.03 1.27 1.12 1.42 1.33 1.06
thioester biosynthetic process 5 2.3 1.04 1.28 1.15 1.53 1.22 1.09
Roundabout signaling pathway 2 1.81 1.11 1.52 1.11 1.43 1.62 1.25
regulation of Roundabout signaling pathway 1 1.04 1.02 -1.06 1.23 1.3 3.59 1.24
protein localization to synapse 1 1.3 1.23 1.1 1.08 1.16 2.99 1.24
phosphate ion transmembrane transport 4 -1.25 -1.17 -1.77 -1.14 -1.01 2.78 -1.28
maintenance of protein localization in endoplasmic reticulum 3 -1.9 1.28 -1.09 1.08 -1.19 -2.08 1.34
regulation of chromatin binding 3 -1.0 1.07 1.16 1.27 1.61 -1.41 -1.14
non-canonical Wnt receptor signaling pathway 6 1.09 -1.01 1.23 -1.1 1.27 1.47 1.72
establishment of protein localization in extracellular region 1 1.79 1.14 -1.18 1.07 1.25 -5.71 1.37
positive regulation of Wnt receptor signaling pathway by establishment of Wnt protein localization in extracellular region 1 1.79 1.14 -1.18 1.07 1.25 -5.71 1.37
protein deacylation 11 1.53 1.15 1.12 1.23 1.27 1.36 1.13
RNA stem-loop binding 2 1.54 -1.06 1.11 1.22 1.17 1.23 -1.02
snRNA stem-loop binding 1 1.41 -1.11 1.3 1.34 1.31 1.54 -1.14
ceramide transporter activity 1 -2.39 1.47 1.51 1.07 -1.25 -2.16 1.24
ER to Golgi ceramide transport 1 -2.39 1.47 1.51 1.07 -1.25 -2.16 1.24
juvenile hormone mediated signaling pathway 3 -1.19 1.31 1.42 1.17 1.93 1.0 1.17
ceramide transport 1 -2.39 1.47 1.51 1.07 -1.25 -2.16 1.24
maintenance of blood-brain barrier 1 7.29 -3.52 -1.24 -1.54 -1.02 7.02 -1.25
exploration behavior 1 3.78 1.32 1.35 -1.13 1.11 1.73 1.58
locomotory exploration behavior 1 3.78 1.32 1.35 -1.13 1.11 1.73 1.58
oligopeptide transmembrane transporter activity 3 1.69 -1.17 -1.51 -1.15 -1.07 1.17 1.2
cell proliferation involved in compound eye morphogenesis 1 -1.2 1.15 1.53 1.19 1.27 1.15 1.24
ribonucleoprotein granule 26 1.39 1.14 1.33 1.09 1.3 1.57 1.15
ubiquitin-specific protease activator activity 1 1.14 1.09 1.34 -1.05 1.24 1.35 2.12
response to topologically incorrect protein 2 1.04 1.38 1.16 -1.1 1.05 1.03 1.56
peptidyl-threonine dephosphorylation 1 1.22 1.23 -1.22 1.31 1.05 -1.8 -1.36
endodermal cell differentiation 1 8.12 -1.58 1.44 -1.54 1.01 1.69 1.21
pre-mRNA binding 1 1.28 1.07 1.73 1.12 1.48 1.94 1.41
limb joint morphogenesis 8 -2.19 1.03 -1.69 -1.64 2.1 1.1 1.32
filtration diaphragm 3 -3.44 1.01 1.01 1.15 1.01 -2.84 -1.29
muscle cell chemotaxis toward tendon cell 1 1.49 1.07 1.15 1.04 -1.03 1.53 -1.09
presynaptic periactive zone 2 1.13 1.16 1.42 1.03 1.54 1.68 1.68
N-glycan fucosylation 1 -1.64 1.12 -1.15 1.5 1.42 -1.98 -1.63
GDP-fucose import into Golgi lumen 1 -1.64 1.12 -1.15 1.5 1.42 -1.98 -1.63
fatty acid beta-oxidation multienzyme complex 2 2.42 1.07 -1.08 1.02 1.26 1.66 -1.08
peptide bond cleavage involved in epidermal growth factor receptor ligand maturation 1 -1.2 -1.0 -1.26 -1.23 1.12 -1.78 1.11
netrin-activated signaling pathway 1 -10.89 1.57 1.23 -1.08 -1.19 -6.39 1.44
termination of G-protein coupled receptor signaling pathway 9 1.61 1.14 1.6 1.12 1.38 1.47 1.34
chitin-based cuticle attachment to epithelium 3 6.48 -1.33 -1.2 -1.65 -1.09 5.63 1.91
protein-based cuticle attachment to epithelium 12 1.66 -1.21 -1.1 -1.18 -1.09 1.51 1.5
regulation of locomotion 16 1.62 -1.06 1.25 -1.04 1.18 1.21 1.39
negative regulation of locomotion 2 2.1 1.1 1.42 -1.08 1.39 1.72 1.26
negative regulation of multicellular organism growth 4 1.6 1.06 1.17 -1.17 1.27 2.71 1.48
embryonic cleavage 4 1.73 1.15 1.27 1.05 1.09 1.55 1.23
snRNA modification 2 -1.23 1.23 1.84 1.26 1.56 -1.27 1.05
regulation of fibroblast growth factor receptor signaling pathway 2 -1.9 1.49 1.19 1.1 1.08 -1.77 1.19
negative regulation of fibroblast growth factor receptor signaling pathway 2 -1.9 1.49 1.19 1.1 1.08 -1.77 1.19
thermosensory behavior 6 1.6 -1.4 -1.4 -1.32 -1.22 1.3 1.62
epithelial fluid transport 9 1.44 -1.07 -1.0 -1.13 1.2 1.6 1.1
cellular acyl-CoA homeostasis 6 -3.11 -1.44 -2.62 1.15 1.36 -3.71 -1.6
long-term strengthening of neuromuscular junction 2 -1.81 1.29 2.08 -1.04 1.39 1.52 1.29
gliogenesis 57 1.43 -1.08 1.21 -1.07 1.26 1.62 1.2
glial cell growth 6 -1.14 -1.15 -1.08 -1.34 1.14 2.33 1.04
perineurial glial growth 6 -1.14 -1.15 -1.08 -1.34 1.14 2.33 1.04
maintenance of oocyte nucleus location involved in oocyte dorsal/ventral axis specification 1 1.08 1.36 1.49 -1.03 1.39 1.74 1.47
leucokinin receptor activity 1 1.19 -1.18 -1.07 -1.08 2.45 1.28 2.37
cell migration involved in gastrulation 8 1.53 -1.02 1.51 -1.06 1.32 1.72 1.01
macrophage activation 1 2.18 -2.11 2.19 1.49 1.48 1.37 1.38
fructose 1,6-bisphosphate 1-phosphatase activity 1 6.67 1.2 1.32 -2.53 -1.76 2.31 2.31
neurotransmitter metabolic process 6 -1.15 1.13 -1.61 -1.13 -1.28 -2.46 1.45
neurotransmitter catabolic process 2 -1.99 1.48 -3.26 -1.27 -2.14 -11.86 3.38
retrograde transport, endosome to Golgi 2 -1.61 1.37 1.68 1.0 1.09 1.3 1.14
lipoprotein catabolic process 2 2.75 1.12 1.29 1.19 1.61 1.16 1.22
SH2 domain binding 4 1.97 -1.06 1.04 -1.03 1.04 1.79 1.15
lysophosphatidic acid acyltransferase activity 1 1.37 1.22 1.4 1.12 1.37 1.84 1.71
xenobiotic catabolic process 4 -1.27 -1.2 -4.97 -1.06 -1.84 -3.14 1.18
ketone biosynthetic process 12 1.31 -1.17 -1.03 -1.07 1.06 1.52 1.13
response to cocaine 13 1.28 1.17 1.57 1.07 1.39 1.83 1.27
maintenance of polarity of follicular epithelium 2 -2.09 1.21 1.5 1.33 2.17 -1.63 -1.29
establishment of planar polarity of embryonic epithelium 1 -2.32 1.45 1.45 1.19 1.32 -1.02 1.2
maintenance of polarity of embryonic epithelium 1 1.75 -1.09 1.21 -1.06 -1.12 -1.14 -1.06
neuropeptide F receptor activity 1 -1.53 -1.53 2.77 -1.11 -1.08 -1.73 1.51
ribosomal large subunit biogenesis 1 1.48 1.28 1.8 1.26 1.7 1.35 1.33
host cell surface receptor binding 1 2.63 -1.41 1.69 -1.89 -1.48 14.61 -1.02
sphingolipid delta-4 desaturase activity 1 -6.62 1.41 1.16 1.17 1.23 -3.29 -1.25
negative regulation of protein import into nucleus 5 2.19 1.12 1.26 1.06 1.21 2.05 1.7
penicillin metabolic process 1 -1.31 -1.76 1.72 1.22 1.97 3.11 1.28
penicillin biosynthetic process 1 -1.31 -1.76 1.72 1.22 1.97 3.11 1.28
negative regulation of phosphorylation 4 1.29 -1.03 1.47 -1.02 1.17 1.39 1.53
positive regulation of phosphorylation 8 1.51 1.21 1.82 1.05 1.45 2.01 1.56
regulation of NF-kappaB import into nucleus 1 1.41 1.35 1.47 1.02 1.54 2.41 1.84
positive regulation of NF-kappaB import into nucleus 1 1.41 1.35 1.47 1.02 1.54 2.41 1.84
GDP-L-fucose biosynthetic process 2 -1.67 1.21 1.13 1.24 1.36 -1.89 -1.14
'de novo' GDP-L-fucose biosynthetic process 2 -1.67 1.21 1.13 1.24 1.36 -1.89 -1.14
fucose biosynthetic process 2 -1.67 1.21 1.13 1.24 1.36 -1.89 -1.14
L-fucose metabolic process 2 -1.67 1.21 1.13 1.24 1.36 -1.89 -1.14
thiamine diphosphate metabolic process 1 1.06 1.62 -1.26 1.22 -1.14 -1.11 1.12
water-soluble vitamin biosynthetic process 7 1.81 1.34 -1.5 -1.06 -1.3 1.43 1.2
vitamin K biosynthetic process 1 1.46 1.06 1.55 -1.07 1.35 1.82 1.43
vitamin K metabolic process 1 1.46 1.06 1.55 -1.07 1.35 1.82 1.43
hemolymph coagulation 4 2.28 -1.81 -1.98 -1.93 -1.56 2.0 -1.05
sarcolemma 1 1.33 1.32 2.26 1.11 1.52 1.39 1.48
plasmatocyte differentiation 4 1.61 1.03 1.11 -1.07 1.04 1.16 1.15
regulation of membrane potential 25 1.35 1.01 -1.06 -1.33 -1.11 1.68 1.19
cellular biogenic amine catabolic process 5 -1.3 1.11 -1.68 -1.14 -1.45 -2.28 1.45
dopamine biosynthetic process 3 -1.04 -2.12 -1.47 -1.4 -1.53 1.41 2.4
dopamine metabolic process 6 -1.15 -1.33 -1.39 -1.24 -1.48 -1.23 1.83
dopamine catabolic process 1 -8.98 1.77 -2.05 -1.02 -2.08 -14.22 1.22
catecholamine biosynthetic process 3 -1.04 -2.12 -1.47 -1.4 -1.53 1.41 2.4
catecholamine catabolic process 1 -8.98 1.77 -2.05 -1.02 -2.08 -14.22 1.22
choline catabolic process 1 2.27 1.23 -5.17 -1.59 -2.2 -9.9 9.42
serotonin biosynthetic process 3 1.22 -1.67 -1.93 -1.69 -1.72 1.14 2.21
serotonin metabolic process 4 -1.49 -1.27 -1.96 -1.49 -1.8 -1.76 1.9
serotonin catabolic process 1 -8.98 1.77 -2.05 -1.02 -2.08 -14.22 1.22
indole-containing compound biosynthetic process 5 1.73 -1.47 -1.62 -1.41 -1.53 1.76 1.53
indole-containing compound catabolic process 3 -1.86 1.07 -1.41 -1.17 -1.45 -1.76 -1.05
melanin biosynthetic process 4 1.82 -1.08 -1.09 -1.03 -1.18 1.82 -1.13
ethanolamine-containing compound metabolic process 9 -1.03 1.01 -1.15 -1.07 -1.12 -1.49 1.71
hormone biosynthetic process 17 1.38 -1.6 -1.55 -1.49 -1.23 1.24 1.42
hormone catabolic process 5 -1.49 1.14 -1.05 -1.06 -1.26 -2.36 1.19
arginine biosynthetic process via ornithine 1 -15.39 1.51 -7.96 1.39 1.15 -4.77 -1.11
ribonucleoside catabolic process 3 -2.8 1.04 -1.39 1.2 1.32 -1.87 -1.06
positive regulation of eye photoreceptor cell development 1 2.02 1.25 1.56 1.13 1.49 2.5 1.69
benzene-containing compound metabolic process 9 -1.02 -1.18 -1.26 -1.16 -1.28 -1.1 1.52
hyperosmotic salinity response 1 1.22 1.33 2.18 1.07 1.72 2.05 1.61
neuron maturation 19 1.17 -1.01 1.21 1.01 1.4 1.66 1.06
pteridine-containing compound metabolic process 19 1.66 1.0 1.01 1.02 -1.03 1.17 1.15
pteridine-containing compound biosynthetic process 17 1.71 -1.0 -1.01 -1.01 -1.05 1.15 1.18
pteridine-containing compound catabolic process 1 -1.35 1.22 1.7 1.18 1.15 -1.09 1.03
lipid phosphatase activity 2 -1.51 1.0 1.16 1.09 1.56 -1.48 -1.22
microbody 39 1.3 -1.06 -1.53 1.05 1.16 -1.5 -1.16
peptide deformylase activity 2 1.03 1.02 -2.05 1.3 1.27 -1.09 -2.35
behavioral response to starvation 4 -1.14 -2.62 -2.82 -2.72 -3.01 -3.18 1.82
periplasmic space 9 1.87 -1.07 1.01 -1.1 -1.04 1.24 -1.01
cholesterol homeostasis 3 -6.81 -2.38 -1.29 1.48 -2.64 -3.47 -5.64
actomyosin 1 1.76 1.07 1.13 1.08 1.49 1.28 1.15
mitochondrial nucleoid 1 1.18 1.16 1.75 1.38 1.68 1.06 -1.24
regulation of retinal cone cell fate specification 2 -1.43 1.42 1.17 1.08 1.59 -1.55 1.31
compound eye cone cell fate commitment 7 1.02 1.24 1.18 1.18 1.59 1.22 1.33
cardioblast cell fate specification 1 -1.42 1.01 1.2 1.29 2.44 -1.59 1.35
crystal cell differentiation 8 1.09 1.04 1.08 1.05 1.19 1.34 1.82
regulation of crystal cell differentiation 7 1.04 1.03 1.09 1.03 1.17 1.42 1.89
positive regulation of crystal cell differentiation 1 -1.18 -1.04 -1.07 -1.26 1.04 1.06 5.07
muscle cell fate commitment 8 -1.1 -1.16 -1.07 -1.18 -1.07 -1.08 2.39
muscle cell fate specification 3 1.42 1.19 1.29 1.07 1.29 2.0 1.68
ovulation cycle 1 -1.49 2.58 -1.26 -1.23 -1.23 -1.38 1.24
succinate-CoA ligase complex 4 1.26 -1.07 1.22 -1.12 1.17 1.73 -1.33
dosage compensation complex assembly 3 1.47 1.24 1.5 1.08 1.32 1.62 1.47
thiamine-containing compound metabolic process 1 1.06 1.62 -1.26 1.22 -1.14 -1.11 1.12
thiamine-containing compound biosynthetic process 1 1.06 1.62 -1.26 1.22 -1.14 -1.11 1.12
flavin-containing compound metabolic process 2 1.78 2.05 -2.11 -2.16 -2.52 2.14 1.44
flavin-containing compound biosynthetic process 2 1.78 2.05 -2.11 -2.16 -2.52 2.14 1.44
drinking behavior 2 -1.36 -1.02 1.18 1.1 1.66 -1.79 1.09
long-chain fatty acid biosynthetic process 1 12.72 -1.88 -1.16 -3.3 -1.54 3.13 2.87
very long-chain fatty acid biosynthetic process 1 12.72 -1.88 -1.16 -3.3 -1.54 3.13 2.87
nucleosome mobilization 5 1.33 1.2 1.59 1.27 1.63 1.57 1.26
signal transduction in response to DNA damage 9 1.53 1.18 1.1 1.13 1.27 1.31 1.44
DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis 2 1.7 1.37 1.03 1.24 1.62 1.04 1.2
ATP synthesis coupled electron transport 59 1.05 1.03 1.22 1.05 1.09 1.56 -1.33
mitochondrial ATP synthesis coupled electron transport 57 1.06 1.03 1.23 1.05 1.1 1.56 -1.33
tRNA 3'-trailer cleavage 1 1.37 1.18 1.82 1.25 1.62 1.5 1.42
tRNA 3'-end processing 1 1.37 1.18 1.82 1.25 1.62 1.5 1.42
snRNA transcription from RNA polymerase III promoter 3 1.69 1.17 1.43 1.09 1.41 1.27 1.23
tRNA transcription from RNA polymerase III promoter 1 1.67 1.25 1.56 1.07 1.53 1.47 1.26
histone methyltransferase activity (H4-K20 specific) 3 1.11 1.29 1.61 1.13 1.69 1.86 1.45
histone methyltransferase activity (H3-K4 specific) 4 1.72 1.25 1.86 1.03 1.8 2.11 1.88
polo kinase kinase activity 1 1.11 1.2 3.72 1.08 1.65 2.06 2.0
protein homooligomerization 4 1.26 1.29 1.33 1.14 1.48 1.55 1.11
fucose binding 2 1.18 -1.09 -1.2 -1.39 -1.4 -1.1 2.98
pheromone metabolic process 9 1.62 -1.49 -1.71 -1.43 -1.39 1.17 1.34
pheromone biosynthetic process 3 1.42 -3.74 -5.02 -3.4 -2.87 -1.24 2.33
vitamin B6 metabolic process 4 2.09 1.04 -1.32 1.26 1.04 1.32 1.12
vitamin B6 biosynthetic process 4 2.09 1.04 -1.32 1.26 1.04 1.32 1.12
histone deacetylase binding 13 2.66 -1.15 1.12 1.01 1.08 1.67 1.03
peptidoglycan binding 12 -1.13 -1.64 -1.19 -1.04 -1.82 -1.69 -1.29
D-amino acid transport 1 -1.04 -22.78 -24.12 -1.99 7.91 4.55 1.12
D-amino acid transmembrane transporter activity 1 -1.04 -22.78 -24.12 -1.99 7.91 4.55 1.12
glucoside transport 2 1.24 -2.16 -1.19 -2.0 -1.13 3.38 1.3
lipoprotein transport 1 -1.18 2.03 -1.34 -1.0 -1.31 -1.12 -1.14
amyloid precursor protein metabolic process 1 1.02 1.3 1.25 1.11 1.03 1.74 1.33
negative regulation of transcription factor import into nucleus 4 2.74 1.08 1.33 1.02 1.2 2.19 1.75
camera-type eye development 1 -1.1 -1.15 -1.07 -1.18 1.52 1.28 1.24
ribosome binding 6 1.66 1.06 1.42 1.03 1.28 1.53 1.23
ribosomal small subunit binding 1 2.01 1.25 1.56 -1.2 1.13 3.31 1.74
cysteine-type endopeptidase inhibitor activity involved in apoptotic process 1 -1.96 -1.03 2.81 1.35 1.53 -2.84 -1.09
cysteine-type endopeptidase regulator activity involved in apoptotic process 1 -1.96 -1.03 2.81 1.35 1.53 -2.84 -1.09
peptide biosynthetic process 4 -2.1 1.35 -1.25 1.15 -1.28 -1.79 1.11
DNA methylation involved in embryo development 1 1.54 1.07 -1.03 1.11 1.17 1.09 1.04
synaptic cleft 1 3.21 -1.32 1.06 -1.26 1.51 5.17 1.89
amino acid import 4 -2.33 1.09 -2.25 -1.01 1.43 -1.47 -1.72
L-amino acid import 1 -51.3 1.56 -15.93 -1.24 2.78 -3.27 -134.18
cellular metabolic compound salvage 6 1.62 1.11 -1.15 1.11 1.11 1.24 -1.06
regulation of GTP cyclohydrolase I activity 2 6.83 -2.51 -2.16 -2.15 -1.79 -1.27 2.69
amino acid salvage 1 1.92 1.16 1.15 1.28 1.06 2.87 -1.21
receptor metabolic process 7 1.34 -1.03 1.06 -1.07 1.17 1.5 1.02
ubiquitin binding 2 1.76 1.35 1.96 1.2 1.97 1.51 1.56
meiotic spindle stabilization 4 1.18 1.25 1.5 1.11 1.42 1.76 1.44
induction of bacterial agglutination 1 -1.2 -1.21 1.01 1.71 2.04 -1.29 -1.16
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process 2 1.22 -1.04 1.69 -1.06 1.27 -1.09 -1.19
nucleotide salvage 1 8.31 1.05 -1.79 -1.54 -1.19 1.17 2.54
rhythmic excitation 1 9.13 1.03 1.44 -1.07 -1.11 1.07 1.06
P granule 13 1.42 1.03 1.1 1.02 1.09 1.51 -1.01
terminal button 22 1.26 1.08 1.07 -1.18 1.13 1.67 1.31
varicosity 1 -1.06 -1.47 -1.01 -1.23 -1.12 1.54 -1.14
dendritic spine 4 1.47 1.02 1.26 -1.09 1.32 1.72 1.43
response to amino acid stimulus 4 1.59 -1.01 1.38 1.29 1.34 1.2 -1.18
perikaryon 1 -1.51 1.58 1.98 1.08 1.74 1.62 1.22
negative regulation of protein complex disassembly 17 1.02 1.13 1.55 1.04 1.43 1.45 1.22
laminin complex 1 3.52 1.3 1.81 1.23 2.46 6.46 1.6
glutathione binding 1 5.44 1.27 1.83 1.24 1.81 2.29 1.39
apical junction complex 45 1.96 -1.09 1.26 -1.14 1.29 2.5 1.48
apical junction assembly 33 2.06 -1.11 1.37 -1.16 1.26 2.36 1.49
positive regulation of DNA binding 1 2.81 1.45 1.89 1.09 1.48 2.58 1.71
negative regulation of DNA binding 3 1.1 1.28 1.83 1.03 1.28 1.14 1.67
regulation of protein binding 1 1.3 1.31 1.72 1.5 1.61 1.9 1.2
proteoglycan binding 1 3.21 -1.21 1.67 1.12 1.32 6.4 2.23
heparan sulfate proteoglycan binding 1 3.21 -1.21 1.67 1.12 1.32 6.4 2.23
regulation of MAP kinase activity 15 1.26 1.16 1.47 1.13 1.4 1.82 1.2
positive regulation of MAP kinase activity 9 1.14 1.19 1.51 1.11 1.38 1.84 1.15
negative regulation of MAP kinase activity 6 1.46 1.13 1.41 1.17 1.43 1.78 1.28
negative regulation of sequence-specific DNA binding transcription factor activity 4 2.01 1.08 1.16 1.02 1.02 1.35 1.88
cellular alkene metabolic process 1 -1.74 1.11 -2.01 1.51 1.27 -1.87 -1.55
alkene biosynthetic process 1 -1.74 1.11 -2.01 1.51 1.27 -1.87 -1.55
regulation of secondary metabolic process 6 1.65 -1.7 -1.31 -1.28 -1.22 1.14 -1.32
proton-transporting ATP synthase complex assembly 2 1.21 1.11 1.39 1.2 1.21 1.72 -1.33
regulation of ATPase activity 1 -1.06 1.13 1.64 1.31 1.74 1.65 1.23
regulation of generation of precursor metabolites and energy 1 -2.86 1.25 -1.2 1.45 1.26 1.29 -1.32
regulation of RNA stability 2 2.6 1.13 1.81 1.28 1.81 2.02 1.35
regulation of mRNA stability 2 2.6 1.13 1.81 1.28 1.81 2.02 1.35
cell surface binding 17 1.52 -1.27 -1.19 -1.21 -1.12 1.67 1.0
eukaryotic cell surface binding 2 2.1 -1.18 1.11 -1.38 1.18 2.66 3.0
positive regulation of JUN kinase activity 3 -1.04 1.28 1.57 1.15 1.45 1.3 1.45
negative regulation of JUN kinase activity 4 1.5 -1.01 1.32 1.18 1.35 1.51 1.15
regulation of neuron apoptotic process 11 1.33 1.08 1.15 -1.03 1.14 1.6 1.39
negative regulation of neuron apoptotic process 11 1.33 1.08 1.15 -1.03 1.14 1.6 1.39
molybdopterin cofactor binding 1 1.38 1.39 -1.09 1.59 1.39 -1.89 1.34
positive regulation of GTPase activity 5 1.0 1.24 1.63 1.21 1.82 1.58 1.21
regulation of translation in response to stress 4 2.6 -1.22 -1.07 -1.29 1.28 1.91 1.61
regulation of translational initiation in response to stress 4 2.6 -1.22 -1.07 -1.29 1.28 1.91 1.61
Ku70:Ku80 complex 1 1.33 1.54 1.93 1.1 1.72 1.13 1.74
maintenance of DNA repeat elements 2 1.62 -1.0 1.14 1.16 1.41 1.05 -1.1
peroxisomal transport 3 1.5 1.17 -1.6 1.44 1.46 -2.19 -1.64
cellular amide metabolic process 5 -1.4 -1.19 -1.57 -1.07 -1.0 -1.05 -1.49
amide biosynthetic process 3 -2.21 -1.28 -2.94 -1.05 1.16 -1.62 -1.65
cellular amide catabolic process 1 2.85 -1.01 1.16 1.03 -1.08 1.74 -1.1
regulation of DNA-dependent transcription in response to stress 2 -1.52 1.4 1.63 1.11 1.53 1.64 1.52
RNA polyadenylation 17 1.35 1.11 1.23 1.12 1.29 1.65 1.19
axon terminus 26 1.26 1.07 1.08 -1.15 1.13 1.67 1.27
2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity 1 1.92 1.16 1.15 1.28 1.06 2.87 -1.21
2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity 1 1.92 1.16 1.15 1.28 1.06 2.87 -1.21
2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity 1 1.67 1.48 1.35 1.44 1.31 1.18 1.35
dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity 1 1.74 1.44 1.67 1.01 1.35 1.38 1.19
acireductone synthase activity 1 1.92 1.16 1.15 1.28 1.06 2.87 -1.21
negative regulation of multi-organism process 14 1.67 -1.01 1.49 1.13 1.44 1.14 -1.02
positive regulation of multi-organism process 1 8.35 -1.25 -1.3 -1.07 -1.15 1.62 -1.07
regulation of symbiosis, encompassing mutualism through parasitism 7 2.04 -1.02 1.37 1.07 1.52 1.47 1.08
histone H3 acetylation 6 1.33 1.29 1.52 1.18 1.35 1.37 1.35
histone H2A acetylation 1 1.8 1.23 1.54 1.26 1.37 1.4 1.76
histone H3-K9 acetylation 2 1.05 1.43 1.59 1.17 1.33 1.34 1.37
histone H4-R3 methylation 1 1.39 1.1 1.39 1.26 1.71 1.23 1.23
histone acetyltransferase activity (H3-K9 specific) 1 -1.13 1.58 1.91 1.11 1.62 2.4 2.13
H2A histone acetyltransferase activity 1 1.8 1.23 1.54 1.26 1.37 1.4 1.76
histone methyltransferase activity (H4-R3 specific) 1 1.39 1.1 1.39 1.26 1.71 1.23 1.23
cell wall macromolecule metabolic process 9 -1.18 -1.16 -1.42 -1.31 -1.28 -2.35 -1.08
glucan metabolic process 9 2.15 1.01 -1.12 1.0 1.05 2.73 1.34
regulation of endocrine process 2 -1.1 -1.02 1.14 1.0 1.02 1.69 1.12
membrane biogenesis 3 1.33 1.11 1.68 -1.36 1.02 2.57 1.24
modulation of growth of symbiont involved in interaction with host 7 2.04 -1.02 1.37 1.07 1.52 1.47 1.08
negative regulation of growth of symbiont involved in interaction with host 7 2.04 -1.02 1.37 1.07 1.52 1.47 1.08
'de novo' UMP biosynthetic process 1 1.61 1.06 1.09 1.15 1.38 -1.09 1.01
fully spanning plasma membrane 1 -1.09 1.03 1.58 1.01 1.26 -1.16 1.18
cellular lipid catabolic process 27 -1.83 -1.24 -1.62 1.14 1.08 -2.79 -1.74
regulation of multicellular organismal metabolic process 1 1.86 -1.04 1.59 -1.1 2.08 2.71 1.26
cellular polysaccharide catabolic process 1 2.98 -1.08 1.5 -1.31 1.12 4.86 1.33
cellular polysaccharide metabolic process 15 1.66 1.11 1.03 1.05 1.17 1.91 1.35
glycerol ether catabolic process 2 1.6 1.03 -1.14 -1.01 1.9 -1.45 -1.11
cellular carbohydrate catabolic process 39 1.53 1.02 -1.21 -1.06 -1.05 1.4 1.2
neuron projection terminus 26 1.26 1.07 1.08 -1.15 1.13 1.67 1.27
neuron spine 4 1.47 1.02 1.26 -1.09 1.32 1.72 1.43
regulation of transcription involved in anterior/posterior axis specification 2 1.78 1.0 1.2 -1.2 -1.03 1.22 -1.04
dendritic spine head 3 1.62 -1.01 1.32 -1.1 1.45 2.01 1.64
sodium-dependent phosphate transport 1 -51.3 1.56 -15.93 -1.24 2.78 -3.27 -134.18
cellular response to fibroblast growth factor stimulus 10 1.63 -1.12 2.13 -1.03 1.14 1.56 1.09
small conjugating protein ligase binding 9 1.11 1.17 1.66 1.19 1.63 1.3 1.36
small protein conjugating enzyme binding 1 1.42 -1.23 1.7 1.22 1.08 1.57 -1.21
interspecies interaction between organisms 2 1.04 1.05 1.19 -1.29 -1.39 2.64 1.17
extracellular matrix part 13 1.55 -1.17 1.15 -1.23 1.13 2.04 1.39
vacuolar part 30 -1.55 -1.0 1.28 -1.14 -1.08 1.41 -1.12
microbody part 14 1.87 1.14 -1.32 1.28 1.36 -1.33 -1.09
endosomal part 3 -1.2 1.14 1.51 1.07 1.24 1.91 1.43
contractile fiber part 31 2.32 -1.44 -1.08 -1.22 1.23 1.92 -1.17
nuclear membrane part 2 -1.02 -2.05 1.59 1.21 2.03 -1.95 -2.17
mitochondrial membrane part 108 1.14 1.02 1.21 1.03 1.09 1.55 -1.26
external encapsulating structure part 11 1.96 -1.06 1.02 -1.08 -1.01 1.22 1.03
protein targeting to ER 15 -1.21 1.37 -1.05 1.04 -1.19 -1.54 1.26
regulated secretory pathway 1 4.01 -1.11 1.04 -1.06 1.03 1.05 1.13
regulation of viral genome replication 4 1.27 1.23 1.52 1.17 1.6 1.47 1.34
negative regulation of viral genome replication 4 1.27 1.23 1.52 1.17 1.6 1.47 1.34
innate immune response 52 1.72 -1.32 -1.33 -1.27 -1.15 1.39 1.14
regulation of innate immune response 11 2.21 -1.14 1.08 -1.08 1.02 1.67 1.13
positive regulation of innate immune response 5 1.98 -1.06 1.18 -1.06 1.11 1.79 1.28
membrane raft 3 1.56 1.01 1.01 1.02 1.02 1.3 1.71
uridine-diphosphatase activity 1 -1.51 1.28 -1.3 1.09 -1.1 -3.57 1.37
response to copper ion 3 -14.42 1.56 1.38 1.09 -1.89 -6.59 -1.3
myosin II binding 2 -1.98 1.16 2.07 1.03 1.58 -1.28 1.01
neuronal ion channel clustering 1 1.29 -1.71 -1.84 -1.91 -1.32 16.38 -1.61
spectrosome 6 -1.16 1.09 1.81 1.07 1.73 1.26 1.26
basal protein localization 6 -1.45 1.22 1.54 1.08 1.45 -1.08 -1.07
apical part of cell 62 1.31 1.12 1.35 1.0 1.28 1.5 1.32
glutamate synthase activity, NADH or NADPH as acceptor 1 2.14 1.19 1.24 1.03 -1.73 3.68 2.51
zonula adherens assembly 8 -1.0 1.29 1.57 1.09 1.44 1.45 1.58
establishment or maintenance of neuroblast polarity 10 -1.07 1.12 1.77 1.0 1.45 1.54 1.19
establishment of epithelial cell apical/basal polarity 7 1.7 1.04 1.19 -1.07 1.56 1.4 1.47
maintenance of epithelial cell apical/basal polarity 4 1.21 1.16 1.51 1.18 1.38 1.16 1.05
establishment of neuroblast polarity 4 -1.89 1.09 2.72 -1.04 1.73 -1.21 1.17
maintenance of neuroblast polarity 1 1.14 -1.24 1.17 -1.53 1.18 15.9 1.17
sarcomere organization 19 2.14 -1.13 1.26 -1.14 1.25 1.79 -1.0
cell-cell junction organization 45 1.62 -1.06 1.35 -1.1 1.25 1.89 1.32
cell-cell junction maintenance 2 -1.01 1.25 1.94 1.07 1.78 1.99 1.84
zonula adherens maintenance 1 3.86 1.45 2.61 -1.03 2.28 4.0 3.57
tricarboxylic acid cycle enzyme complex 10 1.04 -1.01 1.14 -1.12 -1.04 1.51 -1.27
isocitrate dehydrogenase complex (NAD+) 1 -1.07 1.16 -1.05 -1.13 1.15 1.71 1.06
pyruvate dehydrogenase (lipoamide) phosphatase complex 1 1.97 1.3 1.52 -1.19 1.01 1.99 1.65
proton-transporting ATP synthase complex 19 1.33 1.01 1.2 -1.01 1.12 1.63 -1.2
proton-transporting ATP synthase complex, catalytic core F(1) 9 1.58 -1.04 1.09 -1.06 1.03 1.78 -1.26
proton-transporting ATP synthase, central stalk 1 1.03 1.03 1.17 1.01 1.11 1.58 -1.38
respiratory chain complex I 37 1.15 1.04 1.27 1.07 1.11 1.72 -1.29
luciferin monooxygenase activity 1 2.47 -1.2 -1.84 1.79 2.31 -2.71 -1.43
nuclear mRNA cis splicing, via spliceosome 1 -1.16 -1.03 -1.07 1.26 1.12 -1.31 -1.69
alpha-catenin binding 1 1.17 1.11 1.06 1.15 1.09 1.09 1.68
rhabdomere membrane biogenesis 3 1.33 1.11 1.68 -1.36 1.02 2.57 1.24
positive regulation of compound eye photoreceptor development 1 2.02 1.25 1.56 1.13 1.49 2.5 1.69
equator specification 6 -1.25 -1.43 -1.32 -1.53 -1.4 -1.25 3.26
leukocyte activation 1 2.18 -2.11 2.19 1.49 1.48 1.37 1.38
carnitine biosynthetic process 1 1.3 -1.08 -1.07 -1.13 -1.19 1.96 -1.06
cellular respiration 97 1.02 1.04 1.22 1.01 1.13 1.55 -1.22
clathrin-coated endocytic vesicle 1 -1.65 1.56 1.35 1.0 1.12 1.4 1.32
farnesyl diphosphate biosynthetic process 1 4.21 1.14 2.47 -1.3 1.39 2.06 1.87
farnesyl diphosphate metabolic process 1 4.21 1.14 2.47 -1.3 1.39 2.06 1.87
regulation of nitric oxide biosynthetic process 1 1.39 -1.03 1.89 -1.0 1.66 2.5 1.68
positive regulation of nitric oxide biosynthetic process 1 1.39 -1.03 1.89 -1.0 1.66 2.5 1.68
endothelial cell differentiation 3 1.7 1.01 1.41 -1.21 1.32 4.52 2.14
ecdysteroid metabolic process 15 1.26 -1.14 -1.0 -1.06 1.15 1.51 1.09
ecdysteroid biosynthetic process 12 1.31 -1.17 -1.03 -1.07 1.06 1.52 1.13
R8 cell development 3 1.3 1.12 1.37 1.13 1.55 1.07 1.27
response to ethanol 44 1.51 1.01 1.21 -1.06 1.21 1.25 1.3
behavioral response to ethanol 35 1.52 -1.02 1.16 -1.06 1.28 1.26 1.37
locomotor rhythm 31 1.06 1.1 1.36 -1.15 -1.02 1.63 1.1
regulation of nurse cell apoptotic process 5 1.15 1.23 1.79 1.07 1.35 1.85 1.46
male analia development 2 2.83 1.39 1.21 1.02 1.24 1.39 1.47
female analia development 2 2.83 1.39 1.21 1.02 1.24 1.39 1.47
sevenless signaling pathway 9 1.54 1.11 1.39 1.09 1.39 1.67 1.31
regulation of sevenless signaling pathway 1 -4.89 -1.17 -1.75 -1.1 -1.11 -9.33 -1.59
dynein light chain binding 1 -1.29 1.22 1.62 1.06 1.22 1.25 1.14
dynein intermediate chain binding 2 1.32 -1.03 1.69 1.08 1.5 1.12 -1.03
gibberellin 20-oxidase activity 1 -2.43 -1.01 2.24 -1.36 -1.68 -4.63 2.94
regulation of imaginal disc growth 19 1.56 1.12 1.34 1.06 1.25 1.29 1.24
negative regulation of imaginal disc growth 3 1.85 1.08 1.39 -1.08 1.25 1.14 1.32
negative regulation of hemocyte differentiation 8 1.16 1.08 1.01 -1.03 1.06 1.37 1.55
positive regulation of hemocyte differentiation 1 -1.18 -1.04 -1.07 -1.26 1.04 1.06 5.07
negative regulation of neuron differentiation 5 -1.22 1.17 1.2 1.05 1.31 -1.53 1.09
negative regulation of R7 cell differentiation 1 -4.89 -1.17 -1.75 -1.1 -1.11 -9.33 -1.59
regulation of salivary gland boundary specification 8 1.56 -1.2 -1.1 1.04 1.14 1.2 -1.02
negative regulation of salivary gland boundary specification 8 1.56 -1.2 -1.1 1.04 1.14 1.2 -1.02
positive regulation of protein catabolic process 1 2.44 1.03 1.21 1.16 1.33 1.95 1.23
negative regulation of cyclin-dependent protein kinase activity 1 2.05 1.25 2.19 1.12 2.03 2.13 2.15
positive regulation of epidermal growth factor receptor signaling pathway 8 1.07 1.11 1.54 1.04 1.59 1.25 1.43
positive regulation of S phase of mitotic cell cycle 5 1.47 1.12 1.21 1.09 1.33 1.59 1.23
negative regulation of Toll signaling pathway 3 5.73 -1.65 -1.56 -1.86 -1.27 7.14 1.48
regulation of anti-apoptosis 2 1.05 1.08 1.9 1.35 1.37 -1.31 1.1
positive regulation of cell adhesion 2 1.24 1.07 1.55 1.24 2.26 1.04 1.52
negative regulation of cell size 13 1.4 1.18 1.18 1.0 1.22 1.64 1.25
negative regulation of chromatin assembly or disassembly 1 1.22 1.33 2.18 1.07 1.72 2.05 1.61
positive regulation of eclosion 1 1.76 1.07 1.13 1.08 1.49 1.28 1.15
positive regulation of gene expression, epigenetic 14 1.54 1.18 1.37 1.13 1.35 1.46 1.35
negative regulation of innate immune response 3 3.2 -1.5 -1.25 -1.29 -1.32 1.18 1.06
negative regulation of isoprenoid metabolic process 1 -84.21 -3.59 1.42 2.07 1.14 -58.36 -15.07
negative regulation of lipid metabolic process 2 -18.13 -1.6 1.31 1.68 1.16 -11.26 -4.64
positive regulation of lipid metabolic process 1 -3.9 1.39 1.21 1.36 1.18 -2.17 -1.43
negative regulation of meiosis 1 1.5 1.02 1.68 -1.05 1.78 1.86 1.49
positive regulation of meiosis 1 -1.51 1.58 1.98 1.08 1.74 1.62 1.22
positive regulation of mitosis 2 -1.01 1.03 1.05 1.11 1.69 -1.0 -1.02
positive regulation of mitotic metaphase/anaphase transition 2 -1.01 1.03 1.05 1.11 1.69 -1.0 -1.02
negative regulation of nurse cell apoptotic process 1 1.41 1.35 1.47 1.02 1.54 2.41 1.84
positive regulation of nurse cell apoptotic process 2 1.07 1.35 1.52 1.17 1.22 1.39 1.44
pH reduction 6 -1.56 1.28 1.81 1.0 1.29 1.81 1.32
positive regulation of pole plasm oskar mRNA localization 2 -1.78 1.46 1.88 1.15 2.04 -1.01 1.92
negative regulation of sevenless signaling pathway 1 -4.89 -1.17 -1.75 -1.1 -1.11 -9.33 -1.59
negative regulation of smoothened signaling pathway 15 1.43 1.17 1.37 1.01 1.27 1.9 1.34
positive regulation of smoothened signaling pathway 9 1.35 1.08 1.43 1.16 1.54 1.59 1.09
regulation of RNA polymerase II transcriptional preinitiation complex assembly 3 1.71 1.26 1.41 1.3 1.44 1.38 1.2
positive regulation of translational elongation 1 1.71 1.01 1.01 -1.13 1.21 1.32 1.15
positive regulation of translational termination 1 1.71 1.01 1.01 -1.13 1.21 1.32 1.15
negative regulation of DNA recombination 2 -1.59 1.15 1.13 1.19 1.42 -1.74 -1.31
positive regulation of exocytosis 4 -1.5 1.3 1.55 1.16 1.38 1.25 1.13
negative regulation of juvenile hormone metabolic process 1 -84.21 -3.59 1.42 2.07 1.14 -58.36 -15.07
negative regulation of muscle contraction 1 13.14 -1.35 -1.29 -1.22 -1.17 -1.49 -1.27
positive regulation of phosphate metabolic process 8 1.51 1.21 1.82 1.05 1.45 2.01 1.56
regulation of oskar mRNA translation 12 1.38 1.02 1.27 -1.05 1.15 1.71 1.06
positive regulation of oskar mRNA translation 3 1.65 1.1 1.35 -1.02 1.27 1.67 1.22
ADP metabolic process 2 -1.29 -1.01 -1.04 1.37 1.42 -2.05 -1.57
ATP metabolic process 36 1.35 -1.02 1.24 -1.12 1.07 1.65 -1.08
GMP metabolic process 2 1.15 1.21 1.23 -1.01 1.16 1.11 2.05
IMP metabolic process 7 1.14 1.03 -1.12 -1.04 -1.13 1.95 -1.01
WW domain binding 3 2.14 -1.08 1.3 -1.28 -1.29 2.35 1.56
dTDP metabolic process 1 1.27 1.13 1.91 1.21 1.41 -1.17 -1.08
dUTP metabolic process 1 -1.36 -1.27 1.07 1.7 1.82 -3.47 -2.13
cytidine metabolic process 3 -2.8 1.04 -1.39 1.2 1.32 -1.87 -1.06
nucleobase catabolic process 3 2.92 -1.42 -1.24 -1.35 -1.35 1.45 1.16
guanosine biosynthetic process 2 -1.08 1.07 1.01 1.12 1.08 -1.67 -1.22
queuosine metabolic process 2 -1.08 1.07 1.01 1.12 1.08 -1.67 -1.22
7-methylguanosine biosynthetic process 2 -1.08 1.07 1.01 1.12 1.08 -1.67 -1.22
pyrimidine ribonucleoside catabolic process 3 -2.8 1.04 -1.39 1.2 1.32 -1.87 -1.06
pyrimidine nucleoside catabolic process 3 -2.8 1.04 -1.39 1.2 1.32 -1.87 -1.06
tetrahydrobiopterin metabolic process 4 7.84 -1.48 -1.41 -1.58 -1.23 1.76 2.48
rhodopsin metabolic process 9 -1.72 -1.52 -1.96 1.48 1.03 -1.74 -1.95
heme a metabolic process 1 -1.08 1.29 1.99 1.12 1.3 1.57 -1.3
glycerol-3-phosphate catabolic process 2 1.2 1.12 -1.49 1.16 1.79 -1.21 -1.08
polyol biosynthetic process 1 1.86 -1.46 -1.12 -1.51 1.13 1.83 1.71
polyol catabolic process 3 1.78 -1.48 -2.01 -1.34 1.14 1.58 -1.45
aldehyde catabolic process 1 1.1 -1.81 -2.08 -1.81 -1.6 3.21 -1.83
indolalkylamine catabolic process 3 -1.86 1.07 -1.41 -1.17 -1.45 -1.76 -1.05
indolalkylamine biosynthetic process 3 1.22 -1.67 -1.93 -1.69 -1.72 1.14 2.21
positive regulation of JNK cascade 12 1.07 1.28 1.47 1.07 1.29 1.52 1.25
octopamine metabolic process 2 -2.63 1.33 -1.47 -1.06 -1.42 -3.88 1.1
octopamine catabolic process 1 -8.98 1.77 -2.05 -1.02 -2.08 -14.22 1.22
ethanolamine biosynthetic process 1 1.07 -1.05 2.34 1.23 1.45 3.99 1.1
phosphatidylethanolamine metabolic process 1 1.07 -1.05 2.34 1.23 1.45 3.99 1.1
diacylglycerol metabolic process 3 1.83 -1.12 1.21 -1.09 1.79 -1.71 -1.19
CDP-diacylglycerol metabolic process 1 3.07 1.1 2.07 -1.42 3.13 -1.11 1.4
disaccharide biosynthetic process 3 3.57 -2.83 -2.37 -2.36 -1.16 5.45 -1.46
acetyl-CoA catabolic process 36 -1.0 1.09 1.26 -1.05 1.07 1.52 -1.04
monosaccharide catabolic process 33 1.52 1.06 -1.18 -1.03 -1.06 1.37 1.2
GDP-L-fucose metabolic process 2 -1.67 1.21 1.13 1.24 1.36 -1.89 -1.14
negative regulation of JAK-STAT cascade 5 -1.37 1.15 1.03 1.03 1.17 -1.54 1.05
organophosphate catabolic process 4 2.25 1.02 1.6 1.03 1.46 1.59 1.17
icosanoid biosynthetic process 1 -1.74 1.11 -2.01 1.51 1.27 -1.87 -1.55
neutral lipid biosynthetic process 3 2.65 1.06 2.5 -1.19 1.69 1.64 1.56
neutral lipid catabolic process 2 1.6 1.03 -1.14 -1.01 1.9 -1.45 -1.11
acylglycerol biosynthetic process 3 2.65 1.06 2.5 -1.19 1.69 1.64 1.56
acylglycerol catabolic process 2 1.6 1.03 -1.14 -1.01 1.9 -1.45 -1.11
membrane lipid catabolic process 7 -6.83 -3.3 -2.99 1.5 -1.08 -6.52 -5.81
membrane lipid biosynthetic process 10 -1.24 1.25 1.26 1.0 1.07 -1.27 1.5
phosphatidylcholine metabolic process 2 -1.14 1.06 1.34 1.11 -1.05 -1.18 1.93
phosphatidylglycerol metabolic process 1 -3.36 1.4 1.32 1.25 1.35 -2.25 1.21
phosphatidic acid metabolic process 1 -3.17 -1.24 -2.56 1.51 2.33 -10.59 -5.09
ether lipid metabolic process 1 5.42 -21.99 -24.45 -20.82 -3.99 -1.47 6.54
glyoxylate metabolic process 2 1.28 -1.08 -1.85 -1.68 -1.27 1.71 -1.21
nicotinamide nucleotide metabolic process 11 1.88 1.17 -1.48 -1.05 1.08 1.25 1.36
nicotinate nucleotide metabolic process 1 8.31 1.05 -1.79 -1.54 -1.19 1.17 2.54
S-adenosylmethionine metabolic process 1 1.6 1.05 1.23 -1.23 1.41 1.78 1.98
protoporphyrinogen IX metabolic process 1 1.62 1.26 1.09 -1.07 1.01 1.21 1.32
glycerolipid catabolic process 2 1.6 1.03 -1.14 -1.01 1.9 -1.45 -1.11
glycerol ether biosynthetic process 4 3.17 -2.08 -1.12 -2.44 1.05 1.32 2.23
ceramide biosynthetic process 2 -1.99 1.43 1.45 1.05 1.2 -1.4 -1.17
ceramide catabolic process 3 -3.87 -1.6 -1.06 1.31 -1.04 -6.06 -3.71
sphingoid metabolic process 7 -1.82 -1.06 1.22 1.15 1.12 -2.11 -1.7
sphingoid biosynthetic process 2 -1.99 1.43 1.45 1.05 1.2 -1.4 -1.17
sphingoid catabolic process 3 -3.87 -1.6 -1.06 1.31 -1.04 -6.06 -3.71
xylosylprotein 4-beta-galactosyltransferase activity 1 1.66 1.11 1.34 1.35 1.53 1.06 -1.05
glucosyltransferase activity 13 1.53 -1.16 1.01 -1.3 1.09 1.41 1.06
negative regulation of photoreceptor cell differentiation 5 -1.22 1.17 1.2 1.05 1.31 -1.53 1.09
dosage compensation complex 6 1.37 1.23 1.41 1.11 1.23 1.51 1.37
positive regulation of Ras protein signal transduction 2 1.82 1.14 1.61 1.13 1.83 2.54 1.37
negative regulation of Ras protein signal transduction 7 -1.35 1.4 1.44 1.09 1.53 1.07 1.44
maintenance of pole plasm mRNA location 3 1.53 1.04 1.01 1.11 1.01 -1.06 -1.06
establishment of pole plasm mRNA localization 1 1.48 -1.03 1.16 1.42 1.58 1.23 -1.33
regulation of mitotic centrosome separation 2 -1.01 1.14 1.18 1.02 1.37 1.57 1.31
regulation of centrosome cycle 6 1.2 1.12 1.42 1.02 1.4 1.58 1.19
negative regulation of organ growth 11 1.66 1.23 1.62 1.04 1.47 1.49 1.37
positive regulation of organ growth 11 1.2 1.28 1.51 1.16 1.65 1.9 1.4
sphingolipid transporter activity 1 -2.39 1.47 1.51 1.07 -1.25 -2.16 1.24
sphingolipid binding 1 -2.39 1.47 1.51 1.07 -1.25 -2.16 1.24
regulation of insulin receptor signaling pathway 10 1.25 1.09 1.37 -1.04 1.17 1.16 1.59
negative regulation of insulin receptor signaling pathway 7 1.27 1.12 1.56 -1.01 1.31 1.27 1.5
positive regulation of insulin receptor signaling pathway 2 1.0 -1.0 -1.17 -1.4 -1.23 -1.17 2.26
tetrahydrofolate metabolic process 3 5.63 -2.2 -1.59 -2.04 -1.72 1.86 1.99
tetrahydrofolate biosynthetic process 1 33.5 -5.63 -5.79 -6.03 -4.58 -1.32 6.94
regulation of oviposition 9 -1.14 -1.28 -1.17 -1.58 1.06 -1.04 1.22
dorsal closure, leading edge cell differentiation 5 1.03 1.07 2.19 -1.04 1.49 -1.17 1.24
dorsal closure, amnioserosa morphology change 10 1.22 1.15 1.79 1.05 1.63 1.42 1.38
amnioserosa maintenance 5 -1.1 1.14 1.38 1.06 1.23 -1.08 1.88
negative regulation of retinal cell programmed cell death 7 1.19 -1.06 1.77 -1.01 1.35 1.16 1.21
negative regulation of compound eye retinal cell programmed cell death 7 1.19 -1.06 1.77 -1.01 1.35 1.16 1.21
induction of retinal programmed cell death 1 1.68 -1.09 1.22 1.16 1.11 1.33 1.07
induction of compound eye retinal cell programmed cell death 1 1.68 -1.09 1.22 1.16 1.11 1.33 1.07
sperm storage 8 1.66 -1.63 -1.61 -1.67 -1.3 1.96 -1.5
insecticide catabolic process 4 -1.27 -1.2 -4.97 -1.06 -1.84 -3.14 1.18
galactoside 6-L-fucosyltransferase activity 1 1.63 1.17 -1.53 -1.05 -1.49 4.17 1.53
muscle cell homeostasis 8 1.75 -1.12 1.33 -1.09 1.16 1.67 -1.03
viral entry into host cell 2 1.04 1.05 1.19 -1.29 -1.39 2.64 1.17
host cell surface binding 1 2.63 -1.41 1.69 -1.89 -1.48 14.61 -1.02
negative regulation of nucleocytoplasmic transport 6 2.03 1.13 1.29 1.08 1.28 1.86 1.59
regulation of protein export from nucleus 1 1.39 1.22 1.43 1.19 1.67 1.14 1.14
negative regulation of protein export from nucleus 1 1.39 1.22 1.43 1.19 1.67 1.14 1.14
lipid phosphorylation 22 1.41 1.06 1.08 -1.0 1.3 1.56 1.24
glycolipid transport 1 -2.99 1.35 -1.24 1.41 -1.1 -2.55 -1.06
phosphorylated carbohydrate dephosphorylation 3 2.42 1.04 1.61 -1.01 1.39 1.64 1.29
branched duct epithelial cell fate determination, open tracheal system 8 2.56 -1.13 -1.03 -1.23 1.24 1.31 1.76
filopodium assembly 7 1.05 1.06 1.31 1.03 1.18 1.91 1.22
phosphatidylinositol phosphorylation 22 1.41 1.06 1.08 -1.0 1.3 1.56 1.24
inositol phosphate dephosphorylation 3 2.42 1.04 1.61 -1.01 1.39 1.64 1.29
isoprenoid transport 1 -6.48 -6.48 -8.02 2.81 1.04 -8.53 -8.65
terpenoid transport 1 -6.48 -6.48 -8.02 2.81 1.04 -8.53 -8.65
tetraterpenoid transport 1 -6.48 -6.48 -8.02 2.81 1.04 -8.53 -8.65
carotenoid transport 1 -6.48 -6.48 -8.02 2.81 1.04 -8.53 -8.65
regulation of hormone biosynthetic process 2 -8.29 -1.83 1.21 1.4 1.08 -7.35 -3.84
regulation of lipid biosynthetic process 6 -3.09 -1.16 1.01 1.27 1.37 -3.44 -2.07
nucleoside triphosphate adenylate kinase activity 1 -1.71 -1.23 1.26 1.63 1.63 -3.14 -2.07
tetrahydrofolylpolyglutamate metabolic process 1 -2.47 1.42 -1.59 1.58 -1.34 -2.64 -1.65
tetrahydrofolylpolyglutamate biosynthetic process 1 -2.47 1.42 -1.59 1.58 -1.34 -2.64 -1.65
regulation of mitochondrial membrane permeability 1 3.39 -1.48 1.02 -1.33 1.2 1.81 1.97
alpha-(1->3)-fucosyltransferase activity 4 -1.8 1.18 1.3 1.19 1.58 -1.36 -1.16
alpha-(1->6)-fucosyltransferase activity 1 1.63 1.17 -1.53 -1.05 -1.49 4.17 1.53
peptide-O-fucosyltransferase activity 1 -1.56 -1.04 -1.16 1.31 -1.19 -1.77 -1.4
ER retention sequence binding 1 -1.48 1.27 1.01 1.14 -1.01 -1.37 1.53
carboxylic acid transport 54 -1.28 -1.1 -1.53 -1.18 -1.03 1.07 -1.12
hydroxylysine metabolic process 1 -1.51 -1.6 -1.42 1.8 -1.74 2.0 -2.55
hydroxylysine catabolic process 1 -1.51 -1.6 -1.42 1.8 -1.74 2.0 -2.55
fatty-acyl-CoA biosynthetic process 4 1.86 1.19 1.27 1.15 1.54 1.19 1.01
cellular ketone body metabolic process 1 -1.42 1.61 -1.39 -1.13 -1.97 3.73 -1.22
ketone body catabolic process 1 -1.42 1.61 -1.39 -1.13 -1.97 3.73 -1.22
positive phototaxis 2 1.78 -1.02 1.5 -1.1 1.34 2.13 1.12
negative phototaxis 1 -1.56 1.9 2.35 1.42 1.33 1.03 1.8
nonassociative learning 7 1.25 1.0 1.45 1.14 1.48 1.86 1.46
sensitization 1 1.44 -1.21 -1.33 1.15 1.76 5.15 2.78
3'-phosphoadenosine 5'-phosphosulfate transport 1 1.9 1.27 1.23 1.06 1.26 2.28 1.58
3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity 2 1.45 1.3 1.01 1.18 1.09 1.6 1.46
histone methyltransferase activity (H3-K36 specific) 1 1.08 1.46 1.5 -1.1 1.11 1.44 1.39
beta-1,4-mannosylglycolipid beta-1,3-N-acetylglucosaminyltransferase activity 1 1.3 1.32 1.55 1.56 1.38 -1.43 -1.27
N-acetyllactosamine beta-1,3-glucuronosyltransferase activity 2 -1.0 -1.2 -1.45 -1.61 -1.38 1.39 5.09
asioloorosomucoid beta-1,3-glucuronosyltransferase activity 2 -1.0 -1.2 -1.45 -1.61 -1.38 1.39 5.09
galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity 2 -1.0 -1.2 -1.45 -1.61 -1.38 1.39 5.09
7-beta-hydroxysteroid dehydrogenase (NADP+) activity 1 1.03 -1.04 1.2 -1.01 1.0 2.11 -1.07
testosterone dehydrogenase (NAD+) activity 1 1.03 -1.04 1.2 -1.01 1.0 2.11 -1.07
inositol tetrakisphosphate 5-kinase activity 1 -1.15 1.56 -1.07 1.07 -1.15 -1.25 1.09
glycosylphosphatidylinositol diacylglycerol-lyase activity 2 2.29 1.0 -1.19 -1.05 1.0 1.66 1.76
nucleoside-triphosphate diphosphatase activity 1 -1.36 -1.27 1.07 1.7 1.82 -3.47 -2.13
regulation of response to osmotic stress 1 -6.38 -3.77 -11.1 -5.2 -1.19 28.07 -1.66
vesicle transport along microtubule 1 1.21 1.12 1.66 1.2 1.79 2.51 1.99
mitochondrion transport along microtubule 5 -1.72 1.29 1.54 1.18 1.39 1.16 1.27
3',5'-cyclic-GMP phosphodiesterase activity 5 1.32 1.17 1.39 1.05 1.28 2.17 1.4
alanine-oxo-acid transaminase activity 1 -2.33 1.13 1.14 1.09 1.76 1.77 -1.09
bis(5'-adenosyl)-triphosphatase activity 1 2.29 1.26 1.38 1.23 1.51 1.35 -1.03
cysteamine dioxygenase activity 1 2.58 1.06 1.36 1.25 1.89 1.41 1.2
ecdysone oxidase activity 1 1.11 1.03 -1.05 1.12 4.21 1.26 -1.02
insulin-like growth factor receptor signaling pathway 2 -5.92 1.37 1.08 1.24 1.25 -4.11 -1.32
receptor antagonist activity 2 1.75 1.03 1.01 1.06 1.08 1.1 1.1
mRNA 5'-UTR binding 1 -1.51 1.63 1.29 1.08 1.13 1.32 1.66
heme o metabolic process 1 -1.18 1.24 1.2 1.18 -1.04 1.79 -1.68
heme O biosynthetic process 1 -1.18 1.24 1.2 1.18 -1.04 1.79 -1.68
ubiquinone binding 1 1.51 -1.05 1.4 1.02 1.33 1.88 -1.23
focal adhesion assembly 1 -1.1 -1.15 -1.07 -1.18 1.52 1.28 1.24
R1/R6 development 1 2.43 1.22 1.86 1.12 2.17 2.26 2.36
compound eye corneal lens development 2 2.59 1.11 1.99 1.1 2.05 1.65 1.78
cuticle pigmentation 11 1.56 -1.44 -1.19 -1.25 -1.22 1.2 1.58
sex-specific pigmentation 3 1.97 1.09 1.06 -1.03 1.05 1.06 1.01
compound eye pigmentation 12 1.67 -1.11 -1.16 -1.06 -1.06 -1.02 1.25
regulation of eye pigmentation 5 -1.48 1.1 1.53 1.11 1.49 -1.35 1.53
regulation of compound eye pigmentation 5 -1.48 1.1 1.53 1.11 1.49 -1.35 1.53
adult chitin-containing cuticle pigmentation 5 1.15 -1.36 -1.08 -1.2 -1.43 1.07 1.86
negative regulation of developmental pigmentation 2 2.98 1.16 1.17 1.04 1.29 1.15 1.23
regulation of male pigmentation 1 1.95 -1.01 1.39 -1.03 1.33 1.49 1.42
negative regulation of male pigmentation 1 1.95 -1.01 1.39 -1.03 1.33 1.49 1.42
wing disc anterior/posterior pattern formation 12 1.55 -1.26 -1.12 -1.07 1.12 1.32 -1.04
establishment of body hair or bristle planar orientation 5 2.56 -1.0 1.21 -1.16 1.38 2.42 1.68
establishment of body hair planar orientation 1 1.7 -1.08 -1.05 -1.16 1.03 1.04 1.05
establishment of thoracic bristle planar orientation 2 1.54 1.4 2.06 1.24 1.94 2.07 1.64
male germ-line stem cell division 5 1.44 1.28 1.52 1.25 1.58 1.33 1.36
spermatocyte division 12 1.41 1.22 1.06 1.3 1.57 -1.11 1.0
germ-line cyst encapsulation 10 1.3 1.19 1.37 1.1 1.51 1.67 1.42
female germ-line cyst encapsulation 10 1.3 1.19 1.37 1.1 1.51 1.67 1.42
male germ-line cyst encapsulation 1 2.54 -1.11 -1.09 1.14 1.59 3.23 1.89
germarium-derived cystoblast division 2 -1.06 1.04 1.19 1.36 1.87 -1.4 -1.21
regulation of long-term neuronal synaptic plasticity 1 -1.14 1.2 1.7 1.09 2.04 1.39 1.74
activin receptor complex 2 -1.14 1.57 1.93 1.23 1.67 1.43 1.4
activin binding 2 -1.14 1.57 1.93 1.23 1.67 1.43 1.4
Golgi vesicle budding 1 -2.28 1.35 -1.05 1.06 -1.19 -1.24 1.52
vesicle targeting, to, from or within Golgi 1 -1.49 1.52 1.25 1.12 1.19 1.46 1.78
vesicle targeting, rough ER to cis-Golgi 1 -1.49 1.52 1.25 1.12 1.19 1.46 1.78
COPII vesicle coating 1 -1.49 1.52 1.25 1.12 1.19 1.46 1.78
mitochondrial iron ion transport 1 -1.62 1.12 -1.09 1.38 1.65 -1.57 1.22
lauric acid metabolic process 1 1.6 1.35 -1.72 -1.6 -1.17 -1.33 1.5
flap endonuclease activity 1 2.54 1.11 1.06 1.23 1.48 1.16 -1.04
response to pain 2 1.88 -1.18 1.22 1.16 1.43 1.98 1.19
behavioral response to pain 2 1.88 -1.18 1.22 1.16 1.43 1.98 1.19
vesicle fusion with Golgi apparatus 1 -1.71 1.25 1.03 1.37 1.03 -1.21 1.5
intracellular distribution of mitochondria 3 -1.04 1.59 1.47 1.15 1.39 1.02 1.35
mesoderm morphogenesis 27 1.38 1.0 1.14 -1.07 1.1 1.58 1.18
synaptic vesicle membrane organization 1 -1.53 1.15 2.49 1.01 1.71 1.37 1.07
signal recognition particle 9 -1.25 1.37 1.01 1.14 -1.09 -1.57 1.26
CARD domain binding 1 1.78 1.11 1.56 1.24 1.76 -1.03 1.11
negative regulation of behavior 1 1.49 1.07 1.15 1.04 -1.03 1.53 -1.09
negative regulation of viral reproduction 4 1.27 1.23 1.52 1.17 1.6 1.47 1.34
imaginal disc-derived wing expansion 6 2.01 -1.04 1.17 -1.02 1.2 1.5 1.51
metalloenzyme inhibitor activity 1 8.96 -2.17 1.12 -1.71 -1.16 3.1 2.84
ectodermal digestive tract morphogenesis 4 1.19 1.28 -1.02 1.12 1.64 1.2 1.13
oocyte morphogenesis 1 1.25 1.21 2.24 1.64 2.85 9.21 1.2
positive regulation of muscle organ development 6 2.17 -1.15 1.0 -1.2 1.03 1.63 1.19
muscle organ morphogenesis 4 2.88 -1.16 1.03 -1.17 1.2 1.86 1.03
collateral sprouting 3 -1.12 1.14 1.65 1.16 1.31 -1.01 1.22
collateral sprouting of injured axon 3 -1.12 1.14 1.65 1.16 1.31 -1.01 1.22
axon extension involved in development 6 1.15 1.12 1.61 1.08 1.39 1.07 1.23
response to axon injury 4 -1.08 1.15 1.5 1.12 1.22 -1.04 1.21
sprouting of injured axon 3 -1.12 1.14 1.65 1.16 1.31 -1.01 1.22
proboscis development 6 1.03 1.0 1.19 1.01 1.08 1.14 1.54
epidermis morphogenesis 5 1.0 1.15 1.73 1.35 1.48 1.06 1.17
proboscis morphogenesis 1 -1.31 1.06 2.72 1.23 2.11 1.21 1.47
haltere morphogenesis 1 5.22 -1.53 1.19 1.44 -1.43 -1.39 -1.19
cardiac muscle tissue development 5 1.62 -1.11 1.15 -1.06 1.18 1.57 1.06
compound eye corneal lens morphogenesis 1 2.43 1.22 1.86 1.12 2.17 2.26 2.36
calcium-induced calcium release activity 1 2.63 1.01 1.53 -1.05 1.46 2.52 1.76
antennal joint morphogenesis 1 1.21 1.22 1.16 1.1 1.2 1.57 1.03
notum morphogenesis 4 -1.53 1.03 1.15 1.08 1.29 -1.65 -1.02
imaginal disc-derived female genitalia morphogenesis 1 1.36 1.32 2.03 1.27 1.67 1.42 1.61
female genitalia morphogenesis 1 1.36 1.32 2.03 1.27 1.67 1.42 1.61
multicellular organismal homeostasis 22 1.28 -1.0 1.13 -1.11 1.22 1.43 1.52
peripheral nervous system neuron differentiation 5 1.37 -1.05 1.2 -1.12 1.36 2.17 1.48
peripheral nervous system neuron development 5 1.37 -1.05 1.2 -1.12 1.36 2.17 1.48
inositol oxygenase activity 1 3.92 -4.04 -3.69 -3.19 -2.14 5.76 -2.59
NADH dehydrogenase (quinone) activity 30 1.12 1.03 1.27 1.07 1.1 1.73 -1.3
rhodopsin kinase activity 1 2.38 1.14 1.51 1.03 1.36 1.67 1.26
sphingomyelin phosphodiesterase D activity 1 -1.04 1.38 1.42 1.29 1.65 1.05 1.22
sugar-phosphatase activity 3 1.95 -1.01 1.52 -1.38 -1.21 1.92 1.24
tau-protein kinase activity 1 1.73 1.2 1.66 1.31 1.35 4.88 1.77
testosterone 17-beta-dehydrogenase (NAD+) activity 1 1.03 -1.04 1.2 -1.01 1.0 2.11 -1.07
trimethyllysine dioxygenase activity 1 1.3 -1.08 -1.07 -1.13 -1.19 1.96 -1.06
glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity 2 1.46 1.48 1.74 1.25 2.09 1.65 1.44
N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity 2 1.46 1.48 1.74 1.25 2.09 1.65 1.44
glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity 3 2.47 -1.53 -1.66 -1.5 -1.37 1.3 1.19
oxidoreductase activity, acting on NADH or NADPH, oxygen as acceptor 1 2.71 -1.01 1.01 -1.06 -1.03 2.12 1.84
regulation of epithelial cell proliferation 2 1.23 1.09 1.59 1.34 1.35 -1.03 -1.14
negative regulation of mRNA processing 4 1.46 1.2 1.32 1.17 1.27 1.62 1.09
regulation of defense response to virus 2 1.7 1.18 1.38 1.15 1.21 1.1 1.08
regulation of peptidyl-tyrosine phosphorylation 3 1.04 1.16 1.54 1.06 1.26 1.21 1.03
negative regulation of peptidyl-tyrosine phosphorylation 2 -1.04 1.11 1.79 -1.0 1.29 1.24 1.01
low-density lipoprotein particle receptor binding 1 3.66 -1.09 1.54 -1.1 1.65 2.15 1.33
regulation of phagocytosis 1 2.18 -2.11 2.19 1.49 1.48 1.37 1.38
negative regulation of axonogenesis 5 -1.24 1.29 1.61 1.16 1.56 -1.15 1.13
negative regulation of dendrite morphogenesis 5 1.32 1.12 1.2 -1.01 1.18 1.31 1.53
positive regulation of dendrite morphogenesis 1 1.25 1.26 1.64 1.09 1.9 1.54 1.83
negative regulation of immune response 7 1.96 -1.13 1.13 -1.03 1.24 1.15 1.14
positive regulation of immune response 6 1.81 1.02 1.25 1.0 1.15 1.79 1.27
regulation of viral reproduction 4 1.27 1.23 1.52 1.17 1.6 1.47 1.34
thymidylate synthase (FAD) activity 1 1.78 1.14 -1.44 1.08 1.0 3.89 1.83
circadian sleep/wake cycle, sleep 1 -1.57 1.18 1.13 1.01 1.08 -1.1 1.28
positive regulation of synaptic transmission 2 -1.81 1.29 2.08 -1.04 1.39 1.52 1.29
coagulation 5 1.95 -1.51 -1.67 -1.6 -1.41 1.79 -1.02
multicellular organismal movement 2 -1.89 -1.52 -1.42 -1.43 -1.62 -1.61 2.67
musculoskeletal movement 2 -1.89 -1.52 -1.42 -1.43 -1.62 -1.61 2.67
cobalt ion binding 1 2.85 -1.01 1.16 1.03 -1.08 1.74 -1.1
neuromuscular process 14 1.16 1.16 1.49 1.02 1.5 1.39 1.36
sensory perception of bitter taste 2 -1.31 -1.2 -1.22 -1.24 3.17 1.22 -1.17
positive chemotaxis 5 1.16 -1.25 1.29 -1.0 1.37 2.36 -1.31
negative chemotaxis 4 -1.03 -1.01 1.19 1.16 1.89 -1.4 -1.09
negative regulation of chemotaxis 1 1.49 1.07 1.15 1.04 -1.03 1.53 -1.09
pigment cell differentiation 1 1.43 1.13 3.64 1.22 1.75 1.43 1.9
magnetoreception 1 1.37 -1.11 -1.04 1.15 1.03 2.71 1.13
detection of mechanical stimulus involved in sensory perception 3 1.34 -1.14 1.07 -1.03 1.11 1.5 1.37
detection of light stimulus involved in magnetoreception 1 1.37 -1.11 -1.04 1.15 1.03 2.71 1.13
detection of mechanical stimulus 3 1.34 -1.14 1.07 -1.03 1.11 1.5 1.37
regulation of lipid catabolic process 1 -3.9 1.39 1.21 1.36 1.18 -2.17 -1.43
negative regulation of lipid catabolic process 1 -3.9 1.39 1.21 1.36 1.18 -2.17 -1.43
regulation of nitric-oxide synthase activity 1 1.08 1.16 -1.5 1.55 1.01 -2.04 -1.2
negative regulation of nitric-oxide synthase activity 1 1.08 1.16 -1.5 1.55 1.01 -2.04 -1.2
microtubule plus-end binding 1 1.58 -1.1 -1.13 -1.09 -1.05 -1.25 1.03
microtubule minus-end binding 3 2.17 1.08 1.62 1.15 1.7 2.3 1.31
GTPase binding 33 1.09 1.2 1.54 1.1 1.4 1.28 1.4
snRNA transport 2 1.9 1.18 1.33 1.29 1.62 1.23 1.13
tRNA transport 1 1.48 1.1 1.33 1.32 1.54 -1.18 -1.04
negative regulation of transport 13 1.41 1.11 1.22 1.06 1.16 1.64 1.33
negative regulation of lipid biosynthetic process 1 -84.21 -3.59 1.42 2.07 1.14 -58.36 -15.07
positive regulation of small GTPase mediated signal transduction 2 1.82 1.14 1.61 1.13 1.83 2.54 1.37
negative regulation of small GTPase mediated signal transduction 7 -1.35 1.4 1.44 1.09 1.53 1.07 1.44
protein tetramerization 3 1.61 1.24 1.33 1.08 1.47 1.59 1.11
positive regulation of sequence-specific DNA binding transcription factor activity 8 1.24 1.17 1.52 1.19 1.56 1.5 1.11
positive regulation of NF-kappaB transcription factor activity 2 1.33 1.09 1.29 1.43 1.67 1.2 -1.13
positive regulation of binding 1 2.81 1.45 1.89 1.09 1.48 2.58 1.71
negative regulation of binding 3 1.1 1.28 1.83 1.03 1.28 1.14 1.67
regulation of DNA binding 7 1.27 1.36 1.52 1.13 1.3 1.15 1.52
DNA ligation involved in DNA repair 2 1.6 1.14 1.36 1.04 1.35 1.44 1.13
synaptic growth at neuromuscular junction 18 1.09 1.23 1.45 1.08 1.28 1.56 1.28
coenzyme transporter activity 1 -1.28 1.24 -1.24 1.18 -1.13 -1.69 1.59
cofactor catabolic process 38 1.01 1.1 1.28 -1.04 1.08 1.52 -1.03
cofactor biosynthetic process 53 1.51 1.12 1.11 1.08 1.1 1.22 1.09
protein insertion into membrane 2 -1.2 1.31 1.29 1.27 1.21 1.76 -1.19
release of sequestered calcium ion into cytosol 1 2.52 1.29 3.07 -1.16 1.37 5.13 2.97
cytoplasmic sequestering of protein 4 2.74 1.08 1.33 1.02 1.2 2.19 1.75
negative regulation of protein transport 8 1.65 1.12 1.19 1.05 1.14 1.51 1.37
maintenance of RNA location 3 1.53 1.04 1.01 1.11 1.01 -1.06 -1.06
protein oligomerization 7 1.05 1.23 1.4 1.02 1.36 1.37 1.51
regulation of cellular component movement 12 1.86 -1.05 1.08 -1.07 1.19 1.24 1.56
negative regulation of cellular component movement 2 2.1 1.1 1.42 -1.08 1.39 1.72 1.26
regulation of sequestering of calcium ion 2 1.38 1.1 1.6 1.13 1.03 2.02 1.52
negative regulation of sequestering of calcium ion 2 1.38 1.1 1.6 1.13 1.03 2.02 1.52
cell tip 1 3.87 -1.1 1.38 1.1 2.2 1.95 1.38
protein homotetramerization 2 1.92 1.2 1.42 1.06 1.79 1.71 1.14
establishment of meiotic spindle orientation 1 1.58 -1.1 -1.13 -1.09 -1.05 -1.25 1.03
mitotic sister chromatid separation 5 1.35 1.08 1.24 1.1 1.53 1.17 1.04
attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation 1 -1.05 1.32 1.38 -1.11 1.3 2.36 1.79
G1 phase 2 1.34 1.36 1.26 1.22 1.44 1.51 1.45
G2 phase 1 1.67 1.26 1.32 1.4 1.23 1.13 1.21
prophase 3 1.29 1.04 1.3 -1.01 1.37 1.56 1.26
telophase 1 1.4 1.02 1.15 1.14 1.72 -1.18 -1.16
interphase of meiotic cell cycle 1 1.43 -1.05 1.72 1.27 1.65 1.43 -1.28
S phase of meiotic cell cycle 1 1.43 -1.05 1.72 1.27 1.65 1.43 -1.28
regulation of oxidoreductase activity 2 1.57 1.18 -1.18 1.24 1.17 1.04 1.44
negative regulation of transferase activity 12 1.53 1.14 1.46 1.09 1.41 1.69 1.32
positive regulation of ligase activity 2 -1.3 1.19 -1.18 1.16 -1.1 -2.07 -1.12
negative regulation of ligase activity 1 1.67 1.26 1.32 1.4 1.23 1.13 1.21
positive regulation of oxidoreductase activity 1 2.28 1.19 1.07 -1.0 1.37 2.2 2.5
negative regulation of oxidoreductase activity 1 1.08 1.16 -1.5 1.55 1.01 -2.04 -1.2
neuron apoptotic process 2 -1.07 1.32 1.73 -1.0 -1.14 1.12 1.39
stress-activated MAPK cascade 26 -1.01 1.14 1.45 1.09 1.5 1.22 1.4
peptide hormone receptor binding 1 2.14 -13.11 -13.63 -12.76 -16.87 -14.38 5.61
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle 1 1.67 1.26 1.32 1.4 1.23 1.13 1.21
regulation of ubiquitin-protein ligase activity 4 1.88 1.03 1.57 1.14 1.19 1.34 1.27
regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle 1 1.67 1.26 1.32 1.4 1.23 1.13 1.21
negative regulation of ubiquitin-protein ligase activity 1 1.67 1.26 1.32 1.4 1.23 1.13 1.21
intracellular pH reduction 6 -1.56 1.28 1.81 1.0 1.29 1.81 1.32
regulation of intracellular pH 6 -1.56 1.28 1.81 1.0 1.29 1.81 1.32
maintenance of protein location in nucleus 1 1.16 1.03 1.19 1.34 1.67 -1.1 1.01
cytosolic calcium ion homeostasis 4 1.44 1.13 1.5 -1.03 1.13 1.91 1.33
regulation of filopodium assembly 9 1.19 1.09 1.6 1.1 1.48 -1.13 1.2
negative regulation of filopodium assembly 2 -1.38 -1.03 2.18 1.01 1.59 -1.39 -1.04
positive regulation of filopodium assembly 5 1.14 1.08 1.54 1.11 1.41 -1.3 1.15
negative regulation of cytoskeleton organization 17 1.02 1.13 1.55 1.04 1.43 1.45 1.22
4 iron, 4 sulfur cluster binding 15 1.46 1.1 1.27 -1.03 1.06 1.96 1.05
mitochondrial calcium ion homeostasis 1 1.37 1.05 1.44 -1.12 1.01 2.39 -1.18
histone H3-K4 methylation 7 1.95 1.22 1.67 1.19 1.69 1.86 1.5
regulation of histone H3-K4 methylation 1 -1.35 1.14 1.74 1.14 1.47 1.35 1.12
positive regulation of histone H3-K4 methylation 1 -1.35 1.14 1.74 1.14 1.47 1.35 1.12
response to calcium ion 3 -1.58 -1.06 -1.06 1.03 1.08 -1.26 -1.33
response to methylmercury 1 -1.7 -15.86 -19.15 -19.05 -4.94 3.57 1.25
meiotic recombination checkpoint 1 1.5 1.02 1.68 -1.05 1.78 1.86 1.49
defense response to virus 11 2.24 -1.18 1.31 -1.13 1.34 1.77 1.19
histamine transport 1 9.63 -2.21 -1.97 -1.79 -1.94 -1.46 -1.99
serotonin uptake 1 -1.06 -1.11 -1.0 -1.08 -1.15 3.37 -1.04
bacterial cell surface binding 13 1.62 -1.3 -1.27 -1.27 -1.21 1.78 -1.04
Gram-negative bacterial cell surface binding 6 2.33 -1.4 -1.19 -1.23 -1.04 2.23 1.13
centrosome localization 6 1.32 1.16 1.58 1.07 1.39 1.47 1.24
endoplasmic reticulum localization 1 1.43 1.44 -1.25 1.13 1.04 -1.73 1.42
Golgi localization 1 1.07 1.7 2.32 1.13 1.82 2.48 3.32
mitochondrion localization 9 -1.42 1.39 1.56 1.16 1.41 1.21 1.26
establishment of mitochondrion localization 5 -1.72 1.29 1.54 1.18 1.39 1.16 1.27
maintenance of organelle location 1 1.08 1.36 1.49 -1.03 1.39 1.74 1.47
maintenance of nucleus location 1 1.08 1.36 1.49 -1.03 1.39 1.74 1.47
oocyte nucleus localization involved in oocyte dorsal/ventral axis specification 10 1.34 1.14 1.18 1.1 1.17 1.62 1.12
nuclear pore localization 1 1.83 -1.06 1.02 1.15 1.17 1.57 -1.03
localization within membrane 4 -1.25 1.15 1.55 1.16 1.41 1.33 -1.14
establishment of Golgi localization 1 1.07 1.7 2.32 1.13 1.82 2.48 3.32
establishment of ER localization 1 1.43 1.44 -1.25 1.13 1.04 -1.73 1.42
actin filament capping 2 -1.38 -1.03 2.18 1.01 1.59 -1.39 -1.04
interaction with host 2 1.04 1.05 1.19 -1.29 -1.39 2.64 1.17
inositol tetrakisphosphate kinase activity 1 -1.15 1.56 -1.07 1.07 -1.15 -1.25 1.09
response to redox state 1 1.13 1.09 1.52 1.04 1.43 -1.06 -1.03
positive regulation of cell division 1 -1.14 1.41 1.3 1.24 1.17 1.85 1.43
positive regulation of nuclear division 2 -1.01 1.03 1.05 1.11 1.69 -1.0 -1.02
response to growth factor stimulus 13 1.49 -1.07 1.91 -1.01 1.18 1.43 1.11
phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity 1 2.96 1.13 1.75 -1.2 1.98 1.94 1.75
entry into cell of other organism involved in symbiotic interaction 2 1.04 1.05 1.19 -1.29 -1.39 2.64 1.17
entry into other organism involved in symbiotic interaction 2 1.04 1.05 1.19 -1.29 -1.39 2.64 1.17
histone demethylase activity (H3-K36 specific) 2 1.08 1.24 1.45 1.25 1.55 1.06 1.05
protein autoubiquitination 1 1.42 -1.23 1.7 1.22 1.08 1.57 -1.21
regulation of mitochondrial membrane potential 1 1.38 1.05 1.33 1.44 1.46 1.81 -1.29
regulation of focal adhesion assembly 1 2.96 1.13 1.75 -1.2 1.98 1.94 1.75
negative regulation of focal adhesion assembly 1 2.96 1.13 1.75 -1.2 1.98 1.94 1.75
regulation of protein kinase B signaling cascade 1 2.96 1.13 1.75 -1.2 1.98 1.94 1.75
negative regulation of protein kinase B signaling cascade 1 2.96 1.13 1.75 -1.2 1.98 1.94 1.75
membrane depolarization 2 1.57 1.42 -5.94 -5.79 -4.29 -1.73 2.07
positive regulation of calcium ion transport 2 2.64 -1.06 1.57 1.01 1.45 3.25 1.94
L-glutamate import 1 -51.3 1.56 -15.93 -1.24 2.78 -3.27 -134.18
positive regulation of transmission of nerve impulse 2 -1.81 1.29 2.08 -1.04 1.39 1.52 1.29
Se-methyltransferase activity 2 -2.66 1.46 -3.05 1.35 1.97 -1.55 -1.14
movement in host environment 2 1.04 1.05 1.19 -1.29 -1.39 2.64 1.17
positive energy taxis 2 1.78 -1.02 1.5 -1.1 1.34 2.13 1.12
negative energy taxis 1 -1.56 1.9 2.35 1.42 1.33 1.03 1.8
movement in environment of other organism involved in symbiotic interaction 2 1.04 1.05 1.19 -1.29 -1.39 2.64 1.17
imidazole-containing compound metabolic process 2 1.02 -1.27 1.33 1.09 1.3 1.8 1.14
inositol monophosphate phosphatase activity 6 1.86 -1.14 -1.69 -1.19 1.02 1.47 1.43
asymmetric neuroblast division resulting in ganglion mother cell formation 2 -1.54 1.67 1.31 1.18 1.85 -1.54 1.65
divalent inorganic cation homeostasis 12 1.64 1.02 1.45 -1.07 -1.01 1.57 1.18
monovalent inorganic cation homeostasis 9 -1.27 1.25 1.91 -1.01 1.19 1.86 1.45
zinc ion homeostasis 2 -1.14 1.23 2.03 1.09 1.14 1.23 1.14
calcium ion homeostasis 10 1.86 -1.02 1.36 -1.1 -1.04 1.64 1.18
transition metal ion homeostasis 1 -2.45 1.57 -1.18 1.13 -1.31 -2.1 1.39
acylglycerol homeostasis 1 1.16 1.22 2.13 1.14 1.8 2.14 1.55
phospholipid homeostasis 1 -1.95 1.39 1.68 1.01 1.49 -1.24 1.08
sterol homeostasis 4 -4.57 -1.96 -1.16 1.4 -1.7 -2.27 -3.58
entry into diapause 1 -1.14 1.2 1.7 1.09 2.04 1.39 1.74
rhythmic synaptic transmission 1 9.13 1.03 1.44 -1.07 -1.11 1.07 1.06
retina development in camera-type eye 1 -1.1 -1.15 -1.07 -1.18 1.52 1.28 1.24
cardiac muscle contraction 1 -2.87 2.31 -2.71 -1.16 1.45 1.26 1.68
regulation of protein glycosylation 1 -1.37 -1.13 -1.19 -1.54 1.82 7.35 2.8
canonical Wnt receptor signaling pathway 8 1.24 1.0 1.39 1.04 1.59 1.21 1.49
Wnt receptor signaling pathway, planar cell polarity pathway 4 1.06 -1.1 1.26 -1.16 1.25 1.67 1.42
large conductance calcium-activated potassium channel activity 1 -2.53 -3.67 1.72 2.84 -2.74 -4.98 -3.6
regulation of postsynaptic membrane potential 4 1.21 1.34 -2.02 -2.31 -1.7 1.03 1.76
regulation of excitatory postsynaptic membrane potential 2 1.57 1.42 -5.94 -5.79 -4.29 -1.73 2.07
regulation of retinal cone cell fate commitment 2 -1.43 1.42 1.17 1.08 1.59 -1.55 1.31
lipase activator activity 2 -1.41 1.32 1.65 1.18 1.23 1.2 -1.03
delamination 8 1.85 1.18 1.27 1.06 1.22 1.87 1.48
oenocyte delamination 2 2.23 1.23 1.34 1.08 1.47 1.18 1.41
germ-line stem-cell niche homeostasis 4 1.24 1.27 1.46 1.22 1.66 1.51 1.42
regulation of glial cell proliferation 4 1.83 1.22 1.55 -1.02 1.23 1.76 1.45
positive regulation of glial cell proliferation 2 2.9 -1.05 1.75 -1.19 1.16 1.75 1.33
negative regulation of glial cell proliferation 2 1.15 1.57 1.36 1.13 1.31 1.77 1.58
positive regulation of transcription initiation from RNA polymerase II promoter 2 1.1 1.32 1.52 1.2 1.24 1.14 1.45
regulation of ovulation 2 1.79 1.12 1.06 1.1 1.24 1.64 1.35
formation of a compartment boundary 1 1.36 -1.06 1.89 1.07 1.62 -1.06 1.23
germ plasm 13 1.42 1.03 1.1 1.02 1.09 1.51 -1.01
regulation of sarcomere organization 1 6.86 -1.53 -1.01 -1.17 1.13 2.97 1.11
GTP cyclohydrolase I regulator activity 1 33.5 -5.63 -5.79 -6.03 -4.58 -1.32 6.94
leucine import 3 1.2 -1.03 -1.17 1.06 1.15 -1.13 2.49
flight 4 2.08 1.01 -1.1 -1.13 1.05 2.84 1.39
innervation 1 -2.0 1.87 1.43 1.14 2.42 -2.25 1.78
axonogenesis involved in innervation 1 -2.0 1.87 1.43 1.14 2.42 -2.25 1.78
cytosolic calcium ion transport 1 2.52 1.29 3.07 -1.16 1.37 5.13 2.97
calcium ion transport into cytosol 1 2.52 1.29 3.07 -1.16 1.37 5.13 2.97
trachea development 3 1.59 -1.2 1.46 -1.32 -1.06 1.27 -1.04
trachea morphogenesis 1 4.21 -1.18 -1.09 -1.07 -1.3 -1.11 -1.25
regulation of cell projection assembly 14 1.07 1.12 1.53 1.12 1.42 -1.16 1.1
respiratory system development 181 1.4 1.03 1.27 -1.03 1.25 1.52 1.28
negative regulation of mitotic anaphase-promoting complex activity 1 1.67 1.26 1.32 1.4 1.23 1.13 1.21
regulation of peptide hormone processing 1 -2.9 -1.14 1.64 1.56 2.18 -4.01 -1.31
negative regulation of peptide hormone processing 1 -2.9 -1.14 1.64 1.56 2.18 -4.01 -1.31
morphogenesis of an epithelial fold 7 1.32 1.05 1.42 1.01 1.41 1.46 1.64
morphogenesis of an epithelial bud 3 -1.1 -1.05 -1.04 -1.15 -1.04 1.01 1.54
multicellular organismal iron ion homeostasis 1 -2.45 1.57 -1.18 1.13 -1.31 -2.1 1.39
regulation of vesicle-mediated transport 25 1.05 1.04 1.38 1.1 1.22 1.61 1.14
regulation of microtubule-based movement 2 1.32 1.15 1.52 1.06 1.31 2.78 1.59
regulation of endoribonuclease activity 1 1.58 1.16 -1.09 1.12 1.04 1.36 -1.13
regulation of ribonuclease activity 1 1.58 1.16 -1.09 1.12 1.04 1.36 -1.13
negative regulation of ribonuclease activity 1 1.58 1.16 -1.09 1.12 1.04 1.36 -1.13
negative regulation of endoribonuclease activity 1 1.58 1.16 -1.09 1.12 1.04 1.36 -1.13
cell fate commitment involved in formation of primary germ layers 17 1.6 1.01 1.08 -1.06 1.04 1.29 1.13
establishment of glial blood-brain barrier 16 2.59 -1.2 1.31 -1.17 1.29 2.35 1.44
cardiac cell fate specification 1 -1.42 1.01 1.2 1.29 2.44 -1.59 1.35
regulation of gene silencing by RNA 8 1.82 1.17 1.15 1.09 1.12 1.83 1.43
negative regulation of gene silencing by RNA 5 1.71 1.18 1.16 1.09 1.12 2.11 1.55
regulation of gene silencing 34 1.39 1.19 1.17 1.11 1.2 1.51 1.4
negative regulation of gene silencing 12 1.32 1.18 1.16 1.15 1.16 1.51 1.32
left/right pattern formation 1 -1.92 1.09 4.17 -1.09 2.38 -1.63 1.77
kidney morphogenesis 3 -1.1 -1.05 -1.04 -1.15 -1.04 1.01 1.54
endodermal digestive tract morphogenesis 1 -5.18 1.12 -1.52 1.19 -1.17 -3.69 1.24
ovum-producing ovary development 1 -1.49 2.58 -1.26 -1.23 -1.23 -1.38 1.24
regulation of wound healing 1 9.2 -1.31 -1.17 -1.11 -1.07 7.07 1.71
peptidoglycan recognition protein signaling pathway 8 1.83 1.08 1.26 1.07 1.21 1.54 1.2
regulation of peptidoglycan recognition protein signaling pathway 4 2.19 -1.16 1.49 1.19 -1.07 -1.21 -1.53
positive regulation of peptidoglycan recognition protein signaling pathway 1 8.35 -1.25 -1.3 -1.07 -1.15 1.62 -1.07
negative regulation of peptidoglycan recognition protein signaling pathway 3 1.4 -1.13 1.86 1.28 -1.04 -1.52 -1.72
regulation of neural retina development 2 -1.43 1.42 1.17 1.08 1.59 -1.55 1.31
regulation of protein tyrosine kinase activity 5 1.47 1.14 1.46 -1.01 1.32 1.52 1.27
positive regulation of protein tyrosine kinase activity 1 -1.21 1.16 2.16 -1.11 1.4 1.68 1.37
negative regulation of protein tyrosine kinase activity 4 1.69 1.13 1.32 1.01 1.3 1.49 1.25
establishment of monopolar cell polarity 10 1.54 1.16 1.19 -1.02 1.43 1.47 1.4
type I terminal button 2 2.85 1.08 1.12 -1.03 -1.01 2.59 1.3
cell surface receptor signaling pathway involved in heart development 3 1.09 1.1 1.13 1.08 1.18 1.14 2.09
canonical Wnt receptor signaling pathway involved in heart development 3 1.09 1.1 1.13 1.08 1.18 1.14 2.09
renal filtration cell differentiation 11 1.64 -1.04 1.33 -1.09 1.12 1.26 1.37
nephrocyte differentiation 11 1.64 -1.04 1.33 -1.09 1.12 1.26 1.37
pericardial nephrocyte differentiation 9 1.9 -1.04 1.48 -1.11 1.17 1.39 1.52
anterior Malpighian tubule development 12 -1.05 -1.01 1.18 -1.15 1.13 1.62 1.06
posterior Malpighian tubule development 2 1.35 -1.06 1.02 -1.25 -1.0 1.06 2.86
Malpighian tubule bud morphogenesis 3 -1.1 -1.05 -1.04 -1.15 -1.04 1.01 1.54
cell rearrangement involved in Malpighian tubule morphogenesis 3 2.04 1.05 1.89 -1.07 1.16 1.0 1.3
cell morphogenesis involved in Malpighian tubule morphogenesis 1 3.86 1.45 2.61 -1.03 2.28 4.0 3.57
establishment or maintenance of monopolar cell polarity 10 1.54 1.16 1.19 -1.02 1.43 1.47 1.4
cell chemotaxis involved in Malpighian tubule morphogenesis 3 2.04 1.05 1.89 -1.07 1.16 1.0 1.3
BMP signaling pathway involved in Malpighian tubule cell chemotaxis 3 2.04 1.05 1.89 -1.07 1.16 1.0 1.3
intracellular protein transmembrane transport 5 -1.62 1.28 -1.17 -1.01 -1.28 -1.9 1.13
aspartic-type peptidase activity 19 -1.6 -1.03 1.15 -1.16 -1.46 -1.86 -1.32
serine-type exopeptidase activity 13 -1.19 -1.2 -1.0 -1.01 -1.57 -1.53 1.1
apoptosis in response to endoplasmic reticulum stress 1 -1.56 1.12 -1.6 -1.09 -1.49 -1.56 -1.26
proline-rich region binding 1 -2.96 1.13 1.63 1.21 1.47 -2.66 -1.29
proton-transporting two-sector ATPase complex assembly 2 1.21 1.11 1.39 1.2 1.21 1.72 -1.33
clustering of voltage-gated calcium channels 1 1.29 -1.71 -1.84 -1.91 -1.32 16.38 -1.61
histone lysine demethylation 6 1.15 1.33 1.71 1.16 1.56 1.61 1.38
occluding junction 26 2.55 -1.23 1.25 -1.28 1.23 3.22 1.62
kynurenine metabolic process 1 1.33 -1.46 -1.36 -1.56 -1.39 2.84 -1.33
synaptonemal complex disassembly 1 1.38 -1.04 1.41 1.16 1.34 2.25 1.03
actin-mediated cell contraction 4 -1.26 1.28 1.59 1.06 1.39 1.15 1.23
tyrosyl-DNA phosphodiesterase activity 1 -1.61 -1.07 -1.0 -1.17 -1.28 -1.58 -1.34
proton-transporting ATP synthase complex biogenesis 2 1.21 1.11 1.39 1.2 1.21 1.72 -1.33
phosphatidylinositol-4-phosphate binding 1 -2.39 1.47 1.51 1.07 -1.25 -2.16 1.24
extracellular matrix constituent secretion 2 1.62 -1.11 1.06 -1.19 1.17 -1.33 -1.09
radical SAM enzyme activity 1 1.58 1.18 1.95 1.1 1.45 3.43 -1.02
ferritin complex 3 -1.78 1.04 1.19 1.02 -1.06 -2.25 -1.21
positive regulation of stress-activated protein kinase signaling cascade 12 1.07 1.28 1.47 1.07 1.29 1.52 1.25
lipoprotein particle receptor binding 1 3.66 -1.09 1.54 -1.1 1.65 2.15 1.33
triglyceride homeostasis 10 -1.54 -1.28 -1.3 -1.03 -1.36 -1.47 -1.44
regulation of ERK1 and ERK2 cascade 3 1.06 1.01 -1.21 -1.22 -1.32 -1.26 1.87
positive regulation of ERK1 and ERK2 cascade 3 1.06 1.01 -1.21 -1.22 -1.32 -1.26 1.87
high mobility group box 1 binding 1 3.82 -1.26 1.16 -1.51 1.23 1.8 1.55
chaperone cofactor-dependent protein refolding 1 1.92 1.17 1.75 1.1 1.32 1.14 1.27
glutamine binding 1 -1.12 1.14 1.63 1.21 1.33 1.0 1.05
carbamoyl phosphate metabolic process 1 -1.12 1.14 1.63 1.21 1.33 1.0 1.05
carbamoyl phosphate biosynthetic process 1 -1.12 1.14 1.63 1.21 1.33 1.0 1.05
nonhomologous end joining complex 2 -1.03 1.29 1.58 1.29 1.51 -1.21 1.27
plus-end specific microtubule depolymerization 1 1.23 1.19 1.22 1.26 1.69 -1.05 1.08
respiratory chain 68 1.11 1.0 1.19 1.01 1.07 1.57 -1.31
repressing transcription factor binding 13 1.29 -1.04 -1.01 -1.14 1.25 1.49 1.64
histone H3-K36 demethylation 2 1.08 1.24 1.45 1.25 1.55 1.06 1.05
L-glutamine aminotransferase activity 2 -1.0 -1.44 1.48 -1.44 1.38 1.11 2.78
cytidylyltransferase activity 5 1.44 -1.22 1.18 -1.16 1.33 -1.05 1.53
cadmium ion transmembrane transport 1 -1.37 1.35 1.68 1.28 1.12 -1.35 -1.15
mitochondrion morphogenesis 2 1.03 1.2 1.34 1.27 1.61 1.2 -1.12
calcium ion transmembrane transport 7 1.59 1.03 1.19 -1.08 -1.01 1.55 1.32
dendrite self-avoidance 7 1.17 1.14 1.29 1.13 1.33 1.54 1.21
juvenile hormone response element binding 2 -1.22 1.25 1.18 1.1 1.78 -1.07 1.14
regulation of protein processing 1 -2.9 -1.14 1.64 1.56 2.18 -4.01 -1.31
nucleosome-dependent ATPase activity 2 1.37 1.25 2.22 1.17 1.97 1.84 1.81
proteasome binding 1 1.49 1.1 1.49 1.27 1.56 -1.75 1.05
cyclic nucleotide transport 1 1.9 -1.14 -1.37 1.0 -1.16 1.35 -1.12
cGMP transport 1 1.9 -1.14 -1.37 1.0 -1.16 1.35 -1.12
spindle envelope 4 1.54 1.11 1.47 1.01 1.35 1.6 1.17
peptidyl-lysine 5-dioxygenase activity 2 1.13 1.08 1.05 -1.04 1.19 1.95 1.17
phosphorylation of RNA polymerase II C-terminal domain 1 -1.89 -1.04 1.09 1.37 2.39 -1.87 -1.49
chromatin maintenance 1 -1.2 1.03 1.07 -1.11 1.52 -1.28 -1.06
heterochromatin maintenance 1 -1.2 1.03 1.07 -1.11 1.52 -1.28 -1.06
basement membrane assembly 1 -1.47 1.17 2.02 1.22 1.63 -1.12 1.4
divalent metal ion transport 28 1.38 -1.01 1.09 -1.09 1.16 1.51 1.18
growth factor receptor binding 19 2.02 -1.49 -1.23 -1.57 1.04 2.84 1.44
myosin VI binding 3 -1.98 1.02 1.13 1.07 1.24 -1.12 -1.15
myosin VI light chain binding 1 -3.92 1.08 1.44 1.19 1.39 -1.01 -1.05
positive regulation of protein exit from endoplasmic reticulum 2 -1.03 1.1 -1.05 1.06 -1.29 -1.58 1.34
investment cone 3 -1.57 1.04 1.08 1.04 1.05 -1.06 -1.09
regulation of glycogen metabolic process 1 -2.86 1.25 -1.2 1.45 1.26 1.29 -1.32
pre-miRNA binding 1 1.6 1.11 4.34 -1.01 3.45 5.33 3.25
E-box binding 1 1.39 -1.11 1.11 -1.25 1.17 1.75 1.6
regulation of production of small RNA involved in gene silencing by RNA 2 2.75 1.11 1.02 1.03 -1.06 1.3 1.12
small RNA loading onto RISC 6 1.25 1.16 1.42 1.05 1.43 1.57 1.49
siRNA loading onto RISC involved in chromatin silencing by small RNA 2 1.38 1.18 -1.01 1.15 1.25 2.63 1.7
contractile ring 5 -1.53 1.2 1.44 1.14 1.64 1.07 1.08
dephosphorylation of RNA polymerase II C-terminal domain 1 1.1 1.03 1.12 1.08 1.22 -1.0 1.51
endoplasmic reticulum exit site 1 -2.09 1.34 1.35 1.01 1.51 -1.24 2.45
protein localization in endoplasmic reticulum 18 -1.3 1.35 -1.06 1.05 -1.19 -1.62 1.27
left/right axis specification 1 -1.92 1.09 4.17 -1.09 2.38 -1.63 1.77
demethylation 7 1.18 1.25 1.72 1.13 1.59 1.68 1.3
translation preinitiation complex 1 2.17 1.18 1.52 -1.1 1.33 2.16 1.32
neuron death 2 -1.07 1.32 1.73 -1.0 -1.14 1.12 1.39
response to magnetism 1 1.37 -1.11 -1.04 1.15 1.03 2.71 1.13
histone mRNA catabolic process 1 1.7 -1.05 -1.07 -1.09 -1.18 1.33 1.14
ribonucleoprotein complex localization 1 2.15 -1.01 1.44 1.25 1.44 1.28 1.21
subsynaptic reticulum 1 4.69 -1.04 -1.32 -1.4 -1.38 1.37 -1.05
cellular response to biotic stimulus 4 -1.08 1.29 1.46 1.13 1.58 1.05 1.4
cellular response to molecule of bacterial origin 2 1.04 1.17 1.37 1.17 1.75 1.28 1.1
cellular response to lipopolysaccharide 2 1.04 1.17 1.37 1.17 1.75 1.28 1.1
cellular response to carbon dioxide 2 1.12 1.05 1.51 -1.02 1.24 1.35 1.06
translocon complex 8 -1.51 1.3 -1.14 -1.0 -1.28 -1.7 1.22
cellular response to ethanol 1 1.36 1.32 2.03 1.27 1.67 1.42 1.61
cellular response to growth factor stimulus 12 1.59 -1.08 1.97 -1.01 1.17 1.52 1.1
cellular response to organic nitrogen 4 1.59 -1.01 1.38 1.29 1.34 1.2 -1.18
cellular response to amine stimulus 4 1.59 -1.01 1.38 1.29 1.34 1.2 -1.18
succinate transmembrane transport 1 -1.02 -2.78 1.86 -1.91 2.75 13.01 -1.81
malate transmembrane transport 2 1.03 -1.5 1.48 -1.27 1.66 3.63 -1.34
ribonucleoprotein complex export from nucleus 1 2.15 -1.01 1.44 1.25 1.44 1.28 1.21
rRNA-containing ribonucleoprotein complex export from nucleus 1 2.15 -1.01 1.44 1.25 1.44 1.28 1.21
cellular response to oxygen radical 2 1.69 1.17 1.01 1.09 1.11 1.41 -1.08
cellular response to superoxide 2 1.69 1.17 1.01 1.09 1.11 1.41 -1.08
cellular response to oxygen levels 25 1.18 1.19 1.57 1.15 1.38 1.41 1.17
cellular response to hypoxia 23 1.23 1.22 1.66 1.15 1.44 1.48 1.21
protein localization to chromosome, centromeric region 1 2.47 1.54 1.18 1.04 1.48 1.78 1.43
cellular response to xenobiotic stimulus 10 1.1 -1.02 -1.79 -1.06 -1.28 -1.46 1.06
cellular response to osmotic stress 2 1.01 1.17 1.53 -1.02 1.61 1.26 1.23
cellular response to salt stress 1 1.22 1.33 2.18 1.07 1.72 2.05 1.61
cellular hyperosmotic response 1 1.22 1.33 2.18 1.07 1.72 2.05 1.61
cellular hyperosmotic salinity response 1 1.22 1.33 2.18 1.07 1.72 2.05 1.61
cellular response to radiation 16 -1.25 -1.45 -1.52 -1.39 -1.3 1.12 -1.06
cellular response to ionizing radiation 1 -1.03 1.12 1.58 1.2 2.16 1.52 1.14
cellular response to X-ray 1 -1.03 1.12 1.58 1.2 2.16 1.52 1.14
cellular response to light stimulus 15 -1.27 -1.49 -1.61 -1.44 -1.39 1.09 -1.07
cellular response to light intensity 1 3.41 -1.85 -1.6 -1.39 -1.6 6.88 -1.28
cellular response to high light intensity 1 3.41 -1.85 -1.6 -1.39 -1.6 6.88 -1.28
semaphorin-plexin signaling pathway 2 1.11 -1.03 1.73 -1.06 1.28 1.08 1.11
inositol phosphate catabolic process 3 2.42 1.04 1.61 -1.01 1.39 1.64 1.29
cell wall organization or biogenesis 9 -1.18 -1.16 -1.42 -1.31 -1.28 -2.35 -1.08
histone H3-K27 demethylation 1 1.79 1.29 2.63 1.3 1.91 2.12 1.41
acyl-CoA biosynthetic process 5 2.3 1.04 1.28 1.15 1.53 1.22 1.09
lysophospholipid acyltransferase activity 4 1.01 1.34 1.66 -1.03 1.72 1.33 1.31
optomotor response 2 1.16 1.09 1.72 1.19 1.37 1.2 2.11
Slit-Robo signaling complex 1 2.19 1.14 2.0 1.19 2.09 1.71 1.7
striated muscle myosin thick filament assembly 4 2.6 -1.28 1.1 -1.18 1.07 1.9 -1.04
protein localization in extracellular region 1 1.79 1.14 -1.18 1.07 1.25 -5.71 1.37
anatomical structure maturation 3 3.11 -1.4 1.27 -1.39 1.24 4.46 1.69
organic substance transport 97 -1.4 -1.24 -1.57 -1.12 -1.07 -1.03 -1.27
nitrogen compound transport 51 -1.34 -1.08 -1.59 -1.16 1.0 -1.05 -1.09
response to BMP stimulus 1 -1.42 1.06 1.32 1.03 1.22 -1.52 1.31
response to fibroblast growth factor stimulus 10 1.63 -1.12 2.13 -1.03 1.14 1.56 1.09
G1/S transition checkpoint 2 1.09 1.49 1.71 1.02 1.44 1.9 1.73
protein transmembrane transport 5 -1.62 1.28 -1.17 -1.01 -1.28 -1.9 1.13
negative regulation of protein serine/threonine kinase activity 7 1.54 1.14 1.5 1.16 1.5 1.83 1.37
positive regulation of protein serine/threonine kinase activity 9 1.14 1.19 1.51 1.11 1.38 1.84 1.15
nitrogen cycle metabolic process 1 -31.89 1.77 -20.72 1.41 1.0 -12.66 -3.5
conversion of methionyl-tRNA to N-formyl-methionyl-tRNA 1 1.38 1.09 1.78 1.2 1.53 2.7 -1.25
cellular component maintenance at cellular level 12 -1.17 1.2 1.56 1.1 1.45 1.12 1.1
nephron development 3 -1.1 -1.05 -1.04 -1.15 -1.04 1.01 1.54
nephron epithelium development 3 -1.1 -1.05 -1.04 -1.15 -1.04 1.01 1.54
nephron morphogenesis 3 -1.1 -1.05 -1.04 -1.15 -1.04 1.01 1.54
kidney epithelium development 3 -1.1 -1.05 -1.04 -1.15 -1.04 1.01 1.54
nephron tubule morphogenesis 3 -1.1 -1.05 -1.04 -1.15 -1.04 1.01 1.54
nephron tubule formation 3 -1.1 -1.05 -1.04 -1.15 -1.04 1.01 1.54
nephron tubule development 3 -1.1 -1.05 -1.04 -1.15 -1.04 1.01 1.54
nephron epithelium morphogenesis 3 -1.1 -1.05 -1.04 -1.15 -1.04 1.01 1.54
stem cell proliferation 5 1.52 1.24 1.48 1.18 1.44 1.13 1.17
regulation of stem cell proliferation 2 -1.24 1.36 -1.02 -1.09 1.25 1.32 3.25
epithelial cell fate commitment 3 1.0 1.08 1.89 1.0 1.21 -1.44 -1.04
vesicle uncoating 2 -1.44 1.22 1.71 1.06 1.91 1.53 1.42
volume-sensitive chloride channel activity 1 3.44 -1.08 -1.56 -1.91 1.81 5.18 1.78
monocarboxylic acid catabolic process 15 -1.0 1.02 -1.46 1.02 1.13 -1.74 -1.3
signal transduction by p53 class mediator 2 1.7 1.37 1.03 1.24 1.62 1.04 1.2
signal transduction by p53 class mediator resulting in induction of apoptosis 2 1.7 1.37 1.03 1.24 1.62 1.04 1.2
cellular lactam metabolic process 1 -1.31 -1.76 1.72 1.22 1.97 3.11 1.28
cellular lactam biosynthetic process 1 -1.31 -1.76 1.72 1.22 1.97 3.11 1.28
modified amino acid binding 5 -1.4 -1.12 -1.47 1.21 1.21 -1.15 -1.62
sulfur compound transport 2 -2.47 -1.07 -3.17 1.42 1.77 -1.97 -2.08
modified amino acid transmembrane transporter activity 1 -7.18 -1.45 -9.47 1.62 3.49 -2.41 -5.84
medium-term memory 5 -2.06 1.08 1.11 1.07 -1.16 -1.78 -1.05
microtubule anchoring at microtubule organizing center 1 -1.51 -1.02 1.38 1.04 1.42 1.11 -1.1
photoreceptor cell axon guidance 3 -1.41 1.34 1.88 1.12 1.32 1.49 1.42
pyridine-containing compound metabolic process 11 1.88 1.17 -1.48 -1.05 1.08 1.25 1.36
pyridine-containing compound biosynthetic process 3 1.9 1.5 -1.09 1.01 1.09 1.23 1.86
pyrimidine-containing compound transmembrane transport 4 -1.46 1.25 1.0 1.26 1.04 -1.57 1.43
ADP-D-ribose binding 1 1.71 1.0 1.2 1.14 1.43 1.37 1.01
poly-ADP-D-ribose binding 1 1.71 1.0 1.2 1.14 1.43 1.37 1.01
clathrin-mediated endocytosis 1 4.7 -1.51 -1.0 -1.26 1.19 8.29 2.05
DNA topoisomerase (ATP-hydrolyzing) regulator activity 1 1.69 1.07 1.4 1.09 1.95 1.43 1.53
DNA topoisomerase (ATP-hydrolyzing) activator activity 1 1.69 1.07 1.4 1.09 1.95 1.43 1.53
maintenance of protein localization to organelle 4 -1.56 1.22 -1.02 1.14 -1.0 -1.78 1.25
establishment of protein localization in endoplasmic reticulum 15 -1.21 1.37 -1.05 1.04 -1.19 -1.54 1.26
establishment of protein localization in Golgi 10 -1.16 1.12 1.17 1.04 1.21 1.41 1.65
protein localization to peroxisome 3 1.5 1.17 -1.6 1.44 1.46 -2.19 -1.64
establishment of protein localization to peroxisome 3 1.5 1.17 -1.6 1.44 1.46 -2.19 -1.64
protein localization to vacuole 4 1.47 1.26 2.02 1.17 1.52 1.6 1.47
establishment of protein localization to vacuole 4 1.47 1.26 2.02 1.17 1.52 1.6 1.47
S-nitrosoglutathione reductase activity 1 1.29 1.1 1.03 1.22 1.29 1.66 -1.14
regulation of reactive oxygen species metabolic process 8 1.29 1.23 1.39 1.25 1.52 1.58 1.24
3R-hydroxyacyl-CoA dehydratase activity 1 -1.23 1.06 -2.67 1.58 1.11 -5.4 -1.98
regulation of nitric oxide metabolic process 1 1.29 1.1 1.03 1.22 1.29 1.66 -1.14
histone H3-K4 trimethylation 1 1.69 1.2 1.93 1.03 2.02 2.04 1.95
regulation of mitotic anaphase 1 1.43 1.15 2.06 1.04 1.96 1.44 1.33
regulation of trehalose metabolic process 1 1.03 -1.29 -2.06 -2.17 -1.97 -2.33 4.44
positive regulation of microtubule nucleation 1 2.49 1.3 2.87 -1.0 2.26 3.13 2.77
positive regulation of cell cycle process 13 1.26 1.06 1.08 1.01 1.3 1.62 1.07
regulation of ribosome biogenesis 2 1.63 1.23 1.65 1.22 1.61 2.39 1.43
positive regulation of ribosome biogenesis 2 1.63 1.23 1.65 1.22 1.61 2.39 1.43
translation regulator activity, nucleic acid binding 7 1.85 1.07 2.03 1.03 1.61 1.55 1.78
regulation of decapentaplegic signaling pathway 6 1.3 1.01 1.61 -1.03 1.09 1.53 1.36
positive regulation of decapentaplegic signaling pathway 1 1.81 1.21 1.48 1.18 1.37 1.47 1.47
negative regulation of decapentaplegic signaling pathway 3 1.28 -1.1 1.11 -1.15 -1.09 1.84 1.01
regulation of cell-substrate junction assembly 1 2.96 1.13 1.75 -1.2 1.98 1.94 1.75
COPII-coated vesicle budding 1 -1.49 1.52 1.25 1.12 1.19 1.46 1.78
tissue migration 36 1.66 -1.04 1.31 -1.09 1.2 1.63 1.1
epithelium migration 28 1.66 -1.03 1.29 -1.07 1.21 1.38 1.11
regulation of mitochondrial fission 2 -1.0 1.14 -1.27 1.12 -1.13 -1.52 -1.35
positive regulation of mitochondrial fission 2 -1.0 1.14 -1.27 1.12 -1.13 -1.52 -1.35
establishment of epithelial cell polarity 11 1.26 1.04 1.35 -1.0 1.51 1.34 1.27
establishment of epithelial cell planar polarity 4 -1.26 1.08 1.52 1.16 1.36 1.11 -1.02
regulation of establishment of planar polarity 4 1.06 -1.1 1.26 -1.16 1.25 1.67 1.42
microtubule cytoskeleton organization involved in establishment of planar polarity 3 1.57 1.03 1.21 -1.01 1.13 2.03 1.55
regulation of triglyceride metabolic process 2 -1.95 -1.1 -1.54 1.16 1.88 -3.69 -2.32
regulation of histone H4 acetylation 1 1.8 1.23 1.54 1.26 1.37 1.4 1.76
positive regulation of histone H4 acetylation 1 1.8 1.23 1.54 1.26 1.37 1.4 1.76
cell-cell adhesion involved in establishment of planar polarity 1 1.3 1.94 1.14 1.03 1.07 1.88 1.31
cell elongation involved in imaginal disc-derived wing morphogenesis 5 1.41 1.11 1.92 1.05 1.98 1.8 1.61
regulation of muscle system process 5 2.39 -1.02 -2.05 -2.54 -2.17 1.16 1.24
spindle assembly involved in mitosis 3 -1.0 1.13 1.24 1.35 1.53 -1.14 -1.07
regulation of protein deacetylation 1 1.03 1.14 1.11 1.37 1.92 -1.3 1.15
positive regulation of protein deacetylation 1 1.03 1.14 1.11 1.37 1.92 -1.3 1.15
negative regulation of intracellular protein transport 6 2.03 1.13 1.29 1.08 1.28 1.86 1.59
regulation of DNA-dependent DNA replication 6 -1.5 1.09 1.13 1.11 1.33 -1.52 1.28
regulation of heart induction 3 1.09 1.1 1.13 1.08 1.18 1.14 2.09
phagosome maturation 1 1.76 1.27 1.35 1.51 1.34 1.49 1.23
ceramide binding 1 -2.39 1.47 1.51 1.07 -1.25 -2.16 1.24
adipokinetic hormone receptor binding 1 2.14 -13.11 -13.63 -12.76 -16.87 -14.38 5.61
energy homeostasis 1 1.86 -1.04 1.59 -1.1 2.08 2.71 1.26
mitochondrial respiratory chain complex I biogenesis 1 1.08 1.05 1.31 1.03 1.07 1.99 -1.52
mitochondrial respiratory chain complex III biogenesis 2 1.1 1.08 1.56 1.1 1.12 1.34 -1.21
regulation of membrane lipid distribution 2 2.57 -1.14 1.03 -1.07 2.13 1.16 1.16
dendritic spine organization 1 -2.52 1.99 1.32 1.32 1.09 -1.34 1.43
dendritic spine maintenance 1 -2.52 1.99 1.32 1.32 1.09 -1.34 1.43
pre-mRNA intronic binding 1 1.28 1.07 1.73 1.12 1.48 1.94 1.41
regulation of cellular response to insulin stimulus 10 1.25 1.09 1.37 -1.04 1.17 1.16 1.59
negative regulation of cellular response to insulin stimulus 7 1.27 1.12 1.56 -1.01 1.31 1.27 1.5
positive regulation of cellular response to insulin stimulus 2 1.0 -1.0 -1.17 -1.4 -1.23 -1.17 2.26
regulation of defense response to fungus 7 2.0 -1.32 -1.17 1.03 1.03 1.92 1.18
regulation of planar cell polarity pathway involved in axis elongation 2 -1.01 1.74 1.54 1.1 1.38 1.44 1.44
regulation of G1/S transition of mitotic cell cycle 4 1.12 1.32 1.7 1.08 1.32 1.61 1.38
regulation of non-canonical Wnt receptor signaling pathway 2 -1.01 1.74 1.54 1.1 1.38 1.44 1.44
regulation of Wnt receptor signaling pathway, planar cell polarity pathway 2 -1.01 1.74 1.54 1.1 1.38 1.44 1.44
negative regulation of DNA-dependent DNA replication 3 -2.66 -1.02 1.24 1.05 1.35 -2.2 1.46
negative regulation of cysteine-type endopeptidase activity 2 1.22 -1.04 1.69 -1.06 1.27 -1.09 -1.19
negative regulation of G1/S transition of mitotic cell cycle 1 1.02 1.34 2.07 -1.09 1.41 2.33 1.77
positive regulation of transcription initiation, DNA-dependent 2 1.1 1.32 1.52 1.2 1.24 1.14 1.45
regulation of cell motility 10 2.17 -1.1 1.06 -1.11 1.21 1.34 1.71
negative regulation of cell motility 2 2.1 1.1 1.42 -1.08 1.39 1.72 1.26
regulation of ubiquitin-specific protease activity 1 1.14 1.09 1.34 -1.05 1.24 1.35 2.12
regulation of peptidyl-cysteine S-nitrosylation 1 1.29 1.1 1.03 1.22 1.29 1.66 -1.14
regulation of neural precursor cell proliferation 9 -1.33 1.16 1.4 1.11 1.64 1.16 1.09
negative regulation of neural precursor cell proliferation 7 -1.32 1.13 1.47 1.06 1.79 1.22 1.08
negative regulation of reproductive process 6 1.39 1.2 1.49 1.11 1.54 1.6 1.43
positive regulation of reproductive process 4 -1.29 1.41 1.69 1.16 1.58 1.17 1.66
positive regulation of receptor activity 1 -1.21 1.16 2.16 -1.11 1.4 1.68 1.37
regulation of epithelial cell migration, open tracheal system 5 2.13 -1.29 -1.2 -1.27 1.01 -1.13 2.14
regulation of DNA biosynthetic process 1 1.35 1.23 1.65 1.22 1.74 1.39 1.1
regulation of photoreceptor cell axon guidance 2 1.11 -1.03 1.73 -1.06 1.28 1.08 1.11
positive regulation of synaptic vesicle exocytosis 1 -1.65 1.56 1.35 1.0 1.12 1.4 1.32
semaphorin-plexin signaling pathway involved in regulation of photoreceptor cell axon guidance 2 1.11 -1.03 1.73 -1.06 1.28 1.08 1.11
regulation of clathrin-mediated endocytosis 2 -1.04 1.44 1.65 1.12 1.42 2.02 1.59
positive regulation of clathrin-mediated endocytosis 1 -1.65 1.56 1.35 1.0 1.12 1.4 1.32
regulation of protein neddylation 1 1.11 1.42 1.38 1.05 1.25 1.67 1.2
negative regulation of protein neddylation 1 1.11 1.42 1.38 1.05 1.25 1.67 1.2
regulation of histone H4-K16 acetylation 1 1.8 1.23 1.54 1.26 1.37 1.4 1.76
positive regulation of histone H4-K16 acetylation 1 1.8 1.23 1.54 1.26 1.37 1.4 1.76
regulation of transcription regulatory region DNA binding 2 -1.31 1.44 1.67 1.2 1.16 1.11 1.5
negative regulation of transcription regulatory region DNA binding 2 -1.31 1.44 1.67 1.2 1.16 1.11 1.5
regulation of peptidyl-lysine acetylation 5 1.41 1.17 1.61 1.2 1.61 1.62 1.46
negative regulation of peptidyl-lysine acetylation 1 1.22 1.34 1.86 1.14 2.08 2.98 1.75
positive regulation of peptidyl-lysine acetylation 2 1.41 1.2 1.81 1.29 1.46 1.33 1.45
regulation of steroid hormone secretion 1 -1.14 1.41 1.3 1.24 1.17 1.85 1.43
starch binding 5 -2.58 1.33 -1.39 1.01 -2.26 -3.22 1.03
negative regulation of chromosome organization 2 1.22 1.33 2.01 1.1 1.89 2.47 1.68
positive regulation of chromosome organization 6 1.14 1.12 1.43 1.22 1.52 1.14 1.15
regulation of cation channel activity 3 1.93 -1.03 1.33 1.03 1.24 2.17 1.55
positive regulation of cation channel activity 2 2.64 -1.06 1.57 1.01 1.45 3.25 1.94
regulation of muscle cell chemotaxis toward tendon cell 1 1.49 1.07 1.15 1.04 -1.03 1.53 -1.09
negative regulation of muscle cell chemotaxis toward tendon cell 1 1.49 1.07 1.15 1.04 -1.03 1.53 -1.09
Roundabout signaling pathway involved in muscle cell chemotaxis toward tendon cell 1 1.49 1.07 1.15 1.04 -1.03 1.53 -1.09